#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Abnormal neural hierarchy in processing of verbal information in patients with schizophrenia
#Text=Previous research indicates abnormal comprehension of verbal information in patients with schizophrenia.
1-1	0-8	Abnormal	_
1-2	9-15	neural	_
1-3	16-25	hierarchy	_
1-4	26-28	in	_
1-5	29-39	processing	_
1-6	40-42	of	_
1-7	43-49	verbal	_
1-8	50-61	information	_
1-9	62-64	in	_
1-10	65-73	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]
1-11	74-78	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]
1-12	79-92	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]
1-13	93-101	Previous	_
1-14	102-110	research	_
1-15	111-120	indicates	_
1-16	121-129	abnormal	_
1-17	130-143	comprehension	_
1-18	144-146	of	_
1-19	147-153	verbal	_
1-20	154-165	information	_
1-21	166-168	in	_
1-22	169-177	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[2]
1-23	178-182	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[2]
1-24	183-196	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[2]
1-25	196-197	.	_

#Text=Yet the neural mechanism underlying the breakdown of verbal information processing in schizophrenia is poorly understood.
2-1	198-201	Yet	_
2-2	202-205	the	_
2-3	206-212	neural	_
2-4	213-222	mechanism	_
2-5	223-233	underlying	_
2-6	234-237	the	_
2-7	238-247	breakdown	_
2-8	248-250	of	_
2-9	251-257	verbal	_
2-10	258-269	information	_
2-11	270-280	processing	_
2-12	281-283	in	_
2-13	284-297	schizophrenia	_
2-14	298-300	is	_
2-15	301-307	poorly	_
2-16	308-318	understood	_
2-17	318-319	.	_

#Text=Imaging studies in healthy populations have shown a network of brain areas involved in hierarchical processing of verbal information over time.
3-1	320-327	Imaging	_
3-2	328-335	studies	_
3-3	336-338	in	_
3-4	339-346	healthy	_
3-5	347-358	populations	_
3-6	359-363	have	_
3-7	364-369	shown	_
3-8	370-371	a	_
3-9	372-379	network	_
3-10	380-382	of	_
3-11	383-388	brain	_
3-12	389-394	areas	_
3-13	395-403	involved	_
3-14	404-406	in	_
3-15	407-419	hierarchical	_
3-16	420-430	processing	_
3-17	431-433	of	_
3-18	434-440	verbal	_
3-19	441-452	information	_
3-20	453-457	over	_
3-21	458-462	time	_
3-22	462-463	.	_

#Text=Here, we identified critical aspects of this hierarchy, examining patients with schizophrenia.
4-1	464-468	Here	_
4-2	468-469	,	_
4-3	470-472	we	_
4-4	473-483	identified	_
4-5	484-492	critical	_
4-6	493-500	aspects	_
4-7	501-503	of	_
4-8	504-508	this	_
4-9	509-518	hierarchy	_
4-10	518-519	,	_
4-11	520-529	examining	_
4-12	530-538	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[3]
4-13	539-543	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[3]
4-14	544-557	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[3]
4-15	557-558	.	_

#Text=Using functional magnetic resonance imaging, we examined various levels of information comprehension elicited by naturally presented verbal stimuli; from a set of randomly shuffled words to an intact story.
5-1	559-564	Using	_
5-2	565-575	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]
5-3	576-584	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]
5-4	585-594	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]
5-5	595-602	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]
5-6	602-603	,	_
5-7	604-606	we	_
5-8	607-615	examined	_
5-9	616-623	various	_
5-10	624-630	levels	_
5-11	631-633	of	_
5-12	634-645	information	_
5-13	646-659	comprehension	_
5-14	660-668	elicited	_
5-15	669-671	by	_
5-16	672-681	naturally	_
5-17	682-691	presented	_
5-18	692-698	verbal	_
5-19	699-706	stimuli	_
5-20	706-707	;	_
5-21	708-712	from	_
5-22	713-714	a	_
5-23	715-718	set	_
5-24	719-721	of	_
5-25	722-730	randomly	_
5-26	731-739	shuffled	_
5-27	740-745	words	_
5-28	746-748	to	_
5-29	749-751	an	_
5-30	752-758	intact	_
5-31	759-764	story	_
5-32	764-765	.	_

#Text=Specifically, patients with first episode schizophrenia (N = 15), their non-manifesting siblings (N = 14) and healthy controls (N = 15) listened to a narrated story and randomly scrambled versions of it.
6-1	766-778	Specifically	_
6-2	778-779	,	_
6-3	780-788	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]
6-4	789-793	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]
6-5	794-799	first	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]
6-6	800-807	episode	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]
6-7	808-821	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]
6-8	822-823	(	_
6-9	823-824	N	_
6-10	824-825	 	_
6-11	825-826	=	_
6-12	826-827	 	_
6-13	827-829	15	_
6-14	829-830	)	_
6-15	830-831	,	_
6-16	832-837	their	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]
6-17	838-853	non-manifesting	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]
6-18	854-862	siblings	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]
6-19	863-864	(	_
6-20	864-865	N	_
6-21	865-866	 	_
6-22	866-867	=	_
6-23	867-868	 	_
6-24	868-870	14	_
6-25	870-871	)	_
6-26	872-875	and	_
6-27	876-883	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]
6-28	884-892	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]
6-29	893-894	(	_
6-30	894-895	N	_
6-31	895-896	 	_
6-32	896-897	=	_
6-33	897-898	 	_
6-34	898-900	15	_
6-35	900-901	)	_
6-36	902-910	listened	_
6-37	911-913	to	_
6-38	914-915	a	_
6-39	916-924	narrated	_
6-40	925-930	story	_
6-41	931-934	and	_
6-42	935-943	randomly	_
6-43	944-953	scrambled	_
6-44	954-962	versions	_
6-45	963-965	of	_
6-46	966-968	it	_
6-47	968-969	.	_

#Text=To quantify the degree of dissimilarity between the groups, we adopted an inter-subject correlation (inter-SC) approach, which estimates differences in synchronization of neural responses within and between groups.
7-1	970-972	To	_
7-2	973-981	quantify	_
7-3	982-985	the	_
7-4	986-992	degree	_
7-5	993-995	of	_
7-6	996-1009	dissimilarity	_
7-7	1010-1017	between	_
7-8	1018-1021	the	_
7-9	1022-1028	groups	_
7-10	1028-1029	,	_
7-11	1030-1032	we	_
7-12	1033-1040	adopted	_
7-13	1041-1043	an	_
7-14	1044-1057	inter-subject	_
7-15	1058-1069	correlation	_
7-16	1070-1071	(	_
7-17	1071-1079	inter-SC	_
7-18	1079-1080	)	_
7-19	1081-1089	approach	_
7-20	1089-1090	,	_
7-21	1091-1096	which	_
7-22	1097-1106	estimates	_
7-23	1107-1118	differences	_
7-24	1119-1121	in	_
7-25	1122-1137	synchronization	_
7-26	1138-1140	of	_
7-27	1141-1147	neural	_
7-28	1148-1157	responses	_
7-29	1158-1164	within	_
7-30	1165-1168	and	_
7-31	1169-1176	between	_
7-32	1177-1183	groups	_
7-33	1183-1184	.	_

#Text=The temporal topography found in healthy and siblings groups were consistent with our previous findings – high synchronization in responses from early sensory toward high order perceptual and cognitive areas.
8-1	1185-1188	The	_
8-2	1189-1197	temporal	_
8-3	1198-1208	topography	_
8-4	1209-1214	found	_
8-5	1215-1217	in	_
8-6	1218-1225	healthy	_
8-7	1226-1229	and	_
8-8	1230-1238	siblings	_
8-9	1239-1245	groups	_
8-10	1246-1250	were	_
8-11	1251-1261	consistent	_
8-12	1262-1266	with	_
8-13	1267-1270	our	_
8-14	1271-1279	previous	_
8-15	1280-1288	findings	_
8-16	1289-1290	–	_
8-17	1291-1295	high	_
8-18	1296-1311	synchronization	_
8-19	1312-1314	in	_
8-20	1315-1324	responses	_
8-21	1325-1329	from	_
8-22	1330-1335	early	_
8-23	1336-1343	sensory	_
8-24	1344-1350	toward	_
8-25	1351-1355	high	_
8-26	1356-1361	order	_
8-27	1362-1372	perceptual	_
8-28	1373-1376	and	_
8-29	1377-1386	cognitive	_
8-30	1387-1392	areas	_
8-31	1392-1393	.	_

#Text=In patients with schizophrenia, stimuli with short and intermediate temporal scales evoked a typical pattern of reliable responses, whereas story condition (long temporal scale) revealed robust and widespread disruption of the inter-SCs.
9-1	1394-1396	In	_
9-2	1397-1405	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[8]
9-3	1406-1410	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[8]
9-4	1411-1424	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[8]
9-5	1424-1425	,	_
9-6	1426-1433	stimuli	_
9-7	1434-1438	with	_
9-8	1439-1444	short	_
9-9	1445-1448	and	_
9-10	1449-1461	intermediate	_
9-11	1462-1470	temporal	_
9-12	1471-1477	scales	_
9-13	1478-1484	evoked	_
9-14	1485-1486	a	_
9-15	1487-1494	typical	_
9-16	1495-1502	pattern	_
9-17	1503-1505	of	_
9-18	1506-1514	reliable	_
9-19	1515-1524	responses	_
9-20	1524-1525	,	_
9-21	1526-1533	whereas	_
9-22	1534-1539	story	_
9-23	1540-1549	condition	_
9-24	1550-1551	(	_
9-25	1551-1555	long	_
9-26	1556-1564	temporal	_
9-27	1565-1570	scale	_
9-28	1570-1571	)	_
9-29	1572-1580	revealed	_
9-30	1581-1587	robust	_
9-31	1588-1591	and	_
9-32	1592-1602	widespread	_
9-33	1603-1613	disruption	_
9-34	1614-1616	of	_
9-35	1617-1620	the	_
9-36	1621-1630	inter-SCs	_
9-37	1630-1631	.	_

#Text=In addition, the more similar the neural activity of patients with schizophrenia was to the average response in the healthy group, the less severe the positive symptoms of the patients.
10-1	1632-1634	In	_
10-2	1635-1643	addition	_
10-3	1643-1644	,	_
10-4	1645-1648	the	_
10-5	1649-1653	more	_
10-6	1654-1661	similar	_
10-7	1662-1665	the	_
10-8	1666-1672	neural	_
10-9	1673-1681	activity	_
10-10	1682-1684	of	_
10-11	1685-1693	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[9]
10-12	1694-1698	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[9]
10-13	1699-1712	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[9]
10-14	1713-1716	was	_
10-15	1717-1719	to	_
10-16	1720-1723	the	_
10-17	1724-1731	average	_
10-18	1732-1740	response	_
10-19	1741-1743	in	_
10-20	1744-1747	the	_
10-21	1748-1755	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[10]
10-22	1756-1761	group	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[10]
10-23	1761-1762	,	_
10-24	1763-1766	the	_
10-25	1767-1771	less	_
10-26	1772-1778	severe	_
10-27	1779-1782	the	_
10-28	1783-1791	positive	_
10-29	1792-1800	symptoms	_
10-30	1801-1803	of	_
10-31	1804-1807	the	_
10-32	1808-1816	patients	_
10-33	1816-1817	.	_

#Text=Our findings suggest that system-level neural indication of abnormal verbal information processing in schizophrenia reflects disease manifestations.
11-1	1818-1821	Our	_
11-2	1822-1830	findings	_
11-3	1831-1838	suggest	_
11-4	1839-1843	that	_
11-5	1844-1856	system-level	_
11-6	1857-1863	neural	_
11-7	1864-1874	indication	_
11-8	1875-1877	of	_
11-9	1878-1886	abnormal	_
11-10	1887-1893	verbal	_
11-11	1894-1905	information	_
11-12	1906-1916	processing	_
11-13	1917-1919	in	_
11-14	1920-1933	schizophrenia	_
11-15	1934-1942	reflects	_
11-16	1943-1950	disease	_
11-17	1951-1965	manifestations	_
11-18	1965-1966	.	_

#Text=Highlights
#Text=Critical aspects in semantic information processing in patients with schizophrenia, their non-manifesting siblings and healthy controls
#Text=High synchronization in responses in early sensory areas in all groups
#Text=Robust disruption of the responses in high order perceptual and cognitive areas in patients with schizophrenia
#Text=Introduction
#Text=Cognitive deficits are believed to be a core feature of schizophrenia, observed in patients during the prodromal phase of the illness, mainly in processing speed, working memory, verbal learning, executive functions, and social cognition and are maintained or further increased after the first episode of the disease.
12-1	1967-1977	Highlights	_
12-2	1978-1986	Critical	_
12-3	1987-1994	aspects	_
12-4	1995-1997	in	_
12-5	1998-2006	semantic	_
12-6	2007-2018	information	_
12-7	2019-2029	processing	_
12-8	2030-2032	in	_
12-9	2033-2041	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[11]
12-10	2042-2046	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[11]
12-11	2047-2060	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[11]
12-12	2060-2061	,	_
12-13	2062-2067	their	_
12-14	2068-2083	non-manifesting	_
12-15	2084-2092	siblings	_
12-16	2093-2096	and	_
12-17	2097-2104	healthy	_
12-18	2105-2113	controls	_
12-19	2114-2118	High	_
12-20	2119-2134	synchronization	_
12-21	2135-2137	in	_
12-22	2138-2147	responses	_
12-23	2148-2150	in	_
12-24	2151-2156	early	_
12-25	2157-2164	sensory	_
12-26	2165-2170	areas	_
12-27	2171-2173	in	_
12-28	2174-2177	all	_
12-29	2178-2184	groups	_
12-30	2185-2191	Robust	_
12-31	2192-2202	disruption	_
12-32	2203-2205	of	_
12-33	2206-2209	the	_
12-34	2210-2219	responses	_
12-35	2220-2222	in	_
12-36	2223-2227	high	_
12-37	2228-2233	order	_
12-38	2234-2244	perceptual	_
12-39	2245-2248	and	_
12-40	2249-2258	cognitive	_
12-41	2259-2264	areas	_
12-42	2265-2267	in	_
12-43	2268-2276	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[12]
12-44	2277-2281	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[12]
12-45	2282-2295	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[12]
12-46	2296-2308	Introduction	_
12-47	2309-2318	Cognitive	_
12-48	2319-2327	deficits	_
12-49	2328-2331	are	_
12-50	2332-2340	believed	_
12-51	2341-2343	to	_
12-52	2344-2346	be	_
12-53	2347-2348	a	_
12-54	2349-2353	core	_
12-55	2354-2361	feature	_
12-56	2362-2364	of	_
12-57	2365-2378	schizophrenia	_
12-58	2378-2379	,	_
12-59	2380-2388	observed	_
12-60	2389-2391	in	_
12-61	2392-2400	patients	_
12-62	2401-2407	during	_
12-63	2408-2411	the	_
12-64	2412-2421	prodromal	_
12-65	2422-2427	phase	_
12-66	2428-2430	of	_
12-67	2431-2434	the	_
12-68	2435-2442	illness	_
12-69	2442-2443	,	_
12-70	2444-2450	mainly	_
12-71	2451-2453	in	_
12-72	2454-2464	processing	_
12-73	2465-2470	speed	_
12-74	2470-2471	,	_
12-75	2472-2479	working	_
12-76	2480-2486	memory	_
12-77	2486-2487	,	_
12-78	2488-2494	verbal	_
12-79	2495-2503	learning	_
12-80	2503-2504	,	_
12-81	2505-2514	executive	_
12-82	2515-2524	functions	_
12-83	2524-2525	,	_
12-84	2526-2529	and	_
12-85	2530-2536	social	_
12-86	2537-2546	cognition	_
12-87	2547-2550	and	_
12-88	2551-2554	are	_
12-89	2555-2565	maintained	_
12-90	2566-2568	or	_
12-91	2569-2576	further	_
12-92	2577-2586	increased	_
12-93	2587-2592	after	_
12-94	2593-2596	the	_
12-95	2597-2602	first	_
12-96	2603-2610	episode	_
12-97	2611-2613	of	_
12-98	2614-2617	the	_
12-99	2618-2625	disease	_
12-100	2625-2626	.	_

#Text=Although functional impairment in schizophrenia can manifest at the level of simple cognitive tasks, the deficits become more prominent during high processing loads, multiple tasks or distraction, which challenge the processing of cognitive information.
13-1	2627-2635	Although	_
13-2	2636-2646	functional	_
13-3	2647-2657	impairment	_
13-4	2658-2660	in	_
13-5	2661-2674	schizophrenia	_
13-6	2675-2678	can	_
13-7	2679-2687	manifest	_
13-8	2688-2690	at	_
13-9	2691-2694	the	_
13-10	2695-2700	level	_
13-11	2701-2703	of	_
13-12	2704-2710	simple	_
13-13	2711-2720	cognitive	_
13-14	2721-2726	tasks	_
13-15	2726-2727	,	_
13-16	2728-2731	the	_
13-17	2732-2740	deficits	_
13-18	2741-2747	become	_
13-19	2748-2752	more	_
13-20	2753-2762	prominent	_
13-21	2763-2769	during	_
13-22	2770-2774	high	_
13-23	2775-2785	processing	_
13-24	2786-2791	loads	_
13-25	2791-2792	,	_
13-26	2793-2801	multiple	_
13-27	2802-2807	tasks	_
13-28	2808-2810	or	_
13-29	2811-2822	distraction	_
13-30	2822-2823	,	_
13-31	2824-2829	which	_
13-32	2830-2839	challenge	_
13-33	2840-2843	the	_
13-34	2844-2854	processing	_
13-35	2855-2857	of	_
13-36	2858-2867	cognitive	_
13-37	2868-2879	information	_
13-38	2879-2880	.	_

#Text=Insensitivity to contextual information is thought to be one of the hallmarks of the semantic deficits of patients with schizophrenia (e.g.,).
14-1	2881-2894	Insensitivity	_
14-2	2895-2897	to	_
14-3	2898-2908	contextual	_
14-4	2909-2920	information	_
14-5	2921-2923	is	_
14-6	2924-2931	thought	_
14-7	2932-2934	to	_
14-8	2935-2937	be	_
14-9	2938-2941	one	_
14-10	2942-2944	of	_
14-11	2945-2948	the	_
14-12	2949-2958	hallmarks	_
14-13	2959-2961	of	_
14-14	2962-2965	the	_
14-15	2966-2974	semantic	_
14-16	2975-2983	deficits	_
14-17	2984-2986	of	_
14-18	2987-2995	patients	_
14-19	2996-3000	with	_
14-20	3001-3014	schizophrenia	_
14-21	3015-3016	(	_
14-22	3016-3019	e.g	_
14-23	3019-3020	.	_
14-24	3020-3021	,	_
14-25	3021-3022	)	_
14-26	3022-3023	.	_

#Text=Various studies have reported deficits in both language production and language comprehension.
15-1	3024-3031	Various	_
15-2	3032-3039	studies	_
15-3	3040-3044	have	_
15-4	3045-3053	reported	_
15-5	3054-3062	deficits	_
15-6	3063-3065	in	_
15-7	3066-3070	both	_
15-8	3071-3079	language	_
15-9	3080-3090	production	_
15-10	3091-3094	and	_
15-11	3095-3103	language	_
15-12	3104-3117	comprehension	_
15-13	3117-3118	.	_

#Text=For example, a study in patients with schizophrenia showed that manipulations with discourse coherence resulted in greater impairment in processing stories relative to healthy controls, although, using a sentence continuation task, did not reveal behavioral differences between patients and controls.
16-1	3119-3122	For	_
16-2	3123-3130	example	_
16-3	3130-3131	,	_
16-4	3132-3133	a	_
16-5	3134-3139	study	_
16-6	3140-3142	in	_
16-7	3143-3151	patients	_
16-8	3152-3156	with	_
16-9	3157-3170	schizophrenia	_
16-10	3171-3177	showed	_
16-11	3178-3182	that	_
16-12	3183-3196	manipulations	_
16-13	3197-3201	with	_
16-14	3202-3211	discourse	_
16-15	3212-3221	coherence	_
16-16	3222-3230	resulted	_
16-17	3231-3233	in	_
16-18	3234-3241	greater	_
16-19	3242-3252	impairment	_
16-20	3253-3255	in	_
16-21	3256-3266	processing	_
16-22	3267-3274	stories	_
16-23	3275-3283	relative	_
16-24	3284-3286	to	_
16-25	3287-3294	healthy	_
16-26	3295-3303	controls	_
16-27	3303-3304	,	_
16-28	3305-3313	although	_
16-29	3313-3314	,	_
16-30	3315-3320	using	_
16-31	3321-3322	a	_
16-32	3323-3331	sentence	_
16-33	3332-3344	continuation	_
16-34	3345-3349	task	_
16-35	3349-3350	,	_
16-36	3351-3354	did	_
16-37	3355-3358	not	_
16-38	3359-3365	reveal	_
16-39	3366-3376	behavioral	_
16-40	3377-3388	differences	_
16-41	3389-3396	between	_
16-42	3397-3405	patients	_
16-43	3406-3409	and	_
16-44	3410-3418	controls	_
16-45	3418-3419	.	_

#Text=Another study further showed that the semantic deficits were mostly found in patients with positive symptoms of thought disturbance (, but see).
17-1	3420-3427	Another	_
17-2	3428-3433	study	_
17-3	3434-3441	further	_
17-4	3442-3448	showed	_
17-5	3449-3453	that	_
17-6	3454-3457	the	_
17-7	3458-3466	semantic	_
17-8	3467-3475	deficits	_
17-9	3476-3480	were	_
17-10	3481-3487	mostly	_
17-11	3488-3493	found	_
17-12	3494-3496	in	_
17-13	3497-3505	patients	_
17-14	3506-3510	with	_
17-15	3511-3519	positive	_
17-16	3520-3528	symptoms	_
17-17	3529-3531	of	_
17-18	3532-3539	thought	_
17-19	3540-3551	disturbance	_
17-20	3552-3553	(	_
17-21	3553-3554	,	_
17-22	3555-3558	but	_
17-23	3559-3562	see	_
17-24	3562-3563	)	_
17-25	3563-3564	.	_

#Text=It is important to note, that language deficits in schizophrenia underlie the major symptoms of psychosis, specifically hallucinations (verbal, auditory) and disorganized language output (positive thought disorder).
18-1	3565-3567	It	_
18-2	3568-3570	is	_
18-3	3571-3580	important	_
18-4	3581-3583	to	_
18-5	3584-3588	note	_
18-6	3588-3589	,	_
18-7	3590-3594	that	_
18-8	3595-3603	language	_
18-9	3604-3612	deficits	_
18-10	3613-3615	in	_
18-11	3616-3629	schizophrenia	_
18-12	3630-3638	underlie	_
18-13	3639-3642	the	_
18-14	3643-3648	major	_
18-15	3649-3657	symptoms	_
18-16	3658-3660	of	_
18-17	3661-3670	psychosis	_
18-18	3670-3671	,	_
18-19	3672-3684	specifically	_
18-20	3685-3699	hallucinations	_
18-21	3700-3701	(	_
18-22	3701-3707	verbal	_
18-23	3707-3708	,	_
18-24	3709-3717	auditory	_
18-25	3717-3718	)	_
18-26	3719-3722	and	_
18-27	3723-3735	disorganized	_
18-28	3736-3744	language	_
18-29	3745-3751	output	_
18-30	3752-3753	(	_
18-31	3753-3761	positive	_
18-32	3762-3769	thought	_
18-33	3770-3778	disorder	_
18-34	3778-3779	)	_
18-35	3779-3780	.	_

#Text=Accordingly, a series of neurocognitive theories have proposed that clinical symptoms in schizophrenia reflect internal speech, or thinking in words, as one of the self-disturbances of the disease.
19-1	3781-3792	Accordingly	_
19-2	3792-3793	,	_
19-3	3794-3795	a	_
19-4	3796-3802	series	_
19-5	3803-3805	of	_
19-6	3806-3820	neurocognitive	_
19-7	3821-3829	theories	_
19-8	3830-3834	have	_
19-9	3835-3843	proposed	_
19-10	3844-3848	that	_
19-11	3849-3857	clinical	_
19-12	3858-3866	symptoms	_
19-13	3867-3869	in	_
19-14	3870-3883	schizophrenia	_
19-15	3884-3891	reflect	_
19-16	3892-3900	internal	_
19-17	3901-3907	speech	_
19-18	3907-3908	,	_
19-19	3909-3911	or	_
19-20	3912-3920	thinking	_
19-21	3921-3923	in	_
19-22	3924-3929	words	_
19-23	3929-3930	,	_
19-24	3931-3933	as	_
19-25	3934-3937	one	_
19-26	3938-3940	of	_
19-27	3941-3944	the	_
19-28	3945-3962	self-disturbances	_
19-29	3963-3965	of	_
19-30	3966-3969	the	_
19-31	3970-3977	disease	_
19-32	3977-3978	.	_

#Text=More recently,, using synonym identification and sentence comprehension tasks, found that patients with schizophrenia made more errors relative to healthy controls in sentence comprehension but not with words, when the structure of the sentence was modified.
20-1	3979-3983	More	_
20-2	3984-3992	recently	_
20-3	3992-3993	,	_
20-4	3993-3994	,	_
20-5	3995-4000	using	_
20-6	4001-4008	synonym	_
20-7	4009-4023	identification	_
20-8	4024-4027	and	_
20-9	4028-4036	sentence	_
20-10	4037-4050	comprehension	_
20-11	4051-4056	tasks	_
20-12	4056-4057	,	_
20-13	4058-4063	found	_
20-14	4064-4068	that	_
20-15	4069-4077	patients	_
20-16	4078-4082	with	_
20-17	4083-4096	schizophrenia	_
20-18	4097-4101	made	_
20-19	4102-4106	more	_
20-20	4107-4113	errors	_
20-21	4114-4122	relative	_
20-22	4123-4125	to	_
20-23	4126-4133	healthy	_
20-24	4134-4142	controls	_
20-25	4143-4145	in	_
20-26	4146-4154	sentence	_
20-27	4155-4168	comprehension	_
20-28	4169-4172	but	_
20-29	4173-4176	not	_
20-30	4177-4181	with	_
20-31	4182-4187	words	_
20-32	4187-4188	,	_
20-33	4189-4193	when	_
20-34	4194-4197	the	_
20-35	4198-4207	structure	_
20-36	4208-4210	of	_
20-37	4211-4214	the	_
20-38	4215-4223	sentence	_
20-39	4224-4227	was	_
20-40	4228-4236	modified	_
20-41	4236-4237	.	_

#Text=These findings suggest that individuals with schizophrenia are limited in their ability to benefit from accumulating semantic information when processing verbal context.
21-1	4238-4243	These	_
21-2	4244-4252	findings	_
21-3	4253-4260	suggest	_
21-4	4261-4265	that	_
21-5	4266-4277	individuals	_
21-6	4278-4282	with	_
21-7	4283-4296	schizophrenia	_
21-8	4297-4300	are	_
21-9	4301-4308	limited	_
21-10	4309-4311	in	_
21-11	4312-4317	their	_
21-12	4318-4325	ability	_
21-13	4326-4328	to	_
21-14	4329-4336	benefit	_
21-15	4337-4341	from	_
21-16	4342-4354	accumulating	_
21-17	4355-4363	semantic	_
21-18	4364-4375	information	_
21-19	4376-4380	when	_
21-20	4381-4391	processing	_
21-21	4392-4398	verbal	_
21-22	4399-4406	context	_
21-23	4406-4407	.	_

#Text=There has been relatively little exploration of how patients with schizophrenia build up a coherent representation of discourse meaning, which requires the establishment of logical and psychological consistency between the events and propositions described in individual sentences.
22-1	4408-4413	There	_
22-2	4414-4417	has	_
22-3	4418-4422	been	_
22-4	4423-4433	relatively	_
22-5	4434-4440	little	_
22-6	4441-4452	exploration	_
22-7	4453-4455	of	_
22-8	4456-4459	how	_
22-9	4460-4468	patients	_
22-10	4469-4473	with	_
22-11	4474-4487	schizophrenia	_
22-12	4488-4493	build	_
22-13	4494-4496	up	_
22-14	4497-4498	a	_
22-15	4499-4507	coherent	_
22-16	4508-4522	representation	_
22-17	4523-4525	of	_
22-18	4526-4535	discourse	_
22-19	4536-4543	meaning	_
22-20	4543-4544	,	_
22-21	4545-4550	which	_
22-22	4551-4559	requires	_
22-23	4560-4563	the	_
22-24	4564-4577	establishment	_
22-25	4578-4580	of	_
22-26	4581-4588	logical	_
22-27	4589-4592	and	_
22-28	4593-4606	psychological	_
22-29	4607-4618	consistency	_
22-30	4619-4626	between	_
22-31	4627-4630	the	_
22-32	4631-4637	events	_
22-33	4638-4641	and	_
22-34	4642-4654	propositions	_
22-35	4655-4664	described	_
22-36	4665-4667	in	_
22-37	4668-4678	individual	_
22-38	4679-4688	sentences	_
22-39	4688-4689	.	_

#Text=Some memory paradigms suggested that patients with schizophrenia fail to use coherence links across sentences to improve recall of individual sentences.
23-1	4690-4694	Some	_
23-2	4695-4701	memory	_
23-3	4702-4711	paradigms	_
23-4	4712-4721	suggested	_
23-5	4722-4726	that	_
23-6	4727-4735	patients	_
23-7	4736-4740	with	_
23-8	4741-4754	schizophrenia	_
23-9	4755-4759	fail	_
23-10	4760-4762	to	_
23-11	4763-4766	use	_
23-12	4767-4776	coherence	_
23-13	4777-4782	links	_
23-14	4783-4789	across	_
23-15	4790-4799	sentences	_
23-16	4800-4802	to	_
23-17	4803-4810	improve	_
23-18	4811-4817	recall	_
23-19	4818-4820	of	_
23-20	4821-4831	individual	_
23-21	4832-4841	sentences	_
23-22	4841-4842	.	_

#Text=Previous neuroimaging research of semantic processing in scizophrenia has focused mainly on abnormalities in specific brain regions.
24-1	4843-4851	Previous	_
24-2	4852-4864	neuroimaging	_
24-3	4865-4873	research	_
24-4	4874-4876	of	_
24-5	4877-4885	semantic	_
24-6	4886-4896	processing	_
24-7	4897-4899	in	_
24-8	4900-4912	scizophrenia	_
24-9	4913-4916	has	_
24-10	4917-4924	focused	_
24-11	4925-4931	mainly	_
24-12	4932-4934	on	_
24-13	4935-4948	abnormalities	_
24-14	4949-4951	in	_
24-15	4952-4960	specific	_
24-16	4961-4966	brain	_
24-17	4967-4974	regions	_
24-18	4974-4975	.	_

#Text=For example, demonstrated that patients compared to controls failed to recruit the dorsolateral prefrontal cortex (DLPFC), medial frontal and parietal cortices in their responses to incongruous versus congruous or to concrete versus abstract sentences.
25-1	4976-4979	For	_
25-2	4980-4987	example	_
25-3	4987-4988	,	_
25-4	4989-5001	demonstrated	_
25-5	5002-5006	that	_
25-6	5007-5015	patients	_
25-7	5016-5024	compared	_
25-8	5025-5027	to	_
25-9	5028-5036	controls	_
25-10	5037-5043	failed	_
25-11	5044-5046	to	_
25-12	5047-5054	recruit	_
25-13	5055-5058	the	_
25-14	5059-5071	dorsolateral	_
25-15	5072-5082	prefrontal	_
25-16	5083-5089	cortex	_
25-17	5090-5091	(	_
25-18	5091-5096	DLPFC	_
25-19	5096-5097	)	_
25-20	5097-5098	,	_
25-21	5099-5105	medial	_
25-22	5106-5113	frontal	_
25-23	5114-5117	and	_
25-24	5118-5126	parietal	_
25-25	5127-5135	cortices	_
25-26	5136-5138	in	_
25-27	5139-5144	their	_
25-28	5145-5154	responses	_
25-29	5155-5157	to	_
25-30	5158-5169	incongruous	_
25-31	5170-5176	versus	_
25-32	5177-5186	congruous	_
25-33	5187-5189	or	_
25-34	5190-5192	to	_
25-35	5193-5201	concrete	_
25-36	5202-5208	versus	_
25-37	5209-5217	abstract	_
25-38	5218-5227	sentences	_
25-39	5227-5228	.	_

#Text=However, one possible explanation for deficits in semantic information processing might be disturbed large scale brain organization in schizophrenia.
26-1	5229-5236	However	_
26-2	5236-5237	,	_
26-3	5238-5241	one	_
26-4	5242-5250	possible	_
26-5	5251-5262	explanation	_
26-6	5263-5266	for	_
26-7	5267-5275	deficits	_
26-8	5276-5278	in	_
26-9	5279-5287	semantic	_
26-10	5288-5299	information	_
26-11	5300-5310	processing	_
26-12	5311-5316	might	_
26-13	5317-5319	be	_
26-14	5320-5329	disturbed	_
26-15	5330-5335	large	_
26-16	5336-5341	scale	_
26-17	5342-5347	brain	_
26-18	5348-5360	organization	_
26-19	5361-5363	in	_
26-20	5364-5377	schizophrenia	_
26-21	5377-5378	.	_

#Text=Accumulating evidence from neuroimaging studies revealed distributed abnormalities in a widespread set of brain areas involved in sensory, cognitive, and emotional processing in schizophrenia.
27-1	5379-5391	Accumulating	_
27-2	5392-5400	evidence	_
27-3	5401-5405	from	_
27-4	5406-5418	neuroimaging	_
27-5	5419-5426	studies	_
27-6	5427-5435	revealed	_
27-7	5436-5447	distributed	_
27-8	5448-5461	abnormalities	_
27-9	5462-5464	in	_
27-10	5465-5466	a	_
27-11	5467-5477	widespread	_
27-12	5478-5481	set	_
27-13	5482-5484	of	_
27-14	5485-5490	brain	_
27-15	5491-5496	areas	_
27-16	5497-5505	involved	_
27-17	5506-5508	in	_
27-18	5509-5516	sensory	_
27-19	5516-5517	,	_
27-20	5518-5527	cognitive	_
27-21	5527-5528	,	_
27-22	5529-5532	and	_
27-23	5533-5542	emotional	_
27-24	5543-5553	processing	_
27-25	5554-5556	in	_
27-26	5557-5570	schizophrenia	_
27-27	5570-5571	.	_

#Text=A leading proposal to explain such a distributed anomaly is the ‘disconnection hypothesis’, assuming altered fronto-temporal functional connectivity in schizophrenia with greater involvement of the left hemisphere.
28-1	5572-5573	A	_
28-2	5574-5581	leading	_
28-3	5582-5590	proposal	_
28-4	5591-5593	to	_
28-5	5594-5601	explain	_
28-6	5602-5606	such	_
28-7	5607-5608	a	_
28-8	5609-5620	distributed	_
28-9	5621-5628	anomaly	_
28-10	5629-5631	is	_
28-11	5632-5635	the	_
28-12	5636-5637	‘	_
28-13	5637-5650	disconnection	_
28-14	5651-5661	hypothesis	_
28-15	5661-5662	’	_
28-16	5662-5663	,	_
28-17	5664-5672	assuming	_
28-18	5673-5680	altered	_
28-19	5681-5696	fronto-temporal	_
28-20	5697-5707	functional	_
28-21	5708-5720	connectivity	_
28-22	5721-5723	in	_
28-23	5724-5737	schizophrenia	_
28-24	5738-5742	with	_
28-25	5743-5750	greater	_
28-26	5751-5762	involvement	_
28-27	5763-5765	of	_
28-28	5766-5769	the	_
28-29	5770-5774	left	_
28-30	5775-5785	hemisphere	_
28-31	5785-5786	.	_

#Text=This functional dysconnectivity might be the consequence of disturbed anatomical connectivity as presented by diffusion tensor imaging (DTI) studies. revealed alterations in white matter (WM) integrity within the fiber bundles that are implicated in the language functional networks.
29-1	5787-5791	This	_
29-2	5792-5802	functional	_
29-3	5803-5818	dysconnectivity	_
29-4	5819-5824	might	_
29-5	5825-5827	be	_
29-6	5828-5831	the	_
29-7	5832-5843	consequence	_
29-8	5844-5846	of	_
29-9	5847-5856	disturbed	_
29-10	5857-5867	anatomical	_
29-11	5868-5880	connectivity	_
29-12	5881-5883	as	_
29-13	5884-5893	presented	_
29-14	5894-5896	by	_
29-15	5897-5906	diffusion	_
29-16	5907-5913	tensor	_
29-17	5914-5921	imaging	_
29-18	5922-5923	(	_
29-19	5923-5926	DTI	_
29-20	5926-5927	)	_
29-21	5928-5935	studies	_
29-22	5935-5936	.	_
29-23	5937-5945	revealed	_
29-24	5946-5957	alterations	_
29-25	5958-5960	in	_
29-26	5961-5966	white	_
29-27	5967-5973	matter	_
29-28	5974-5975	(	_
29-29	5975-5977	WM	_
29-30	5977-5978	)	_
29-31	5979-5988	integrity	_
29-32	5989-5995	within	_
29-33	5996-5999	the	_
29-34	6000-6005	fiber	_
29-35	6006-6013	bundles	_
29-36	6014-6018	that	_
29-37	6019-6022	are	_
29-38	6023-6033	implicated	_
29-39	6034-6036	in	_
29-40	6037-6040	the	_
29-41	6041-6049	language	_
29-42	6050-6060	functional	_
29-43	6061-6069	networks	_
29-44	6069-6070	.	_

#Text=Furthermore, found that the decrease in functional connectivity was positively correlated with deficiencies in WM integrity in the language-comprehension network in schizophrenia.
30-1	6071-6082	Furthermore	_
30-2	6082-6083	,	_
30-3	6084-6089	found	_
30-4	6090-6094	that	_
30-5	6095-6098	the	_
30-6	6099-6107	decrease	_
30-7	6108-6110	in	_
30-8	6111-6121	functional	_
30-9	6122-6134	connectivity	_
30-10	6135-6138	was	_
30-11	6139-6149	positively	_
30-12	6150-6160	correlated	_
30-13	6161-6165	with	_
30-14	6166-6178	deficiencies	_
30-15	6179-6181	in	_
30-16	6182-6184	WM	_
30-17	6185-6194	integrity	_
30-18	6195-6197	in	_
30-19	6198-6201	the	_
30-20	6202-6224	language-comprehension	_
30-21	6225-6232	network	_
30-22	6233-6235	in	_
30-23	6236-6249	schizophrenia	_
30-24	6249-6250	.	_

#Text=However, what type of processing is affected by such disturbed structural organization, and how the breakdown may lead to severe mental dysfunction is still unclear.
31-1	6251-6258	However	_
31-2	6258-6259	,	_
31-3	6260-6264	what	_
31-4	6265-6269	type	_
31-5	6270-6272	of	_
31-6	6273-6283	processing	_
31-7	6284-6286	is	_
31-8	6287-6295	affected	_
31-9	6296-6298	by	_
31-10	6299-6303	such	_
31-11	6304-6313	disturbed	_
31-12	6314-6324	structural	_
31-13	6325-6337	organization	_
31-14	6337-6338	,	_
31-15	6339-6342	and	_
31-16	6343-6346	how	_
31-17	6347-6350	the	_
31-18	6351-6360	breakdown	_
31-19	6361-6364	may	_
31-20	6365-6369	lead	_
31-21	6370-6372	to	_
31-22	6373-6379	severe	_
31-23	6380-6386	mental	_
31-24	6387-6398	dysfunction	_
31-25	6399-6401	is	_
31-26	6402-6407	still	_
31-27	6408-6415	unclear	_
31-28	6415-6416	.	_

#Text=Previous research on healthy participants revealed a hierarchical organization of areas involved in processing continuously incoming verbal information.
32-1	6417-6425	Previous	_
32-2	6426-6434	research	_
32-3	6435-6437	on	_
32-4	6438-6445	healthy	_
32-5	6446-6458	participants	_
32-6	6459-6467	revealed	_
32-7	6468-6469	a	_
32-8	6470-6482	hierarchical	_
32-9	6483-6495	organization	_
32-10	6496-6498	of	_
32-11	6499-6504	areas	_
32-12	6505-6513	involved	_
32-13	6514-6516	in	_
32-14	6517-6527	processing	_
32-15	6528-6540	continuously	_
32-16	6541-6549	incoming	_
32-17	6550-6556	verbal	_
32-18	6557-6568	information	_
32-19	6568-6569	.	_

#Text=Specifically, it has been shown that the capacity to accumulate and process verbal information over different time scales increased gradually in correspondence with the length of coherent temporal structures in the stimulus, and accordingly, with the amount of information contained in those structures.
33-1	6570-6582	Specifically	_
33-2	6582-6583	,	_
33-3	6584-6586	it	_
33-4	6587-6590	has	_
33-5	6591-6595	been	_
33-6	6596-6601	shown	_
33-7	6602-6606	that	_
33-8	6607-6610	the	_
33-9	6611-6619	capacity	_
33-10	6620-6622	to	_
33-11	6623-6633	accumulate	_
33-12	6634-6637	and	_
33-13	6638-6645	process	_
33-14	6646-6652	verbal	_
33-15	6653-6664	information	_
33-16	6665-6669	over	_
33-17	6670-6679	different	_
33-18	6680-6684	time	_
33-19	6685-6691	scales	_
33-20	6692-6701	increased	_
33-21	6702-6711	gradually	_
33-22	6712-6714	in	_
33-23	6715-6729	correspondence	_
33-24	6730-6734	with	_
33-25	6735-6738	the	_
33-26	6739-6745	length	_
33-27	6746-6748	of	_
33-28	6749-6757	coherent	_
33-29	6758-6766	temporal	_
33-30	6767-6777	structures	_
33-31	6778-6780	in	_
33-32	6781-6784	the	_
33-33	6785-6793	stimulus	_
33-34	6793-6794	,	_
33-35	6795-6798	and	_
33-36	6799-6810	accordingly	_
33-37	6810-6811	,	_
33-38	6812-6816	with	_
33-39	6817-6820	the	_
33-40	6821-6827	amount	_
33-41	6828-6830	of	_
33-42	6831-6842	information	_
33-43	6843-6852	contained	_
33-44	6853-6855	in	_
33-45	6856-6861	those	_
33-46	6862-6872	structures	_
33-47	6872-6873	.	_

#Text=Yet, the neural underpinnings of such complex contextual sensitivity in schizophrenia is not well understood. proposed a model portraying schizophrenia as a disorder of hierarchical temporal processing.
34-1	6874-6877	Yet	_
34-2	6877-6878	,	_
34-3	6879-6882	the	_
34-4	6883-6889	neural	_
34-5	6890-6903	underpinnings	_
34-6	6904-6906	of	_
34-7	6907-6911	such	_
34-8	6912-6919	complex	_
34-9	6920-6930	contextual	_
34-10	6931-6942	sensitivity	_
34-11	6943-6945	in	_
34-12	6946-6959	schizophrenia	_
34-13	6960-6962	is	_
34-14	6963-6966	not	_
34-15	6967-6971	well	_
34-16	6972-6982	understood	_
34-17	6982-6983	.	_
34-18	6984-6992	proposed	_
34-19	6993-6994	a	_
34-20	6995-7000	model	_
34-21	7001-7011	portraying	_
34-22	7012-7025	schizophrenia	_
34-23	7026-7028	as	_
34-24	7029-7030	a	_
34-25	7031-7039	disorder	_
34-26	7040-7042	of	_
34-27	7043-7055	hierarchical	_
34-28	7056-7064	temporal	_
34-29	7065-7075	processing	_
34-30	7075-7076	.	_

#Text=Namely, the researchers suggested that the problem exists at the level of communication between cortical layers; difficulty with the formation and storage of invariant representation at higher hierarchical levels disrupts capacity of these levels and, accordingly, their ability to provide sufficient input to lower levels.
35-1	7077-7083	Namely	_
35-2	7083-7084	,	_
35-3	7085-7088	the	_
35-4	7089-7100	researchers	_
35-5	7101-7110	suggested	_
35-6	7111-7115	that	_
35-7	7116-7119	the	_
35-8	7120-7127	problem	_
35-9	7128-7134	exists	_
35-10	7135-7137	at	_
35-11	7138-7141	the	_
35-12	7142-7147	level	_
35-13	7148-7150	of	_
35-14	7151-7164	communication	_
35-15	7165-7172	between	_
35-16	7173-7181	cortical	_
35-17	7182-7188	layers	_
35-18	7188-7189	;	_
35-19	7190-7200	difficulty	_
35-20	7201-7205	with	_
35-21	7206-7209	the	_
35-22	7210-7219	formation	_
35-23	7220-7223	and	_
35-24	7224-7231	storage	_
35-25	7232-7234	of	_
35-26	7235-7244	invariant	_
35-27	7245-7259	representation	_
35-28	7260-7262	at	_
35-29	7263-7269	higher	_
35-30	7270-7282	hierarchical	_
35-31	7283-7289	levels	_
35-32	7290-7298	disrupts	_
35-33	7299-7307	capacity	_
35-34	7308-7310	of	_
35-35	7311-7316	these	_
35-36	7317-7323	levels	_
35-37	7324-7327	and	_
35-38	7327-7328	,	_
35-39	7329-7340	accordingly	_
35-40	7340-7341	,	_
35-41	7342-7347	their	_
35-42	7348-7355	ability	_
35-43	7356-7358	to	_
35-44	7359-7366	provide	_
35-45	7367-7377	sufficient	_
35-46	7378-7383	input	_
35-47	7384-7386	to	_
35-48	7387-7392	lower	_
35-49	7393-7399	levels	_
35-50	7399-7400	.	_

#Text=In turn, lower levels are forced to transmit the details of the input to higher levels for interpretation.
36-1	7401-7403	In	_
36-2	7404-7408	turn	_
36-3	7408-7409	,	_
36-4	7410-7415	lower	_
36-5	7416-7422	levels	_
36-6	7423-7426	are	_
36-7	7427-7433	forced	_
36-8	7434-7436	to	_
36-9	7437-7445	transmit	_
36-10	7446-7449	the	_
36-11	7450-7457	details	_
36-12	7458-7460	of	_
36-13	7461-7464	the	_
36-14	7465-7470	input	_
36-15	7471-7473	to	_
36-16	7474-7480	higher	_
36-17	7481-7487	levels	_
36-18	7488-7491	for	_
36-19	7492-7506	interpretation	_
36-20	7506-7507	.	_

#Text=Since this bottom-up process requires a certain amount of time, it may be abandoned in favor of rapid, although impaired, processes that lead to increasing inaccuracy in perception.
37-1	7508-7513	Since	_
37-2	7514-7518	this	_
37-3	7519-7528	bottom-up	_
37-4	7529-7536	process	_
37-5	7537-7545	requires	_
37-6	7546-7547	a	_
37-7	7548-7555	certain	_
37-8	7556-7562	amount	_
37-9	7563-7565	of	_
37-10	7566-7570	time	_
37-11	7570-7571	,	_
37-12	7572-7574	it	_
37-13	7575-7578	may	_
37-14	7579-7581	be	_
37-15	7582-7591	abandoned	_
37-16	7592-7594	in	_
37-17	7595-7600	favor	_
37-18	7601-7603	of	_
37-19	7604-7609	rapid	_
37-20	7609-7610	,	_
37-21	7611-7619	although	_
37-22	7620-7628	impaired	_
37-23	7628-7629	,	_
37-24	7630-7639	processes	_
37-25	7640-7644	that	_
37-26	7645-7649	lead	_
37-27	7650-7652	to	_
37-28	7653-7663	increasing	_
37-29	7664-7674	inaccuracy	_
37-30	7675-7677	in	_
37-31	7678-7688	perception	_
37-32	7688-7689	.	_

#Text=Stimuli and analyses flow chart.
38-1	7690-7697	Stimuli	_
38-2	7698-7701	and	_
38-3	7702-7710	analyses	_
38-4	7711-7715	flow	_
38-5	7716-7721	chart	_
38-6	7721-7722	.	_

#Text=(A) A schematic representation of the stimuli used in the experiment.
39-1	7723-7724	(	_
39-2	7724-7725	A	_
39-3	7725-7726	)	_
39-4	7727-7728	A	_
39-5	7729-7738	schematic	_
39-6	7739-7753	representation	_
39-7	7754-7756	of	_
39-8	7757-7760	the	_
39-9	7761-7768	stimuli	_
39-10	7769-7773	used	_
39-11	7774-7776	in	_
39-12	7777-7780	the	_
39-13	7781-7791	experiment	_
39-14	7791-7792	.	_

#Text=A narrated 8-min story and scrambled versions were used.
40-1	7793-7794	A	_
40-2	7795-7803	narrated	_
40-3	7804-7805	8	_
40-4	7805-7806	-	_
40-5	7806-7809	min	_
40-6	7810-7815	story	_
40-7	7816-7819	and	_
40-8	7820-7829	scrambled	_
40-9	7830-7838	versions	_
40-10	7839-7843	were	_
40-11	7844-7848	used	_
40-12	7848-7849	.	_

#Text=In the scrambled versions, an audio recording of the story (blue) was segmented at multiple time scales defined by sentences (intermediate time scale; green) and words (short time scale; red), and then reassembled with the segments in randomly shuffled order.
41-1	7850-7852	In	_
41-2	7853-7856	the	_
41-3	7857-7866	scrambled	_
41-4	7867-7875	versions	_
41-5	7875-7876	,	_
41-6	7877-7879	an	_
41-7	7880-7885	audio	_
41-8	7886-7895	recording	_
41-9	7896-7898	of	_
41-10	7899-7902	the	_
41-11	7903-7908	story	_
41-12	7909-7910	(	_
41-13	7910-7914	blue	_
41-14	7914-7915	)	_
41-15	7916-7919	was	_
41-16	7920-7929	segmented	_
41-17	7930-7932	at	_
41-18	7933-7941	multiple	_
41-19	7942-7946	time	_
41-20	7947-7953	scales	_
41-21	7954-7961	defined	_
41-22	7962-7964	by	_
41-23	7965-7974	sentences	_
41-24	7975-7976	(	_
41-25	7976-7988	intermediate	_
41-26	7989-7993	time	_
41-27	7994-7999	scale	_
41-28	7999-8000	;	_
41-29	8001-8006	green	_
41-30	8006-8007	)	_
41-31	8008-8011	and	_
41-32	8012-8017	words	_
41-33	8018-8019	(	_
41-34	8019-8024	short	_
41-35	8025-8029	time	_
41-36	8030-8035	scale	_
41-37	8035-8036	;	_
41-38	8037-8040	red	_
41-39	8040-8041	)	_
41-40	8041-8042	,	_
41-41	8043-8046	and	_
41-42	8047-8051	then	_
41-43	8052-8063	reassembled	_
41-44	8064-8068	with	_
41-45	8069-8072	the	_
41-46	8073-8081	segments	_
41-47	8082-8084	in	_
41-48	8085-8093	randomly	_
41-49	8094-8102	shuffled	_
41-50	8103-8108	order	_
41-51	8108-8109	.	_

#Text=(B) Analysis steps: inter-SC values were calculated between participants' time courses within each group (B1) and between groups (B3); the differences between groups were estimated using a two-tailed t-test (B2).
42-1	8110-8111	(	_
42-2	8111-8112	B	_
42-3	8112-8113	)	_
42-4	8114-8122	Analysis	_
42-5	8123-8128	steps	_
42-6	8128-8129	:	_
42-7	8130-8138	inter-SC	_
42-8	8139-8145	values	_
42-9	8146-8150	were	_
42-10	8151-8161	calculated	_
42-11	8162-8169	between	_
42-12	8170-8182	participants	_
42-13	8182-8183	'	_
42-14	8184-8188	time	_
42-15	8189-8196	courses	_
42-16	8197-8203	within	_
42-17	8204-8208	each	_
42-18	8209-8214	group	_
42-19	8215-8216	(	_
42-20	8216-8218	B1	_
42-21	8218-8219	)	_
42-22	8220-8223	and	_
42-23	8224-8231	between	_
42-24	8232-8238	groups	_
42-25	8239-8240	(	_
42-26	8240-8242	B3	_
42-27	8242-8243	)	_
42-28	8243-8244	;	_
42-29	8245-8248	the	_
42-30	8249-8260	differences	_
42-31	8261-8268	between	_
42-32	8269-8275	groups	_
42-33	8276-8280	were	_
42-34	8281-8290	estimated	_
42-35	8291-8296	using	_
42-36	8297-8298	a	_
42-37	8299-8309	two-tailed	_
42-38	8310-8316	t-test	_
42-39	8317-8318	(	_
42-40	8318-8320	B2	_
42-41	8320-8321	)	_
42-42	8321-8322	.	_

#Text=In addition, a set of ROIs was defined functionally based on the inter-SC measurements in a group of healthy participants (B4); corresponding between patients' neural activity similarity to average healthy response and the syndrome scale rating (B5).
43-1	8323-8325	In	_
43-2	8326-8334	addition	_
43-3	8334-8335	,	_
43-4	8336-8337	a	_
43-5	8338-8341	set	_
43-6	8342-8344	of	_
43-7	8345-8349	ROIs	_
43-8	8350-8353	was	_
43-9	8354-8361	defined	_
43-10	8362-8374	functionally	_
43-11	8375-8380	based	_
43-12	8381-8383	on	_
43-13	8384-8387	the	_
43-14	8388-8396	inter-SC	_
43-15	8397-8409	measurements	_
43-16	8410-8412	in	_
43-17	8413-8414	a	_
43-18	8415-8420	group	_
43-19	8421-8423	of	_
43-20	8424-8431	healthy	_
43-21	8432-8444	participants	_
43-22	8445-8446	(	_
43-23	8446-8448	B4	_
43-24	8448-8449	)	_
43-25	8449-8450	;	_
43-26	8451-8464	corresponding	_
43-27	8465-8472	between	_
43-28	8473-8481	patients	_
43-29	8481-8482	'	_
43-30	8483-8489	neural	_
43-31	8490-8498	activity	_
43-32	8499-8509	similarity	_
43-33	8510-8512	to	_
43-34	8513-8520	average	_
43-35	8521-8528	healthy	_
43-36	8529-8537	response	_
43-37	8538-8541	and	_
43-38	8542-8545	the	_
43-39	8546-8554	syndrome	_
43-40	8555-8560	scale	_
43-41	8561-8567	rating	_
43-42	8568-8569	(	_
43-43	8569-8571	B5	_
43-44	8571-8572	)	_
43-45	8572-8573	.	_

#Text=(For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
44-1	8574-8575	(	_
44-2	8575-8578	For	_
44-3	8579-8593	interpretation	_
44-4	8594-8596	of	_
44-5	8597-8600	the	_
44-6	8601-8611	references	_
44-7	8612-8614	to	_
44-8	8615-8620	color	_
44-9	8621-8623	in	_
44-10	8624-8628	this	_
44-11	8629-8635	figure	_
44-12	8636-8642	legend	_
44-13	8642-8643	,	_
44-14	8644-8647	the	_
44-15	8648-8654	reader	_
44-16	8655-8657	is	_
44-17	8658-8666	referred	_
44-18	8667-8669	to	_
44-19	8670-8673	the	_
44-20	8674-8677	web	_
44-21	8678-8685	version	_
44-22	8686-8688	of	_
44-23	8689-8693	this	_
44-24	8694-8701	article	_
44-25	8701-8702	.	_
44-26	8702-8703	)	_

#Text=Fig. 1
#Text=Asserting that an important aspect of functional disorganization in schizophrenia encompasses temporal hierarchy in verbal information processing, we used fMRI and employed an advanced methodology to identify differences in processing of auditory verbal information presented over different time scales (i.e. different levels of semantic information complexity) in participants with schizophrenia and healthy controls (Fig. 1A, also see).
45-1	8704-8707	Fig	_
45-2	8707-8708	.	_
45-3	8709-8710	1	_
45-4	8711-8720	Asserting	_
45-5	8721-8725	that	_
45-6	8726-8728	an	_
45-7	8729-8738	important	_
45-8	8739-8745	aspect	_
45-9	8746-8748	of	_
45-10	8749-8759	functional	_
45-11	8760-8775	disorganization	_
45-12	8776-8778	in	_
45-13	8779-8792	schizophrenia	_
45-14	8793-8804	encompasses	_
45-15	8805-8813	temporal	_
45-16	8814-8823	hierarchy	_
45-17	8824-8826	in	_
45-18	8827-8833	verbal	_
45-19	8834-8845	information	_
45-20	8846-8856	processing	_
45-21	8856-8857	,	_
45-22	8858-8860	we	_
45-23	8861-8865	used	_
45-24	8866-8870	fMRI	_
45-25	8871-8874	and	_
45-26	8875-8883	employed	_
45-27	8884-8886	an	_
45-28	8887-8895	advanced	_
45-29	8896-8907	methodology	_
45-30	8908-8910	to	_
45-31	8911-8919	identify	_
45-32	8920-8931	differences	_
45-33	8932-8934	in	_
45-34	8935-8945	processing	_
45-35	8946-8948	of	_
45-36	8949-8957	auditory	_
45-37	8958-8964	verbal	_
45-38	8965-8976	information	_
45-39	8977-8986	presented	_
45-40	8987-8991	over	_
45-41	8992-9001	different	_
45-42	9002-9006	time	_
45-43	9007-9013	scales	_
45-44	9014-9015	(	_
45-45	9015-9018	i.e	_
45-46	9018-9019	.	_
45-47	9020-9029	different	_
45-48	9030-9036	levels	_
45-49	9037-9039	of	_
45-50	9040-9048	semantic	_
45-51	9049-9060	information	_
45-52	9061-9071	complexity	_
45-53	9071-9072	)	_
45-54	9073-9075	in	_
45-55	9076-9088	participants	_
45-56	9089-9093	with	_
45-57	9094-9107	schizophrenia	_
45-58	9108-9111	and	_
45-59	9112-9119	healthy	_
45-60	9120-9128	controls	_
45-61	9129-9130	(	_
45-62	9130-9133	Fig	_
45-63	9133-9134	.	_
45-64	9135-9137	1A	_
45-65	9137-9138	,	_
45-66	9139-9143	also	_
45-67	9144-9147	see	_
45-68	9147-9148	)	_
45-69	9148-9149	.	_

#Text=In addition, we characterized a group of non-manifesting siblings of patients with schizophrenia as a separate experimental group.
46-1	9150-9152	In	_
46-2	9153-9161	addition	_
46-3	9161-9162	,	_
46-4	9163-9165	we	_
46-5	9166-9179	characterized	_
46-6	9180-9181	a	_
46-7	9182-9187	group	_
46-8	9188-9190	of	_
46-9	9191-9206	non-manifesting	_
46-10	9207-9215	siblings	_
46-11	9216-9218	of	_
46-12	9219-9227	patients	_
46-13	9228-9232	with	_
46-14	9233-9246	schizophrenia	_
46-15	9247-9249	as	_
46-16	9250-9251	a	_
46-17	9252-9260	separate	_
46-18	9261-9273	experimental	_
46-19	9274-9279	group	_
46-20	9279-9280	.	_

#Text=There were several reasons to examine the siblings of patients as a separate group.
47-1	9281-9286	There	_
47-2	9287-9291	were	_
47-3	9292-9299	several	_
47-4	9300-9307	reasons	_
47-5	9308-9310	to	_
47-6	9311-9318	examine	_
47-7	9319-9322	the	_
47-8	9323-9331	siblings	_
47-9	9332-9334	of	_
47-10	9335-9343	patients	_
47-11	9344-9346	as	_
47-12	9347-9348	a	_
47-13	9349-9357	separate	_
47-14	9358-9363	group	_
47-15	9363-9364	.	_

#Text=First, cognitive information processing difficulties are seen in high-risk children and unaffected family members, suggesting an inherited origin for this cognitive deficiency.
48-1	9365-9370	First	_
48-2	9370-9371	,	_
48-3	9372-9381	cognitive	_
48-4	9382-9393	information	_
48-5	9394-9404	processing	_
48-6	9405-9417	difficulties	_
48-7	9418-9421	are	_
48-8	9422-9426	seen	_
48-9	9427-9429	in	_
48-10	9430-9439	high-risk	_
48-11	9440-9448	children	_
48-12	9449-9452	and	_
48-13	9453-9463	unaffected	_
48-14	9464-9470	family	_
48-15	9471-9478	members	_
48-16	9478-9479	,	_
48-17	9480-9490	suggesting	_
48-18	9491-9493	an	_
48-19	9494-9503	inherited	_
48-20	9504-9510	origin	_
48-21	9511-9514	for	_
48-22	9515-9519	this	_
48-23	9520-9529	cognitive	_
48-24	9530-9540	deficiency	_
48-25	9540-9541	.	_

#Text=Siblings, albeit to a lesser degree than patients, present with difficulties on a wide array of cognitive tasks, including working memory tasks, attention, language and facial expression recognition.
49-1	9542-9550	Siblings	_
49-2	9550-9551	,	_
49-3	9552-9558	albeit	_
49-4	9559-9561	to	_
49-5	9562-9563	a	_
49-6	9564-9570	lesser	_
49-7	9571-9577	degree	_
49-8	9578-9582	than	_
49-9	9583-9591	patients	_
49-10	9591-9592	,	_
49-11	9593-9600	present	_
49-12	9601-9605	with	_
49-13	9606-9618	difficulties	_
49-14	9619-9621	on	_
49-15	9622-9623	a	_
49-16	9624-9628	wide	_
49-17	9629-9634	array	_
49-18	9635-9637	of	_
49-19	9638-9647	cognitive	_
49-20	9648-9653	tasks	_
49-21	9653-9654	,	_
49-22	9655-9664	including	_
49-23	9665-9672	working	_
49-24	9673-9679	memory	_
49-25	9680-9685	tasks	_
49-26	9685-9686	,	_
49-27	9687-9696	attention	_
49-28	9696-9697	,	_
49-29	9698-9706	language	_
49-30	9707-9710	and	_
49-31	9711-9717	facial	_
49-32	9718-9728	expression	_
49-33	9729-9740	recognition	_
49-34	9740-9741	.	_

#Text=This is one of the pieces of evidence for the genetic basis of neuropsychological disturbances occurring in schizophrenia.
50-1	9742-9746	This	_
50-2	9747-9749	is	_
50-3	9750-9753	one	_
50-4	9754-9756	of	_
50-5	9757-9760	the	_
50-6	9761-9767	pieces	_
50-7	9768-9770	of	_
50-8	9771-9779	evidence	_
50-9	9780-9783	for	_
50-10	9784-9787	the	_
50-11	9788-9795	genetic	_
50-12	9796-9801	basis	_
50-13	9802-9804	of	_
50-14	9805-9823	neuropsychological	_
50-15	9824-9836	disturbances	_
50-16	9837-9846	occurring	_
50-17	9847-9849	in	_
50-18	9850-9863	schizophrenia	_
50-19	9863-9864	.	_

#Text=In general, according to elementary information processing, spatial working memory, and verbal memory may be candidates for cognitive endophenotypes in schizophrenia.
51-1	9865-9867	In	_
51-2	9868-9875	general	_
51-3	9875-9876	,	_
51-4	9877-9886	according	_
51-5	9887-9889	to	_
51-6	9890-9900	elementary	_
51-7	9901-9912	information	_
51-8	9913-9923	processing	_
51-9	9923-9924	,	_
51-10	9925-9932	spatial	_
51-11	9933-9940	working	_
51-12	9941-9947	memory	_
51-13	9947-9948	,	_
51-14	9949-9952	and	_
51-15	9953-9959	verbal	_
51-16	9960-9966	memory	_
51-17	9967-9970	may	_
51-18	9971-9973	be	_
51-19	9974-9984	candidates	_
51-20	9985-9988	for	_
51-21	9989-9998	cognitive	_
51-22	9999-10013	endophenotypes	_
51-23	10014-10016	in	_
51-24	10017-10030	schizophrenia	_
51-25	10030-10031	.	_

#Text=Second, an imaging study demonstrated that first degree relatives may share regional brain volume abnormalities with their affected/pathological siblings in many brain regions.
52-1	10032-10038	Second	_
52-2	10038-10039	,	_
52-3	10040-10042	an	_
52-4	10043-10050	imaging	_
52-5	10051-10056	study	_
52-6	10057-10069	demonstrated	_
52-7	10070-10074	that	_
52-8	10075-10080	first	_
52-9	10081-10087	degree	_
52-10	10088-10097	relatives	_
52-11	10098-10101	may	_
52-12	10102-10107	share	_
52-13	10108-10116	regional	_
52-14	10117-10122	brain	_
52-15	10123-10129	volume	_
52-16	10130-10143	abnormalities	_
52-17	10144-10148	with	_
52-18	10149-10154	their	_
52-19	10155-10163	affected	_
52-20	10163-10164	/	_
52-21	10164-10176	pathological	_
52-22	10177-10185	siblings	_
52-23	10186-10188	in	_
52-24	10189-10193	many	_
52-25	10194-10199	brain	_
52-26	10200-10207	regions	_
52-27	10207-10208	.	_

#Text=All in all, the characterized cognitive deficits provide support that a candidate endophenotype for an illness is associated with unaffected family members too.
53-1	10209-10212	All	_
53-2	10213-10215	in	_
53-3	10216-10219	all	_
53-4	10219-10220	,	_
53-5	10221-10224	the	_
53-6	10225-10238	characterized	_
53-7	10239-10248	cognitive	_
53-8	10249-10257	deficits	_
53-9	10258-10265	provide	_
53-10	10266-10273	support	_
53-11	10274-10278	that	_
53-12	10279-10280	a	_
53-13	10281-10290	candidate	_
53-14	10291-10304	endophenotype	_
53-15	10305-10308	for	_
53-16	10309-10311	an	_
53-17	10312-10319	illness	_
53-18	10320-10322	is	_
53-19	10323-10333	associated	_
53-20	10334-10338	with	_
53-21	10339-10349	unaffected	_
53-22	10350-10356	family	_
53-23	10357-10364	members	_
53-24	10365-10368	too	_
53-25	10368-10369	.	_

#Text=To examine the information integration within different brain areas in these groups, we employed two types of analyses.
54-1	10370-10372	To	_
54-2	10373-10380	examine	_
54-3	10381-10384	the	_
54-4	10385-10396	information	_
54-5	10397-10408	integration	_
54-6	10409-10415	within	_
54-7	10416-10425	different	_
54-8	10426-10431	brain	_
54-9	10432-10437	areas	_
54-10	10438-10440	in	_
54-11	10441-10446	these	_
54-12	10447-10453	groups	_
54-13	10453-10454	,	_
54-14	10455-10457	we	_
54-15	10458-10466	employed	_
54-16	10467-10470	two	_
54-17	10471-10476	types	_
54-18	10477-10479	of	_
54-19	10480-10488	analyses	_
54-20	10488-10489	.	_

#Text=First, we estimated response similarities within each group of participants, applying the inter-subject correlation (inter-SC) method.
55-1	10490-10495	First	_
55-2	10495-10496	,	_
55-3	10497-10499	we	_
55-4	10500-10509	estimated	_
55-5	10510-10518	response	_
55-6	10519-10531	similarities	_
55-7	10532-10538	within	_
55-8	10539-10543	each	_
55-9	10544-10549	group	_
55-10	10550-10552	of	_
55-11	10553-10565	participants	_
55-12	10565-10566	,	_
55-13	10567-10575	applying	_
55-14	10576-10579	the	_
55-15	10580-10593	inter-subject	_
55-16	10594-10605	correlation	_
55-17	10606-10607	(	_
55-18	10607-10615	inter-SC	_
55-19	10615-10616	)	_
55-20	10617-10623	method	_
55-21	10623-10624	.	_

#Text=This data-driven approach, successfully used in previous studies, shows where in the brain and to what extent the stimuli evoke reliably similar responses across individuals (see).
56-1	10625-10629	This	_
56-2	10630-10641	data-driven	_
56-3	10642-10650	approach	_
56-4	10650-10651	,	_
56-5	10652-10664	successfully	_
56-6	10665-10669	used	_
56-7	10670-10672	in	_
56-8	10673-10681	previous	_
56-9	10682-10689	studies	_
56-10	10689-10690	,	_
56-11	10691-10696	shows	_
56-12	10697-10702	where	_
56-13	10703-10705	in	_
56-14	10706-10709	the	_
56-15	10710-10715	brain	_
56-16	10716-10719	and	_
56-17	10720-10722	to	_
56-18	10723-10727	what	_
56-19	10728-10734	extent	_
56-20	10735-10738	the	_
56-21	10739-10746	stimuli	_
56-22	10747-10752	evoke	_
56-23	10753-10761	reliably	_
56-24	10762-10769	similar	_
56-25	10770-10779	responses	_
56-26	10780-10786	across	_
56-27	10787-10798	individuals	_
56-28	10799-10800	(	_
56-29	10800-10803	see	_
56-30	10803-10804	)	_
56-31	10804-10805	.	_

#Text=We asked whether processing of verbal information on different time scales shaped reliably similar neural patterns in the core perceptional areas as well as in the high order cognitive areas within all groups, or whether the neural similarity differs between groups due to diverse ability to integrate information, especially over prolonged time scales.
57-1	10806-10808	We	_
57-2	10809-10814	asked	_
57-3	10815-10822	whether	_
57-4	10823-10833	processing	_
57-5	10834-10836	of	_
57-6	10837-10843	verbal	_
57-7	10844-10855	information	_
57-8	10856-10858	on	_
57-9	10859-10868	different	_
57-10	10869-10873	time	_
57-11	10874-10880	scales	_
57-12	10881-10887	shaped	_
57-13	10888-10896	reliably	_
57-14	10897-10904	similar	_
57-15	10905-10911	neural	_
57-16	10912-10920	patterns	_
57-17	10921-10923	in	_
57-18	10924-10927	the	_
57-19	10928-10932	core	_
57-20	10933-10945	perceptional	_
57-21	10946-10951	areas	_
57-22	10952-10954	as	_
57-23	10955-10959	well	_
57-24	10960-10962	as	_
57-25	10963-10965	in	_
57-26	10966-10969	the	_
57-27	10970-10974	high	_
57-28	10975-10980	order	_
57-29	10981-10990	cognitive	_
57-30	10991-10996	areas	_
57-31	10997-11003	within	_
57-32	11004-11007	all	_
57-33	11008-11014	groups	_
57-34	11014-11015	,	_
57-35	11016-11018	or	_
57-36	11019-11026	whether	_
57-37	11027-11030	the	_
57-38	11031-11037	neural	_
57-39	11038-11048	similarity	_
57-40	11049-11056	differs	_
57-41	11057-11064	between	_
57-42	11065-11071	groups	_
57-43	11072-11075	due	_
57-44	11076-11078	to	_
57-45	11079-11086	diverse	_
57-46	11087-11094	ability	_
57-47	11095-11097	to	_
57-48	11098-11107	integrate	_
57-49	11108-11119	information	_
57-50	11119-11120	,	_
57-51	11121-11131	especially	_
57-52	11132-11136	over	_
57-53	11137-11146	prolonged	_
57-54	11147-11151	time	_
57-55	11152-11158	scales	_
57-56	11158-11159	.	_

#Text=In addition, we studied whether the ‘distance’ between patients' responses and the healthy cohort's response corresponded to the patients' clinical data.
58-1	11160-11162	In	_
58-2	11163-11171	addition	_
58-3	11171-11172	,	_
58-4	11173-11175	we	_
58-5	11176-11183	studied	_
58-6	11184-11191	whether	_
58-7	11192-11195	the	_
58-8	11196-11197	‘	_
58-9	11197-11205	distance	_
58-10	11205-11206	’	_
58-11	11207-11214	between	_
58-12	11215-11223	patients	_
58-13	11223-11224	'	_
58-14	11225-11234	responses	_
58-15	11235-11238	and	_
58-16	11239-11242	the	_
58-17	11243-11250	healthy	_
58-18	11251-11259	cohort's	_
58-19	11260-11268	response	_
58-20	11269-11281	corresponded	_
58-21	11282-11284	to	_
58-22	11285-11288	the	_
58-23	11289-11297	patients	_
58-24	11297-11298	'	_
58-25	11299-11307	clinical	_
58-26	11308-11312	data	_
58-27	11312-11313	.	_

#Text=Here we studied neural synchrony between patients' brains and average response of the healthy cohort; then we plotted the correlation between patient – healthy neural alignments and patients' syndrome scale rating.
59-1	11314-11318	Here	_
59-2	11319-11321	we	_
59-3	11322-11329	studied	_
59-4	11330-11336	neural	_
59-5	11337-11346	synchrony	_
59-6	11347-11354	between	_
59-7	11355-11363	patients	_
59-8	11363-11364	'	_
59-9	11365-11371	brains	_
59-10	11372-11375	and	_
59-11	11376-11383	average	_
59-12	11384-11392	response	_
59-13	11393-11395	of	_
59-14	11396-11399	the	_
59-15	11400-11407	healthy	_
59-16	11408-11414	cohort	_
59-17	11414-11415	;	_
59-18	11416-11420	then	_
59-19	11421-11423	we	_
59-20	11424-11431	plotted	_
59-21	11432-11435	the	_
59-22	11436-11447	correlation	_
59-23	11448-11455	between	_
59-24	11456-11463	patient	_
59-25	11464-11465	–	_
59-26	11466-11473	healthy	_
59-27	11474-11480	neural	_
59-28	11481-11491	alignments	_
59-29	11492-11495	and	_
59-30	11496-11504	patients	_
59-31	11504-11505	'	_
59-32	11506-11514	syndrome	_
59-33	11515-11520	scale	_
59-34	11521-11527	rating	_
59-35	11527-11528	.	_

#Text=The current study aims to identify critical aspects of temporal hierarchy of verbal information processing, by examining it in patients with first episode schizophrenia, their non-manifesting siblings and healthy controls.
60-1	11529-11532	The	_
60-2	11533-11540	current	_
60-3	11541-11546	study	_
60-4	11547-11551	aims	_
60-5	11552-11554	to	_
60-6	11555-11563	identify	_
60-7	11564-11572	critical	_
60-8	11573-11580	aspects	_
60-9	11581-11583	of	_
60-10	11584-11592	temporal	_
60-11	11593-11602	hierarchy	_
60-12	11603-11605	of	_
60-13	11606-11612	verbal	_
60-14	11613-11624	information	_
60-15	11625-11635	processing	_
60-16	11635-11636	,	_
60-17	11637-11639	by	_
60-18	11640-11649	examining	_
60-19	11650-11652	it	_
60-20	11653-11655	in	_
60-21	11656-11664	patients	_
60-22	11665-11669	with	_
60-23	11670-11675	first	_
60-24	11676-11683	episode	_
60-25	11684-11697	schizophrenia	_
60-26	11697-11698	,	_
60-27	11699-11704	their	_
60-28	11705-11720	non-manifesting	_
60-29	11721-11729	siblings	_
60-30	11730-11733	and	_
60-31	11734-11741	healthy	_
60-32	11742-11750	controls	_
60-33	11750-11751	.	_

#Text=Based on the evidence of multi-level impaired semantic processing and information integration among patients with schizophrenia we predict that in the early perceptional areas brain responses, which are driven mainly by the momentary incoming inputs, will be reliable across all groups and conditions.
61-1	11752-11757	Based	_
61-2	11758-11760	on	_
61-3	11761-11764	the	_
61-4	11765-11773	evidence	_
61-5	11774-11776	of	_
61-6	11777-11788	multi-level	_
61-7	11789-11797	impaired	_
61-8	11798-11806	semantic	_
61-9	11807-11817	processing	_
61-10	11818-11821	and	_
61-11	11822-11833	information	_
61-12	11834-11845	integration	_
61-13	11846-11851	among	_
61-14	11852-11860	patients	_
61-15	11861-11865	with	_
61-16	11866-11879	schizophrenia	_
61-17	11880-11882	we	_
61-18	11883-11890	predict	_
61-19	11891-11895	that	_
61-20	11896-11898	in	_
61-21	11899-11902	the	_
61-22	11903-11908	early	_
61-23	11909-11921	perceptional	_
61-24	11922-11927	areas	_
61-25	11928-11933	brain	_
61-26	11934-11943	responses	_
61-27	11943-11944	,	_
61-28	11945-11950	which	_
61-29	11951-11954	are	_
61-30	11955-11961	driven	_
61-31	11962-11968	mainly	_
61-32	11969-11971	by	_
61-33	11972-11975	the	_
61-34	11976-11985	momentary	_
61-35	11986-11994	incoming	_
61-36	11995-12001	inputs	_
61-37	12001-12002	,	_
61-38	12003-12007	will	_
61-39	12008-12010	be	_
61-40	12011-12019	reliable	_
61-41	12020-12026	across	_
61-42	12027-12030	all	_
61-43	12031-12037	groups	_
61-44	12038-12041	and	_
61-45	12042-12052	conditions	_
61-46	12052-12053	.	_

#Text=Also, we hypothesize that responses will be reliable in areas where coherent information at the sentence time scale is necessary to provide reliability; however, we predict disturbed recruitment of the high cognitive areas.
62-1	12054-12058	Also	_
62-2	12058-12059	,	_
62-3	12060-12062	we	_
62-4	12063-12074	hypothesize	_
62-5	12075-12079	that	_
62-6	12080-12089	responses	_
62-7	12090-12094	will	_
62-8	12095-12097	be	_
62-9	12098-12106	reliable	_
62-10	12107-12109	in	_
62-11	12110-12115	areas	_
62-12	12116-12121	where	_
62-13	12122-12130	coherent	_
62-14	12131-12142	information	_
62-15	12143-12145	at	_
62-16	12146-12149	the	_
62-17	12150-12158	sentence	_
62-18	12159-12163	time	_
62-19	12164-12169	scale	_
62-20	12170-12172	is	_
62-21	12173-12182	necessary	_
62-22	12183-12185	to	_
62-23	12186-12193	provide	_
62-24	12194-12205	reliability	_
62-25	12205-12206	;	_
62-26	12207-12214	however	_
62-27	12214-12215	,	_
62-28	12216-12218	we	_
62-29	12219-12226	predict	_
62-30	12227-12236	disturbed	_
62-31	12237-12248	recruitment	_
62-32	12249-12251	of	_
62-33	12252-12255	the	_
62-34	12256-12260	high	_
62-35	12261-12270	cognitive	_
62-36	12271-12276	areas	_
62-37	12276-12277	.	_

#Text=We expect that non-manifesting siblings will exhibit lower (although statistically significant) inter-SCs and thus less noticeable hierarchy in verbal information processing than healthy controls.
63-1	12278-12280	We	_
63-2	12281-12287	expect	_
63-3	12288-12292	that	_
63-4	12293-12308	non-manifesting	_
63-5	12309-12317	siblings	_
63-6	12318-12322	will	_
63-7	12323-12330	exhibit	_
63-8	12331-12336	lower	_
63-9	12337-12338	(	_
63-10	12338-12346	although	_
63-11	12347-12360	statistically	_
63-12	12361-12372	significant	_
63-13	12372-12373	)	_
63-14	12374-12383	inter-SCs	_
63-15	12384-12387	and	_
63-16	12388-12392	thus	_
63-17	12393-12397	less	_
63-18	12398-12408	noticeable	_
63-19	12409-12418	hierarchy	_
63-20	12419-12421	in	_
63-21	12422-12428	verbal	_
63-22	12429-12440	information	_
63-23	12441-12451	processing	_
63-24	12452-12456	than	_
63-25	12457-12464	healthy	_
63-26	12465-12473	controls	_
63-27	12473-12474	.	_

#Text=However, in contrast to their siblings with schizophrenia, we suppose to observe reliable responses in high cognitive areas which determine the context comprehension.
64-1	12475-12482	However	_
64-2	12482-12483	,	_
64-3	12484-12486	in	_
64-4	12487-12495	contrast	_
64-5	12496-12498	to	_
64-6	12499-12504	their	_
64-7	12505-12513	siblings	_
64-8	12514-12518	with	_
64-9	12519-12532	schizophrenia	_
64-10	12532-12533	,	_
64-11	12534-12536	we	_
64-12	12537-12544	suppose	_
64-13	12545-12547	to	_
64-14	12548-12555	observe	_
64-15	12556-12564	reliable	_
64-16	12565-12574	responses	_
64-17	12575-12577	in	_
64-18	12578-12582	high	_
64-19	12583-12592	cognitive	_
64-20	12593-12598	areas	_
64-21	12599-12604	which	_
64-22	12605-12614	determine	_
64-23	12615-12618	the	_
64-24	12619-12626	context	_
64-25	12627-12640	comprehension	_
64-26	12640-12641	.	_

#Text=Materials and methods
#Text=Participants
#Text=Three groups were evaluated: 16 inpatients with first episode schizophrenia recruited from the MAZOR Mental Health Center (3F; 19–46 years, mean age 27; 1 excluded (see Preprocessing section below)); 15 non-manifesting siblings of the patients (5F; 19–37 years, mean age 25; 1 excluded); 32 healthy participants (15 in the main study: 5F; 22–32 years, mean age 26; 12 additional participants (9F; 22–32 years, mean age 26) were used in the ROI selection, 5 excluded).
65-1	12642-12651	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[13]
65-2	12652-12655	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[13]
65-3	12656-12663	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[13]
65-4	12664-12676	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-5	12677-12682	Three	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-6	12683-12689	groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-7	12690-12694	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-8	12695-12704	evaluated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-9	12704-12705	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-10	12706-12708	16	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-11	12709-12719	inpatients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[15]
65-12	12720-12724	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[15]
65-13	12725-12730	first	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[15]
65-14	12731-12738	episode	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[15]
65-15	12739-12752	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[15]
65-16	12753-12762	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-17	12763-12767	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-18	12768-12771	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-19	12772-12777	MAZOR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-20	12778-12784	Mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-21	12785-12791	Health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-22	12792-12798	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-23	12799-12800	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-24	12800-12802	3F	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-25	12802-12803	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-26	12804-12806	19	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-27	12806-12807	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-28	12807-12809	46	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-29	12809-12810	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-30	12810-12815	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-31	12815-12816	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-32	12817-12821	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-33	12822-12825	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-34	12826-12828	27	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-35	12828-12829	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-36	12830-12831	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-37	12832-12840	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-38	12841-12842	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-39	12842-12845	see	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-40	12846-12859	Preprocessing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-41	12860-12867	section	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-42	12868-12873	below	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-43	12873-12874	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-44	12874-12875	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-45	12875-12876	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-46	12877-12879	15	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-47	12880-12895	non-manifesting	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[16]
65-48	12896-12904	siblings	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[16]
65-49	12905-12907	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[16]
65-50	12908-12911	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[16]
65-51	12912-12920	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[16]
65-52	12921-12922	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-53	12922-12924	5F	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-54	12924-12925	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-55	12926-12928	19	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-56	12928-12929	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-57	12929-12931	37	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-58	12931-12932	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-59	12932-12937	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-60	12937-12938	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-61	12939-12943	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-62	12944-12947	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-63	12948-12950	25	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-64	12950-12951	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-65	12952-12953	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-66	12954-12962	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-67	12962-12963	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-68	12963-12964	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-69	12965-12967	32	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-70	12968-12975	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[17]
65-71	12976-12988	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[17]
65-72	12989-12990	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-73	12990-12992	15	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-74	12993-12995	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-75	12996-12999	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-76	13000-13004	main	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-77	13005-13010	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-78	13010-13011	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-79	13012-13014	5F	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-80	13014-13015	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-81	13016-13018	22	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-82	13018-13019	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-83	13019-13021	32	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-84	13021-13022	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-85	13022-13027	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-86	13027-13028	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-87	13029-13033	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-88	13034-13037	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-89	13038-13040	26	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-90	13040-13041	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-91	13042-13044	12	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-92	13045-13055	additional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-93	13056-13068	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-94	13069-13070	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-95	13070-13072	9F	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-96	13072-13073	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-97	13074-13076	22	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-98	13076-13077	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-99	13077-13079	32	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-100	13079-13080	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-101	13080-13085	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-102	13085-13086	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-103	13087-13091	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-104	13092-13095	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-105	13096-13098	26	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-106	13098-13099	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-107	13100-13104	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-108	13105-13109	used	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-109	13110-13112	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-110	13113-13116	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-111	13117-13120	ROI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-112	13121-13130	selection	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-113	13130-13131	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-114	13132-13133	5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-115	13134-13142	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-116	13142-13143	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
65-117	13143-13144	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]

#Text=Socio-demographic characteristics of participants are presented in Table 1A.
66-1	13145-13162	Socio-demographic	_
66-2	13163-13178	characteristics	_
66-3	13179-13181	of	_
66-4	13182-13194	participants	_
66-5	13195-13198	are	_
66-6	13199-13208	presented	_
66-7	13209-13211	in	_
66-8	13212-13217	Table	_
66-9	13218-13220	1A	_
66-10	13220-13221	.	_

#Text=Patients were diagnosed by senior psychiatrists while hospitalized, based on the Structured Clinical Interview for DSM-IV Axis-I Disorders, Patient Edition (SCID-I/P,).
67-1	13222-13230	Patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-2	13231-13235	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-3	13236-13245	diagnosed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-4	13246-13248	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-5	13249-13255	senior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-6	13256-13269	psychiatrists	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-7	13270-13275	while	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-8	13276-13288	hospitalized	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-9	13288-13289	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-10	13290-13295	based	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-11	13296-13298	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-12	13299-13302	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
67-13	13303-13313	Structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-14	13314-13322	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-15	13323-13332	Interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-16	13333-13336	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-17	13337-13343	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-18	13344-13350	Axis-I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-19	13351-13360	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-20	13360-13361	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-21	13362-13369	Patient	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-22	13370-13377	Edition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-23	13378-13379	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-24	13379-13385	SCID-I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-25	13385-13386	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-26	13386-13387	P	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-27	13387-13388	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-28	13388-13389	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[19]
67-29	13389-13390	.	_

#Text=Severity of schizophrenia symptoms was assessed with the Positive and Negative Syndrome Scale (PANSS,).
68-1	13391-13399	Severity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-2	13400-13402	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-3	13403-13416	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-4	13417-13425	symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-5	13426-13429	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-6	13430-13438	assessed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-7	13439-13443	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-8	13444-13447	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-9	13448-13456	Positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[21]
68-10	13457-13460	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[21]
68-11	13461-13469	Negative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[21]
68-12	13470-13478	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[21]
68-13	13479-13484	Scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[21]
68-14	13485-13486	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-15	13486-13491	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-16	13491-13492	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-17	13492-13493	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-18	13493-13494	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]

#Text=Pharmacologic management including therapeutic doses of first-generation and second-generation antipsychotics used for the treatment and PANSS values are shown in Table 1B and Table 1C, respectively (for the individual details see Supplementary Table 1).
69-1	13495-13508	Pharmacologic	_
69-2	13509-13519	management	_
69-3	13520-13529	including	_
69-4	13530-13541	therapeutic	_
69-5	13542-13547	doses	_
69-6	13548-13550	of	_
69-7	13551-13567	first-generation	_
69-8	13568-13571	and	_
69-9	13572-13589	second-generation	_
69-10	13590-13604	antipsychotics	_
69-11	13605-13609	used	_
69-12	13610-13613	for	_
69-13	13614-13617	the	_
69-14	13618-13627	treatment	_
69-15	13628-13631	and	_
69-16	13632-13637	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
69-17	13638-13644	values	_
69-18	13645-13648	are	_
69-19	13649-13654	shown	_
69-20	13655-13657	in	_
69-21	13658-13663	Table	_
69-22	13664-13666	1B	_
69-23	13667-13670	and	_
69-24	13671-13676	Table	_
69-25	13677-13679	1C	_
69-26	13679-13680	,	_
69-27	13681-13693	respectively	_
69-28	13694-13695	(	_
69-29	13695-13698	for	_
69-30	13699-13702	the	_
69-31	13703-13713	individual	_
69-32	13714-13721	details	_
69-33	13722-13725	see	_
69-34	13726-13739	Supplementary	_
69-35	13740-13745	Table	_
69-36	13746-13747	1	_
69-37	13747-13748	)	_
69-38	13748-13749	.	_

#Text=The p values for statistical tests comparing gender, age, bilingualism and years of education are shown in Table 1D.
70-1	13750-13753	The	_
70-2	13754-13755	p	_
70-3	13756-13762	values	_
70-4	13763-13766	for	_
70-5	13767-13778	statistical	_
70-6	13779-13784	tests	_
70-7	13785-13794	comparing	_
70-8	13795-13801	gender	_
70-9	13801-13802	,	_
70-10	13803-13806	age	_
70-11	13806-13807	,	_
70-12	13808-13820	bilingualism	_
70-13	13821-13824	and	_
70-14	13825-13830	years	_
70-15	13831-13833	of	_
70-16	13834-13843	education	_
70-17	13844-13847	are	_
70-18	13848-13853	shown	_
70-19	13854-13856	in	_
70-20	13857-13862	Table	_
70-21	13863-13865	1D	_
70-22	13865-13866	.	_

#Text=The binary values (gender and bilingualism) were tested using the binomial exact test, whereas age and years of education were compared using the Kolmogorov-Smirnoff test since within group distributions for some parameters (e.g., age) were not normal.
71-1	13867-13870	The	_
71-2	13871-13877	binary	_
71-3	13878-13884	values	_
71-4	13885-13886	(	_
71-5	13886-13892	gender	_
71-6	13893-13896	and	_
71-7	13897-13909	bilingualism	_
71-8	13909-13910	)	_
71-9	13911-13915	were	_
71-10	13916-13922	tested	_
71-11	13923-13928	using	_
71-12	13929-13932	the	_
71-13	13933-13941	binomial	_
71-14	13942-13947	exact	_
71-15	13948-13952	test	_
71-16	13952-13953	,	_
71-17	13954-13961	whereas	_
71-18	13962-13965	age	_
71-19	13966-13969	and	_
71-20	13970-13975	years	_
71-21	13976-13978	of	_
71-22	13979-13988	education	_
71-23	13989-13993	were	_
71-24	13994-14002	compared	_
71-25	14003-14008	using	_
71-26	14009-14012	the	_
71-27	14013-14032	Kolmogorov-Smirnoff	_
71-28	14033-14037	test	_
71-29	14038-14043	since	_
71-30	14044-14050	within	_
71-31	14051-14056	group	_
71-32	14057-14070	distributions	_
71-33	14071-14074	for	_
71-34	14075-14079	some	_
71-35	14080-14090	parameters	_
71-36	14091-14092	(	_
71-37	14092-14095	e.g	_
71-38	14095-14096	.	_
71-39	14096-14097	,	_
71-40	14098-14101	age	_
71-41	14101-14102	)	_
71-42	14103-14107	were	_
71-43	14108-14111	not	_
71-44	14112-14118	normal	_
71-45	14118-14119	.	_

#Text=Patients with affective and organic mental disorders (other than schizophrenia), drug- or alcohol-induced psychoses were not included.
72-1	14120-14128	Patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-2	14129-14133	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-3	14134-14143	affective	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-4	14144-14147	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-5	14148-14155	organic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-6	14156-14162	mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-7	14163-14172	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-8	14173-14174	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-9	14174-14179	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-10	14180-14184	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-11	14185-14198	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-12	14198-14199	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-13	14199-14200	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-14	14201-14205	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-15	14205-14206	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-16	14207-14209	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-17	14210-14225	alcohol-induced	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-18	14226-14235	psychoses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-19	14236-14240	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-20	14241-14244	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-21	14245-14253	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]
72-22	14253-14254	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]

#Text=Medical and neurological illnesses were ruled out by reports from patients' treating physicians and medical records.
73-1	14255-14262	Medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-2	14263-14266	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-3	14267-14279	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-4	14280-14289	illnesses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-5	14290-14294	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-6	14295-14300	ruled	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-7	14301-14304	out	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-8	14305-14307	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-9	14308-14315	reports	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-10	14316-14320	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-11	14321-14329	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-12	14329-14330	'	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-13	14331-14339	treating	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-14	14340-14350	physicians	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-15	14351-14354	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-16	14355-14362	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-17	14363-14370	records	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
73-18	14370-14371	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]

#Text=Socio-demographic characteristics of individuals participated in the study (A), pharmacologic management (B), clinical characteristics for the patients with schizophrenia (C), and non-parametric statistical comparison between groups presented in p-values (D).
74-1	14372-14389	Socio-demographic	_
74-2	14390-14405	characteristics	_
74-3	14406-14408	of	_
74-4	14409-14420	individuals	_
74-5	14421-14433	participated	_
74-6	14434-14436	in	_
74-7	14437-14440	the	_
74-8	14441-14446	study	_
74-9	14447-14448	(	_
74-10	14448-14449	A	_
74-11	14449-14450	)	_
74-12	14450-14451	,	_
74-13	14452-14465	pharmacologic	_
74-14	14466-14476	management	_
74-15	14477-14478	(	_
74-16	14478-14479	B	_
74-17	14479-14480	)	_
74-18	14480-14481	,	_
74-19	14482-14490	clinical	_
74-20	14491-14506	characteristics	_
74-21	14507-14510	for	_
74-22	14511-14514	the	_
74-23	14515-14523	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]
74-24	14524-14528	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]
74-25	14529-14542	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[24]
74-26	14543-14544	(	_
74-27	14544-14545	C	_
74-28	14545-14546	)	_
74-29	14546-14547	,	_
74-30	14548-14551	and	_
74-31	14552-14566	non-parametric	_
74-32	14567-14578	statistical	_
74-33	14579-14589	comparison	_
74-34	14590-14597	between	_
74-35	14598-14604	groups	_
74-36	14605-14614	presented	_
74-37	14615-14617	in	_
74-38	14618-14626	p-values	_
74-39	14627-14628	(	_
74-40	14628-14629	D	_
74-41	14629-14630	)	_
74-42	14630-14631	.	_

#Text=The averaged doses of the medications, treatment duration and positive, negative and general psychopathology scores are shown. ⁎; first-generation agents, ⁎⁎; second-generation agents.
75-1	14632-14635	The	_
75-2	14636-14644	averaged	_
75-3	14645-14650	doses	_
75-4	14651-14653	of	_
75-5	14654-14657	the	_
75-6	14658-14669	medications	_
75-7	14669-14670	,	_
75-8	14671-14680	treatment	_
75-9	14681-14689	duration	_
75-10	14690-14693	and	_
75-11	14694-14702	positive	_
75-12	14702-14703	,	_
75-13	14704-14712	negative	_
75-14	14713-14716	and	_
75-15	14717-14724	general	_
75-16	14725-14740	psychopathology	_
75-17	14741-14747	scores	_
75-18	14748-14751	are	_
75-19	14752-14757	shown	_
75-20	14757-14758	.	_
75-21	14759-14760	⁎	_
75-22	14760-14761	;	_
75-23	14762-14778	first-generation	_
75-24	14779-14785	agents	_
75-25	14785-14786	,	_
75-26	14787-14788	⁎	_
75-27	14788-14789	⁎	_
75-28	14789-14790	;	_
75-29	14791-14808	second-generation	_
75-30	14809-14815	agents	_
75-31	14815-14816	.	_

#Text=Table 1\t \t
#Text=A.
76-1	14817-14822	Table	_
76-2	14823-14824	1	_
76-3	14828-14829	A	_
76-4	14829-14830	.	_

#Text=Socio-demographic characteristics of individuals participated in the study\t \t\tPatients with schizophrenia (N = 15)\tSiblings (N = 14)\tHealthy controls (main study, N = 15)\t \tMean\tSD\t%\tMean\tSD\t%\tMean\tSD\t%\t \tGender\t\t\t20 F\t\t\t36 F\t\t\t33 F\t \tBilingualism\t\t\t40 bil\t\t\t50 bil\t\t\t33 bil\t \tYears of education\t11.8\t1.9\t\t13.6\t2.7\t\t13.3\t1.4\t\t \tAge\t26.9\t7.5\t\t25\t5.8\t\t25.7\t3.5\t\t \tHandedness\t\t\t100 R\t\t\t100 R\t\t\t100 R\t \t  \t \t
#Text=B.
77-1	14831-14848	Socio-demographic	_
77-2	14849-14864	characteristics	_
77-3	14865-14867	of	_
77-4	14868-14879	individuals	_
77-5	14880-14892	participated	_
77-6	14893-14895	in	_
77-7	14896-14899	the	_
77-8	14900-14905	study	_
77-9	14909-14917	Patients	_
77-10	14918-14922	with	_
77-11	14923-14936	schizophrenia	_
77-12	14937-14938	(	_
77-13	14938-14939	N	_
77-14	14939-14940	 	_
77-15	14940-14941	=	_
77-16	14941-14942	 	_
77-17	14942-14944	15	_
77-18	14944-14945	)	_
77-19	14946-14954	Siblings	_
77-20	14955-14956	(	_
77-21	14956-14957	N	_
77-22	14957-14958	 	_
77-23	14958-14959	=	_
77-24	14959-14960	 	_
77-25	14960-14962	14	_
77-26	14962-14963	)	_
77-27	14964-14971	Healthy	_
77-28	14972-14980	controls	_
77-29	14981-14982	(	_
77-30	14982-14986	main	_
77-31	14987-14992	study	_
77-32	14992-14993	,	_
77-33	14994-14995	N	_
77-34	14995-14996	 	_
77-35	14996-14997	=	_
77-36	14997-14998	 	_
77-37	14998-15000	15	_
77-38	15000-15001	)	_
77-39	15004-15008	Mean	_
77-40	15009-15011	SD	_
77-41	15012-15013	%	_
77-42	15014-15018	Mean	_
77-43	15019-15021	SD	_
77-44	15022-15023	%	_
77-45	15024-15028	Mean	_
77-46	15029-15031	SD	_
77-47	15032-15033	%	_
77-48	15036-15042	Gender	_
77-49	15045-15047	20	_
77-50	15047-15048	 	_
77-51	15048-15049	F	_
77-52	15052-15054	36	_
77-53	15054-15055	 	_
77-54	15055-15056	F	_
77-55	15059-15061	33	_
77-56	15061-15062	 	_
77-57	15062-15063	F	_
77-58	15066-15078	Bilingualism	_
77-59	15081-15083	40	_
77-60	15084-15087	bil	_
77-61	15090-15092	50	_
77-62	15093-15096	bil	_
77-63	15099-15101	33	_
77-64	15102-15105	bil	_
77-65	15108-15113	Years	_
77-66	15114-15116	of	_
77-67	15117-15126	education	_
77-68	15127-15131	11.8	_
77-69	15132-15135	1.9	_
77-70	15137-15141	13.6	_
77-71	15142-15145	2.7	_
77-72	15147-15151	13.3	_
77-73	15152-15155	1.4	_
77-74	15159-15162	Age	_
77-75	15163-15167	26.9	_
77-76	15168-15171	7.5	_
77-77	15173-15175	25	_
77-78	15176-15179	5.8	_
77-79	15181-15185	25.7	_
77-80	15186-15189	3.5	_
77-81	15193-15203	Handedness	_
77-82	15206-15209	100	_
77-83	15210-15211	R	_
77-84	15214-15217	100	_
77-85	15218-15219	R	_
77-86	15222-15225	100	_
77-87	15226-15227	R	_
77-88	15236-15237	B	_
77-89	15237-15238	.	_

#Text=Pharmacologic management for the treating patients with schizophrenia\t \tPharmacological name of antipsychotic, antidepressant and mood stabilizer\tDose: mean(mg); SD\tCloropromazine equivalent: Mean (mg/day); SD\tTreatment duration: mean (months); SD\t \tRisperidone⁎⁎\t5; 1.4\t250; 71\t3.3; 1.1\t \tQuetiapine⁎⁎\t433; 151\t577; 201\t4.8; 3.4\t \tZuclopenthixol⁎\t207; 143\t104; 71\t3.9; 3.2\t \tHaloperidol⁎\t2; 0\t167; 115\t4; 1.7\t \tAmisulpride⁎⁎\t350; 71\t175; 35\t8; 4.2\t \tClozapine⁎⁎\t200; 0\t600; 0\t5; 0\t \tOlanzapine⁎⁎\t12; 4\t240; 89\t2.4; 0.6\t \tClotiapine⁎⁎\t30; 14\t75; 35\t8.3; 3.9\t \tClonazepam\t5; 0\t\t1.5; 0\t \tLamotrigine\t125; 0\t\t4; 0\t \tClomipramine\t75; 0\t\t11; 0\t \tValproic acid\t1000; 0\t\t4; 1.4\t \t⁎first-generation agents; ⁎⁎second-generation agents\t \t  \t \t
#Text=C.
78-1	15239-15252	Pharmacologic	_
78-2	15253-15263	management	_
78-3	15264-15267	for	_
78-4	15268-15271	the	_
78-5	15272-15280	treating	_
78-6	15281-15289	patients	_
78-7	15290-15294	with	_
78-8	15295-15308	schizophrenia	_
78-9	15311-15326	Pharmacological	_
78-10	15327-15331	name	_
78-11	15332-15334	of	_
78-12	15335-15348	antipsychotic	_
78-13	15348-15349	,	_
78-14	15350-15364	antidepressant	_
78-15	15365-15368	and	_
78-16	15369-15373	mood	_
78-17	15374-15384	stabilizer	_
78-18	15385-15389	Dose	_
78-19	15389-15390	:	_
78-20	15391-15395	mean	_
78-21	15395-15396	(	_
78-22	15396-15398	mg	_
78-23	15398-15399	)	_
78-24	15399-15400	;	_
78-25	15401-15403	SD	_
78-26	15404-15418	Cloropromazine	_
78-27	15419-15429	equivalent	_
78-28	15429-15430	:	_
78-29	15431-15435	Mean	_
78-30	15436-15437	(	_
78-31	15437-15439	mg	_
78-32	15439-15440	/	_
78-33	15440-15443	day	_
78-34	15443-15444	)	_
78-35	15444-15445	;	_
78-36	15446-15448	SD	_
78-37	15449-15458	Treatment	_
78-38	15459-15467	duration	_
78-39	15467-15468	:	_
78-40	15469-15473	mean	_
78-41	15474-15475	(	_
78-42	15475-15481	months	_
78-43	15481-15482	)	_
78-44	15482-15483	;	_
78-45	15484-15486	SD	_
78-46	15489-15500	Risperidone	_
78-47	15500-15501	⁎	_
78-48	15501-15502	⁎	_
78-49	15503-15504	5	_
78-50	15504-15505	;	_
78-51	15506-15509	1.4	_
78-52	15510-15513	250	_
78-53	15513-15514	;	_
78-54	15515-15517	71	_
78-55	15518-15521	3.3	_
78-56	15521-15522	;	_
78-57	15523-15526	1.1	_
78-58	15529-15539	Quetiapine	_
78-59	15539-15540	⁎	_
78-60	15540-15541	⁎	_
78-61	15542-15545	433	_
78-62	15545-15546	;	_
78-63	15547-15550	151	_
78-64	15551-15554	577	_
78-65	15554-15555	;	_
78-66	15556-15559	201	_
78-67	15560-15563	4.8	_
78-68	15563-15564	;	_
78-69	15565-15568	3.4	_
78-70	15571-15585	Zuclopenthixol	_
78-71	15585-15586	⁎	_
78-72	15587-15590	207	_
78-73	15590-15591	;	_
78-74	15592-15595	143	_
78-75	15596-15599	104	_
78-76	15599-15600	;	_
78-77	15601-15603	71	_
78-78	15604-15607	3.9	_
78-79	15607-15608	;	_
78-80	15609-15612	3.2	_
78-81	15615-15626	Haloperidol	_
78-82	15626-15627	⁎	_
78-83	15628-15629	2	_
78-84	15629-15630	;	_
78-85	15631-15632	0	_
78-86	15633-15636	167	_
78-87	15636-15637	;	_
78-88	15638-15641	115	_
78-89	15642-15643	4	_
78-90	15643-15644	;	_
78-91	15645-15648	1.7	_
78-92	15651-15662	Amisulpride	_
78-93	15662-15663	⁎	_
78-94	15663-15664	⁎	_
78-95	15665-15668	350	_
78-96	15668-15669	;	_
78-97	15670-15672	71	_
78-98	15673-15676	175	_
78-99	15676-15677	;	_
78-100	15678-15680	35	_
78-101	15681-15682	8	_
78-102	15682-15683	;	_
78-103	15684-15687	4.2	_
78-104	15690-15699	Clozapine	_
78-105	15699-15700	⁎	_
78-106	15700-15701	⁎	_
78-107	15702-15705	200	_
78-108	15705-15706	;	_
78-109	15707-15708	0	_
78-110	15709-15712	600	_
78-111	15712-15713	;	_
78-112	15714-15715	0	_
78-113	15716-15717	5	_
78-114	15717-15718	;	_
78-115	15719-15720	0	_
78-116	15723-15733	Olanzapine	_
78-117	15733-15734	⁎	_
78-118	15734-15735	⁎	_
78-119	15736-15738	12	_
78-120	15738-15739	;	_
78-121	15740-15741	4	_
78-122	15742-15745	240	_
78-123	15745-15746	;	_
78-124	15747-15749	89	_
78-125	15750-15753	2.4	_
78-126	15753-15754	;	_
78-127	15755-15758	0.6	_
78-128	15761-15771	Clotiapine	_
78-129	15771-15772	⁎	_
78-130	15772-15773	⁎	_
78-131	15774-15776	30	_
78-132	15776-15777	;	_
78-133	15778-15780	14	_
78-134	15781-15783	75	_
78-135	15783-15784	;	_
78-136	15785-15787	35	_
78-137	15788-15791	8.3	_
78-138	15791-15792	;	_
78-139	15793-15796	3.9	_
78-140	15799-15809	Clonazepam	_
78-141	15810-15811	5	_
78-142	15811-15812	;	_
78-143	15813-15814	0	_
78-144	15816-15819	1.5	_
78-145	15819-15820	;	_
78-146	15821-15822	0	_
78-147	15825-15836	Lamotrigine	_
78-148	15837-15840	125	_
78-149	15840-15841	;	_
78-150	15842-15843	0	_
78-151	15845-15846	4	_
78-152	15846-15847	;	_
78-153	15848-15849	0	_
78-154	15852-15864	Clomipramine	_
78-155	15865-15867	75	_
78-156	15867-15868	;	_
78-157	15869-15870	0	_
78-158	15872-15874	11	_
78-159	15874-15875	;	_
78-160	15876-15877	0	_
78-161	15880-15888	Valproic	_
78-162	15889-15893	acid	_
78-163	15894-15898	1000	_
78-164	15898-15899	;	_
78-165	15900-15901	0	_
78-166	15903-15904	4	_
78-167	15904-15905	;	_
78-168	15906-15909	1.4	_
78-169	15912-15913	⁎	_
78-170	15913-15929	first-generation	_
78-171	15930-15936	agents	_
78-172	15936-15937	;	_
78-173	15938-15939	⁎	_
78-174	15939-15940	⁎	_
78-175	15940-15957	second-generation	_
78-176	15958-15964	agents	_
78-177	15973-15974	C	_
78-178	15974-15975	.	_

#Text=Clinical characteristics for the patients with schizophrenia\t \t\tDiagnosed (months)\tPANSS total\tPANSS positive\tPANSS negative\tPANSS general\t \tMean; SD\t4.5; 3.1\t91.5; 25.7\t21.7; 6.2\t25.3; 7.2\t44.4; 14.8\t \t  \t \t
#Text=D.
79-1	15976-15984	Clinical	_
79-2	15985-16000	characteristics	_
79-3	16001-16004	for	_
79-4	16005-16008	the	_
79-5	16009-16017	patients	_
79-6	16018-16022	with	_
79-7	16023-16036	schizophrenia	_
79-8	16040-16049	Diagnosed	_
79-9	16050-16051	(	_
79-10	16051-16057	months	_
79-11	16057-16058	)	_
79-12	16059-16064	PANSS	_
79-13	16065-16070	total	_
79-14	16071-16076	PANSS	_
79-15	16077-16085	positive	_
79-16	16086-16091	PANSS	_
79-17	16092-16100	negative	_
79-18	16101-16106	PANSS	_
79-19	16107-16114	general	_
79-20	16117-16121	Mean	_
79-21	16121-16122	;	_
79-22	16123-16125	SD	_
79-23	16126-16129	4.5	_
79-24	16129-16130	;	_
79-25	16131-16134	3.1	_
79-26	16135-16139	91.5	_
79-27	16139-16140	;	_
79-28	16141-16145	25.7	_
79-29	16146-16150	21.7	_
79-30	16150-16151	;	_
79-31	16152-16155	6.2	_
79-32	16156-16160	25.3	_
79-33	16160-16161	;	_
79-34	16162-16165	7.2	_
79-35	16166-16170	44.4	_
79-36	16170-16171	;	_
79-37	16172-16176	14.8	_
79-38	16185-16186	D	_
79-39	16186-16187	.	_

#Text=Statistical comparison between groups\t \t\tHealthy – patients\tSiblings – patients\tHealthy – siblings\t \tAge\t0.31\t0.32\t0.48\t \tYears of education\t0.05\t0.24\t0.17\t \tThe differences between groups (p values) were defined by the Kolmogorov-Smirnoff test\t \t  \t \t
#Text=Gender\t \t\tHealthy\tSiblings\tPatients\t \tHealthy\t\t0.20\t0.16\t \tSiblings\t0.38\t\t0.06\t \tPatients\t0.08\t0.02*\t\t \tThe differences between groups (p values) were defined by the binomial exact test\t \t  \t \t
#Text=Mother language\t \t\tHealthy\tSiblings\tPatients\t \tHealthy\t\t0.21\t0.40\t \tSiblings\t0.08\t\t0.21\t \tPatients\t0.20\t0.40\t\t \t
#Text=The differences between groups (p values) were defined by the binomial exact test.
80-1	16188-16199	Statistical	_
80-2	16200-16210	comparison	_
80-3	16211-16218	between	_
80-4	16219-16225	groups	_
80-5	16229-16236	Healthy	_
80-6	16237-16238	–	_
80-7	16239-16247	patients	_
80-8	16248-16256	Siblings	_
80-9	16257-16258	–	_
80-10	16259-16267	patients	_
80-11	16268-16275	Healthy	_
80-12	16276-16277	–	_
80-13	16278-16286	siblings	_
80-14	16289-16292	Age	_
80-15	16293-16297	0.31	_
80-16	16298-16302	0.32	_
80-17	16303-16307	0.48	_
80-18	16310-16315	Years	_
80-19	16316-16318	of	_
80-20	16319-16328	education	_
80-21	16329-16333	0.05	_
80-22	16334-16338	0.24	_
80-23	16339-16343	0.17	_
80-24	16346-16349	The	_
80-25	16350-16361	differences	_
80-26	16362-16369	between	_
80-27	16370-16376	groups	_
80-28	16377-16378	(	_
80-29	16378-16379	p	_
80-30	16380-16386	values	_
80-31	16386-16387	)	_
80-32	16388-16392	were	_
80-33	16393-16400	defined	_
80-34	16401-16403	by	_
80-35	16404-16407	the	_
80-36	16408-16427	Kolmogorov-Smirnoff	_
80-37	16428-16432	test	_
80-38	16441-16447	Gender	_
80-39	16451-16458	Healthy	_
80-40	16459-16467	Siblings	_
80-41	16468-16476	Patients	_
80-42	16479-16486	Healthy	_
80-43	16488-16492	0.20	_
80-44	16493-16497	0.16	_
80-45	16500-16508	Siblings	_
80-46	16509-16513	0.38	_
80-47	16515-16519	0.06	_
80-48	16522-16530	Patients	_
80-49	16531-16535	0.08	_
80-50	16536-16540	0.02	_
80-51	16540-16541	*	_
80-52	16545-16548	The	_
80-53	16549-16560	differences	_
80-54	16561-16568	between	_
80-55	16569-16575	groups	_
80-56	16576-16577	(	_
80-57	16577-16578	p	_
80-58	16579-16585	values	_
80-59	16585-16586	)	_
80-60	16587-16591	were	_
80-61	16592-16599	defined	_
80-62	16600-16602	by	_
80-63	16603-16606	the	_
80-64	16607-16615	binomial	_
80-65	16616-16621	exact	_
80-66	16622-16626	test	_
80-67	16635-16641	Mother	_
80-68	16642-16650	language	_
80-69	16654-16661	Healthy	_
80-70	16662-16670	Siblings	_
80-71	16671-16679	Patients	_
80-72	16682-16689	Healthy	_
80-73	16691-16695	0.21	_
80-74	16696-16700	0.40	_
80-75	16703-16711	Siblings	_
80-76	16712-16716	0.08	_
80-77	16718-16722	0.21	_
80-78	16725-16733	Patients	_
80-79	16734-16738	0.20	_
80-80	16739-16743	0.40	_
80-81	16748-16751	The	_
80-82	16752-16763	differences	_
80-83	16764-16771	between	_
80-84	16772-16778	groups	_
80-85	16779-16780	(	_
80-86	16780-16781	p	_
80-87	16782-16788	values	_
80-88	16788-16789	)	_
80-89	16790-16794	were	_
80-90	16795-16802	defined	_
80-91	16803-16805	by	_
80-92	16806-16809	the	_
80-93	16810-16818	binomial	_
80-94	16819-16824	exact	_
80-95	16825-16829	test	_
80-96	16829-16830	.	_

#Text=Healthy participants were recruited from the local community, and reported no previous neurological or psychiatric symptoms or hearing impairments.
81-1	16831-16838	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[26]
81-2	16839-16851	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[26]
81-3	16852-16856	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-4	16857-16866	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-5	16867-16871	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-6	16872-16875	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-7	16876-16881	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-8	16882-16891	community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-9	16891-16892	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-10	16893-16896	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-11	16897-16905	reported	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-12	16906-16908	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-13	16909-16917	previous	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-14	16918-16930	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-15	16931-16933	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-16	16934-16945	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-17	16946-16954	symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-18	16955-16957	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-19	16958-16965	hearing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-20	16966-16977	impairments	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
81-21	16977-16978	.	_

#Text=All participants were Hebrew speakers with adequate language comprehension.
82-1	16979-16982	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
82-2	16983-16995	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
82-3	16996-17000	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
82-4	17001-17007	Hebrew	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
82-5	17008-17016	speakers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
82-6	17017-17021	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
82-7	17022-17030	adequate	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
82-8	17031-17039	language	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
82-9	17040-17053	comprehension	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
82-10	17053-17054	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]

#Text=Procedures were approved by the Helsinki Committee on Activities Involving Human Subjects in Tel Aviv Sourasky Medical Center (TASMC) and MAZOR Mental Health Center; all participants provided written informed consent to participate in the study.
#Text=fMRI data acquisition
#Text=fMRI scanning was performed with a 3.0 T Signa Excite echo speed scanner (General Electric Medical Systems), using an 8-channel head coil, at TASMC.
83-1	17055-17065	Procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-2	17066-17070	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-3	17071-17079	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-4	17080-17082	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-5	17083-17086	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-6	17087-17095	Helsinki	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-7	17096-17105	Committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-8	17106-17108	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-9	17109-17119	Activities	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-10	17120-17129	Involving	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-11	17130-17135	Human	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-12	17136-17144	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-13	17145-17147	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-14	17148-17151	Tel	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-15	17152-17156	Aviv	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-16	17157-17165	Sourasky	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-17	17166-17173	Medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-18	17174-17180	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-19	17181-17182	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-20	17182-17187	TASMC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-21	17187-17188	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-22	17189-17192	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-23	17193-17198	MAZOR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-24	17199-17205	Mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-25	17206-17212	Health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-26	17213-17219	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-27	17219-17220	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-28	17221-17224	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-29	17225-17237	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-30	17238-17246	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-31	17247-17254	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-32	17255-17263	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-33	17264-17271	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-34	17272-17274	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-35	17275-17286	participate	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-36	17287-17289	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-37	17290-17293	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-38	17294-17299	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-39	17299-17300	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-40	17301-17305	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[29]
83-41	17306-17310	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-42	17311-17322	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-43	17323-17327	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[30]
83-44	17328-17336	scanning	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-45	17337-17340	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-46	17341-17350	performed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-47	17351-17355	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-48	17356-17357	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-49	17358-17361	3.0	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-50	17361-17362	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-51	17362-17363	T	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-52	17364-17369	Signa	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-53	17370-17376	Excite	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-54	17377-17381	echo	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-55	17382-17387	speed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-56	17388-17395	scanner	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-57	17396-17397	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-58	17397-17404	General	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-59	17405-17413	Electric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-60	17414-17421	Medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-61	17422-17429	Systems	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-62	17429-17430	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-63	17430-17431	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-64	17432-17437	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-65	17438-17440	an	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-66	17441-17442	8	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-67	17442-17443	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-68	17443-17450	channel	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-69	17451-17455	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-70	17456-17460	coil	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-71	17460-17461	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-72	17462-17464	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-73	17465-17470	TASMC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]
83-74	17470-17471	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[28]

#Text=Structural scans included a T1-weighted 3D axial spoiled gradient echo (SPGR) pulse sequence (repetition time (TR)/echo time (TE) = 8.94/3.48 ms, slice thickness = 1 mm, flip angle = 13°, pixel size = 1 mm, field-of-view (FOV) = 256 × 256 mm).
84-1	17472-17482	Structural	_
84-2	17483-17488	scans	_
84-3	17489-17497	included	_
84-4	17498-17499	a	_
84-5	17500-17502	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[31]
84-6	17502-17503	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[31]
84-7	17503-17511	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[31]
84-8	17512-17514	3D	_
84-9	17515-17520	axial	_
84-10	17521-17528	spoiled	_
84-11	17529-17537	gradient	_
84-12	17538-17542	echo	_
84-13	17543-17544	(	_
84-14	17544-17548	SPGR	_
84-15	17548-17549	)	_
84-16	17550-17555	pulse	_
84-17	17556-17564	sequence	_
84-18	17565-17566	(	_
84-19	17566-17576	repetition	_
84-20	17577-17581	time	_
84-21	17582-17583	(	_
84-22	17583-17585	TR	_
84-23	17585-17586	)	_
84-24	17586-17587	/	_
84-25	17587-17591	echo	_
84-26	17592-17596	time	_
84-27	17597-17598	(	_
84-28	17598-17600	TE	_
84-29	17600-17601	)	_
84-30	17601-17602	 	_
84-31	17602-17603	=	_
84-32	17603-17604	 	_
84-33	17604-17608	8.94	_
84-34	17608-17609	/	_
84-35	17609-17613	3.48	_
84-36	17613-17614	 	_
84-37	17614-17616	ms	_
84-38	17616-17617	,	_
84-39	17618-17623	slice	_
84-40	17624-17633	thickness	_
84-41	17633-17634	 	_
84-42	17634-17635	=	_
84-43	17635-17636	 	_
84-44	17636-17637	1	_
84-45	17637-17638	 	_
84-46	17638-17640	mm	_
84-47	17640-17641	,	_
84-48	17642-17646	flip	_
84-49	17647-17652	angle	_
84-50	17652-17653	 	_
84-51	17653-17654	=	_
84-52	17654-17655	 	_
84-53	17655-17657	13	_
84-54	17657-17658	°	_
84-55	17658-17659	,	_
84-56	17660-17665	pixel	_
84-57	17666-17670	size	_
84-58	17670-17671	 	_
84-59	17671-17672	=	_
84-60	17672-17673	 	_
84-61	17673-17674	1	_
84-62	17674-17675	 	_
84-63	17675-17677	mm	_
84-64	17677-17678	,	_
84-65	17679-17692	field-of-view	_
84-66	17693-17694	(	_
84-67	17694-17697	FOV	_
84-68	17697-17698	)	_
84-69	17698-17699	 	_
84-70	17699-17700	=	_
84-71	17700-17701	 	_
84-72	17701-17704	256	_
84-73	17704-17705	 	_
84-74	17705-17706	×	_
84-75	17706-17707	 	_
84-76	17707-17710	256	_
84-77	17710-17711	 	_
84-78	17711-17713	mm	_
84-79	17713-17714	)	_
84-80	17714-17715	.	_

#Text=Functional whole-brain scans were performed in interleaved order with a T2*-weighted gradient echo planar imaging pulse sequence (TR/TE = 3000/35 ms, flip angle = 90°, pixel size = 1.56 mm, FOV = 200 × 200 mm, slice thickness = 3 mm, 39 slices/volume).
85-1	17716-17726	Functional	_
85-2	17727-17738	whole-brain	_
85-3	17739-17744	scans	_
85-4	17745-17749	were	_
85-5	17750-17759	performed	_
85-6	17760-17762	in	_
85-7	17763-17774	interleaved	_
85-8	17775-17780	order	_
85-9	17781-17785	with	_
85-10	17786-17787	a	_
85-11	17788-17790	T2	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[32]
85-12	17790-17791	*	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[32]
85-13	17791-17792	-	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[32]
85-14	17792-17800	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[32]
85-15	17801-17809	gradient	_
85-16	17810-17814	echo	_
85-17	17815-17821	planar	_
85-18	17822-17829	imaging	_
85-19	17830-17835	pulse	_
85-20	17836-17844	sequence	_
85-21	17845-17846	(	_
85-22	17846-17848	TR	_
85-23	17848-17849	/	_
85-24	17849-17851	TE	_
85-25	17851-17852	 	_
85-26	17852-17853	=	_
85-27	17853-17854	 	_
85-28	17854-17858	3000	_
85-29	17858-17859	/	_
85-30	17859-17861	35	_
85-31	17861-17862	 	_
85-32	17862-17864	ms	_
85-33	17864-17865	,	_
85-34	17866-17870	flip	_
85-35	17871-17876	angle	_
85-36	17876-17877	 	_
85-37	17877-17878	=	_
85-38	17878-17879	 	_
85-39	17879-17881	90	_
85-40	17881-17882	°	_
85-41	17882-17883	,	_
85-42	17884-17889	pixel	_
85-43	17890-17894	size	_
85-44	17894-17895	 	_
85-45	17895-17896	=	_
85-46	17896-17897	 	_
85-47	17897-17901	1.56	_
85-48	17901-17902	 	_
85-49	17902-17904	mm	_
85-50	17904-17905	,	_
85-51	17906-17909	FOV	_
85-52	17909-17910	 	_
85-53	17910-17911	=	_
85-54	17911-17912	 	_
85-55	17912-17915	200	_
85-56	17915-17916	 	_
85-57	17916-17917	×	_
85-58	17917-17918	 	_
85-59	17918-17921	200	_
85-60	17921-17922	 	_
85-61	17922-17924	mm	_
85-62	17924-17925	,	_
85-63	17926-17931	slice	_
85-64	17932-17941	thickness	_
85-65	17941-17942	 	_
85-66	17942-17943	=	_
85-67	17943-17944	 	_
85-68	17944-17945	3	_
85-69	17945-17946	 	_
85-70	17946-17948	mm	_
85-71	17948-17949	,	_
85-72	17950-17952	39	_
85-73	17953-17959	slices	_
85-74	17959-17960	/	_
85-75	17960-17966	volume	_
85-76	17966-17967	)	_
85-77	17967-17968	.	_

#Text=MRI-compatible headphones (OPTOACTIVEtm) were used to considerably attenuate the scanner noise and to present the audio stimuli.
86-1	17969-17983	MRI-compatible	_
86-2	17984-17994	headphones	_
86-3	17995-17996	(	_
86-4	17996-18008	OPTOACTIVEtm	_
86-5	18008-18009	)	_
86-6	18010-18014	were	_
86-7	18015-18019	used	_
86-8	18020-18022	to	_
86-9	18023-18035	considerably	_
86-10	18036-18045	attenuate	_
86-11	18046-18049	the	_
86-12	18050-18057	scanner	_
86-13	18058-18063	noise	_
86-14	18064-18067	and	_
86-15	18068-18070	to	_
86-16	18071-18078	present	_
86-17	18079-18082	the	_
86-18	18083-18088	audio	_
86-19	18089-18096	stimuli	_
86-20	18096-18097	.	_

#Text=Stimuli and experimental procedure
#Text=Stimuli were generated from an 8-min narrated story told in Hebrew by a professional storyteller.
87-1	18098-18105	Stimuli	_
87-2	18106-18109	and	_
87-3	18110-18122	experimental	_
87-4	18123-18132	procedure	_
87-5	18133-18140	Stimuli	_
87-6	18141-18145	were	_
87-7	18146-18155	generated	_
87-8	18156-18160	from	_
87-9	18161-18163	an	_
87-10	18164-18165	8	_
87-11	18165-18166	-	_
87-12	18166-18169	min	_
87-13	18170-18178	narrated	_
87-14	18179-18184	story	_
87-15	18185-18189	told	_
87-16	18190-18192	in	_
87-17	18193-18199	Hebrew	_
87-18	18200-18202	by	_
87-19	18203-18204	a	_
87-20	18205-18217	professional	_
87-21	18218-18229	storyteller	_
87-22	18229-18230	.	_

#Text=Participants listened to the whole story (forward condition), as well as to stimuli created by scrambling of the language structures in the story (Fig. 1A).
88-1	18231-18243	Participants	_
88-2	18244-18252	listened	_
88-3	18253-18255	to	_
88-4	18256-18259	the	_
88-5	18260-18265	whole	_
88-6	18266-18271	story	_
88-7	18272-18273	(	_
88-8	18273-18280	forward	_
88-9	18281-18290	condition	_
88-10	18290-18291	)	_
88-11	18291-18292	,	_
88-12	18293-18295	as	_
88-13	18296-18300	well	_
88-14	18301-18303	as	_
88-15	18304-18306	to	_
88-16	18307-18314	stimuli	_
88-17	18315-18322	created	_
88-18	18323-18325	by	_
88-19	18326-18336	scrambling	_
88-20	18337-18339	of	_
88-21	18340-18343	the	_
88-22	18344-18352	language	_
88-23	18353-18363	structures	_
88-24	18364-18366	in	_
88-25	18367-18370	the	_
88-26	18371-18376	story	_
88-27	18377-18378	(	_
88-28	18378-18381	Fig	_
88-29	18381-18382	.	_
88-30	18383-18385	1A	_
88-31	18385-18386	)	_
88-32	18386-18387	.	_

#Text=Specifically, in scrambled conditions, the end points of each word and sentence were defined manually and scrambled by a random shuffling of the order of the segments.
89-1	18388-18400	Specifically	_
89-2	18400-18401	,	_
89-3	18402-18404	in	_
89-4	18405-18414	scrambled	_
89-5	18415-18425	conditions	_
89-6	18425-18426	,	_
89-7	18427-18430	the	_
89-8	18431-18434	end	_
89-9	18435-18441	points	_
89-10	18442-18444	of	_
89-11	18445-18449	each	_
89-12	18450-18454	word	_
89-13	18455-18458	and	_
89-14	18459-18467	sentence	_
89-15	18468-18472	were	_
89-16	18473-18480	defined	_
89-17	18481-18489	manually	_
89-18	18490-18493	and	_
89-19	18494-18503	scrambled	_
89-20	18504-18506	by	_
89-21	18507-18508	a	_
89-22	18509-18515	random	_
89-23	18516-18525	shuffling	_
89-24	18526-18528	of	_
89-25	18529-18532	the	_
89-26	18533-18538	order	_
89-27	18539-18541	of	_
89-28	18542-18545	the	_
89-29	18546-18554	segments	_
89-30	18554-18555	.	_

#Text=In the scrambled words, two short words were joined in cases where we could not separate the adjacent words.
90-1	18556-18558	In	_
90-2	18559-18562	the	_
90-3	18563-18572	scrambled	_
90-4	18573-18578	words	_
90-5	18578-18579	,	_
90-6	18580-18583	two	_
90-7	18584-18589	short	_
90-8	18590-18595	words	_
90-9	18596-18600	were	_
90-10	18601-18607	joined	_
90-11	18608-18610	in	_
90-12	18611-18616	cases	_
90-13	18617-18622	where	_
90-14	18623-18625	we	_
90-15	18626-18631	could	_
90-16	18632-18635	not	_
90-17	18636-18644	separate	_
90-18	18645-18648	the	_
90-19	18649-18657	adjacent	_
90-20	18658-18663	words	_
90-21	18663-18664	.	_

#Text=In the scrambled sentences, we verified that two consecutive sentences from the original story did not follow each other.
91-1	18665-18667	In	_
91-2	18668-18671	the	_
91-3	18672-18681	scrambled	_
91-4	18682-18691	sentences	_
91-5	18691-18692	,	_
91-6	18693-18695	we	_
91-7	18696-18704	verified	_
91-8	18705-18709	that	_
91-9	18710-18713	two	_
91-10	18714-18725	consecutive	_
91-11	18726-18735	sentences	_
91-12	18736-18740	from	_
91-13	18741-18744	the	_
91-14	18745-18753	original	_
91-15	18754-18759	story	_
91-16	18760-18763	did	_
91-17	18764-18767	not	_
91-18	18768-18774	follow	_
91-19	18775-18779	each	_
91-20	18780-18785	other	_
91-21	18785-18786	.	_

#Text=Short examples of the conditions are provided in Supplementary File 1.
92-1	18787-18792	Short	_
92-2	18793-18801	examples	_
92-3	18802-18804	of	_
92-4	18805-18808	the	_
92-5	18809-18819	conditions	_
92-6	18820-18823	are	_
92-7	18824-18832	provided	_
92-8	18833-18835	in	_
92-9	18836-18849	Supplementary	_
92-10	18850-18854	File	_
92-11	18855-18856	1	_
92-12	18856-18857	.	_

#Text=Each scrambled condition served to isolate the contextual information available for comprehension as a function of that specific language structure, thus yielding the three different time scales (short – “words scram”, intermediate – “sentences scram” and long – story) for information processing.
93-1	18858-18862	Each	_
93-2	18863-18872	scrambled	_
93-3	18873-18882	condition	_
93-4	18883-18889	served	_
93-5	18890-18892	to	_
93-6	18893-18900	isolate	_
93-7	18901-18904	the	_
93-8	18905-18915	contextual	_
93-9	18916-18927	information	_
93-10	18928-18937	available	_
93-11	18938-18941	for	_
93-12	18942-18955	comprehension	_
93-13	18956-18958	as	_
93-14	18959-18960	a	_
93-15	18961-18969	function	_
93-16	18970-18972	of	_
93-17	18973-18977	that	_
93-18	18978-18986	specific	_
93-19	18987-18995	language	_
93-20	18996-19005	structure	_
93-21	19005-19006	,	_
93-22	19007-19011	thus	_
93-23	19012-19020	yielding	_
93-24	19021-19024	the	_
93-25	19025-19030	three	_
93-26	19031-19040	different	_
93-27	19041-19045	time	_
93-28	19046-19052	scales	_
93-29	19053-19054	(	_
93-30	19054-19059	short	_
93-31	19060-19061	–	_
93-32	19062-19063	“	_
93-33	19063-19068	words	_
93-34	19069-19074	scram	_
93-35	19074-19075	”	_
93-36	19075-19076	,	_
93-37	19077-19089	intermediate	_
93-38	19090-19091	–	_
93-39	19092-19093	“	_
93-40	19093-19102	sentences	_
93-41	19103-19108	scram	_
93-42	19108-19109	”	_
93-43	19110-19113	and	_
93-44	19114-19118	long	_
93-45	19119-19120	–	_
93-46	19121-19126	story	_
93-47	19126-19127	)	_
93-48	19128-19131	for	_
93-49	19132-19143	information	_
93-50	19144-19154	processing	_
93-51	19154-19155	.	_

#Text=Importantly, each scrambled version contained exactly the same information, only at a different level of language time scale (i.e. words, sentences).
94-1	19156-19167	Importantly	_
94-2	19167-19168	,	_
94-3	19169-19173	each	_
94-4	19174-19183	scrambled	_
94-5	19184-19191	version	_
94-6	19192-19201	contained	_
94-7	19202-19209	exactly	_
94-8	19210-19213	the	_
94-9	19214-19218	same	_
94-10	19219-19230	information	_
94-11	19230-19231	,	_
94-12	19232-19236	only	_
94-13	19237-19239	at	_
94-14	19240-19241	a	_
94-15	19242-19251	different	_
94-16	19252-19257	level	_
94-17	19258-19260	of	_
94-18	19261-19269	language	_
94-19	19270-19274	time	_
94-20	19275-19280	scale	_
94-21	19281-19282	(	_
94-22	19282-19285	i.e	_
94-23	19285-19286	.	_
94-24	19287-19292	words	_
94-25	19292-19293	,	_
94-26	19294-19303	sentences	_
94-27	19303-19304	)	_
94-28	19304-19305	.	_

#Text=Short stimulus included 656 words (a word lasted on average 0.7 s); intermediate stimulus included 76 sentences (a sentence lasted on average 6.1 s).
95-1	19306-19311	Short	_
95-2	19312-19320	stimulus	_
95-3	19321-19329	included	_
95-4	19330-19333	656	_
95-5	19334-19339	words	_
95-6	19340-19341	(	_
95-7	19341-19342	a	_
95-8	19343-19347	word	_
95-9	19348-19354	lasted	_
95-10	19355-19357	on	_
95-11	19358-19365	average	_
95-12	19366-19369	0.7	_
95-13	19369-19370	 	_
95-14	19370-19371	s	_
95-15	19371-19372	)	_
95-16	19372-19373	;	_
95-17	19374-19386	intermediate	_
95-18	19387-19395	stimulus	_
95-19	19396-19404	included	_
95-20	19405-19407	76	_
95-21	19408-19417	sentences	_
95-22	19418-19419	(	_
95-23	19419-19420	a	_
95-24	19421-19429	sentence	_
95-25	19430-19436	lasted	_
95-26	19437-19439	on	_
95-27	19440-19447	average	_
95-28	19448-19451	6.1	_
95-29	19451-19452	 	_
95-30	19452-19453	s	_
95-31	19453-19454	)	_
95-32	19454-19455	.	_

#Text=The overall durations of all stimuli were identical. 3 s–silent periods preceded and followed each condition and were discarded from all analyses.
96-1	19456-19459	The	_
96-2	19460-19467	overall	_
96-3	19468-19477	durations	_
96-4	19478-19480	of	_
96-5	19481-19484	all	_
96-6	19485-19492	stimuli	_
96-7	19493-19497	were	_
96-8	19498-19507	identical	_
96-9	19507-19508	.	_
96-10	19509-19510	3	_
96-11	19510-19511	 	_
96-12	19511-19519	s–silent	_
96-13	19520-19527	periods	_
96-14	19528-19536	preceded	_
96-15	19537-19540	and	_
96-16	19541-19549	followed	_
96-17	19550-19554	each	_
96-18	19555-19564	condition	_
96-19	19565-19568	and	_
96-20	19569-19573	were	_
96-21	19574-19583	discarded	_
96-22	19584-19588	from	_
96-23	19589-19592	all	_
96-24	19593-19601	analyses	_
96-25	19601-19602	.	_

#Text=A typical session lasted about 45 min and was comprised of three functional runs, each consisting of the presentation of one condition (8-min each).
97-1	19603-19604	A	_
97-2	19605-19612	typical	_
97-3	19613-19620	session	_
97-4	19621-19627	lasted	_
97-5	19628-19633	about	_
97-6	19634-19636	45	_
97-7	19636-19637	 	_
97-8	19637-19640	min	_
97-9	19641-19644	and	_
97-10	19645-19648	was	_
97-11	19649-19658	comprised	_
97-12	19659-19661	of	_
97-13	19662-19667	three	_
97-14	19668-19678	functional	_
97-15	19679-19683	runs	_
97-16	19683-19684	,	_
97-17	19685-19689	each	_
97-18	19690-19700	consisting	_
97-19	19701-19703	of	_
97-20	19704-19707	the	_
97-21	19708-19720	presentation	_
97-22	19721-19723	of	_
97-23	19724-19727	one	_
97-24	19728-19737	condition	_
97-25	19738-19739	(	_
97-26	19739-19740	8	_
97-27	19740-19741	-	_
97-28	19741-19744	min	_
97-29	19745-19749	each	_
97-30	19749-19750	)	_
97-31	19750-19751	.	_

#Text=The presentation order of conditions within a session was randomized across participants.
98-1	19752-19755	The	_
98-2	19756-19768	presentation	_
98-3	19769-19774	order	_
98-4	19775-19777	of	_
98-5	19778-19788	conditions	_
98-6	19789-19795	within	_
98-7	19796-19797	a	_
98-8	19798-19805	session	_
98-9	19806-19809	was	_
98-10	19810-19820	randomized	_
98-11	19821-19827	across	_
98-12	19828-19840	participants	_
98-13	19840-19841	.	_

#Text=Short 2-min breaks were implemented between the functional and structural scans to verify participants' well-being and awareness and to allow them to relax.
99-1	19842-19847	Short	_
99-2	19848-19849	2	_
99-3	19849-19850	-	_
99-4	19850-19853	min	_
99-5	19854-19860	breaks	_
99-6	19861-19865	were	_
99-7	19866-19877	implemented	_
99-8	19878-19885	between	_
99-9	19886-19889	the	_
99-10	19890-19900	functional	_
99-11	19901-19904	and	_
99-12	19905-19915	structural	_
99-13	19916-19921	scans	_
99-14	19922-19924	to	_
99-15	19925-19931	verify	_
99-16	19932-19944	participants	_
99-17	19944-19945	'	_
99-18	19946-19956	well-being	_
99-19	19957-19960	and	_
99-20	19961-19970	awareness	_
99-21	19971-19974	and	_
99-22	19975-19977	to	_
99-23	19978-19983	allow	_
99-24	19984-19988	them	_
99-25	19989-19991	to	_
99-26	19992-19997	relax	_
99-27	19997-19998	.	_

#Text=Attentive listening was confirmed by brief communication with participants between runs.
100-1	19999-20008	Attentive	_
100-2	20009-20018	listening	_
100-3	20019-20022	was	_
100-4	20023-20032	confirmed	_
100-5	20033-20035	by	_
100-6	20036-20041	brief	_
100-7	20042-20055	communication	_
100-8	20056-20060	with	_
100-9	20061-20073	participants	_
100-10	20074-20081	between	_
100-11	20082-20086	runs	_
100-12	20086-20087	.	_

#Text=At the end of the session, outside the scanner, participants were asked to describe the main plot of the story.
101-1	20088-20090	At	_
101-2	20091-20094	the	_
101-3	20095-20098	end	_
101-4	20099-20101	of	_
101-5	20102-20105	the	_
101-6	20106-20113	session	_
101-7	20113-20114	,	_
101-8	20115-20122	outside	_
101-9	20123-20126	the	_
101-10	20127-20134	scanner	_
101-11	20134-20135	,	_
101-12	20136-20148	participants	_
101-13	20149-20153	were	_
101-14	20154-20159	asked	_
101-15	20160-20162	to	_
101-16	20163-20171	describe	_
101-17	20172-20175	the	_
101-18	20176-20180	main	_
101-19	20181-20185	plot	_
101-20	20186-20188	of	_
101-21	20189-20192	the	_
101-22	20193-20198	story	_
101-23	20198-20199	.	_

#Text=Neuropsychological assessment
#Text=Neuropsychological assessment of individuals participating in the study.
102-1	20200-20218	Neuropsychological	_
102-2	20219-20229	assessment	_
102-3	20230-20248	Neuropsychological	_
102-4	20249-20259	assessment	_
102-5	20260-20262	of	_
102-6	20263-20274	individuals	_
102-7	20275-20288	participating	_
102-8	20289-20291	in	_
102-9	20292-20295	the	_
102-10	20296-20301	study	_
102-11	20301-20302	.	_

#Text=(A) The scores in the cognitive assessment – sub-tests of MoCA and text comprehension tests.
103-1	20303-20304	(	_
103-2	20304-20305	A	_
103-3	20305-20306	)	_
103-4	20307-20310	The	_
103-5	20311-20317	scores	_
103-6	20318-20320	in	_
103-7	20321-20324	the	_
103-8	20325-20334	cognitive	_
103-9	20335-20345	assessment	_
103-10	20346-20347	–	_
103-11	20348-20357	sub-tests	_
103-12	20358-20360	of	_
103-13	20361-20365	MoCA	_
103-14	20366-20369	and	_
103-15	20370-20374	text	_
103-16	20375-20388	comprehension	_
103-17	20389-20394	tests	_
103-18	20394-20395	.	_

#Text=(B) Statistical comparison between groups.
104-1	20396-20397	(	_
104-2	20397-20398	B	_
104-3	20398-20399	)	_
104-4	20400-20411	Statistical	_
104-5	20412-20422	comparison	_
104-6	20423-20430	between	_
104-7	20431-20437	groups	_
104-8	20437-20438	.	_

#Text=The p values defined by the Kolmogorov-Smirnoff test demonstrate between-group differences.
105-1	20439-20442	The	_
105-2	20443-20444	p	_
105-3	20445-20451	values	_
105-4	20452-20459	defined	_
105-5	20460-20462	by	_
105-6	20463-20466	the	_
105-7	20467-20486	Kolmogorov-Smirnoff	_
105-8	20487-20491	test	_
105-9	20492-20503	demonstrate	_
105-10	20504-20517	between-group	_
105-11	20518-20529	differences	_
105-12	20529-20530	.	_

#Text=Table 2\t \t
#Text=A.
106-1	20531-20536	Table	_
106-2	20537-20538	2	_
106-3	20542-20543	A	_
106-4	20543-20544	.	_

#Text=Neuropsychological assessment of individuals participated in the study.
107-1	20545-20563	Neuropsychological	_
107-2	20564-20574	assessment	_
107-3	20575-20577	of	_
107-4	20578-20589	individuals	_
107-5	20590-20602	participated	_
107-6	20603-20605	in	_
107-7	20606-20609	the	_
107-8	20610-20615	study	_
107-9	20615-20616	.	_

#Text=Participants\tSub-tests of MoCA\tText comprehension\t \tExecutive visuo-constructional skills (out of 5)\tNaming (out of 3)\tAttention and Executive function (out of 6)\tLanguage – short-term episodic memory and verbal fluency (out of 3)\tAbstraction (out of 2)\tDelayed recall (verbal) (out of 5)\tOrientation (out of 6)\tStory 1 (out of 4)\tStory 2 (out of 4)\t \tHealthy\t4.53 ± 0.74\t3\t5.87 ± 0.35\t2.8 ± 0.41\t1.87 ± 0.35\t3.93 ± 1.22\t6\t3.47 ± 0.52\t3.53 ± 0.52\t \tSiblings\t4.85 ± 0.37\t3\t5.28 ± 0.81\t3\t1.28 ± 0.51\t3.85 ± 0.98\t6\t3.29 ± 0.49\t3.43 ± 0.53\t \tPatients with schizophrenia\t2.38 ± 1.26\t2.61 ± 0.65\t4.38 ± 1.5\t2.07 ± 0.75\t1.07 ± 0.75\t2.84 ± 1.34\t5.46 ± 0.66\t3.0 ± 0.7\t2.73 ± 0.96\t \t  \t \t
#Text=B.
108-1	20619-20631	Participants	_
108-2	20632-20641	Sub-tests	_
108-3	20642-20644	of	_
108-4	20645-20649	MoCA	_
108-5	20650-20654	Text	_
108-6	20655-20668	comprehension	_
108-7	20671-20680	Executive	_
108-8	20681-20701	visuo-constructional	_
108-9	20702-20708	skills	_
108-10	20709-20710	(	_
108-11	20710-20713	out	_
108-12	20714-20716	of	_
108-13	20717-20718	5	_
108-14	20718-20719	)	_
108-15	20720-20726	Naming	_
108-16	20727-20728	(	_
108-17	20728-20731	out	_
108-18	20732-20734	of	_
108-19	20735-20736	3	_
108-20	20736-20737	)	_
108-21	20738-20747	Attention	_
108-22	20748-20751	and	_
108-23	20752-20761	Executive	_
108-24	20762-20770	function	_
108-25	20771-20772	(	_
108-26	20772-20775	out	_
108-27	20776-20778	of	_
108-28	20779-20780	6	_
108-29	20780-20781	)	_
108-30	20782-20790	Language	_
108-31	20791-20792	–	_
108-32	20793-20803	short-term	_
108-33	20804-20812	episodic	_
108-34	20813-20819	memory	_
108-35	20820-20823	and	_
108-36	20824-20830	verbal	_
108-37	20831-20838	fluency	_
108-38	20839-20840	(	_
108-39	20840-20843	out	_
108-40	20844-20846	of	_
108-41	20847-20848	3	_
108-42	20848-20849	)	_
108-43	20850-20861	Abstraction	_
108-44	20862-20863	(	_
108-45	20863-20866	out	_
108-46	20867-20869	of	_
108-47	20870-20871	2	_
108-48	20871-20872	)	_
108-49	20873-20880	Delayed	_
108-50	20881-20887	recall	_
108-51	20888-20889	(	_
108-52	20889-20895	verbal	_
108-53	20895-20896	)	_
108-54	20897-20898	(	_
108-55	20898-20901	out	_
108-56	20902-20904	of	_
108-57	20905-20906	5	_
108-58	20906-20907	)	_
108-59	20908-20919	Orientation	_
108-60	20920-20921	(	_
108-61	20921-20924	out	_
108-62	20925-20927	of	_
108-63	20928-20929	6	_
108-64	20929-20930	)	_
108-65	20931-20936	Story	_
108-66	20937-20938	1	_
108-67	20939-20940	(	_
108-68	20940-20943	out	_
108-69	20944-20946	of	_
108-70	20947-20948	4	_
108-71	20948-20949	)	_
108-72	20950-20955	Story	_
108-73	20956-20957	2	_
108-74	20958-20959	(	_
108-75	20959-20962	out	_
108-76	20963-20965	of	_
108-77	20966-20967	4	_
108-78	20967-20968	)	_
108-79	20971-20978	Healthy	_
108-80	20979-20983	4.53	_
108-81	20983-20984	 	_
108-82	20984-20985	±	_
108-83	20985-20986	 	_
108-84	20986-20990	0.74	_
108-85	20991-20992	3	_
108-86	20993-20997	5.87	_
108-87	20997-20998	 	_
108-88	20998-20999	±	_
108-89	20999-21000	 	_
108-90	21000-21004	0.35	_
108-91	21005-21008	2.8	_
108-92	21008-21009	 	_
108-93	21009-21010	±	_
108-94	21010-21011	 	_
108-95	21011-21015	0.41	_
108-96	21016-21020	1.87	_
108-97	21020-21021	 	_
108-98	21021-21022	±	_
108-99	21022-21023	 	_
108-100	21023-21027	0.35	_
108-101	21028-21032	3.93	_
108-102	21032-21033	 	_
108-103	21033-21034	±	_
108-104	21034-21035	 	_
108-105	21035-21039	1.22	_
108-106	21040-21041	6	_
108-107	21042-21046	3.47	_
108-108	21046-21047	 	_
108-109	21047-21048	±	_
108-110	21048-21049	 	_
108-111	21049-21053	0.52	_
108-112	21054-21058	3.53	_
108-113	21058-21059	 	_
108-114	21059-21060	±	_
108-115	21060-21061	 	_
108-116	21061-21065	0.52	_
108-117	21068-21076	Siblings	_
108-118	21077-21081	4.85	_
108-119	21081-21082	 	_
108-120	21082-21083	±	_
108-121	21083-21084	 	_
108-122	21084-21088	0.37	_
108-123	21089-21090	3	_
108-124	21091-21095	5.28	_
108-125	21095-21096	 	_
108-126	21096-21097	±	_
108-127	21097-21098	 	_
108-128	21098-21102	0.81	_
108-129	21103-21104	3	_
108-130	21105-21109	1.28	_
108-131	21109-21110	 	_
108-132	21110-21111	±	_
108-133	21111-21112	 	_
108-134	21112-21116	0.51	_
108-135	21117-21121	3.85	_
108-136	21121-21122	 	_
108-137	21122-21123	±	_
108-138	21123-21124	 	_
108-139	21124-21128	0.98	_
108-140	21129-21130	6	_
108-141	21131-21135	3.29	_
108-142	21135-21136	 	_
108-143	21136-21137	±	_
108-144	21137-21138	 	_
108-145	21138-21142	0.49	_
108-146	21143-21147	3.43	_
108-147	21147-21148	 	_
108-148	21148-21149	±	_
108-149	21149-21150	 	_
108-150	21150-21154	0.53	_
108-151	21157-21165	Patients	_
108-152	21166-21170	with	_
108-153	21171-21184	schizophrenia	_
108-154	21185-21189	2.38	_
108-155	21189-21190	 	_
108-156	21190-21191	±	_
108-157	21191-21192	 	_
108-158	21192-21196	1.26	_
108-159	21197-21201	2.61	_
108-160	21201-21202	 	_
108-161	21202-21203	±	_
108-162	21203-21204	 	_
108-163	21204-21208	0.65	_
108-164	21209-21213	4.38	_
108-165	21213-21214	 	_
108-166	21214-21215	±	_
108-167	21215-21216	 	_
108-168	21216-21219	1.5	_
108-169	21220-21224	2.07	_
108-170	21224-21225	 	_
108-171	21225-21226	±	_
108-172	21226-21227	 	_
108-173	21227-21231	0.75	_
108-174	21232-21236	1.07	_
108-175	21236-21237	 	_
108-176	21237-21238	±	_
108-177	21238-21239	 	_
108-178	21239-21243	0.75	_
108-179	21244-21248	2.84	_
108-180	21248-21249	 	_
108-181	21249-21250	±	_
108-182	21250-21251	 	_
108-183	21251-21255	1.34	_
108-184	21256-21260	5.46	_
108-185	21260-21261	 	_
108-186	21261-21262	±	_
108-187	21262-21263	 	_
108-188	21263-21267	0.66	_
108-189	21268-21271	3.0	_
108-190	21271-21272	 	_
108-191	21272-21273	±	_
108-192	21273-21274	 	_
108-193	21274-21277	0.7	_
108-194	21278-21282	2.73	_
108-195	21282-21283	 	_
108-196	21283-21284	±	_
108-197	21284-21285	 	_
108-198	21285-21289	0.96	_
108-199	21298-21299	B	_
108-200	21299-21300	.	_

#Text=Statistical comparison between groups\t \t\tHealthy –Patients\tSiblings – Patients\tHealthy – Siblings\t \tExecutive visuo-constructional skills\t0.001\t0.003\t0.988\t \tNaming\t0.448\t0.696\t1.000\t \tAttention and executive function\t0.005\t0.186\t0.238\t \tLanguage – short-term episodic memory and verbal fluency\t0.045\t0.012\t0.98\t \tAbstraction\t0.015\t0.940\t0.047\t \tDelayed recall (verbal)\t0.117\t0.527\t0.999\t \tOrientation\t0.071\t0.208\t1.000\t \tStory 1\t0.59\t0.83\t0.99\t \tStory 2\t0.05\t0.18\t1.00\t \t
#Text=The differences between groups (p values) were defined by the Kolmogorov-Smirnoff test.
109-1	21301-21312	Statistical	_
109-2	21313-21323	comparison	_
109-3	21324-21331	between	_
109-4	21332-21338	groups	_
109-5	21342-21349	Healthy	_
109-6	21350-21351	–	_
109-7	21351-21359	Patients	_
109-8	21360-21368	Siblings	_
109-9	21369-21370	–	_
109-10	21371-21379	Patients	_
109-11	21380-21387	Healthy	_
109-12	21388-21389	–	_
109-13	21390-21398	Siblings	_
109-14	21401-21410	Executive	_
109-15	21411-21431	visuo-constructional	_
109-16	21432-21438	skills	_
109-17	21439-21444	0.001	_
109-18	21445-21450	0.003	_
109-19	21451-21456	0.988	_
109-20	21459-21465	Naming	_
109-21	21466-21471	0.448	_
109-22	21472-21477	0.696	_
109-23	21478-21483	1.000	_
109-24	21486-21495	Attention	_
109-25	21496-21499	and	_
109-26	21500-21509	executive	_
109-27	21510-21518	function	_
109-28	21519-21524	0.005	_
109-29	21525-21530	0.186	_
109-30	21531-21536	0.238	_
109-31	21539-21547	Language	_
109-32	21548-21549	–	_
109-33	21550-21560	short-term	_
109-34	21561-21569	episodic	_
109-35	21570-21576	memory	_
109-36	21577-21580	and	_
109-37	21581-21587	verbal	_
109-38	21588-21595	fluency	_
109-39	21596-21601	0.045	_
109-40	21602-21607	0.012	_
109-41	21608-21612	0.98	_
109-42	21615-21626	Abstraction	_
109-43	21627-21632	0.015	_
109-44	21633-21638	0.940	_
109-45	21639-21644	0.047	_
109-46	21647-21654	Delayed	_
109-47	21655-21661	recall	_
109-48	21662-21663	(	_
109-49	21663-21669	verbal	_
109-50	21669-21670	)	_
109-51	21671-21676	0.117	_
109-52	21677-21682	0.527	_
109-53	21683-21688	0.999	_
109-54	21691-21702	Orientation	_
109-55	21703-21708	0.071	_
109-56	21709-21714	0.208	_
109-57	21715-21720	1.000	_
109-58	21723-21728	Story	_
109-59	21729-21730	1	_
109-60	21731-21735	0.59	_
109-61	21736-21740	0.83	_
109-62	21741-21745	0.99	_
109-63	21748-21753	Story	_
109-64	21754-21755	2	_
109-65	21756-21760	0.05	_
109-66	21761-21765	0.18	_
109-67	21766-21770	1.00	_
109-68	21774-21777	The	_
109-69	21778-21789	differences	_
109-70	21790-21797	between	_
109-71	21798-21804	groups	_
109-72	21805-21806	(	_
109-73	21806-21807	p	_
109-74	21808-21814	values	_
109-75	21814-21815	)	_
109-76	21816-21820	were	_
109-77	21821-21828	defined	_
109-78	21829-21831	by	_
109-79	21832-21835	the	_
109-80	21836-21855	Kolmogorov-Smirnoff	_
109-81	21856-21860	test	_
109-82	21860-21861	.	_

#Text=All participants were screened by a neuropsychological assessment which included the Montreal Cognitive Assessment (MoCA) and standardized tests of text comprehension.
110-1	21862-21865	All	_
110-2	21866-21878	participants	_
110-3	21879-21883	were	_
110-4	21884-21892	screened	_
110-5	21893-21895	by	_
110-6	21896-21897	a	_
110-7	21898-21916	neuropsychological	_
110-8	21917-21927	assessment	_
110-9	21928-21933	which	_
110-10	21934-21942	included	_
110-11	21943-21946	the	_
110-12	21947-21955	Montreal	_
110-13	21956-21965	Cognitive	_
110-14	21966-21976	Assessment	_
110-15	21977-21978	(	_
110-16	21978-21982	MoCA	_
110-17	21982-21983	)	_
110-18	21984-21987	and	_
110-19	21988-22000	standardized	_
110-20	22001-22006	tests	_
110-21	22007-22009	of	_
110-22	22010-22014	text	_
110-23	22015-22028	comprehension	_
110-24	22028-22029	.	_

#Text=In the text comprehension tests participants were presented with short stories and subsequently required to recall them in as much detail as possible.
111-1	22030-22032	In	_
111-2	22033-22036	the	_
111-3	22037-22041	text	_
111-4	22042-22055	comprehension	_
111-5	22056-22061	tests	_
111-6	22062-22074	participants	_
111-7	22075-22079	were	_
111-8	22080-22089	presented	_
111-9	22090-22094	with	_
111-10	22095-22100	short	_
111-11	22101-22108	stories	_
111-12	22109-22112	and	_
111-13	22113-22125	subsequently	_
111-14	22126-22134	required	_
111-15	22135-22137	to	_
111-16	22138-22144	recall	_
111-17	22145-22149	them	_
111-18	22150-22152	in	_
111-19	22153-22155	as	_
111-20	22156-22160	much	_
111-21	22161-22167	detail	_
111-22	22168-22170	as	_
111-23	22171-22179	possible	_
111-24	22179-22180	.	_

#Text=The text comprehension tests were evaluated on a 4-point scale; 1 = not at all, 4 = perfect understanding.
112-1	22181-22184	The	_
112-2	22185-22189	text	_
112-3	22190-22203	comprehension	_
112-4	22204-22209	tests	_
112-5	22210-22214	were	_
112-6	22215-22224	evaluated	_
112-7	22225-22227	on	_
112-8	22228-22229	a	_
112-9	22230-22231	4	_
112-10	22231-22232	-	_
112-11	22232-22237	point	_
112-12	22238-22243	scale	_
112-13	22243-22244	;	_
112-14	22245-22246	1	_
112-15	22246-22247	 	_
112-16	22247-22248	=	_
112-17	22248-22249	 	_
112-18	22249-22252	not	_
112-19	22253-22255	at	_
112-20	22256-22259	all	_
112-21	22259-22260	,	_
112-22	22261-22262	4	_
112-23	22262-22263	 	_
112-24	22263-22264	=	_
112-25	22264-22265	 	_
112-26	22265-22272	perfect	_
112-27	22273-22286	understanding	_
112-28	22286-22287	.	_

#Text=The scores for the MoCA (separately for the subsets of the test), indicating correct responses and scores for the text comprehension, indicating level of understanding are shown in Table 2A.
113-1	22288-22291	The	_
113-2	22292-22298	scores	_
113-3	22299-22302	for	_
113-4	22303-22306	the	_
113-5	22307-22311	MoCA	_
113-6	22312-22313	(	_
113-7	22313-22323	separately	_
113-8	22324-22327	for	_
113-9	22328-22331	the	_
113-10	22332-22339	subsets	_
113-11	22340-22342	of	_
113-12	22343-22346	the	_
113-13	22347-22351	test	_
113-14	22351-22352	)	_
113-15	22352-22353	,	_
113-16	22354-22364	indicating	_
113-17	22365-22372	correct	_
113-18	22373-22382	responses	_
113-19	22383-22386	and	_
113-20	22387-22393	scores	_
113-21	22394-22397	for	_
113-22	22398-22401	the	_
113-23	22402-22406	text	_
113-24	22407-22420	comprehension	_
113-25	22420-22421	,	_
113-26	22422-22432	indicating	_
113-27	22433-22438	level	_
113-28	22439-22441	of	_
113-29	22442-22455	understanding	_
113-30	22456-22459	are	_
113-31	22460-22465	shown	_
113-32	22466-22468	in	_
113-33	22469-22474	Table	_
113-34	22475-22477	2A	_
113-35	22477-22478	.	_

#Text=Statistical comparison for between-group differences in neuropsychological assessment using the Kolmogorov-Smirnoff test is provided in Table 2B.
114-1	22479-22490	Statistical	_
114-2	22491-22501	comparison	_
114-3	22502-22505	for	_
114-4	22506-22519	between-group	_
114-5	22520-22531	differences	_
114-6	22532-22534	in	_
114-7	22535-22553	neuropsychological	_
114-8	22554-22564	assessment	_
114-9	22565-22570	using	_
114-10	22571-22574	the	_
114-11	22575-22594	Kolmogorov-Smirnoff	_
114-12	22595-22599	test	_
114-13	22600-22602	is	_
114-14	22603-22611	provided	_
114-15	22612-22614	in	_
114-16	22615-22620	Table	_
114-17	22621-22623	2B	_
114-18	22623-22624	.	_

#Text=Data analysis
#Text=Preprocessing
#Text=BrainVoyagerQX 2.4 (Brain Innovation, Maastricht, The Netherlands) was used for preprocessing and co-registration of the standardized anatomical and functional data.
115-1	22625-22629	Data	_
115-2	22630-22638	analysis	_
115-3	22639-22652	Preprocessing	_
115-4	22653-22667	BrainVoyagerQX	_
115-5	22668-22671	2.4	_
115-6	22672-22673	(	_
115-7	22673-22678	Brain	_
115-8	22679-22689	Innovation	_
115-9	22689-22690	,	_
115-10	22691-22701	Maastricht	_
115-11	22701-22702	,	_
115-12	22703-22706	The	_
115-13	22707-22718	Netherlands	_
115-14	22718-22719	)	_
115-15	22720-22723	was	_
115-16	22724-22728	used	_
115-17	22729-22732	for	_
115-18	22733-22746	preprocessing	_
115-19	22747-22750	and	_
115-20	22751-22766	co-registration	_
115-21	22767-22769	of	_
115-22	22770-22773	the	_
115-23	22774-22786	standardized	_
115-24	22787-22797	anatomical	_
115-25	22798-22801	and	_
115-26	22802-22812	functional	_
115-27	22813-22817	data	_
115-28	22817-22818	.	_

#Text=Data analysis was performed separately for each participant.
116-1	22819-22823	Data	_
116-2	22824-22832	analysis	_
116-3	22833-22836	was	_
116-4	22837-22846	performed	_
116-5	22847-22857	separately	_
116-6	22858-22861	for	_
116-7	22862-22866	each	_
116-8	22867-22878	participant	_
116-9	22878-22879	.	_

#Text=The data were high pass filtered at 0.008 Hz and spatially smoothed with a 6 mm full width at half maximum (FWHM) kernel.
117-1	22880-22883	The	_
117-2	22884-22888	data	_
117-3	22889-22893	were	_
117-4	22894-22898	high	_
117-5	22899-22903	pass	_
117-6	22904-22912	filtered	_
117-7	22913-22915	at	_
117-8	22916-22921	0.008	_
117-9	22921-22922	 	_
117-10	22922-22924	Hz	_
117-11	22925-22928	and	_
117-12	22929-22938	spatially	_
117-13	22939-22947	smoothed	_
117-14	22948-22952	with	_
117-15	22953-22954	a	_
117-16	22955-22956	6	_
117-17	22956-22957	 	_
117-18	22957-22959	mm	_
117-19	22960-22964	full	_
117-20	22965-22970	width	_
117-21	22971-22973	at	_
117-22	22974-22978	half	_
117-23	22979-22986	maximum	_
117-24	22987-22988	(	_
117-25	22988-22992	FWHM	_
117-26	22992-22993	)	_
117-27	22994-23000	kernel	_
117-28	23000-23001	.	_

#Text=To avoid the confounding effect of fluctuations in the whole-brain blood-oxygen-level dependent (BOLD) signal, for each TR, each voxel was scaled by the global mean at that time point.
118-1	23002-23004	To	_
118-2	23005-23010	avoid	_
118-3	23011-23014	the	_
118-4	23015-23026	confounding	_
118-5	23027-23033	effect	_
118-6	23034-23036	of	_
118-7	23037-23049	fluctuations	_
118-8	23050-23052	in	_
118-9	23053-23056	the	_
118-10	23057-23068	whole-brain	_
118-11	23069-23087	blood-oxygen-level	_
118-12	23088-23097	dependent	_
118-13	23098-23099	(	_
118-14	23099-23103	BOLD	_
118-15	23103-23104	)	_
118-16	23105-23111	signal	_
118-17	23111-23112	,	_
118-18	23113-23116	for	_
118-19	23117-23121	each	_
118-20	23122-23124	TR	_
118-21	23124-23125	,	_
118-22	23126-23130	each	_
118-23	23131-23136	voxel	_
118-24	23137-23140	was	_
118-25	23141-23147	scaled	_
118-26	23148-23150	by	_
118-27	23151-23154	the	_
118-28	23155-23161	global	_
118-29	23162-23166	mean	_
118-30	23167-23169	at	_
118-31	23170-23174	that	_
118-32	23175-23179	time	_
118-33	23180-23185	point	_
118-34	23185-23186	.	_

#Text=Head motions were detected and corrected using trilinear and sinc interpolations, respectively.
119-1	23187-23191	Head	_
119-2	23192-23199	motions	_
119-3	23200-23204	were	_
119-4	23205-23213	detected	_
119-5	23214-23217	and	_
119-6	23218-23227	corrected	_
119-7	23228-23233	using	_
119-8	23234-23243	trilinear	_
119-9	23244-23247	and	_
119-10	23248-23252	sinc	_
119-11	23253-23267	interpolations	_
119-12	23267-23268	,	_
119-13	23269-23281	respectively	_
119-14	23281-23282	.	_

#Text=Due to extensive head movements (deviations higher than 1.5°/mm relative to the reference) 1 patient, 5 healthy controls and 1 sibling were excluded from the study.
120-1	23283-23286	Due	_
120-2	23287-23289	to	_
120-3	23290-23299	extensive	_
120-4	23300-23304	head	_
120-5	23305-23314	movements	_
120-6	23315-23316	(	_
120-7	23316-23326	deviations	_
120-8	23327-23333	higher	_
120-9	23334-23338	than	_
120-10	23339-23342	1.5	_
120-11	23342-23343	°	_
120-12	23343-23344	/	_
120-13	23344-23346	mm	_
120-14	23347-23355	relative	_
120-15	23356-23358	to	_
120-16	23359-23362	the	_
120-17	23363-23372	reference	_
120-18	23372-23373	)	_
120-19	23374-23375	1	_
120-20	23376-23383	patient	_
120-21	23383-23384	,	_
120-22	23385-23386	5	_
120-23	23387-23394	healthy	_
120-24	23395-23403	controls	_
120-25	23404-23407	and	_
120-26	23408-23409	1	_
120-27	23410-23417	sibling	_
120-28	23418-23422	were	_
120-29	23423-23431	excluded	_
120-30	23432-23436	from	_
120-31	23437-23440	the	_
120-32	23441-23446	study	_
120-33	23446-23447	.	_

#Text=The cortical surface was reconstructed from the anatomical images using standard procedures implemented in the BrainVoyager software.
121-1	23448-23451	The	_
121-2	23452-23460	cortical	_
121-3	23461-23468	surface	_
121-4	23469-23472	was	_
121-5	23473-23486	reconstructed	_
121-6	23487-23491	from	_
121-7	23492-23495	the	_
121-8	23496-23506	anatomical	_
121-9	23507-23513	images	_
121-10	23514-23519	using	_
121-11	23520-23528	standard	_
121-12	23529-23539	procedures	_
121-13	23540-23551	implemented	_
121-14	23552-23554	in	_
121-15	23555-23558	the	_
121-16	23559-23571	BrainVoyager	_
121-17	23572-23580	software	_
121-18	23580-23581	.	_

#Text=The complete functional dataset was transformed to a common 3D Talairach space and projected on a reconstruction of the cortical surface.
122-1	23582-23585	The	_
122-2	23586-23594	complete	_
122-3	23595-23605	functional	_
122-4	23606-23613	dataset	_
122-5	23614-23617	was	_
122-6	23618-23629	transformed	_
122-7	23630-23632	to	_
122-8	23633-23634	a	_
122-9	23635-23641	common	_
122-10	23642-23644	3D	_
122-11	23645-23654	Talairach	_
122-12	23655-23660	space	_
122-13	23661-23664	and	_
122-14	23665-23674	projected	_
122-15	23675-23677	on	_
122-16	23678-23679	a	_
122-17	23680-23694	reconstruction	_
122-18	23695-23697	of	_
122-19	23698-23701	the	_
122-20	23702-23710	cortical	_
122-21	23711-23718	surface	_
122-22	23718-23719	.	_

#Text=Inter-SC analysis
#Text=Hierarchical organization of processing time scales.
123-1	23720-23728	Inter-SC	_
123-2	23729-23737	analysis	_
123-3	23738-23750	Hierarchical	_
123-4	23751-23763	organization	_
123-5	23764-23766	of	_
123-6	23767-23777	processing	_
123-7	23778-23782	time	_
123-8	23783-23789	scales	_
123-9	23789-23790	.	_

#Text=Nested maps presenting response synchronization to stimuli across participants are shown within different experimental groups: healthy participants (A; N = 15), siblings of patients with schizophrenia (B; N = 14) and patients with schizophrenia (C; N = 15).
124-1	23791-23797	Nested	_
124-2	23798-23802	maps	_
124-3	23803-23813	presenting	_
124-4	23814-23822	response	_
124-5	23823-23838	synchronization	_
124-6	23839-23841	to	_
124-7	23842-23849	stimuli	_
124-8	23850-23856	across	_
124-9	23857-23869	participants	_
124-10	23870-23873	are	_
124-11	23874-23879	shown	_
124-12	23880-23886	within	_
124-13	23887-23896	different	_
124-14	23897-23909	experimental	_
124-15	23910-23916	groups	_
124-16	23916-23917	:	_
124-17	23918-23925	healthy	_
124-18	23926-23938	participants	_
124-19	23939-23940	(	_
124-20	23940-23941	A	_
124-21	23941-23942	;	_
124-22	23943-23944	N	_
124-23	23944-23945	 	_
124-24	23945-23946	=	_
124-25	23946-23947	 	_
124-26	23947-23949	15	_
124-27	23949-23950	)	_
124-28	23950-23951	,	_
124-29	23952-23960	siblings	_
124-30	23961-23963	of	_
124-31	23964-23972	patients	_
124-32	23973-23977	with	_
124-33	23978-23991	schizophrenia	_
124-34	23992-23993	(	_
124-35	23993-23994	B	_
124-36	23994-23995	;	_
124-37	23996-23997	N	_
124-38	23997-23998	 	_
124-39	23998-23999	=	_
124-40	23999-24000	 	_
124-41	24000-24002	14	_
124-42	24002-24003	)	_
124-43	24004-24007	and	_
124-44	24008-24016	patients	_
124-45	24017-24021	with	_
124-46	24022-24035	schizophrenia	_
124-47	24036-24037	(	_
124-48	24037-24038	C	_
124-49	24038-24039	;	_
124-50	24040-24041	N	_
124-51	24041-24042	 	_
124-52	24042-24043	=	_
124-53	24043-24044	 	_
124-54	24044-24046	15	_
124-55	24046-24047	)	_
124-56	24047-24048	.	_

#Text=Each voxel is colored in accordance with the level of coherent temporal structure that was required for significant synchronization (inter-SC) in that voxel across all participants.
125-1	24049-24053	Each	_
125-2	24054-24059	voxel	_
125-3	24060-24062	is	_
125-4	24063-24070	colored	_
125-5	24071-24073	in	_
125-6	24074-24084	accordance	_
125-7	24085-24089	with	_
125-8	24090-24093	the	_
125-9	24094-24099	level	_
125-10	24100-24102	of	_
125-11	24103-24111	coherent	_
125-12	24112-24120	temporal	_
125-13	24121-24130	structure	_
125-14	24131-24135	that	_
125-15	24136-24139	was	_
125-16	24140-24148	required	_
125-17	24149-24152	for	_
125-18	24153-24164	significant	_
125-19	24165-24180	synchronization	_
125-20	24181-24182	(	_
125-21	24182-24190	inter-SC	_
125-22	24190-24191	)	_
125-23	24192-24194	in	_
125-24	24195-24199	that	_
125-25	24200-24205	voxel	_
125-26	24206-24212	across	_
125-27	24213-24216	all	_
125-28	24217-24229	participants	_
125-29	24229-24230	.	_

#Text=Red voxels exhibited reliably synchronized responses to all conditions; green voxels - only for the sentences and the intact stimuli; blue voxels responded reliably to the intact story only.
126-1	24231-24234	Red	_
126-2	24235-24241	voxels	_
126-3	24242-24251	exhibited	_
126-4	24252-24260	reliably	_
126-5	24261-24273	synchronized	_
126-6	24274-24283	responses	_
126-7	24284-24286	to	_
126-8	24287-24290	all	_
126-9	24291-24301	conditions	_
126-10	24301-24302	;	_
126-11	24303-24308	green	_
126-12	24309-24315	voxels	_
126-13	24316-24317	-	_
126-14	24318-24322	only	_
126-15	24323-24326	for	_
126-16	24327-24330	the	_
126-17	24331-24340	sentences	_
126-18	24341-24344	and	_
126-19	24345-24348	the	_
126-20	24349-24355	intact	_
126-21	24356-24363	stimuli	_
126-22	24363-24364	;	_
126-23	24365-24369	blue	_
126-24	24370-24376	voxels	_
126-25	24377-24386	responded	_
126-26	24387-24395	reliably	_
126-27	24396-24398	to	_
126-28	24399-24402	the	_
126-29	24403-24409	intact	_
126-30	24410-24415	story	_
126-31	24416-24420	only	_
126-32	24420-24421	.	_

#Text=Note widespread disruption of the inter-SCs in story condition in patients with schizophrenia comparing to both other groups.
127-1	24422-24426	Note	_
127-2	24427-24437	widespread	_
127-3	24438-24448	disruption	_
127-4	24449-24451	of	_
127-5	24452-24455	the	_
127-6	24456-24465	inter-SCs	_
127-7	24466-24468	in	_
127-8	24469-24474	story	_
127-9	24475-24484	condition	_
127-10	24485-24487	in	_
127-11	24488-24496	patients	_
127-12	24497-24501	with	_
127-13	24502-24515	schizophrenia	_
127-14	24516-24525	comparing	_
127-15	24526-24528	to	_
127-16	24529-24533	both	_
127-17	24534-24539	other	_
127-18	24540-24546	groups	_
127-19	24546-24547	.	_

#Text=Abbreviations: A1+, early auditory cortex presumably including primary auditory cortex (A1); mSTG, middle superior temporal gyrus; TPJ, temporo-parietal junction; IPS, intraparietal sulcus; IFS, inferior frontal sulcus; DLPFC, dorsolateral prefrontal cortex; mPFC, medial prefrontal cortex; A, anterior; P, posterior.
128-1	24548-24561	Abbreviations	_
128-2	24561-24562	:	_
128-3	24563-24565	A1	_
128-4	24565-24566	+	_
128-5	24566-24567	,	_
128-6	24568-24573	early	_
128-7	24574-24582	auditory	_
128-8	24583-24589	cortex	_
128-9	24590-24600	presumably	_
128-10	24601-24610	including	_
128-11	24611-24618	primary	_
128-12	24619-24627	auditory	_
128-13	24628-24634	cortex	_
128-14	24635-24636	(	_
128-15	24636-24638	A1	_
128-16	24638-24639	)	_
128-17	24639-24640	;	_
128-18	24641-24645	mSTG	_
128-19	24645-24646	,	_
128-20	24647-24653	middle	_
128-21	24654-24662	superior	_
128-22	24663-24671	temporal	_
128-23	24672-24677	gyrus	_
128-24	24677-24678	;	_
128-25	24679-24682	TPJ	_
128-26	24682-24683	,	_
128-27	24684-24700	temporo-parietal	_
128-28	24701-24709	junction	_
128-29	24709-24710	;	_
128-30	24711-24714	IPS	_
128-31	24714-24715	,	_
128-32	24716-24729	intraparietal	_
128-33	24730-24736	sulcus	_
128-34	24736-24737	;	_
128-35	24738-24741	IFS	_
128-36	24741-24742	,	_
128-37	24743-24751	inferior	_
128-38	24752-24759	frontal	_
128-39	24760-24766	sulcus	_
128-40	24766-24767	;	_
128-41	24768-24773	DLPFC	_
128-42	24773-24774	,	_
128-43	24775-24787	dorsolateral	_
128-44	24788-24798	prefrontal	_
128-45	24799-24805	cortex	_
128-46	24805-24806	;	_
128-47	24807-24811	mPFC	_
128-48	24811-24812	,	_
128-49	24813-24819	medial	_
128-50	24820-24830	prefrontal	_
128-51	24831-24837	cortex	_
128-52	24837-24838	;	_
128-53	24839-24840	A	_
128-54	24840-24841	,	_
128-55	24842-24850	anterior	_
128-56	24850-24851	;	_
128-57	24852-24853	P	_
128-58	24853-24854	,	_
128-59	24855-24864	posterior	_
128-60	24864-24865	.	_

#Text=(For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
129-1	24866-24867	(	_
129-2	24867-24870	For	_
129-3	24871-24885	interpretation	_
129-4	24886-24888	of	_
129-5	24889-24892	the	_
129-6	24893-24903	references	_
129-7	24904-24906	to	_
129-8	24907-24912	color	_
129-9	24913-24915	in	_
129-10	24916-24920	this	_
129-11	24921-24927	figure	_
129-12	24928-24934	legend	_
129-13	24934-24935	,	_
129-14	24936-24939	the	_
129-15	24940-24946	reader	_
129-16	24947-24949	is	_
129-17	24950-24958	referred	_
129-18	24959-24961	to	_
129-19	24962-24965	the	_
129-20	24966-24969	web	_
129-21	24970-24977	version	_
129-22	24978-24980	of	_
129-23	24981-24985	this	_
129-24	24986-24993	article	_
129-25	24993-24994	.	_
129-26	24994-24995	)	_

#Text=Fig. 2
#Text=Data were analyzed using the inter-SC approach, measuring similarity of neural responses across individuals who are presented with the same stimuli.
130-1	24996-24999	Fig	_
130-2	24999-25000	.	_
130-3	25001-25002	2	_
130-4	25003-25007	Data	_
130-5	25008-25012	were	_
130-6	25013-25021	analyzed	_
130-7	25022-25027	using	_
130-8	25028-25031	the	_
130-9	25032-25040	inter-SC	_
130-10	25041-25049	approach	_
130-11	25049-25050	,	_
130-12	25051-25060	measuring	_
130-13	25061-25071	similarity	_
130-14	25072-25074	of	_
130-15	25075-25081	neural	_
130-16	25082-25091	responses	_
130-17	25092-25098	across	_
130-18	25099-25110	individuals	_
130-19	25111-25114	who	_
130-20	25115-25118	are	_
130-21	25119-25128	presented	_
130-22	25129-25133	with	_
130-23	25134-25137	the	_
130-24	25138-25142	same	_
130-25	25143-25150	stimuli	_
130-26	25150-25151	.	_

#Text=For each voxel, inter-SC was calculated as an average , where the individual rj are the Pearson product-moment correlations between that voxel's BOLD time course in one individual and the average of that voxel's BOLD time courses in the remaining individuals.
131-1	25152-25155	For	_
131-2	25156-25160	each	_
131-3	25161-25166	voxel	_
131-4	25166-25167	,	_
131-5	25168-25176	inter-SC	_
131-6	25177-25180	was	_
131-7	25181-25191	calculated	_
131-8	25192-25194	as	_
131-9	25195-25197	an	_
131-10	25198-25205	average	_
131-11	25206-25207	,	_
131-12	25208-25213	where	_
131-13	25214-25217	the	_
131-14	25218-25228	individual	_
131-15	25229-25231	rj	_
131-16	25232-25235	are	_
131-17	25236-25239	the	_
131-18	25240-25247	Pearson	_
131-19	25248-25262	product-moment	_
131-20	25263-25275	correlations	_
131-21	25276-25283	between	_
131-22	25284-25288	that	_
131-23	25289-25296	voxel's	_
131-24	25297-25301	BOLD	_
131-25	25302-25306	time	_
131-26	25307-25313	course	_
131-27	25314-25316	in	_
131-28	25317-25320	one	_
131-29	25321-25331	individual	_
131-30	25332-25335	and	_
131-31	25336-25339	the	_
131-32	25340-25347	average	_
131-33	25348-25350	of	_
131-34	25351-25355	that	_
131-35	25356-25363	voxel's	_
131-36	25364-25368	BOLD	_
131-37	25369-25373	time	_
131-38	25374-25381	courses	_
131-39	25382-25384	in	_
131-40	25385-25388	the	_
131-41	25389-25398	remaining	_
131-42	25399-25410	individuals	_
131-43	25410-25411	.	_

#Text=Inter-SC maps were constructed separately for conditions, within groups (Fig. 1B1 & Fig. 2) and between groups (Fig. 1B3 & Fig. 5).
132-1	25412-25420	Inter-SC	_
132-2	25421-25425	maps	_
132-3	25426-25430	were	_
132-4	25431-25442	constructed	_
132-5	25443-25453	separately	_
132-6	25454-25457	for	_
132-7	25458-25468	conditions	_
132-8	25468-25469	,	_
132-9	25470-25476	within	_
132-10	25477-25483	groups	_
132-11	25484-25485	(	_
132-12	25485-25488	Fig	_
132-13	25488-25489	.	_
132-14	25490-25493	1B1	_
132-15	25494-25495	&	_
132-16	25496-25499	Fig	_
132-17	25499-25500	.	_
132-18	25501-25502	2	_
132-19	25502-25503	)	_
132-20	25504-25507	and	_
132-21	25508-25515	between	_
132-22	25516-25522	groups	_
132-23	25523-25524	(	_
132-24	25524-25527	Fig	_
132-25	25527-25528	.	_
132-26	25529-25532	1B3	_
132-27	25533-25534	&	_
132-28	25535-25538	Fig	_
132-29	25538-25539	.	_
132-30	25540-25541	5	_
132-31	25541-25542	)	_
132-32	25542-25543	.	_

#Text=Only voxels that passed statistical significance test (see the following paragraph) were shown on the maps.
133-1	25544-25548	Only	_
133-2	25549-25555	voxels	_
133-3	25556-25560	that	_
133-4	25561-25567	passed	_
133-5	25568-25579	statistical	_
133-6	25580-25592	significance	_
133-7	25593-25597	test	_
133-8	25598-25599	(	_
133-9	25599-25602	see	_
133-10	25603-25606	the	_
133-11	25607-25616	following	_
133-12	25617-25626	paragraph	_
133-13	25626-25627	)	_
133-14	25628-25632	were	_
133-15	25633-25638	shown	_
133-16	25639-25641	on	_
133-17	25642-25645	the	_
133-18	25646-25650	maps	_
133-19	25650-25651	.	_

#Text=Controlling for false positives
#Text=Statistical significance of correlations was assessed using a bootstrapping procedure based on phase-randomization.
134-1	25652-25663	Controlling	_
134-2	25664-25667	for	_
134-3	25668-25673	false	_
134-4	25674-25683	positives	_
134-5	25684-25695	Statistical	_
134-6	25696-25708	significance	_
134-7	25709-25711	of	_
134-8	25712-25724	correlations	_
134-9	25725-25728	was	_
134-10	25729-25737	assessed	_
134-11	25738-25743	using	_
134-12	25744-25745	a	_
134-13	25746-25759	bootstrapping	_
134-14	25760-25769	procedure	_
134-15	25770-25775	based	_
134-16	25776-25778	on	_
134-17	25779-25798	phase-randomization	_
134-18	25798-25799	.	_

#Text=The null hypothesis was that the BOLD signal in each voxel in each participant was independent of the BOLD signal values in the corresponding voxel in any other participant at any point in time (i.e., no inter-SC between any pair of individuals).
135-1	25800-25803	The	_
135-2	25804-25808	null	_
135-3	25809-25819	hypothesis	_
135-4	25820-25823	was	_
135-5	25824-25828	that	_
135-6	25829-25832	the	_
135-7	25833-25837	BOLD	_
135-8	25838-25844	signal	_
135-9	25845-25847	in	_
135-10	25848-25852	each	_
135-11	25853-25858	voxel	_
135-12	25859-25861	in	_
135-13	25862-25866	each	_
135-14	25867-25878	participant	_
135-15	25879-25882	was	_
135-16	25883-25894	independent	_
135-17	25895-25897	of	_
135-18	25898-25901	the	_
135-19	25902-25906	BOLD	_
135-20	25907-25913	signal	_
135-21	25914-25920	values	_
135-22	25921-25923	in	_
135-23	25924-25927	the	_
135-24	25928-25941	corresponding	_
135-25	25942-25947	voxel	_
135-26	25948-25950	in	_
135-27	25951-25954	any	_
135-28	25955-25960	other	_
135-29	25961-25972	participant	_
135-30	25973-25975	at	_
135-31	25976-25979	any	_
135-32	25980-25985	point	_
135-33	25986-25988	in	_
135-34	25989-25993	time	_
135-35	25994-25995	(	_
135-36	25995-25998	i.e	_
135-37	25998-25999	.	_
135-38	25999-26000	,	_
135-39	26001-26003	no	_
135-40	26004-26012	inter-SC	_
135-41	26013-26020	between	_
135-42	26021-26024	any	_
135-43	26025-26029	pair	_
135-44	26030-26032	of	_
135-45	26033-26044	individuals	_
135-46	26044-26045	)	_
135-47	26045-26046	.	_

#Text=For all conditions, a phase-randomization of each voxel's time course was performed by applying a fast Fourier transform to the signal, randomizing the phase of each Fourier component, and inverting the Fourier transformation.
136-1	26047-26050	For	_
136-2	26051-26054	all	_
136-3	26055-26065	conditions	_
136-4	26065-26066	,	_
136-5	26067-26068	a	_
136-6	26069-26088	phase-randomization	_
136-7	26089-26091	of	_
136-8	26092-26096	each	_
136-9	26097-26104	voxel's	_
136-10	26105-26109	time	_
136-11	26110-26116	course	_
136-12	26117-26120	was	_
136-13	26121-26130	performed	_
136-14	26131-26133	by	_
136-15	26134-26142	applying	_
136-16	26143-26144	a	_
136-17	26145-26149	fast	_
136-18	26150-26157	Fourier	_
136-19	26158-26167	transform	_
136-20	26168-26170	to	_
136-21	26171-26174	the	_
136-22	26175-26181	signal	_
136-23	26181-26182	,	_
136-24	26183-26194	randomizing	_
136-25	26195-26198	the	_
136-26	26199-26204	phase	_
136-27	26205-26207	of	_
136-28	26208-26212	each	_
136-29	26213-26220	Fourier	_
136-30	26221-26230	component	_
136-31	26230-26231	,	_
136-32	26232-26235	and	_
136-33	26236-26245	inverting	_
136-34	26246-26249	the	_
136-35	26250-26257	Fourier	_
136-36	26258-26272	transformation	_
136-37	26272-26273	.	_

#Text=This procedure scrambles the phase of the BOLD time courses but leaves its power spectrum intact.
137-1	26274-26278	This	_
137-2	26279-26288	procedure	_
137-3	26289-26298	scrambles	_
137-4	26299-26302	the	_
137-5	26303-26308	phase	_
137-6	26309-26311	of	_
137-7	26312-26315	the	_
137-8	26316-26320	BOLD	_
137-9	26321-26325	time	_
137-10	26326-26333	courses	_
137-11	26334-26337	but	_
137-12	26338-26344	leaves	_
137-13	26345-26348	its	_
137-14	26349-26354	power	_
137-15	26355-26363	spectrum	_
137-16	26364-26370	intact	_
137-17	26370-26371	.	_

#Text=For each randomly phase-scrambled surrogate dataset, we computed the inter-SC coefficients for all voxels in the exact same manner as the empirical correlation maps described above.
138-1	26372-26375	For	_
138-2	26376-26380	each	_
138-3	26381-26389	randomly	_
138-4	26390-26405	phase-scrambled	_
138-5	26406-26415	surrogate	_
138-6	26416-26423	dataset	_
138-7	26423-26424	,	_
138-8	26425-26427	we	_
138-9	26428-26436	computed	_
138-10	26437-26440	the	_
138-11	26441-26449	inter-SC	_
138-12	26450-26462	coefficients	_
138-13	26463-26466	for	_
138-14	26467-26470	all	_
138-15	26471-26477	voxels	_
138-16	26478-26480	in	_
138-17	26481-26484	the	_
138-18	26485-26490	exact	_
138-19	26491-26495	same	_
138-20	26496-26502	manner	_
138-21	26503-26505	as	_
138-22	26506-26509	the	_
138-23	26510-26519	empirical	_
138-24	26520-26531	correlation	_
138-25	26532-26536	maps	_
138-26	26537-26546	described	_
138-27	26547-26552	above	_
138-28	26552-26553	.	_

#Text=This procedure was performed 5000 times allowing for estimation of a null distribution of average correlations within the voxel.
139-1	26554-26558	This	_
139-2	26559-26568	procedure	_
139-3	26569-26572	was	_
139-4	26573-26582	performed	_
139-5	26583-26587	5000	_
139-6	26588-26593	times	_
139-7	26594-26602	allowing	_
139-8	26603-26606	for	_
139-9	26607-26617	estimation	_
139-10	26618-26620	of	_
139-11	26621-26622	a	_
139-12	26623-26627	null	_
139-13	26628-26640	distribution	_
139-14	26641-26643	of	_
139-15	26644-26651	average	_
139-16	26652-26664	correlations	_
139-17	26665-26671	within	_
139-18	26672-26675	the	_
139-19	26676-26681	voxel	_
139-20	26681-26682	.	_

#Text=Statistical significance (p values) was estimated by comparing empirical correlation values (without phase-randomization) to these null distributions as a percentile from the tails of the distribution.
140-1	26683-26694	Statistical	_
140-2	26695-26707	significance	_
140-3	26708-26709	(	_
140-4	26709-26710	p	_
140-5	26711-26717	values	_
140-6	26717-26718	)	_
140-7	26719-26722	was	_
140-8	26723-26732	estimated	_
140-9	26733-26735	by	_
140-10	26736-26745	comparing	_
140-11	26746-26755	empirical	_
140-12	26756-26767	correlation	_
140-13	26768-26774	values	_
140-14	26775-26776	(	_
140-15	26776-26783	without	_
140-16	26784-26803	phase-randomization	_
140-17	26803-26804	)	_
140-18	26805-26807	to	_
140-19	26808-26813	these	_
140-20	26814-26818	null	_
140-21	26819-26832	distributions	_
140-22	26833-26835	as	_
140-23	26836-26837	a	_
140-24	26838-26848	percentile	_
140-25	26849-26853	from	_
140-26	26854-26857	the	_
140-27	26858-26863	tails	_
140-28	26864-26866	of	_
140-29	26867-26870	the	_
140-30	26871-26883	distribution	_
140-31	26883-26884	.	_

#Text=The resulting map of inter-SCs was corrected for multiple comparisons, using bootstrapped p values by The Benjamini – Hochberg – Yekutieli false-discovery procedure, with the threshold 0.05.
141-1	26885-26888	The	_
141-2	26889-26898	resulting	_
141-3	26899-26902	map	_
141-4	26903-26905	of	_
141-5	26906-26915	inter-SCs	_
141-6	26916-26919	was	_
141-7	26920-26929	corrected	_
141-8	26930-26933	for	_
141-9	26934-26942	multiple	_
141-10	26943-26954	comparisons	_
141-11	26954-26955	,	_
141-12	26956-26961	using	_
141-13	26962-26974	bootstrapped	_
141-14	26975-26976	p	_
141-15	26977-26983	values	_
141-16	26984-26986	by	_
141-17	26987-26990	The	_
141-18	26991-27000	Benjamini	_
141-19	27001-27002	–	_
141-20	27003-27011	Hochberg	_
141-21	27012-27013	–	_
141-22	27014-27023	Yekutieli	_
141-23	27024-27039	false-discovery	_
141-24	27040-27049	procedure	_
141-25	27049-27050	,	_
141-26	27051-27055	with	_
141-27	27056-27059	the	_
141-28	27060-27069	threshold	_
141-29	27070-27074	0.05	_
141-30	27074-27075	.	_

#Text=Comparison between groups
#Text=Comparison of inter-SCs between different groups.
142-1	27076-27086	Comparison	_
142-2	27087-27094	between	_
142-3	27095-27101	groups	_
142-4	27102-27112	Comparison	_
142-5	27113-27115	of	_
142-6	27116-27125	inter-SCs	_
142-7	27126-27133	between	_
142-8	27134-27143	different	_
142-9	27144-27150	groups	_
142-10	27150-27151	.	_

#Text=(A) Significant differences between responses of healthy participants and siblings to story condition (two-tailed t-test).
143-1	27152-27153	(	_
143-2	27153-27154	A	_
143-3	27154-27155	)	_
143-4	27156-27167	Significant	_
143-5	27168-27179	differences	_
143-6	27180-27187	between	_
143-7	27188-27197	responses	_
143-8	27198-27200	of	_
143-9	27201-27208	healthy	_
143-10	27209-27221	participants	_
143-11	27222-27225	and	_
143-12	27226-27234	siblings	_
143-13	27235-27237	to	_
143-14	27238-27243	story	_
143-15	27244-27253	condition	_
143-16	27254-27255	(	_
143-17	27255-27265	two-tailed	_
143-18	27266-27272	t-test	_
143-19	27272-27273	)	_
143-20	27273-27274	.	_

#Text=In regions colored in yellow inter-SCs were significantly higher in healthy participants than in siblings.
144-1	27275-27277	In	_
144-2	27278-27285	regions	_
144-3	27286-27293	colored	_
144-4	27294-27296	in	_
144-5	27297-27303	yellow	_
144-6	27304-27313	inter-SCs	_
144-7	27314-27318	were	_
144-8	27319-27332	significantly	_
144-9	27333-27339	higher	_
144-10	27340-27342	in	_
144-11	27343-27350	healthy	_
144-12	27351-27363	participants	_
144-13	27364-27368	than	_
144-14	27369-27371	in	_
144-15	27372-27380	siblings	_
144-16	27380-27381	.	_

#Text=Insert: Maps of inter-SC for intact story in both healthy groups.
145-1	27382-27388	Insert	_
145-2	27388-27389	:	_
145-3	27390-27394	Maps	_
145-4	27395-27397	of	_
145-5	27398-27406	inter-SC	_
145-6	27407-27410	for	_
145-7	27411-27417	intact	_
145-8	27418-27423	story	_
145-9	27424-27426	in	_
145-10	27427-27431	both	_
145-11	27432-27439	healthy	_
145-12	27440-27446	groups	_
145-13	27446-27447	.	_

#Text=Dark blue, voxels that showed highly synchronized responses in healthy participants; cyan, voxels that showed highly synchronized responses in siblings; light blue, overlap.
146-1	27448-27452	Dark	_
146-2	27453-27457	blue	_
146-3	27457-27458	,	_
146-4	27459-27465	voxels	_
146-5	27466-27470	that	_
146-6	27471-27477	showed	_
146-7	27478-27484	highly	_
146-8	27485-27497	synchronized	_
146-9	27498-27507	responses	_
146-10	27508-27510	in	_
146-11	27511-27518	healthy	_
146-12	27519-27531	participants	_
146-13	27531-27532	;	_
146-14	27533-27537	cyan	_
146-15	27537-27538	,	_
146-16	27539-27545	voxels	_
146-17	27546-27550	that	_
146-18	27551-27557	showed	_
146-19	27558-27564	highly	_
146-20	27565-27577	synchronized	_
146-21	27578-27587	responses	_
146-22	27588-27590	in	_
146-23	27591-27599	siblings	_
146-24	27599-27600	;	_
146-25	27601-27606	light	_
146-26	27607-27611	blue	_
146-27	27611-27612	,	_
146-28	27613-27620	overlap	_
146-29	27620-27621	.	_

#Text=(B) Significant differences between responses of healthy participants and patients with schizophrenia to story condition (two-tailed t-test).
147-1	27622-27623	(	_
147-2	27623-27624	B	_
147-3	27624-27625	)	_
147-4	27626-27637	Significant	_
147-5	27638-27649	differences	_
147-6	27650-27657	between	_
147-7	27658-27667	responses	_
147-8	27668-27670	of	_
147-9	27671-27678	healthy	_
147-10	27679-27691	participants	_
147-11	27692-27695	and	_
147-12	27696-27704	patients	_
147-13	27705-27709	with	_
147-14	27710-27723	schizophrenia	_
147-15	27724-27726	to	_
147-16	27727-27732	story	_
147-17	27733-27742	condition	_
147-18	27743-27744	(	_
147-19	27744-27754	two-tailed	_
147-20	27755-27761	t-test	_
147-21	27761-27762	)	_
147-22	27762-27763	.	_

#Text=Same presentation format as in (A).
148-1	27764-27768	Same	_
148-2	27769-27781	presentation	_
148-3	27782-27788	format	_
148-4	27789-27791	as	_
148-5	27792-27794	in	_
148-6	27795-27796	(	_
148-7	27796-27797	A	_
148-8	27797-27798	)	_
148-9	27798-27799	.	_

#Text=Same abbreviations as in Fig. 2.
149-1	27800-27804	Same	_
149-2	27805-27818	abbreviations	_
149-3	27819-27821	as	_
149-4	27822-27824	in	_
149-5	27825-27828	Fig	_
149-6	27828-27829	.	_
149-7	27830-27831	2	_
149-8	27831-27832	.	_

#Text=(For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
150-1	27833-27834	(	_
150-2	27834-27837	For	_
150-3	27838-27852	interpretation	_
150-4	27853-27855	of	_
150-5	27856-27859	the	_
150-6	27860-27870	references	_
150-7	27871-27873	to	_
150-8	27874-27879	color	_
150-9	27880-27882	in	_
150-10	27883-27887	this	_
150-11	27888-27894	figure	_
150-12	27895-27901	legend	_
150-13	27901-27902	,	_
150-14	27903-27906	the	_
150-15	27907-27913	reader	_
150-16	27914-27916	is	_
150-17	27917-27925	referred	_
150-18	27926-27928	to	_
150-19	27929-27932	the	_
150-20	27933-27936	web	_
150-21	27937-27944	version	_
150-22	27945-27947	of	_
150-23	27948-27952	this	_
150-24	27953-27960	article	_
150-25	27960-27961	.	_
150-26	27961-27962	)	_

#Text=Fig. 3
#Text=To test the differences between groups, a two-tailed t-test was performed within each voxel that showed significant difference of inter-SC values in at least one of the inspected groups.
151-1	27963-27966	Fig	_
151-2	27966-27967	.	_
151-3	27968-27969	3	_
151-4	27970-27972	To	_
151-5	27973-27977	test	_
151-6	27978-27981	the	_
151-7	27982-27993	differences	_
151-8	27994-28001	between	_
151-9	28002-28008	groups	_
151-10	28008-28009	,	_
151-11	28010-28011	a	_
151-12	28012-28022	two-tailed	_
151-13	28023-28029	t-test	_
151-14	28030-28033	was	_
151-15	28034-28043	performed	_
151-16	28044-28050	within	_
151-17	28051-28055	each	_
151-18	28056-28061	voxel	_
151-19	28062-28066	that	_
151-20	28067-28073	showed	_
151-21	28074-28085	significant	_
151-22	28086-28096	difference	_
151-23	28097-28099	of	_
151-24	28100-28108	inter-SC	_
151-25	28109-28115	values	_
151-26	28116-28118	in	_
151-27	28119-28121	at	_
151-28	28122-28127	least	_
151-29	28128-28131	one	_
151-30	28132-28134	of	_
151-31	28135-28138	the	_
151-32	28139-28148	inspected	_
151-33	28149-28155	groups	_
151-34	28155-28156	.	_

#Text=The voxel-wised t-test was done by comparing the Fisher-transformed correlation values computed in each voxel of participants from different groups.
152-1	28157-28160	The	_
152-2	28161-28172	voxel-wised	_
152-3	28173-28179	t-test	_
152-4	28180-28183	was	_
152-5	28184-28188	done	_
152-6	28189-28191	by	_
152-7	28192-28201	comparing	_
152-8	28202-28205	the	_
152-9	28206-28224	Fisher-transformed	_
152-10	28225-28236	correlation	_
152-11	28237-28243	values	_
152-12	28244-28252	computed	_
152-13	28253-28255	in	_
152-14	28256-28260	each	_
152-15	28261-28266	voxel	_
152-16	28267-28269	of	_
152-17	28270-28282	participants	_
152-18	28283-28287	from	_
152-19	28288-28297	different	_
152-20	28298-28304	groups	_
152-21	28304-28305	.	_

#Text=In other words, two-tailed t-tests were employed to show the brain regions that had more consistent or less consistent responses between groups (Fig. 1B2 & Fig. 3).
153-1	28306-28308	In	_
153-2	28309-28314	other	_
153-3	28315-28320	words	_
153-4	28320-28321	,	_
153-5	28322-28332	two-tailed	_
153-6	28333-28340	t-tests	_
153-7	28341-28345	were	_
153-8	28346-28354	employed	_
153-9	28355-28357	to	_
153-10	28358-28362	show	_
153-11	28363-28366	the	_
153-12	28367-28372	brain	_
153-13	28373-28380	regions	_
153-14	28381-28385	that	_
153-15	28386-28389	had	_
153-16	28390-28394	more	_
153-17	28395-28405	consistent	_
153-18	28406-28408	or	_
153-19	28409-28413	less	_
153-20	28414-28424	consistent	_
153-21	28425-28434	responses	_
153-22	28435-28442	between	_
153-23	28443-28449	groups	_
153-24	28450-28451	(	_
153-25	28451-28454	Fig	_
153-26	28454-28455	.	_
153-27	28456-28459	1B2	_
153-28	28460-28461	&	_
153-29	28462-28465	Fig	_
153-30	28465-28466	.	_
153-31	28467-28468	3	_
153-32	28468-28469	)	_
153-33	28469-28470	.	_

#Text=Selection of regions of interest (ROIs) with different processing time scales
#Text=Response reliability profiles in ROIs across processing hierarchy.
154-1	28471-28480	Selection	_
154-2	28481-28483	of	_
154-3	28484-28491	regions	_
154-4	28492-28494	of	_
154-5	28495-28503	interest	_
154-6	28504-28505	(	_
154-7	28505-28509	ROIs	_
154-8	28509-28510	)	_
154-9	28511-28515	with	_
154-10	28516-28525	different	_
154-11	28526-28536	processing	_
154-12	28537-28541	time	_
154-13	28542-28548	scales	_
154-14	28549-28557	Response	_
154-15	28558-28569	reliability	_
154-16	28570-28578	profiles	_
154-17	28579-28581	in	_
154-18	28582-28586	ROIs	_
154-19	28587-28593	across	_
154-20	28594-28604	processing	_
154-21	28605-28614	hierarchy	_
154-22	28614-28615	.	_

#Text=Inter-SCs are plotted for each of the stimuli, for each of the ROIs.
155-1	28616-28625	Inter-SCs	_
155-2	28626-28629	are	_
155-3	28630-28637	plotted	_
155-4	28638-28641	for	_
155-5	28642-28646	each	_
155-6	28647-28649	of	_
155-7	28650-28653	the	_
155-8	28654-28661	stimuli	_
155-9	28661-28662	,	_
155-10	28663-28666	for	_
155-11	28667-28671	each	_
155-12	28672-28674	of	_
155-13	28675-28678	the	_
155-14	28679-28683	ROIs	_
155-15	28683-28684	.	_

#Text=Dashed lines indicate thresholds for statistically significant correlations assessed using phase-randomization and false discovery rate procedures (see Methods).
156-1	28685-28691	Dashed	_
156-2	28692-28697	lines	_
156-3	28698-28706	indicate	_
156-4	28707-28717	thresholds	_
156-5	28718-28721	for	_
156-6	28722-28735	statistically	_
156-7	28736-28747	significant	_
156-8	28748-28760	correlations	_
156-9	28761-28769	assessed	_
156-10	28770-28775	using	_
156-11	28776-28795	phase-randomization	_
156-12	28796-28799	and	_
156-13	28800-28805	false	_
156-14	28806-28815	discovery	_
156-15	28816-28820	rate	_
156-16	28821-28831	procedures	_
156-17	28832-28833	(	_
156-18	28833-28836	see	_
156-19	28837-28844	Methods	_
156-20	28844-28845	)	_
156-21	28845-28846	.	_

#Text=In most of the explored ROIs in the posterior and prefrontal cortices, responses in patients with schizophrenia exhibited substantially reduced correlation relative to healthy participants.
157-1	28847-28849	In	_
157-2	28850-28854	most	_
157-3	28855-28857	of	_
157-4	28858-28861	the	_
157-5	28862-28870	explored	_
157-6	28871-28875	ROIs	_
157-7	28876-28878	in	_
157-8	28879-28882	the	_
157-9	28883-28892	posterior	_
157-10	28893-28896	and	_
157-11	28897-28907	prefrontal	_
157-12	28908-28916	cortices	_
157-13	28916-28917	,	_
157-14	28918-28927	responses	_
157-15	28928-28930	in	_
157-16	28931-28939	patients	_
157-17	28940-28944	with	_
157-18	28945-28958	schizophrenia	_
157-19	28959-28968	exhibited	_
157-20	28969-28982	substantially	_
157-21	28983-28990	reduced	_
157-22	28991-29002	correlation	_
157-23	29003-29011	relative	_
157-24	29012-29014	to	_
157-25	29015-29022	healthy	_
157-26	29023-29035	participants	_
157-27	29035-29036	.	_

#Text=Note that the ROIs were functionally defined based on responses of an independent group of participants (see Methods).
158-1	29037-29041	Note	_
158-2	29042-29046	that	_
158-3	29047-29050	the	_
158-4	29051-29055	ROIs	_
158-5	29056-29060	were	_
158-6	29061-29073	functionally	_
158-7	29074-29081	defined	_
158-8	29082-29087	based	_
158-9	29088-29090	on	_
158-10	29091-29100	responses	_
158-11	29101-29103	of	_
158-12	29104-29106	an	_
158-13	29107-29118	independent	_
158-14	29119-29124	group	_
158-15	29125-29127	of	_
158-16	29128-29140	participants	_
158-17	29141-29142	(	_
158-18	29142-29145	see	_
158-19	29146-29153	Methods	_
158-20	29153-29154	)	_
158-21	29154-29155	.	_

#Text=Horizontal lines indicate thresholds for statistically significant correlations assessed using phase-randomization and FDR procedures.
159-1	29156-29166	Horizontal	_
159-2	29167-29172	lines	_
159-3	29173-29181	indicate	_
159-4	29182-29192	thresholds	_
159-5	29193-29196	for	_
159-6	29197-29210	statistically	_
159-7	29211-29222	significant	_
159-8	29223-29235	correlations	_
159-9	29236-29244	assessed	_
159-10	29245-29250	using	_
159-11	29251-29270	phase-randomization	_
159-12	29271-29274	and	_
159-13	29275-29278	FDR	_
159-14	29279-29289	procedures	_
159-15	29289-29290	.	_

#Text=Error bars indicate estimated standard error.
160-1	29291-29296	Error	_
160-2	29297-29301	bars	_
160-3	29302-29310	indicate	_
160-4	29311-29320	estimated	_
160-5	29321-29329	standard	_
160-6	29330-29335	error	_
160-7	29335-29336	.	_

#Text=Asterisks denote significant differences between groups, ⁎p < 0.05 one-tailed, paired t-test.
161-1	29337-29346	Asterisks	_
161-2	29347-29353	denote	_
161-3	29354-29365	significant	_
161-4	29366-29377	differences	_
161-5	29378-29385	between	_
161-6	29386-29392	groups	_
161-7	29392-29393	,	_
161-8	29394-29395	⁎	_
161-9	29395-29396	p	_
161-10	29396-29397	 	_
161-11	29397-29398	<	_
161-12	29398-29399	 	_
161-13	29399-29403	0.05	_
161-14	29404-29414	one-tailed	_
161-15	29414-29415	,	_
161-16	29416-29422	paired	_
161-17	29423-29429	t-test	_
161-18	29429-29430	.	_

#Text=Fig. 4
#Text=Talairach coordinates of independently defined ROIs.
162-1	29431-29434	Fig	_
162-2	29434-29435	.	_
162-3	29436-29437	4	_
162-4	29438-29447	Talairach	_
162-5	29448-29459	coordinates	_
162-6	29460-29462	of	_
162-7	29463-29476	independently	_
162-8	29477-29484	defined	_
162-9	29485-29489	ROIs	_
162-10	29489-29490	.	_

#Text=The Talairach coordinates were derived from a separate, independent group of healthy participants.
163-1	29491-29494	The	_
163-2	29495-29504	Talairach	_
163-3	29505-29516	coordinates	_
163-4	29517-29521	were	_
163-5	29522-29529	derived	_
163-6	29530-29534	from	_
163-7	29535-29536	a	_
163-8	29537-29545	separate	_
163-9	29545-29546	,	_
163-10	29547-29558	independent	_
163-11	29559-29564	group	_
163-12	29565-29567	of	_
163-13	29568-29575	healthy	_
163-14	29576-29588	participants	_
163-15	29588-29589	.	_

#Text=Table 3\t \t
#Text=\tArea\tMean\t \tx\ty\tz\t \tRight hemisphere\tA1 +\t52\t− 19\t6\t \tmSTG\t55\t− 34\t0\t \tTPJ\t50\t− 55\t20\t \tDLPFC\t43\t22\t26\t \tLeft hemisphere\tA1 +\t− 51\t− 22\t7\t \tmSTG\t− 57\t− 31\t1\t \tTPJ\t− 52\t− 48\t21\t \tDLPFC\t− 44\t24\t28\t \tMedial\tmPFC\t− 1\t30\t36\t \tPrecuneus\t− 1\t− 60\t33\t \t
#Text=Although all our healthy participants exhibited consistent time scale topography, identifying the ROIs based on these data would bias the analyses toward the healthy control group.
164-1	29590-29595	Table	_
164-2	29596-29597	3	_
164-3	29602-29606	Area	_
164-4	29607-29611	Mean	_
164-5	29614-29615	x	_
164-6	29616-29617	y	_
164-7	29618-29619	z	_
164-8	29622-29627	Right	_
164-9	29628-29638	hemisphere	_
164-10	29639-29641	A1	_
164-11	29641-29642	 	_
164-12	29642-29643	+	_
164-13	29644-29646	52	_
164-14	29647-29648	−	_
164-15	29648-29649	 	_
164-16	29649-29651	19	_
164-17	29652-29653	6	_
164-18	29656-29660	mSTG	_
164-19	29661-29663	55	_
164-20	29664-29665	−	_
164-21	29665-29666	 	_
164-22	29666-29668	34	_
164-23	29669-29670	0	_
164-24	29673-29676	TPJ	_
164-25	29677-29679	50	_
164-26	29680-29681	−	_
164-27	29681-29682	 	_
164-28	29682-29684	55	_
164-29	29685-29687	20	_
164-30	29690-29695	DLPFC	_
164-31	29696-29698	43	_
164-32	29699-29701	22	_
164-33	29702-29704	26	_
164-34	29707-29711	Left	_
164-35	29712-29722	hemisphere	_
164-36	29723-29725	A1	_
164-37	29725-29726	 	_
164-38	29726-29727	+	_
164-39	29728-29729	−	_
164-40	29729-29730	 	_
164-41	29730-29732	51	_
164-42	29733-29734	−	_
164-43	29734-29735	 	_
164-44	29735-29737	22	_
164-45	29738-29739	7	_
164-46	29742-29746	mSTG	_
164-47	29747-29748	−	_
164-48	29748-29749	 	_
164-49	29749-29751	57	_
164-50	29752-29753	−	_
164-51	29753-29754	 	_
164-52	29754-29756	31	_
164-53	29757-29758	1	_
164-54	29761-29764	TPJ	_
164-55	29765-29766	−	_
164-56	29766-29767	 	_
164-57	29767-29769	52	_
164-58	29770-29771	−	_
164-59	29771-29772	 	_
164-60	29772-29774	48	_
164-61	29775-29777	21	_
164-62	29780-29785	DLPFC	_
164-63	29786-29787	−	_
164-64	29787-29788	 	_
164-65	29788-29790	44	_
164-66	29791-29793	24	_
164-67	29794-29796	28	_
164-68	29799-29805	Medial	_
164-69	29806-29810	mPFC	_
164-70	29811-29812	−	_
164-71	29812-29813	 	_
164-72	29813-29814	1	_
164-73	29815-29817	30	_
164-74	29818-29820	36	_
164-75	29823-29832	Precuneus	_
164-76	29833-29834	−	_
164-77	29834-29835	 	_
164-78	29835-29836	1	_
164-79	29837-29838	−	_
164-80	29838-29839	 	_
164-81	29839-29841	60	_
164-82	29842-29844	33	_
164-83	29848-29856	Although	_
164-84	29857-29860	all	_
164-85	29861-29864	our	_
164-86	29865-29872	healthy	_
164-87	29873-29885	participants	_
164-88	29886-29895	exhibited	_
164-89	29896-29906	consistent	_
164-90	29907-29911	time	_
164-91	29912-29917	scale	_
164-92	29918-29928	topography	_
164-93	29928-29929	,	_
164-94	29930-29941	identifying	_
164-95	29942-29945	the	_
164-96	29946-29950	ROIs	_
164-97	29951-29956	based	_
164-98	29957-29959	on	_
164-99	29960-29965	these	_
164-100	29966-29970	data	_
164-101	29971-29976	would	_
164-102	29977-29981	bias	_
164-103	29982-29985	the	_
164-104	29986-29994	analyses	_
164-105	29995-30001	toward	_
164-106	30002-30005	the	_
164-107	30006-30013	healthy	_
164-108	30014-30021	control	_
164-109	30022-30027	group	_
164-110	30027-30028	.	_

#Text=Therefore, we defined the average ROIs with short, intermediate and long temporal scales from a separate, independent group of 12 healthy participants.
165-1	30029-30038	Therefore	_
165-2	30038-30039	,	_
165-3	30040-30042	we	_
165-4	30043-30050	defined	_
165-5	30051-30054	the	_
165-6	30055-30062	average	_
165-7	30063-30067	ROIs	_
165-8	30068-30072	with	_
165-9	30073-30078	short	_
165-10	30078-30079	,	_
165-11	30080-30092	intermediate	_
165-12	30093-30096	and	_
165-13	30097-30101	long	_
165-14	30102-30110	temporal	_
165-15	30111-30117	scales	_
165-16	30118-30122	from	_
165-17	30123-30124	a	_
165-18	30125-30133	separate	_
165-19	30133-30134	,	_
165-20	30135-30146	independent	_
165-21	30147-30152	group	_
165-22	30153-30155	of	_
165-23	30156-30158	12	_
165-24	30159-30166	healthy	_
165-25	30167-30179	participants	_
165-26	30179-30180	.	_

#Text=Specifically, the temporal scale of each ROI in this group was defined according to the response reliability in that region across stimuli scrambled on the aforementioned different time scales (for details see).
166-1	30181-30193	Specifically	_
166-2	30193-30194	,	_
166-3	30195-30198	the	_
166-4	30199-30207	temporal	_
166-5	30208-30213	scale	_
166-6	30214-30216	of	_
166-7	30217-30221	each	_
166-8	30222-30225	ROI	_
166-9	30226-30228	in	_
166-10	30229-30233	this	_
166-11	30234-30239	group	_
166-12	30240-30243	was	_
166-13	30244-30251	defined	_
166-14	30252-30261	according	_
166-15	30262-30264	to	_
166-16	30265-30268	the	_
166-17	30269-30277	response	_
166-18	30278-30289	reliability	_
166-19	30290-30292	in	_
166-20	30293-30297	that	_
166-21	30298-30304	region	_
166-22	30305-30311	across	_
166-23	30312-30319	stimuli	_
166-24	30320-30329	scrambled	_
166-25	30330-30332	on	_
166-26	30333-30336	the	_
166-27	30337-30351	aforementioned	_
166-28	30352-30361	different	_
166-29	30362-30366	time	_
166-30	30367-30373	scales	_
166-31	30374-30375	(	_
166-32	30375-30378	for	_
166-33	30379-30386	details	_
166-34	30387-30390	see	_
166-35	30390-30391	)	_
166-36	30391-30392	.	_

#Text=The coordinates of these ROIs were applied to derive ROIs in each participant in the current study.
167-1	30393-30396	The	_
167-2	30397-30408	coordinates	_
167-3	30409-30411	of	_
167-4	30412-30417	these	_
167-5	30418-30422	ROIs	_
167-6	30423-30427	were	_
167-7	30428-30435	applied	_
167-8	30436-30438	to	_
167-9	30439-30445	derive	_
167-10	30446-30450	ROIs	_
167-11	30451-30453	in	_
167-12	30454-30458	each	_
167-13	30459-30470	participant	_
167-14	30471-30473	in	_
167-15	30474-30477	the	_
167-16	30478-30485	current	_
167-17	30486-30491	study	_
167-18	30491-30492	.	_

#Text=Namely, ROIs with a predicted time scale were selected: middle superior temporal gyrus (mSTG), temporal-parietal junction (TPJ), DLPFC, medial prefrontal cortex (mPFC) and precuneus (Fig. 1B4 & Fig. 4).
168-1	30493-30499	Namely	_
168-2	30499-30500	,	_
168-3	30501-30505	ROIs	_
168-4	30506-30510	with	_
168-5	30511-30512	a	_
168-6	30513-30522	predicted	_
168-7	30523-30527	time	_
168-8	30528-30533	scale	_
168-9	30534-30538	were	_
168-10	30539-30547	selected	_
168-11	30547-30548	:	_
168-12	30549-30555	middle	_
168-13	30556-30564	superior	_
168-14	30565-30573	temporal	_
168-15	30574-30579	gyrus	_
168-16	30580-30581	(	_
168-17	30581-30585	mSTG	_
168-18	30585-30586	)	_
168-19	30586-30587	,	_
168-20	30588-30605	temporal-parietal	_
168-21	30606-30614	junction	_
168-22	30615-30616	(	_
168-23	30616-30619	TPJ	_
168-24	30619-30620	)	_
168-25	30620-30621	,	_
168-26	30622-30627	DLPFC	_
168-27	30627-30628	,	_
168-28	30629-30635	medial	_
168-29	30636-30646	prefrontal	_
168-30	30647-30653	cortex	_
168-31	30654-30655	(	_
168-32	30655-30659	mPFC	_
168-33	30659-30660	)	_
168-34	30661-30664	and	_
168-35	30665-30674	precuneus	_
168-36	30675-30676	(	_
168-37	30676-30679	Fig	_
168-38	30679-30680	.	_
168-39	30681-30684	1B4	_
168-40	30685-30686	&	_
168-41	30687-30690	Fig	_
168-42	30690-30691	.	_
168-43	30692-30693	4	_
168-44	30693-30694	)	_
168-45	30694-30695	.	_

#Text=An early auditory ROI (A1+) was defined as the set of voxels that correlated the most with the stimulus audio envelope.
169-1	30696-30698	An	_
169-2	30699-30704	early	_
169-3	30705-30713	auditory	_
169-4	30714-30717	ROI	_
169-5	30718-30719	(	_
169-6	30719-30721	A1	_
169-7	30721-30722	+	_
169-8	30722-30723	)	_
169-9	30724-30727	was	_
169-10	30728-30735	defined	_
169-11	30736-30738	as	_
169-12	30739-30742	the	_
169-13	30743-30746	set	_
169-14	30747-30749	of	_
169-15	30750-30756	voxels	_
169-16	30757-30761	that	_
169-17	30762-30772	correlated	_
169-18	30773-30776	the	_
169-19	30777-30781	most	_
169-20	30782-30786	with	_
169-21	30787-30790	the	_
169-22	30791-30799	stimulus	_
169-23	30800-30805	audio	_
169-24	30806-30814	envelope	_
169-25	30814-30815	.	_

#Text=To compute the correlation between BOLD signals and the audio envelope, we bandpassed the audio signal between 4 and 4000 Hz, extracted the envelope of the signal using a Hilbert transform, and then downsampled the envelope to the sampling rate of the BOLD signal using an anti-aliasing low-pass finite impulse response filter.
170-1	30816-30818	To	_
170-2	30819-30826	compute	_
170-3	30827-30830	the	_
170-4	30831-30842	correlation	_
170-5	30843-30850	between	_
170-6	30851-30855	BOLD	_
170-7	30856-30863	signals	_
170-8	30864-30867	and	_
170-9	30868-30871	the	_
170-10	30872-30877	audio	_
170-11	30878-30886	envelope	_
170-12	30886-30887	,	_
170-13	30888-30890	we	_
170-14	30891-30901	bandpassed	_
170-15	30902-30905	the	_
170-16	30906-30911	audio	_
170-17	30912-30918	signal	_
170-18	30919-30926	between	_
170-19	30927-30928	4	_
170-20	30929-30932	and	_
170-21	30933-30937	4000	_
170-22	30937-30938	 	_
170-23	30938-30940	Hz	_
170-24	30940-30941	,	_
170-25	30942-30951	extracted	_
170-26	30952-30955	the	_
170-27	30956-30964	envelope	_
170-28	30965-30967	of	_
170-29	30968-30971	the	_
170-30	30972-30978	signal	_
170-31	30979-30984	using	_
170-32	30985-30986	a	_
170-33	30987-30994	Hilbert	_
170-34	30995-31004	transform	_
170-35	31004-31005	,	_
170-36	31006-31009	and	_
170-37	31010-31014	then	_
170-38	31015-31026	downsampled	_
170-39	31027-31030	the	_
170-40	31031-31039	envelope	_
170-41	31040-31042	to	_
170-42	31043-31046	the	_
170-43	31047-31055	sampling	_
170-44	31056-31060	rate	_
170-45	31061-31063	of	_
170-46	31064-31067	the	_
170-47	31068-31072	BOLD	_
170-48	31073-31079	signal	_
170-49	31080-31085	using	_
170-50	31086-31088	an	_
170-51	31089-31102	anti-aliasing	_
170-52	31103-31111	low-pass	_
170-53	31112-31118	finite	_
170-54	31119-31126	impulse	_
170-55	31127-31135	response	_
170-56	31136-31142	filter	_
170-57	31142-31143	.	_

#Text=Table 3 provides Talairach coordinates for the centers of the noted regions.
171-1	31144-31149	Table	_
171-2	31150-31151	3	_
171-3	31152-31160	provides	_
171-4	31161-31170	Talairach	_
171-5	31171-31182	coordinates	_
171-6	31183-31186	for	_
171-7	31187-31190	the	_
171-8	31191-31198	centers	_
171-9	31199-31201	of	_
171-10	31202-31205	the	_
171-11	31206-31211	noted	_
171-12	31212-31219	regions	_
171-13	31219-31220	.	_

#Text=In addition, to confirm that our method of ROI selection does not bias in favor of healthy participants, while brains in patients with schizophrenia are characterized by cortical atrophy, we defined another set of ROIs – A1+, mSTG, TPJ and precuneus based on the responses obtained in our patients with schizophrenia for the same stimuli.
172-1	31221-31223	In	_
172-2	31224-31232	addition	_
172-3	31232-31233	,	_
172-4	31234-31236	to	_
172-5	31237-31244	confirm	_
172-6	31245-31249	that	_
172-7	31250-31253	our	_
172-8	31254-31260	method	_
172-9	31261-31263	of	_
172-10	31264-31267	ROI	_
172-11	31268-31277	selection	_
172-12	31278-31282	does	_
172-13	31283-31286	not	_
172-14	31287-31291	bias	_
172-15	31292-31294	in	_
172-16	31295-31300	favor	_
172-17	31301-31303	of	_
172-18	31304-31311	healthy	_
172-19	31312-31324	participants	_
172-20	31324-31325	,	_
172-21	31326-31331	while	_
172-22	31332-31338	brains	_
172-23	31339-31341	in	_
172-24	31342-31350	patients	_
172-25	31351-31355	with	_
172-26	31356-31369	schizophrenia	_
172-27	31370-31373	are	_
172-28	31374-31387	characterized	_
172-29	31388-31390	by	_
172-30	31391-31399	cortical	_
172-31	31400-31407	atrophy	_
172-32	31407-31408	,	_
172-33	31409-31411	we	_
172-34	31412-31419	defined	_
172-35	31420-31427	another	_
172-36	31428-31431	set	_
172-37	31432-31434	of	_
172-38	31435-31439	ROIs	_
172-39	31440-31441	–	_
172-40	31442-31444	A1	_
172-41	31444-31445	+	_
172-42	31445-31446	,	_
172-43	31447-31451	mSTG	_
172-44	31451-31452	,	_
172-45	31453-31456	TPJ	_
172-46	31457-31460	and	_
172-47	31461-31470	precuneus	_
172-48	31471-31476	based	_
172-49	31477-31479	on	_
172-50	31480-31483	the	_
172-51	31484-31493	responses	_
172-52	31494-31502	obtained	_
172-53	31503-31505	in	_
172-54	31506-31509	our	_
172-55	31510-31518	patients	_
172-56	31519-31523	with	_
172-57	31524-31537	schizophrenia	_
172-58	31538-31541	for	_
172-59	31542-31545	the	_
172-60	31546-31550	same	_
172-61	31551-31558	stimuli	_
172-62	31558-31559	.	_

#Text=This procedure for ROI selection certainly biased the responses toward the patients group, but the outcomes were similar to previous results with a set of independently defined ROIs.
173-1	31560-31564	This	_
173-2	31565-31574	procedure	_
173-3	31575-31578	for	_
173-4	31579-31582	ROI	_
173-5	31583-31592	selection	_
173-6	31593-31602	certainly	_
173-7	31603-31609	biased	_
173-8	31610-31613	the	_
173-9	31614-31623	responses	_
173-10	31624-31630	toward	_
173-11	31631-31634	the	_
173-12	31635-31643	patients	_
173-13	31644-31649	group	_
173-14	31649-31650	,	_
173-15	31651-31654	but	_
173-16	31655-31658	the	_
173-17	31659-31667	outcomes	_
173-18	31668-31672	were	_
173-19	31673-31680	similar	_
173-20	31681-31683	to	_
173-21	31684-31692	previous	_
173-22	31693-31700	results	_
173-23	31701-31705	with	_
173-24	31706-31707	a	_
173-25	31708-31711	set	_
173-26	31712-31714	of	_
173-27	31715-31728	independently	_
173-28	31729-31736	defined	_
173-29	31737-31741	ROIs	_
173-30	31741-31742	.	_

#Text=Response amplitude
#Text=Due to the nature of our experimental design (continuous real-life stimuli), we cannot directly assess changes in response amplitude relative to a blank (no-task) baseline.
174-1	31743-31751	Response	_
174-2	31752-31761	amplitude	_
174-3	31762-31765	Due	_
174-4	31766-31768	to	_
174-5	31769-31772	the	_
174-6	31773-31779	nature	_
174-7	31780-31782	of	_
174-8	31783-31786	our	_
174-9	31787-31799	experimental	_
174-10	31800-31806	design	_
174-11	31807-31808	(	_
174-12	31808-31818	continuous	_
174-13	31819-31828	real-life	_
174-14	31829-31836	stimuli	_
174-15	31836-31837	)	_
174-16	31837-31838	,	_
174-17	31839-31841	we	_
174-18	31842-31848	cannot	_
174-19	31849-31857	directly	_
174-20	31858-31864	assess	_
174-21	31865-31872	changes	_
174-22	31873-31875	in	_
174-23	31876-31884	response	_
174-24	31885-31894	amplitude	_
174-25	31895-31903	relative	_
174-26	31904-31906	to	_
174-27	31907-31908	a	_
174-28	31909-31914	blank	_
174-29	31915-31916	(	_
174-30	31916-31923	no-task	_
174-31	31923-31924	)	_
174-32	31925-31933	baseline	_
174-33	31933-31934	.	_

#Text=To estimate response amplitude, we measured the standard deviation (SD) of the percent BOLD signal change of the responses over time.
175-1	31935-31937	To	_
175-2	31938-31946	estimate	_
175-3	31947-31955	response	_
175-4	31956-31965	amplitude	_
175-5	31965-31966	,	_
175-6	31967-31969	we	_
175-7	31970-31978	measured	_
175-8	31979-31982	the	_
175-9	31983-31991	standard	_
175-10	31992-32001	deviation	_
175-11	32002-32003	(	_
175-12	32003-32005	SD	_
175-13	32005-32006	)	_
175-14	32007-32009	of	_
175-15	32010-32013	the	_
175-16	32014-32021	percent	_
175-17	32022-32026	BOLD	_
175-18	32027-32033	signal	_
175-19	32034-32040	change	_
175-20	32041-32043	of	_
175-21	32044-32047	the	_
175-22	32048-32057	responses	_
175-23	32058-32062	over	_
175-24	32063-32067	time	_
175-25	32067-32068	.	_

#Text=This measure provides a proxy for the overall signal modulations because small signal fluctuations should produce lower SD and larger fluctuations should produce higher SD.
176-1	32069-32073	This	_
176-2	32074-32081	measure	_
176-3	32082-32090	provides	_
176-4	32091-32092	a	_
176-5	32093-32098	proxy	_
176-6	32099-32102	for	_
176-7	32103-32106	the	_
176-8	32107-32114	overall	_
176-9	32115-32121	signal	_
176-10	32122-32133	modulations	_
176-11	32134-32141	because	_
176-12	32142-32147	small	_
176-13	32148-32154	signal	_
176-14	32155-32167	fluctuations	_
176-15	32168-32174	should	_
176-16	32175-32182	produce	_
176-17	32183-32188	lower	_
176-18	32189-32191	SD	_
176-19	32192-32195	and	_
176-20	32196-32202	larger	_
176-21	32203-32215	fluctuations	_
176-22	32216-32222	should	_
176-23	32223-32230	produce	_
176-24	32231-32237	higher	_
176-25	32238-32240	SD	_
176-26	32240-32241	.	_

#Text=The SD was assessed independently for each ROI and each condition, first within each participant and then averaged across participants.
177-1	32242-32245	The	_
177-2	32246-32248	SD	_
177-3	32249-32252	was	_
177-4	32253-32261	assessed	_
177-5	32262-32275	independently	_
177-6	32276-32279	for	_
177-7	32280-32284	each	_
177-8	32285-32288	ROI	_
177-9	32289-32292	and	_
177-10	32293-32297	each	_
177-11	32298-32307	condition	_
177-12	32307-32308	,	_
177-13	32309-32314	first	_
177-14	32315-32321	within	_
177-15	32322-32326	each	_
177-16	32327-32338	participant	_
177-17	32339-32342	and	_
177-18	32343-32347	then	_
177-19	32348-32356	averaged	_
177-20	32357-32363	across	_
177-21	32364-32376	participants	_
177-22	32376-32377	.	_

#Text=Results
#Text=Response reliability across whole brain for different time scales
#Text=To estimate the level of synchronization in response time courses of participants that listened to a narrated story and scrambled versions of it (Fig. 1) we, first, calculated the inter-SC values across the entire stimuli within each group on a voxel-by-voxel basis (see Methods).
178-1	32378-32385	Results	_
178-2	32386-32394	Response	_
178-3	32395-32406	reliability	_
178-4	32407-32413	across	_
178-5	32414-32419	whole	_
178-6	32420-32425	brain	_
178-7	32426-32429	for	_
178-8	32430-32439	different	_
178-9	32440-32444	time	_
178-10	32445-32451	scales	_
178-11	32452-32454	To	_
178-12	32455-32463	estimate	_
178-13	32464-32467	the	_
178-14	32468-32473	level	_
178-15	32474-32476	of	_
178-16	32477-32492	synchronization	_
178-17	32493-32495	in	_
178-18	32496-32504	response	_
178-19	32505-32509	time	_
178-20	32510-32517	courses	_
178-21	32518-32520	of	_
178-22	32521-32533	participants	_
178-23	32534-32538	that	_
178-24	32539-32547	listened	_
178-25	32548-32550	to	_
178-26	32551-32552	a	_
178-27	32553-32561	narrated	_
178-28	32562-32567	story	_
178-29	32568-32571	and	_
178-30	32572-32581	scrambled	_
178-31	32582-32590	versions	_
178-32	32591-32593	of	_
178-33	32594-32596	it	_
178-34	32597-32598	(	_
178-35	32598-32601	Fig	_
178-36	32601-32602	.	_
178-37	32603-32604	1	_
178-38	32604-32605	)	_
178-39	32606-32608	we	_
178-40	32608-32609	,	_
178-41	32610-32615	first	_
178-42	32615-32616	,	_
178-43	32617-32627	calculated	_
178-44	32628-32631	the	_
178-45	32632-32640	inter-SC	_
178-46	32641-32647	values	_
178-47	32648-32654	across	_
178-48	32655-32658	the	_
178-49	32659-32665	entire	_
178-50	32666-32673	stimuli	_
178-51	32674-32680	within	_
178-52	32681-32685	each	_
178-53	32686-32691	group	_
178-54	32692-32694	on	_
178-55	32695-32696	a	_
178-56	32697-32711	voxel-by-voxel	_
178-57	32712-32717	basis	_
178-58	32718-32719	(	_
178-59	32719-32722	see	_
178-60	32723-32730	Methods	_
178-61	32730-32731	)	_
178-62	32731-32732	.	_

#Text=Following, we constructed a nested map (Fig. 2).
179-1	32733-32742	Following	_
179-2	32742-32743	,	_
179-3	32744-32746	we	_
179-4	32747-32758	constructed	_
179-5	32759-32760	a	_
179-6	32761-32767	nested	_
179-7	32768-32771	map	_
179-8	32772-32773	(	_
179-9	32773-32776	Fig	_
179-10	32776-32777	.	_
179-11	32778-32779	2	_
179-12	32779-32780	)	_
179-13	32780-32781	.	_

#Text=The voxels on the map were classified according to the shortest temporal scale that evoked significantly synchronized responses across participants (for the statistical criteria see Methods).
180-1	32782-32785	The	_
180-2	32786-32792	voxels	_
180-3	32793-32795	on	_
180-4	32796-32799	the	_
180-5	32800-32803	map	_
180-6	32804-32808	were	_
180-7	32809-32819	classified	_
180-8	32820-32829	according	_
180-9	32830-32832	to	_
180-10	32833-32836	the	_
180-11	32837-32845	shortest	_
180-12	32846-32854	temporal	_
180-13	32855-32860	scale	_
180-14	32861-32865	that	_
180-15	32866-32872	evoked	_
180-16	32873-32886	significantly	_
180-17	32887-32899	synchronized	_
180-18	32900-32909	responses	_
180-19	32910-32916	across	_
180-20	32917-32929	participants	_
180-21	32930-32931	(	_
180-22	32931-32934	for	_
180-23	32935-32938	the	_
180-24	32939-32950	statistical	_
180-25	32951-32959	criteria	_
180-26	32960-32963	see	_
180-27	32964-32971	Methods	_
180-28	32971-32972	)	_
180-29	32972-32973	.	_

#Text=Specifically, voxels at the lowest level in this topography (red-colored) demonstrated reliably synchronized responses to all conditions, including scrambled words and sentences; areas at the intermediate level (green-colored) exhibited high inter-SCs to scrambled sentences and story; areas at the top level in the topography (blue-colored) showed significantly synchronized responses only to the story condition.
181-1	32974-32986	Specifically	_
181-2	32986-32987	,	_
181-3	32988-32994	voxels	_
181-4	32995-32997	at	_
181-5	32998-33001	the	_
181-6	33002-33008	lowest	_
181-7	33009-33014	level	_
181-8	33015-33017	in	_
181-9	33018-33022	this	_
181-10	33023-33033	topography	_
181-11	33034-33035	(	_
181-12	33035-33046	red-colored	_
181-13	33046-33047	)	_
181-14	33048-33060	demonstrated	_
181-15	33061-33069	reliably	_
181-16	33070-33082	synchronized	_
181-17	33083-33092	responses	_
181-18	33093-33095	to	_
181-19	33096-33099	all	_
181-20	33100-33110	conditions	_
181-21	33110-33111	,	_
181-22	33112-33121	including	_
181-23	33122-33131	scrambled	_
181-24	33132-33137	words	_
181-25	33138-33141	and	_
181-26	33142-33151	sentences	_
181-27	33151-33152	;	_
181-28	33153-33158	areas	_
181-29	33159-33161	at	_
181-30	33162-33165	the	_
181-31	33166-33178	intermediate	_
181-32	33179-33184	level	_
181-33	33185-33186	(	_
181-34	33186-33199	green-colored	_
181-35	33199-33200	)	_
181-36	33201-33210	exhibited	_
181-37	33211-33215	high	_
181-38	33216-33225	inter-SCs	_
181-39	33226-33228	to	_
181-40	33229-33238	scrambled	_
181-41	33239-33248	sentences	_
181-42	33249-33252	and	_
181-43	33253-33258	story	_
181-44	33258-33259	;	_
181-45	33260-33265	areas	_
181-46	33266-33268	at	_
181-47	33269-33272	the	_
181-48	33273-33276	top	_
181-49	33277-33282	level	_
181-50	33283-33285	in	_
181-51	33286-33289	the	_
181-52	33290-33300	topography	_
181-53	33301-33302	(	_
181-54	33302-33314	blue-colored	_
181-55	33314-33315	)	_
181-56	33316-33322	showed	_
181-57	33323-33336	significantly	_
181-58	33337-33349	synchronized	_
181-59	33350-33359	responses	_
181-60	33360-33364	only	_
181-61	33365-33367	to	_
181-62	33368-33371	the	_
181-63	33372-33377	story	_
181-64	33378-33387	condition	_
181-65	33387-33388	.	_

#Text=The time-scale gradient found in the healthy group (N = 15, Fig. 2A) replicated our previous findings – early areas (A1+) showed high synchronization, disregarding scrambling, in all conditions; intermediate-level areas, such as mSTG, showed reliable responses up to sentence coherency; and story evoked reliable responses in a wide network of the parietal and frontal areas.
182-1	33389-33392	The	_
182-2	33393-33403	time-scale	_
182-3	33404-33412	gradient	_
182-4	33413-33418	found	_
182-5	33419-33421	in	_
182-6	33422-33425	the	_
182-7	33426-33433	healthy	_
182-8	33434-33439	group	_
182-9	33440-33441	(	_
182-10	33441-33442	N	_
182-11	33442-33443	 	_
182-12	33443-33444	=	_
182-13	33444-33445	 	_
182-14	33445-33447	15	_
182-15	33447-33448	,	_
182-16	33449-33452	Fig	_
182-17	33452-33453	.	_
182-18	33454-33456	2A	_
182-19	33456-33457	)	_
182-20	33458-33468	replicated	_
182-21	33469-33472	our	_
182-22	33473-33481	previous	_
182-23	33482-33490	findings	_
182-24	33491-33492	–	_
182-25	33493-33498	early	_
182-26	33499-33504	areas	_
182-27	33505-33506	(	_
182-28	33506-33508	A1	_
182-29	33508-33509	+	_
182-30	33509-33510	)	_
182-31	33511-33517	showed	_
182-32	33518-33522	high	_
182-33	33523-33538	synchronization	_
182-34	33538-33539	,	_
182-35	33540-33552	disregarding	_
182-36	33553-33563	scrambling	_
182-37	33563-33564	,	_
182-38	33565-33567	in	_
182-39	33568-33571	all	_
182-40	33572-33582	conditions	_
182-41	33582-33583	;	_
182-42	33584-33602	intermediate-level	_
182-43	33603-33608	areas	_
182-44	33608-33609	,	_
182-45	33610-33614	such	_
182-46	33615-33617	as	_
182-47	33618-33622	mSTG	_
182-48	33622-33623	,	_
182-49	33624-33630	showed	_
182-50	33631-33639	reliable	_
182-51	33640-33649	responses	_
182-52	33650-33652	up	_
182-53	33653-33655	to	_
182-54	33656-33664	sentence	_
182-55	33665-33674	coherency	_
182-56	33674-33675	;	_
182-57	33676-33679	and	_
182-58	33680-33685	story	_
182-59	33686-33692	evoked	_
182-60	33693-33701	reliable	_
182-61	33702-33711	responses	_
182-62	33712-33714	in	_
182-63	33715-33716	a	_
182-64	33717-33721	wide	_
182-65	33722-33729	network	_
182-66	33730-33732	of	_
182-67	33733-33736	the	_
182-68	33737-33745	parietal	_
182-69	33746-33749	and	_
182-70	33750-33757	frontal	_
182-71	33758-33763	areas	_
182-72	33763-33764	.	_

#Text=A similar hierarchy, with a slight lateralization effect in the prefrontal cortex was found within the siblings group (N = 14, Fig. 2B).
183-1	33765-33766	A	_
183-2	33767-33774	similar	_
183-3	33775-33784	hierarchy	_
183-4	33784-33785	,	_
183-5	33786-33790	with	_
183-6	33791-33792	a	_
183-7	33793-33799	slight	_
183-8	33800-33814	lateralization	_
183-9	33815-33821	effect	_
183-10	33822-33824	in	_
183-11	33825-33828	the	_
183-12	33829-33839	prefrontal	_
183-13	33840-33846	cortex	_
183-14	33847-33850	was	_
183-15	33851-33856	found	_
183-16	33857-33863	within	_
183-17	33864-33867	the	_
183-18	33868-33876	siblings	_
183-19	33877-33882	group	_
183-20	33883-33884	(	_
183-21	33884-33885	N	_
183-22	33885-33886	 	_
183-23	33886-33887	=	_
183-24	33887-33888	 	_
183-25	33888-33890	14	_
183-26	33890-33891	,	_
183-27	33892-33895	Fig	_
183-28	33895-33896	.	_
183-29	33897-33899	2B	_
183-30	33899-33900	)	_
183-31	33900-33901	.	_

#Text=Within the schizophrenia group (N = 15), the reliability of responses obtained in the A1+ for the shortest temporal scale (scrambled words, Fig. 2C, red) was similar to those observed in the both healthy and siblings groups.
184-1	33902-33908	Within	_
184-2	33909-33912	the	_
184-3	33913-33926	schizophrenia	_
184-4	33927-33932	group	_
184-5	33933-33934	(	_
184-6	33934-33935	N	_
184-7	33935-33936	 	_
184-8	33936-33937	=	_
184-9	33937-33938	 	_
184-10	33938-33940	15	_
184-11	33940-33941	)	_
184-12	33941-33942	,	_
184-13	33943-33946	the	_
184-14	33947-33958	reliability	_
184-15	33959-33961	of	_
184-16	33962-33971	responses	_
184-17	33972-33980	obtained	_
184-18	33981-33983	in	_
184-19	33984-33987	the	_
184-20	33988-33990	A1	_
184-21	33990-33991	+	_
184-22	33992-33995	for	_
184-23	33996-33999	the	_
184-24	34000-34008	shortest	_
184-25	34009-34017	temporal	_
184-26	34018-34023	scale	_
184-27	34024-34025	(	_
184-28	34025-34034	scrambled	_
184-29	34035-34040	words	_
184-30	34040-34041	,	_
184-31	34042-34045	Fig	_
184-32	34045-34046	.	_
184-33	34047-34049	2C	_
184-34	34049-34050	,	_
184-35	34051-34054	red	_
184-36	34054-34055	)	_
184-37	34056-34059	was	_
184-38	34060-34067	similar	_
184-39	34068-34070	to	_
184-40	34071-34076	those	_
184-41	34077-34085	observed	_
184-42	34086-34088	in	_
184-43	34089-34092	the	_
184-44	34093-34097	both	_
184-45	34098-34105	healthy	_
184-46	34106-34109	and	_
184-47	34110-34118	siblings	_
184-48	34119-34125	groups	_
184-49	34125-34126	.	_

#Text=Scrambled sentences (intermediate temporal scale) evoked reliable, although spatially less extended responses in patients (Fig. 2C, green).
185-1	34127-34136	Scrambled	_
185-2	34137-34146	sentences	_
185-3	34147-34148	(	_
185-4	34148-34160	intermediate	_
185-5	34161-34169	temporal	_
185-6	34170-34175	scale	_
185-7	34175-34176	)	_
185-8	34177-34183	evoked	_
185-9	34184-34192	reliable	_
185-10	34192-34193	,	_
185-11	34194-34202	although	_
185-12	34203-34212	spatially	_
185-13	34213-34217	less	_
185-14	34218-34226	extended	_
185-15	34227-34236	responses	_
185-16	34237-34239	in	_
185-17	34240-34248	patients	_
185-18	34249-34250	(	_
185-19	34250-34253	Fig	_
185-20	34253-34254	.	_
185-21	34255-34257	2C	_
185-22	34257-34258	,	_
185-23	34259-34264	green	_
185-24	34264-34265	)	_
185-25	34265-34266	.	_

#Text=However, robust and widespread disruption in the response synchronization was found for the story condition (long temporal scale) with only some high inter-SCs in the TPJ and precuneus (Fig. 2C, blue).
186-1	34267-34274	However	_
186-2	34274-34275	,	_
186-3	34276-34282	robust	_
186-4	34283-34286	and	_
186-5	34287-34297	widespread	_
186-6	34298-34308	disruption	_
186-7	34309-34311	in	_
186-8	34312-34315	the	_
186-9	34316-34324	response	_
186-10	34325-34340	synchronization	_
186-11	34341-34344	was	_
186-12	34345-34350	found	_
186-13	34351-34354	for	_
186-14	34355-34358	the	_
186-15	34359-34364	story	_
186-16	34365-34374	condition	_
186-17	34375-34376	(	_
186-18	34376-34380	long	_
186-19	34381-34389	temporal	_
186-20	34390-34395	scale	_
186-21	34395-34396	)	_
186-22	34397-34401	with	_
186-23	34402-34406	only	_
186-24	34407-34411	some	_
186-25	34412-34416	high	_
186-26	34417-34426	inter-SCs	_
186-27	34427-34429	in	_
186-28	34430-34433	the	_
186-29	34434-34437	TPJ	_
186-30	34438-34441	and	_
186-31	34442-34451	precuneus	_
186-32	34452-34453	(	_
186-33	34453-34456	Fig	_
186-34	34456-34457	.	_
186-35	34458-34460	2C	_
186-36	34460-34461	,	_
186-37	34462-34466	blue	_
186-38	34466-34467	)	_
186-39	34467-34468	.	_

#Text=No significant inter-SC correlations were found in the prefrontal regions, such as mPFC or DLPFC.
187-1	34469-34471	No	_
187-2	34472-34483	significant	_
187-3	34484-34492	inter-SC	_
187-4	34493-34505	correlations	_
187-5	34506-34510	were	_
187-6	34511-34516	found	_
187-7	34517-34519	in	_
187-8	34520-34523	the	_
187-9	34524-34534	prefrontal	_
187-10	34535-34542	regions	_
187-11	34542-34543	,	_
187-12	34544-34548	such	_
187-13	34549-34551	as	_
187-14	34552-34556	mPFC	_
187-15	34557-34559	or	_
187-16	34560-34565	DLPFC	_
187-17	34565-34566	.	_

#Text=Importantly, there were no regions that exhibited significant inter-SC correlations only in the patients with schizophrenia but not within the healthy individuals.
188-1	34567-34578	Importantly	_
188-2	34578-34579	,	_
188-3	34580-34585	there	_
188-4	34586-34590	were	_
188-5	34591-34593	no	_
188-6	34594-34601	regions	_
188-7	34602-34606	that	_
188-8	34607-34616	exhibited	_
188-9	34617-34628	significant	_
188-10	34629-34637	inter-SC	_
188-11	34638-34650	correlations	_
188-12	34651-34655	only	_
188-13	34656-34658	in	_
188-14	34659-34662	the	_
188-15	34663-34671	patients	_
188-16	34672-34676	with	_
188-17	34677-34690	schizophrenia	_
188-18	34691-34694	but	_
188-19	34695-34698	not	_
188-20	34699-34705	within	_
188-21	34706-34709	the	_
188-22	34710-34717	healthy	_
188-23	34718-34729	individuals	_
188-24	34729-34730	.	_

#Text=In addition, taking into account specific language abilities of patients with schizophrenia, we divided the group of patients into two sub-groups: monolingual patients (N = 9) and bilingual patients (N = 6).
189-1	34731-34733	In	_
189-2	34734-34742	addition	_
189-3	34742-34743	,	_
189-4	34744-34750	taking	_
189-5	34751-34755	into	_
189-6	34756-34763	account	_
189-7	34764-34772	specific	_
189-8	34773-34781	language	_
189-9	34782-34791	abilities	_
189-10	34792-34794	of	_
189-11	34795-34803	patients	_
189-12	34804-34808	with	_
189-13	34809-34822	schizophrenia	_
189-14	34822-34823	,	_
189-15	34824-34826	we	_
189-16	34827-34834	divided	_
189-17	34835-34838	the	_
189-18	34839-34844	group	_
189-19	34845-34847	of	_
189-20	34848-34856	patients	_
189-21	34857-34861	into	_
189-22	34862-34865	two	_
189-23	34866-34876	sub-groups	_
189-24	34876-34877	:	_
189-25	34878-34889	monolingual	_
189-26	34890-34898	patients	_
189-27	34899-34900	(	_
189-28	34900-34901	N	_
189-29	34901-34902	 	_
189-30	34902-34903	=	_
189-31	34903-34904	 	_
189-32	34904-34905	9	_
189-33	34905-34906	)	_
189-34	34907-34910	and	_
189-35	34911-34920	bilingual	_
189-36	34921-34929	patients	_
189-37	34930-34931	(	_
189-38	34931-34932	N	_
189-39	34932-34933	 	_
189-40	34933-34934	=	_
189-41	34934-34935	 	_
189-42	34935-34936	6	_
189-43	34936-34937	)	_
189-44	34937-34938	.	_

#Text=Note that the temporal hierarchies within these subgroups were very similar (Supplementary Fig. 1) and looked like the map shown in Fig. 2C.
190-1	34939-34943	Note	_
190-2	34944-34948	that	_
190-3	34949-34952	the	_
190-4	34953-34961	temporal	_
190-5	34962-34973	hierarchies	_
190-6	34974-34980	within	_
190-7	34981-34986	these	_
190-8	34987-34996	subgroups	_
190-9	34997-35001	were	_
190-10	35002-35006	very	_
190-11	35007-35014	similar	_
190-12	35015-35016	(	_
190-13	35016-35029	Supplementary	_
190-14	35030-35033	Fig	_
190-15	35033-35034	.	_
190-16	35035-35036	1	_
190-17	35036-35037	)	_
190-18	35038-35041	and	_
190-19	35042-35048	looked	_
190-20	35049-35053	like	_
190-21	35054-35057	the	_
190-22	35058-35061	map	_
190-23	35062-35067	shown	_
190-24	35068-35070	in	_
190-25	35071-35074	Fig	_
190-26	35074-35075	.	_
190-27	35076-35078	2C	_
190-28	35078-35079	.	_

#Text=Next, we directly compared results obtained for the story condition in healthy participants and siblings (Fig. 3A).
191-1	35080-35084	Next	_
191-2	35084-35085	,	_
191-3	35086-35088	we	_
191-4	35089-35097	directly	_
191-5	35098-35106	compared	_
191-6	35107-35114	results	_
191-7	35115-35123	obtained	_
191-8	35124-35127	for	_
191-9	35128-35131	the	_
191-10	35132-35137	story	_
191-11	35138-35147	condition	_
191-12	35148-35150	in	_
191-13	35151-35158	healthy	_
191-14	35159-35171	participants	_
191-15	35172-35175	and	_
191-16	35176-35184	siblings	_
191-17	35185-35186	(	_
191-18	35186-35189	Fig	_
191-19	35189-35190	.	_
191-20	35191-35193	3A	_
191-21	35193-35194	)	_
191-22	35194-35195	.	_

#Text=Overlapping regions for highly synchronized responses were found in A1+, along the STG up to TPJ, in the inferior frontal sulcus (IFS) and DLPFC (light blue, Fig. 3A).
192-1	35196-35207	Overlapping	_
192-2	35208-35215	regions	_
192-3	35216-35219	for	_
192-4	35220-35226	highly	_
192-5	35227-35239	synchronized	_
192-6	35240-35249	responses	_
192-7	35250-35254	were	_
192-8	35255-35260	found	_
192-9	35261-35263	in	_
192-10	35264-35266	A1	_
192-11	35266-35267	+	_
192-12	35267-35268	,	_
192-13	35269-35274	along	_
192-14	35275-35278	the	_
192-15	35279-35282	STG	_
192-16	35283-35285	up	_
192-17	35286-35288	to	_
192-18	35289-35292	TPJ	_
192-19	35292-35293	,	_
192-20	35294-35296	in	_
192-21	35297-35300	the	_
192-22	35301-35309	inferior	_
192-23	35310-35317	frontal	_
192-24	35318-35324	sulcus	_
192-25	35325-35326	(	_
192-26	35326-35329	IFS	_
192-27	35329-35330	)	_
192-28	35331-35334	and	_
192-29	35335-35340	DLPFC	_
192-30	35341-35342	(	_
192-31	35342-35347	light	_
192-32	35348-35352	blue	_
192-33	35352-35353	,	_
192-34	35354-35357	Fig	_
192-35	35357-35358	.	_
192-36	35359-35361	3A	_
192-37	35361-35362	)	_
192-38	35362-35363	.	_

#Text=In addition, synchronized responses in the angular gyrus, superior and middle frontal gyri, lateral and medial prefrontal regions (dark blue, Fig. 3A) were found in the healthy group but not in siblings.
193-1	35364-35366	In	_
193-2	35367-35375	addition	_
193-3	35375-35376	,	_
193-4	35377-35389	synchronized	_
193-5	35390-35399	responses	_
193-6	35400-35402	in	_
193-7	35403-35406	the	_
193-8	35407-35414	angular	_
193-9	35415-35420	gyrus	_
193-10	35420-35421	,	_
193-11	35422-35430	superior	_
193-12	35431-35434	and	_
193-13	35435-35441	middle	_
193-14	35442-35449	frontal	_
193-15	35450-35454	gyri	_
193-16	35454-35455	,	_
193-17	35456-35463	lateral	_
193-18	35464-35467	and	_
193-19	35468-35474	medial	_
193-20	35475-35485	prefrontal	_
193-21	35486-35493	regions	_
193-22	35494-35495	(	_
193-23	35495-35499	dark	_
193-24	35500-35504	blue	_
193-25	35504-35505	,	_
193-26	35506-35509	Fig	_
193-27	35509-35510	.	_
193-28	35511-35513	3A	_
193-29	35513-35514	)	_
193-30	35515-35519	were	_
193-31	35520-35525	found	_
193-32	35526-35528	in	_
193-33	35529-35532	the	_
193-34	35533-35540	healthy	_
193-35	35541-35546	group	_
193-36	35547-35550	but	_
193-37	35551-35554	not	_
193-38	35555-35557	in	_
193-39	35558-35566	siblings	_
193-40	35566-35567	.	_

#Text=Moreover, two-tailed t-test revealed statistically significant differences even in the overlapped regions (see Comparison between groups in Methods).
194-1	35568-35576	Moreover	_
194-2	35576-35577	,	_
194-3	35578-35588	two-tailed	_
194-4	35589-35595	t-test	_
194-5	35596-35604	revealed	_
194-6	35605-35618	statistically	_
194-7	35619-35630	significant	_
194-8	35631-35642	differences	_
194-9	35643-35647	even	_
194-10	35648-35650	in	_
194-11	35651-35654	the	_
194-12	35655-35665	overlapped	_
194-13	35666-35673	regions	_
194-14	35674-35675	(	_
194-15	35675-35678	see	_
194-16	35679-35689	Comparison	_
194-17	35690-35697	between	_
194-18	35698-35704	groups	_
194-19	35705-35707	in	_
194-20	35708-35715	Methods	_
194-21	35715-35716	)	_
194-22	35716-35717	.	_

#Text=In regions colored in yellow in Fig. 3A inter-SCs were higher in the healthy group than in siblings in the story condition.
195-1	35718-35720	In	_
195-2	35721-35728	regions	_
195-3	35729-35736	colored	_
195-4	35737-35739	in	_
195-5	35740-35746	yellow	_
195-6	35747-35749	in	_
195-7	35750-35753	Fig	_
195-8	35753-35754	.	_
195-9	35755-35757	3A	_
195-10	35758-35767	inter-SCs	_
195-11	35768-35772	were	_
195-12	35773-35779	higher	_
195-13	35780-35782	in	_
195-14	35783-35786	the	_
195-15	35787-35794	healthy	_
195-16	35795-35800	group	_
195-17	35801-35805	than	_
195-18	35806-35808	in	_
195-19	35809-35817	siblings	_
195-20	35818-35820	in	_
195-21	35821-35824	the	_
195-22	35825-35830	story	_
195-23	35831-35840	condition	_
195-24	35840-35841	.	_

#Text=Notably, no regions with a significant opposite effect (e.g. inter-SCs higher for siblings) were found.
196-1	35842-35849	Notably	_
196-2	35849-35850	,	_
196-3	35851-35853	no	_
196-4	35854-35861	regions	_
196-5	35862-35866	with	_
196-6	35867-35868	a	_
196-7	35869-35880	significant	_
196-8	35881-35889	opposite	_
196-9	35890-35896	effect	_
196-10	35897-35898	(	_
196-11	35898-35901	e.g	_
196-12	35901-35902	.	_
196-13	35903-35912	inter-SCs	_
196-14	35913-35919	higher	_
196-15	35920-35923	for	_
196-16	35924-35932	siblings	_
196-17	35932-35933	)	_
196-18	35934-35938	were	_
196-19	35939-35944	found	_
196-20	35944-35945	.	_

#Text=Much more prominent were the differences between the healthy group and patients with schizophrenia (Fig. 3B).
197-1	35946-35950	Much	_
197-2	35951-35955	more	_
197-3	35956-35965	prominent	_
197-4	35966-35970	were	_
197-5	35971-35974	the	_
197-6	35975-35986	differences	_
197-7	35987-35994	between	_
197-8	35995-35998	the	_
197-9	35999-36006	healthy	_
197-10	36007-36012	group	_
197-11	36013-36016	and	_
197-12	36017-36025	patients	_
197-13	36026-36030	with	_
197-14	36031-36044	schizophrenia	_
197-15	36045-36046	(	_
197-16	36046-36049	Fig	_
197-17	36049-36050	.	_
197-18	36051-36053	3B	_
197-19	36053-36054	)	_
197-20	36054-36055	.	_

#Text=Overlap regions were found only in the A1+ and mSTG (Fig. 3B, light blue).
198-1	36056-36063	Overlap	_
198-2	36064-36071	regions	_
198-3	36072-36076	were	_
198-4	36077-36082	found	_
198-5	36083-36087	only	_
198-6	36088-36090	in	_
198-7	36091-36094	the	_
198-8	36095-36097	A1	_
198-9	36097-36098	+	_
198-10	36099-36102	and	_
198-11	36103-36107	mSTG	_
198-12	36108-36109	(	_
198-13	36109-36112	Fig	_
198-14	36112-36113	.	_
198-15	36114-36116	3B	_
198-16	36116-36117	,	_
198-17	36118-36123	light	_
198-18	36124-36128	blue	_
198-19	36128-36129	)	_
198-20	36129-36130	.	_

#Text=Statistical comparison between groups with two-tailed t-test is depicted with yellow in Fig. 3B.
199-1	36131-36142	Statistical	_
199-2	36143-36153	comparison	_
199-3	36154-36161	between	_
199-4	36162-36168	groups	_
199-5	36169-36173	with	_
199-6	36174-36184	two-tailed	_
199-7	36185-36191	t-test	_
199-8	36192-36194	is	_
199-9	36195-36203	depicted	_
199-10	36204-36208	with	_
199-11	36209-36215	yellow	_
199-12	36216-36218	in	_
199-13	36219-36222	Fig	_
199-14	36222-36223	.	_
199-15	36224-36226	3B	_
199-16	36226-36227	.	_

#Text=ROIs sensitive to temporal scales
#Text=To further explore the time-scale gradient within each group we performed ROI analyses in several predefined regions.
200-1	36228-36232	ROIs	_
200-2	36233-36242	sensitive	_
200-3	36243-36245	to	_
200-4	36246-36254	temporal	_
200-5	36255-36261	scales	_
200-6	36262-36264	To	_
200-7	36265-36272	further	_
200-8	36273-36280	explore	_
200-9	36281-36284	the	_
200-10	36285-36295	time-scale	_
200-11	36296-36304	gradient	_
200-12	36305-36311	within	_
200-13	36312-36316	each	_
200-14	36317-36322	group	_
200-15	36323-36325	we	_
200-16	36326-36335	performed	_
200-17	36336-36339	ROI	_
200-18	36340-36348	analyses	_
200-19	36349-36351	in	_
200-20	36352-36359	several	_
200-21	36360-36370	predefined	_
200-22	36371-36378	regions	_
200-23	36378-36379	.	_

#Text=The ROIs were defined based on responses of an independent group of healthy participants (N = 12, see Methods and Table 3 for the coordinates).
201-1	36380-36383	The	_
201-2	36384-36388	ROIs	_
201-3	36389-36393	were	_
201-4	36394-36401	defined	_
201-5	36402-36407	based	_
201-6	36408-36410	on	_
201-7	36411-36420	responses	_
201-8	36421-36423	of	_
201-9	36424-36426	an	_
201-10	36427-36438	independent	_
201-11	36439-36444	group	_
201-12	36445-36447	of	_
201-13	36448-36455	healthy	_
201-14	36456-36468	participants	_
201-15	36469-36470	(	_
201-16	36470-36471	N	_
201-17	36471-36472	 	_
201-18	36472-36473	=	_
201-19	36473-36474	 	_
201-20	36474-36476	12	_
201-21	36476-36477	,	_
201-22	36478-36481	see	_
201-23	36482-36489	Methods	_
201-24	36490-36493	and	_
201-25	36494-36499	Table	_
201-26	36500-36501	3	_
201-27	36502-36505	for	_
201-28	36506-36509	the	_
201-29	36510-36521	coordinates	_
201-30	36521-36522	)	_
201-31	36522-36523	.	_

#Text=Time courses from the predefined regions that are known to have short (e.g., A1+), intermediate (e.g., mSTG) and long temporal capacity (e.g., TPJ, prefrontal, precuneus) were sampled in each participant and included in the analyses.
202-1	36524-36528	Time	_
202-2	36529-36536	courses	_
202-3	36537-36541	from	_
202-4	36542-36545	the	_
202-5	36546-36556	predefined	_
202-6	36557-36564	regions	_
202-7	36565-36569	that	_
202-8	36570-36573	are	_
202-9	36574-36579	known	_
202-10	36580-36582	to	_
202-11	36583-36587	have	_
202-12	36588-36593	short	_
202-13	36594-36595	(	_
202-14	36595-36598	e.g	_
202-15	36598-36599	.	_
202-16	36599-36600	,	_
202-17	36601-36603	A1	_
202-18	36603-36604	+	_
202-19	36604-36605	)	_
202-20	36605-36606	,	_
202-21	36607-36619	intermediate	_
202-22	36620-36621	(	_
202-23	36621-36624	e.g	_
202-24	36624-36625	.	_
202-25	36625-36626	,	_
202-26	36627-36631	mSTG	_
202-27	36631-36632	)	_
202-28	36633-36636	and	_
202-29	36637-36641	long	_
202-30	36642-36650	temporal	_
202-31	36651-36659	capacity	_
202-32	36660-36661	(	_
202-33	36661-36664	e.g	_
202-34	36664-36665	.	_
202-35	36665-36666	,	_
202-36	36667-36670	TPJ	_
202-37	36670-36671	,	_
202-38	36672-36682	prefrontal	_
202-39	36682-36683	,	_
202-40	36684-36693	precuneus	_
202-41	36693-36694	)	_
202-42	36695-36699	were	_
202-43	36700-36707	sampled	_
202-44	36708-36710	in	_
202-45	36711-36715	each	_
202-46	36716-36727	participant	_
202-47	36728-36731	and	_
202-48	36732-36740	included	_
202-49	36741-36743	in	_
202-50	36744-36747	the	_
202-51	36748-36756	analyses	_
202-52	36756-36757	.	_

#Text=Consistent with our voxel-wise analysis, early auditory areas exhibited highly synchronized responses in all conditions and within all groups (Fig. 4).
203-1	36758-36768	Consistent	_
203-2	36769-36773	with	_
203-3	36774-36777	our	_
203-4	36778-36788	voxel-wise	_
203-5	36789-36797	analysis	_
203-6	36797-36798	,	_
203-7	36799-36804	early	_
203-8	36805-36813	auditory	_
203-9	36814-36819	areas	_
203-10	36820-36829	exhibited	_
203-11	36830-36836	highly	_
203-12	36837-36849	synchronized	_
203-13	36850-36859	responses	_
203-14	36860-36862	in	_
203-15	36863-36866	all	_
203-16	36867-36877	conditions	_
203-17	36878-36881	and	_
203-18	36882-36888	within	_
203-19	36889-36892	all	_
203-20	36893-36899	groups	_
203-21	36900-36901	(	_
203-22	36901-36904	Fig	_
203-23	36904-36905	.	_
203-24	36906-36907	4	_
203-25	36907-36908	)	_
203-26	36908-36909	.	_

#Text=Horizontal lines in Fig. 4 indicate thresholds for statistically significant correlations assessed using phase-randomization and false discovery rate procedures (see Methods).
204-1	36910-36920	Horizontal	_
204-2	36921-36926	lines	_
204-3	36927-36929	in	_
204-4	36930-36933	Fig	_
204-5	36933-36934	.	_
204-6	36935-36936	4	_
204-7	36937-36945	indicate	_
204-8	36946-36956	thresholds	_
204-9	36957-36960	for	_
204-10	36961-36974	statistically	_
204-11	36975-36986	significant	_
204-12	36987-36999	correlations	_
204-13	37000-37008	assessed	_
204-14	37009-37014	using	_
204-15	37015-37034	phase-randomization	_
204-16	37035-37038	and	_
204-17	37039-37044	false	_
204-18	37045-37054	discovery	_
204-19	37055-37059	rate	_
204-20	37060-37070	procedures	_
204-21	37071-37072	(	_
204-22	37072-37075	see	_
204-23	37076-37083	Methods	_
204-24	37083-37084	)	_
204-25	37084-37085	.	_

#Text=In the mSTG, high inter-SCs to story and scrambled sentences but not to scrambled words were found.
205-1	37086-37088	In	_
205-2	37089-37092	the	_
205-3	37093-37097	mSTG	_
205-4	37097-37098	,	_
205-5	37099-37103	high	_
205-6	37104-37113	inter-SCs	_
205-7	37114-37116	to	_
205-8	37117-37122	story	_
205-9	37123-37126	and	_
205-10	37127-37136	scrambled	_
205-11	37137-37146	sentences	_
205-12	37147-37150	but	_
205-13	37151-37154	not	_
205-14	37155-37157	to	_
205-15	37158-37167	scrambled	_
205-16	37168-37173	words	_
205-17	37174-37178	were	_
205-18	37179-37184	found	_
205-19	37184-37185	.	_

#Text=Importantly, A1 + and mSTG (Fig. 4, top) showed a high level of synchronization in patients with schizophrenia: in A1 + the inter-SC coefficients were very close to each other in all groups (r ~ 0.37), in the mSTG inter-SC coefficients were lower, although still significant, in patients (r ~ 0.28) than in healthy participants (r ~ 0.4), but comparable with siblings (r ~ 0.3).
206-1	37186-37197	Importantly	_
206-2	37197-37198	,	_
206-3	37199-37201	A1	_
206-4	37201-37202	 	_
206-5	37202-37203	+	_
206-6	37204-37207	and	_
206-7	37208-37212	mSTG	_
206-8	37213-37214	(	_
206-9	37214-37217	Fig	_
206-10	37217-37218	.	_
206-11	37219-37220	4	_
206-12	37220-37221	,	_
206-13	37222-37225	top	_
206-14	37225-37226	)	_
206-15	37227-37233	showed	_
206-16	37234-37235	a	_
206-17	37236-37240	high	_
206-18	37241-37246	level	_
206-19	37247-37249	of	_
206-20	37250-37265	synchronization	_
206-21	37266-37268	in	_
206-22	37269-37277	patients	_
206-23	37278-37282	with	_
206-24	37283-37296	schizophrenia	_
206-25	37296-37297	:	_
206-26	37298-37300	in	_
206-27	37301-37303	A1	_
206-28	37303-37304	 	_
206-29	37304-37305	+	_
206-30	37306-37309	the	_
206-31	37310-37318	inter-SC	_
206-32	37319-37331	coefficients	_
206-33	37332-37336	were	_
206-34	37337-37341	very	_
206-35	37342-37347	close	_
206-36	37348-37350	to	_
206-37	37351-37355	each	_
206-38	37356-37361	other	_
206-39	37362-37364	in	_
206-40	37365-37368	all	_
206-41	37369-37375	groups	_
206-42	37376-37377	(	_
206-43	37377-37378	r	_
206-44	37378-37379	 	_
206-45	37379-37380	~	_
206-46	37380-37381	 	_
206-47	37381-37385	0.37	_
206-48	37385-37386	)	_
206-49	37386-37387	,	_
206-50	37388-37390	in	_
206-51	37391-37394	the	_
206-52	37395-37399	mSTG	_
206-53	37400-37408	inter-SC	_
206-54	37409-37421	coefficients	_
206-55	37422-37426	were	_
206-56	37427-37432	lower	_
206-57	37432-37433	,	_
206-58	37434-37442	although	_
206-59	37443-37448	still	_
206-60	37449-37460	significant	_
206-61	37460-37461	,	_
206-62	37462-37464	in	_
206-63	37465-37473	patients	_
206-64	37474-37475	(	_
206-65	37475-37476	r	_
206-66	37476-37477	 	_
206-67	37477-37478	~	_
206-68	37478-37479	 	_
206-69	37479-37483	0.28	_
206-70	37483-37484	)	_
206-71	37485-37489	than	_
206-72	37490-37492	in	_
206-73	37493-37500	healthy	_
206-74	37501-37513	participants	_
206-75	37514-37515	(	_
206-76	37515-37516	r	_
206-77	37516-37517	 	_
206-78	37517-37518	~	_
206-79	37518-37519	 	_
206-80	37519-37522	0.4	_
206-81	37522-37523	)	_
206-82	37523-37524	,	_
206-83	37525-37528	but	_
206-84	37529-37539	comparable	_
206-85	37540-37544	with	_
206-86	37545-37553	siblings	_
206-87	37554-37555	(	_
206-88	37555-37556	r	_
206-89	37556-37557	 	_
206-90	37557-37558	~	_
206-91	37558-37559	 	_
206-92	37559-37562	0.3	_
206-93	37562-37563	)	_
206-94	37563-37564	.	_

#Text=Besides these two regions, in most of the explored ROIs in the posterior and prefrontal cortices, responses in patients with schizophrenia exhibited substantially reduced correlation (about 50–60%), relative to healthy participants.
207-1	37565-37572	Besides	_
207-2	37573-37578	these	_
207-3	37579-37582	two	_
207-4	37583-37590	regions	_
207-5	37590-37591	,	_
207-6	37592-37594	in	_
207-7	37595-37599	most	_
207-8	37600-37602	of	_
207-9	37603-37606	the	_
207-10	37607-37615	explored	_
207-11	37616-37620	ROIs	_
207-12	37621-37623	in	_
207-13	37624-37627	the	_
207-14	37628-37637	posterior	_
207-15	37638-37641	and	_
207-16	37642-37652	prefrontal	_
207-17	37653-37661	cortices	_
207-18	37661-37662	,	_
207-19	37663-37672	responses	_
207-20	37673-37675	in	_
207-21	37676-37684	patients	_
207-22	37685-37689	with	_
207-23	37690-37703	schizophrenia	_
207-24	37704-37713	exhibited	_
207-25	37714-37727	substantially	_
207-26	37728-37735	reduced	_
207-27	37736-37747	correlation	_
207-28	37748-37749	(	_
207-29	37749-37754	about	_
207-30	37755-37757	50	_
207-31	37757-37758	–	_
207-32	37758-37761	60%	_
207-33	37761-37762	)	_
207-34	37762-37763	,	_
207-35	37764-37772	relative	_
207-36	37773-37775	to	_
207-37	37776-37783	healthy	_
207-38	37784-37796	participants	_
207-39	37796-37797	.	_

#Text=Moreover, in patients, the story condition evoked significant inter-SCs in the TPJ (r = 0.13) and precuneus (r = 0.15) only (Fig. 4, mid), no synchronized responses were found in the prefrontal regions, such as mPFC or DLPFC (Fig. 4, bottom).
208-1	37798-37806	Moreover	_
208-2	37806-37807	,	_
208-3	37808-37810	in	_
208-4	37811-37819	patients	_
208-5	37819-37820	,	_
208-6	37821-37824	the	_
208-7	37825-37830	story	_
208-8	37831-37840	condition	_
208-9	37841-37847	evoked	_
208-10	37848-37859	significant	_
208-11	37860-37869	inter-SCs	_
208-12	37870-37872	in	_
208-13	37873-37876	the	_
208-14	37877-37880	TPJ	_
208-15	37881-37882	(	_
208-16	37882-37883	r	_
208-17	37883-37884	 	_
208-18	37884-37885	=	_
208-19	37885-37886	 	_
208-20	37886-37890	0.13	_
208-21	37890-37891	)	_
208-22	37892-37895	and	_
208-23	37896-37905	precuneus	_
208-24	37906-37907	(	_
208-25	37907-37908	r	_
208-26	37908-37909	 	_
208-27	37909-37910	=	_
208-28	37910-37911	 	_
208-29	37911-37915	0.15	_
208-30	37915-37916	)	_
208-31	37917-37921	only	_
208-32	37922-37923	(	_
208-33	37923-37926	Fig	_
208-34	37926-37927	.	_
208-35	37928-37929	4	_
208-36	37929-37930	,	_
208-37	37931-37934	mid	_
208-38	37934-37935	)	_
208-39	37935-37936	,	_
208-40	37937-37939	no	_
208-41	37940-37952	synchronized	_
208-42	37953-37962	responses	_
208-43	37963-37967	were	_
208-44	37968-37973	found	_
208-45	37974-37976	in	_
208-46	37977-37980	the	_
208-47	37981-37991	prefrontal	_
208-48	37992-37999	regions	_
208-49	37999-38000	,	_
208-50	38001-38005	such	_
208-51	38006-38008	as	_
208-52	38009-38013	mPFC	_
208-53	38014-38016	or	_
208-54	38017-38022	DLPFC	_
208-55	38023-38024	(	_
208-56	38024-38027	Fig	_
208-57	38027-38028	.	_
208-58	38029-38030	4	_
208-59	38030-38031	,	_
208-60	38032-38038	bottom	_
208-61	38038-38039	)	_
208-62	38039-38040	.	_

#Text=In addition, mixed design ANOVA with one within (condition) and one between (group) subjects factors was performed on the inter-SC coefficients independently in the mPFC and DLPFC.
209-1	38041-38043	In	_
209-2	38044-38052	addition	_
209-3	38052-38053	,	_
209-4	38054-38059	mixed	_
209-5	38060-38066	design	_
209-6	38067-38072	ANOVA	_
209-7	38073-38077	with	_
209-8	38078-38081	one	_
209-9	38082-38088	within	_
209-10	38089-38090	(	_
209-11	38090-38099	condition	_
209-12	38099-38100	)	_
209-13	38101-38104	and	_
209-14	38105-38108	one	_
209-15	38109-38116	between	_
209-16	38117-38118	(	_
209-17	38118-38123	group	_
209-18	38123-38124	)	_
209-19	38125-38133	subjects	_
209-20	38134-38141	factors	_
209-21	38142-38145	was	_
209-22	38146-38155	performed	_
209-23	38156-38158	on	_
209-24	38159-38162	the	_
209-25	38163-38171	inter-SC	_
209-26	38172-38184	coefficients	_
209-27	38185-38198	independently	_
209-28	38199-38201	in	_
209-29	38202-38205	the	_
209-30	38206-38210	mPFC	_
209-31	38211-38214	and	_
209-32	38215-38220	DLPFC	_
209-33	38220-38221	.	_

#Text=Results are presented in Supplementary Table 2.
210-1	38222-38229	Results	_
210-2	38230-38233	are	_
210-3	38234-38243	presented	_
210-4	38244-38246	in	_
210-5	38247-38260	Supplementary	_
210-6	38261-38266	Table	_
210-7	38267-38268	2	_
210-8	38268-38269	.	_

#Text=Response amplitude analysis
#Text=It might be suggested that the decreased synchrony in the prefrontal regions is a result of a smaller signal-to-noise ratio due to hypofrontality of patients with schizophrenia.
211-1	38270-38278	Response	_
211-2	38279-38288	amplitude	_
211-3	38289-38297	analysis	_
211-4	38298-38300	It	_
211-5	38301-38306	might	_
211-6	38307-38309	be	_
211-7	38310-38319	suggested	_
211-8	38320-38324	that	_
211-9	38325-38328	the	_
211-10	38329-38338	decreased	_
211-11	38339-38348	synchrony	_
211-12	38349-38351	in	_
211-13	38352-38355	the	_
211-14	38356-38366	prefrontal	_
211-15	38367-38374	regions	_
211-16	38375-38377	is	_
211-17	38378-38379	a	_
211-18	38380-38386	result	_
211-19	38387-38389	of	_
211-20	38390-38391	a	_
211-21	38392-38399	smaller	_
211-22	38400-38415	signal-to-noise	_
211-23	38416-38421	ratio	_
211-24	38422-38425	due	_
211-25	38426-38428	to	_
211-26	38429-38443	hypofrontality	_
211-27	38444-38446	of	_
211-28	38447-38455	patients	_
211-29	38456-38460	with	_
211-30	38461-38474	schizophrenia	_
211-31	38474-38475	.	_

#Text=To test this possibility we performed response amplitude analysis.
212-1	38476-38478	To	_
212-2	38479-38483	test	_
212-3	38484-38488	this	_
212-4	38489-38500	possibility	_
212-5	38501-38503	we	_
212-6	38504-38513	performed	_
212-7	38514-38522	response	_
212-8	38523-38532	amplitude	_
212-9	38533-38541	analysis	_
212-10	38541-38542	.	_

#Text=Areas that exhibited low inter-SCs within the patient group (or to the temporally scrambled stimuli) nevertheless showed high response amplitudes within the same group and to those same stimuli (Supplementary Fig. 2).
213-1	38543-38548	Areas	_
213-2	38549-38553	that	_
213-3	38554-38563	exhibited	_
213-4	38564-38567	low	_
213-5	38568-38577	inter-SCs	_
213-6	38578-38584	within	_
213-7	38585-38588	the	_
213-8	38589-38596	patient	_
213-9	38597-38602	group	_
213-10	38603-38604	(	_
213-11	38604-38606	or	_
213-12	38607-38609	to	_
213-13	38610-38613	the	_
213-14	38614-38624	temporally	_
213-15	38625-38634	scrambled	_
213-16	38635-38642	stimuli	_
213-17	38642-38643	)	_
213-18	38644-38656	nevertheless	_
213-19	38657-38663	showed	_
213-20	38664-38668	high	_
213-21	38669-38677	response	_
213-22	38678-38688	amplitudes	_
213-23	38689-38695	within	_
213-24	38696-38699	the	_
213-25	38700-38704	same	_
213-26	38705-38710	group	_
213-27	38711-38714	and	_
213-28	38715-38717	to	_
213-29	38718-38723	those	_
213-30	38724-38728	same	_
213-31	38729-38736	stimuli	_
213-32	38737-38738	(	_
213-33	38738-38751	Supplementary	_
213-34	38752-38755	Fig	_
213-35	38755-38756	.	_
213-36	38757-38758	2	_
213-37	38758-38759	)	_
213-38	38759-38760	.	_

#Text=Response amplitudes were estimated by computing the SD of the responses over time within each ROI.
214-1	38761-38769	Response	_
214-2	38770-38780	amplitudes	_
214-3	38781-38785	were	_
214-4	38786-38795	estimated	_
214-5	38796-38798	by	_
214-6	38799-38808	computing	_
214-7	38809-38812	the	_
214-8	38813-38815	SD	_
214-9	38816-38818	of	_
214-10	38819-38822	the	_
214-11	38823-38832	responses	_
214-12	38833-38837	over	_
214-13	38838-38842	time	_
214-14	38843-38849	within	_
214-15	38850-38854	each	_
214-16	38855-38858	ROI	_
214-17	38858-38859	.	_

#Text=Our analysis revealed that the SDs were indistinguishable for all conditions, even in those examined brain areas, in which response synchrony dramatically reduced.
215-1	38860-38863	Our	_
215-2	38864-38872	analysis	_
215-3	38873-38881	revealed	_
215-4	38882-38886	that	_
215-5	38887-38890	the	_
215-6	38891-38894	SDs	_
215-7	38895-38899	were	_
215-8	38900-38917	indistinguishable	_
215-9	38918-38921	for	_
215-10	38922-38925	all	_
215-11	38926-38936	conditions	_
215-12	38936-38937	,	_
215-13	38938-38942	even	_
215-14	38943-38945	in	_
215-15	38946-38951	those	_
215-16	38952-38960	examined	_
215-17	38961-38966	brain	_
215-18	38967-38972	areas	_
215-19	38972-38973	,	_
215-20	38974-38976	in	_
215-21	38977-38982	which	_
215-22	38983-38991	response	_
215-23	38992-39001	synchrony	_
215-24	39002-39014	dramatically	_
215-25	39015-39022	reduced	_
215-26	39022-39023	.	_

#Text=Masked processes underlie comprehension of a story in schizophrenia
#Text=Inter-SC analyses between groups.
216-1	39024-39030	Masked	_
216-2	39031-39040	processes	_
216-3	39041-39049	underlie	_
216-4	39050-39063	comprehension	_
216-5	39064-39066	of	_
216-6	39067-39068	a	_
216-7	39069-39074	story	_
216-8	39075-39077	in	_
216-9	39078-39091	schizophrenia	_
216-10	39092-39100	Inter-SC	_
216-11	39101-39109	analyses	_
216-12	39110-39117	between	_
216-13	39118-39124	groups	_
216-14	39124-39125	.	_

#Text=(A) Inter-SC maps show correlations between patients' response time course and the averaged time courses of healthy participants during the story condition.
217-1	39126-39127	(	_
217-2	39127-39128	A	_
217-3	39128-39129	)	_
217-4	39130-39138	Inter-SC	_
217-5	39139-39143	maps	_
217-6	39144-39148	show	_
217-7	39149-39161	correlations	_
217-8	39162-39169	between	_
217-9	39170-39178	patients	_
217-10	39178-39179	'	_
217-11	39180-39188	response	_
217-12	39189-39193	time	_
217-13	39194-39200	course	_
217-14	39201-39204	and	_
217-15	39205-39208	the	_
217-16	39209-39217	averaged	_
217-17	39218-39222	time	_
217-18	39223-39230	courses	_
217-19	39231-39233	of	_
217-20	39234-39241	healthy	_
217-21	39242-39254	participants	_
217-22	39255-39261	during	_
217-23	39262-39265	the	_
217-24	39266-39271	story	_
217-25	39272-39281	condition	_
217-26	39281-39282	.	_

#Text=The analysis revealed a more standard pattern of response synchronization across patients.
218-1	39283-39286	The	_
218-2	39287-39295	analysis	_
218-3	39296-39304	revealed	_
218-4	39305-39306	a	_
218-5	39307-39311	more	_
218-6	39312-39320	standard	_
218-7	39321-39328	pattern	_
218-8	39329-39331	of	_
218-9	39332-39340	response	_
218-10	39341-39356	synchronization	_
218-11	39357-39363	across	_
218-12	39364-39372	patients	_
218-13	39372-39373	.	_

#Text=The maps are overlaid with the map showing inter-SC within the healthy group.
219-1	39374-39377	The	_
219-2	39378-39382	maps	_
219-3	39383-39386	are	_
219-4	39387-39395	overlaid	_
219-5	39396-39400	with	_
219-6	39401-39404	the	_
219-7	39405-39408	map	_
219-8	39409-39416	showing	_
219-9	39417-39425	inter-SC	_
219-10	39426-39432	within	_
219-11	39433-39436	the	_
219-12	39437-39444	healthy	_
219-13	39445-39450	group	_
219-14	39450-39451	.	_

#Text=(B) Inter-SC maps show correlations between siblings' response time course and the averaged time courses of healthy participants.
220-1	39452-39453	(	_
220-2	39453-39454	B	_
220-3	39454-39455	)	_
220-4	39456-39464	Inter-SC	_
220-5	39465-39469	maps	_
220-6	39470-39474	show	_
220-7	39475-39487	correlations	_
220-8	39488-39495	between	_
220-9	39496-39504	siblings	_
220-10	39504-39505	'	_
220-11	39506-39514	response	_
220-12	39515-39519	time	_
220-13	39520-39526	course	_
220-14	39527-39530	and	_
220-15	39531-39534	the	_
220-16	39535-39543	averaged	_
220-17	39544-39548	time	_
220-18	39549-39556	courses	_
220-19	39557-39559	of	_
220-20	39560-39567	healthy	_
220-21	39568-39580	participants	_
220-22	39580-39581	.	_

#Text=Same presentation format as in (A).
221-1	39582-39586	Same	_
221-2	39587-39599	presentation	_
221-3	39600-39606	format	_
221-4	39607-39609	as	_
221-5	39610-39612	in	_
221-6	39613-39614	(	_
221-7	39614-39615	A	_
221-8	39615-39616	)	_
221-9	39616-39617	.	_

#Text=Same abbreviations as in Fig. 2.
222-1	39618-39622	Same	_
222-2	39623-39636	abbreviations	_
222-3	39637-39639	as	_
222-4	39640-39642	in	_
222-5	39643-39646	Fig	_
222-6	39646-39647	.	_
222-7	39648-39649	2	_
222-8	39649-39650	.	_

#Text=Fig. 5
#Text=Relation of level of response synchronization with syndrome scale rating.
223-1	39651-39654	Fig	_
223-2	39654-39655	.	_
223-3	39656-39657	5	_
223-4	39658-39666	Relation	_
223-5	39667-39669	of	_
223-6	39670-39675	level	_
223-7	39676-39678	of	_
223-8	39679-39687	response	_
223-9	39688-39703	synchronization	_
223-10	39704-39708	with	_
223-11	39709-39717	syndrome	_
223-12	39718-39723	scale	_
223-13	39724-39730	rating	_
223-14	39730-39731	.	_

#Text=Inter-SCs between each patient and average time course of the healthy participants during story presentation are plotted against positive, negative and general syndrome scale in two ROIs: TPJ (A) and precuneus (B).
224-1	39732-39741	Inter-SCs	_
224-2	39742-39749	between	_
224-3	39750-39754	each	_
224-4	39755-39762	patient	_
224-5	39763-39766	and	_
224-6	39767-39774	average	_
224-7	39775-39779	time	_
224-8	39780-39786	course	_
224-9	39787-39789	of	_
224-10	39790-39793	the	_
224-11	39794-39801	healthy	_
224-12	39802-39814	participants	_
224-13	39815-39821	during	_
224-14	39822-39827	story	_
224-15	39828-39840	presentation	_
224-16	39841-39844	are	_
224-17	39845-39852	plotted	_
224-18	39853-39860	against	_
224-19	39861-39869	positive	_
224-20	39869-39870	,	_
224-21	39871-39879	negative	_
224-22	39880-39883	and	_
224-23	39884-39891	general	_
224-24	39892-39900	syndrome	_
224-25	39901-39906	scale	_
224-26	39907-39909	in	_
224-27	39910-39913	two	_
224-28	39914-39918	ROIs	_
224-29	39918-39919	:	_
224-30	39920-39923	TPJ	_
224-31	39924-39925	(	_
224-32	39925-39926	A	_
224-33	39926-39927	)	_
224-34	39928-39931	and	_
224-35	39932-39941	precuneus	_
224-36	39942-39943	(	_
224-37	39943-39944	B	_
224-38	39944-39945	)	_
224-39	39945-39946	.	_

#Text=The choice of the ROIs is based on the fact that in these regions we uncovered significantly synchronized responses to the story condition within patients.
225-1	39947-39950	The	_
225-2	39951-39957	choice	_
225-3	39958-39960	of	_
225-4	39961-39964	the	_
225-5	39965-39969	ROIs	_
225-6	39970-39972	is	_
225-7	39973-39978	based	_
225-8	39979-39981	on	_
225-9	39982-39985	the	_
225-10	39986-39990	fact	_
225-11	39991-39995	that	_
225-12	39996-39998	in	_
225-13	39999-40004	these	_
225-14	40005-40012	regions	_
225-15	40013-40015	we	_
225-16	40016-40025	uncovered	_
225-17	40026-40039	significantly	_
225-18	40040-40052	synchronized	_
225-19	40053-40062	responses	_
225-20	40063-40065	to	_
225-21	40066-40069	the	_
225-22	40070-40075	story	_
225-23	40076-40085	condition	_
225-24	40086-40092	within	_
225-25	40093-40101	patients	_
225-26	40101-40102	.	_

#Text=Strong correlation (p = 0.02) was found with positive symptoms in both ROIs and with general symptoms in the TPJ (p = 0.048).
226-1	40103-40109	Strong	_
226-2	40110-40121	correlation	_
226-3	40122-40123	(	_
226-4	40123-40124	p	_
226-5	40124-40125	 	_
226-6	40125-40126	=	_
226-7	40126-40127	 	_
226-8	40127-40131	0.02	_
226-9	40131-40132	)	_
226-10	40133-40136	was	_
226-11	40137-40142	found	_
226-12	40143-40147	with	_
226-13	40148-40156	positive	_
226-14	40157-40165	symptoms	_
226-15	40166-40168	in	_
226-16	40169-40173	both	_
226-17	40174-40178	ROIs	_
226-18	40179-40182	and	_
226-19	40183-40187	with	_
226-20	40188-40195	general	_
226-21	40196-40204	symptoms	_
226-22	40205-40207	in	_
226-23	40208-40211	the	_
226-24	40212-40215	TPJ	_
226-25	40216-40217	(	_
226-26	40217-40218	p	_
226-27	40218-40219	 	_
226-28	40219-40220	=	_
226-29	40220-40221	 	_
226-30	40221-40226	0.048	_
226-31	40226-40227	)	_
226-32	40227-40228	.	_

#Text=Fig. 6
#Text=Our post-scan conversations with the patients revealed that most of them, regardless of the scores on the cognitive testing, were able to recount the gist of the story relatively accurately.
227-1	40229-40232	Fig	_
227-2	40232-40233	.	_
227-3	40234-40235	6	_
227-4	40236-40239	Our	_
227-5	40240-40249	post-scan	_
227-6	40250-40263	conversations	_
227-7	40264-40268	with	_
227-8	40269-40272	the	_
227-9	40273-40281	patients	_
227-10	40282-40290	revealed	_
227-11	40291-40295	that	_
227-12	40296-40300	most	_
227-13	40301-40303	of	_
227-14	40304-40308	them	_
227-15	40308-40309	,	_
227-16	40310-40320	regardless	_
227-17	40321-40323	of	_
227-18	40324-40327	the	_
227-19	40328-40334	scores	_
227-20	40335-40337	on	_
227-21	40338-40341	the	_
227-22	40342-40351	cognitive	_
227-23	40352-40359	testing	_
227-24	40359-40360	,	_
227-25	40361-40365	were	_
227-26	40366-40370	able	_
227-27	40371-40373	to	_
227-28	40374-40381	recount	_
227-29	40382-40385	the	_
227-30	40386-40390	gist	_
227-31	40391-40393	of	_
227-32	40394-40397	the	_
227-33	40398-40403	story	_
227-34	40404-40414	relatively	_
227-35	40415-40425	accurately	_
227-36	40425-40426	.	_

#Text=This finding led us to a question if low but still significant inter-SCs observed in the TPJ and precuneus reflect processing that is sufficient to understand the plot of the story; or if there is another, masked process that mediates its comprehension.
228-1	40427-40431	This	_
228-2	40432-40439	finding	_
228-3	40440-40443	led	_
228-4	40444-40446	us	_
228-5	40447-40449	to	_
228-6	40450-40451	a	_
228-7	40452-40460	question	_
228-8	40461-40463	if	_
228-9	40464-40467	low	_
228-10	40468-40471	but	_
228-11	40472-40477	still	_
228-12	40478-40489	significant	_
228-13	40490-40499	inter-SCs	_
228-14	40500-40508	observed	_
228-15	40509-40511	in	_
228-16	40512-40515	the	_
228-17	40516-40519	TPJ	_
228-18	40520-40523	and	_
228-19	40524-40533	precuneus	_
228-20	40534-40541	reflect	_
228-21	40542-40552	processing	_
228-22	40553-40557	that	_
228-23	40558-40560	is	_
228-24	40561-40571	sufficient	_
228-25	40572-40574	to	_
228-26	40575-40585	understand	_
228-27	40586-40589	the	_
228-28	40590-40594	plot	_
228-29	40595-40597	of	_
228-30	40598-40601	the	_
228-31	40602-40607	story	_
228-32	40607-40608	;	_
228-33	40609-40611	or	_
228-34	40612-40614	if	_
228-35	40615-40620	there	_
228-36	40621-40623	is	_
228-37	40624-40631	another	_
228-38	40631-40632	,	_
228-39	40633-40639	masked	_
228-40	40640-40647	process	_
228-41	40648-40652	that	_
228-42	40653-40661	mediates	_
228-43	40662-40665	its	_
228-44	40666-40679	comprehension	_
228-45	40679-40680	.	_

#Text=To unmask the potential responses, we calculated correlations of each patient's response time course with the averaged time course of healthy participants during story presentation.
229-1	40681-40683	To	_
229-2	40684-40690	unmask	_
229-3	40691-40694	the	_
229-4	40695-40704	potential	_
229-5	40705-40714	responses	_
229-6	40714-40715	,	_
229-7	40716-40718	we	_
229-8	40719-40729	calculated	_
229-9	40730-40742	correlations	_
229-10	40743-40745	of	_
229-11	40746-40750	each	_
229-12	40751-40760	patient's	_
229-13	40761-40769	response	_
229-14	40770-40774	time	_
229-15	40775-40781	course	_
229-16	40782-40786	with	_
229-17	40787-40790	the	_
229-18	40791-40799	averaged	_
229-19	40800-40804	time	_
229-20	40805-40811	course	_
229-21	40812-40814	of	_
229-22	40815-40822	healthy	_
229-23	40823-40835	participants	_
229-24	40836-40842	during	_
229-25	40843-40848	story	_
229-26	40849-40861	presentation	_
229-27	40861-40862	.	_

#Text=The analysis uncovered a more standard map of response synchronization across patients (Fig. 5A).
230-1	40863-40866	The	_
230-2	40867-40875	analysis	_
230-3	40876-40885	uncovered	_
230-4	40886-40887	a	_
230-5	40888-40892	more	_
230-6	40893-40901	standard	_
230-7	40902-40905	map	_
230-8	40906-40908	of	_
230-9	40909-40917	response	_
230-10	40918-40933	synchronization	_
230-11	40934-40940	across	_
230-12	40941-40949	patients	_
230-13	40950-40951	(	_
230-14	40951-40954	Fig	_
230-15	40954-40955	.	_
230-16	40956-40958	5A	_
230-17	40958-40959	)	_
230-18	40959-40960	.	_

#Text=Namely, we found a more typical pattern of synchronized responses in patients showing high inter-SCs in those brain areas that were not found within the schizophrenia group alone (compared with the blue map in Fig. 2C).
231-1	40961-40967	Namely	_
231-2	40967-40968	,	_
231-3	40969-40971	we	_
231-4	40972-40977	found	_
231-5	40978-40979	a	_
231-6	40980-40984	more	_
231-7	40985-40992	typical	_
231-8	40993-41000	pattern	_
231-9	41001-41003	of	_
231-10	41004-41016	synchronized	_
231-11	41017-41026	responses	_
231-12	41027-41029	in	_
231-13	41030-41038	patients	_
231-14	41039-41046	showing	_
231-15	41047-41051	high	_
231-16	41052-41061	inter-SCs	_
231-17	41062-41064	in	_
231-18	41065-41070	those	_
231-19	41071-41076	brain	_
231-20	41077-41082	areas	_
231-21	41083-41087	that	_
231-22	41088-41092	were	_
231-23	41093-41096	not	_
231-24	41097-41102	found	_
231-25	41103-41109	within	_
231-26	41110-41113	the	_
231-27	41114-41127	schizophrenia	_
231-28	41128-41133	group	_
231-29	41134-41139	alone	_
231-30	41140-41141	(	_
231-31	41141-41149	compared	_
231-32	41150-41154	with	_
231-33	41155-41158	the	_
231-34	41159-41163	blue	_
231-35	41164-41167	map	_
231-36	41168-41170	in	_
231-37	41171-41174	Fig	_
231-38	41174-41175	.	_
231-39	41176-41178	2C	_
231-40	41178-41179	)	_
231-41	41179-41180	.	_

#Text=To present this finding in an easier, visually-friendly way, we superimposed this map on the inter-SC map produced for the healthy group in the story condition (same as the blue map in Fig. 2A).
232-1	41181-41183	To	_
232-2	41184-41191	present	_
232-3	41192-41196	this	_
232-4	41197-41204	finding	_
232-5	41205-41207	in	_
232-6	41208-41210	an	_
232-7	41211-41217	easier	_
232-8	41217-41218	,	_
232-9	41219-41236	visually-friendly	_
232-10	41237-41240	way	_
232-11	41240-41241	,	_
232-12	41242-41244	we	_
232-13	41245-41257	superimposed	_
232-14	41258-41262	this	_
232-15	41263-41266	map	_
232-16	41267-41269	on	_
232-17	41270-41273	the	_
232-18	41274-41282	inter-SC	_
232-19	41283-41286	map	_
232-20	41287-41295	produced	_
232-21	41296-41299	for	_
232-22	41300-41303	the	_
232-23	41304-41311	healthy	_
232-24	41312-41317	group	_
232-25	41318-41320	in	_
232-26	41321-41324	the	_
232-27	41325-41330	story	_
232-28	41331-41340	condition	_
232-29	41341-41342	(	_
232-30	41342-41346	same	_
232-31	41347-41349	as	_
232-32	41350-41353	the	_
232-33	41354-41358	blue	_
232-34	41359-41362	map	_
232-35	41363-41365	in	_
232-36	41366-41369	Fig	_
232-37	41369-41370	.	_
232-38	41371-41373	2A	_
232-39	41373-41374	)	_
232-40	41374-41375	.	_

#Text=Thus, beneath the uncorrelated responses, which may be attributed to distinguishing specifics of each patient with schizophrenia, the more standard responses in different brain regions in the patients could be revealed.
233-1	41376-41380	Thus	_
233-2	41380-41381	,	_
233-3	41382-41389	beneath	_
233-4	41390-41393	the	_
233-5	41394-41406	uncorrelated	_
233-6	41407-41416	responses	_
233-7	41416-41417	,	_
233-8	41418-41423	which	_
233-9	41424-41427	may	_
233-10	41428-41430	be	_
233-11	41431-41441	attributed	_
233-12	41442-41444	to	_
233-13	41445-41459	distinguishing	_
233-14	41460-41469	specifics	_
233-15	41470-41472	of	_
233-16	41473-41477	each	_
233-17	41478-41485	patient	_
233-18	41486-41490	with	_
233-19	41491-41504	schizophrenia	_
233-20	41504-41505	,	_
233-21	41506-41509	the	_
233-22	41510-41514	more	_
233-23	41515-41523	standard	_
233-24	41524-41533	responses	_
233-25	41534-41536	in	_
233-26	41537-41546	different	_
233-27	41547-41552	brain	_
233-28	41553-41560	regions	_
233-29	41561-41563	in	_
233-30	41564-41567	the	_
233-31	41568-41576	patients	_
233-32	41577-41582	could	_
233-33	41583-41585	be	_
233-34	41586-41594	revealed	_
233-35	41594-41595	.	_

#Text=Note that the identical analysis performed for the siblings' response time courses and averaged time course of healthy participants (Fig. 5B) revealed results mostly comparable with the outcomes within the siblings' group (compare Fig. 5B with Fig. 2B).
234-1	41596-41600	Note	_
234-2	41601-41605	that	_
234-3	41606-41609	the	_
234-4	41610-41619	identical	_
234-5	41620-41628	analysis	_
234-6	41629-41638	performed	_
234-7	41639-41642	for	_
234-8	41643-41646	the	_
234-9	41647-41655	siblings	_
234-10	41655-41656	'	_
234-11	41657-41665	response	_
234-12	41666-41670	time	_
234-13	41671-41678	courses	_
234-14	41679-41682	and	_
234-15	41683-41691	averaged	_
234-16	41692-41696	time	_
234-17	41697-41703	course	_
234-18	41704-41706	of	_
234-19	41707-41714	healthy	_
234-20	41715-41727	participants	_
234-21	41728-41729	(	_
234-22	41729-41732	Fig	_
234-23	41732-41733	.	_
234-24	41734-41736	5B	_
234-25	41736-41737	)	_
234-26	41738-41746	revealed	_
234-27	41747-41754	results	_
234-28	41755-41761	mostly	_
234-29	41762-41772	comparable	_
234-30	41773-41777	with	_
234-31	41778-41781	the	_
234-32	41782-41790	outcomes	_
234-33	41791-41797	within	_
234-34	41798-41801	the	_
234-35	41802-41810	siblings	_
234-36	41810-41811	'	_
234-37	41812-41817	group	_
234-38	41818-41819	(	_
234-39	41819-41826	compare	_
234-40	41827-41830	Fig	_
234-41	41830-41831	.	_
234-42	41832-41834	5B	_
234-43	41835-41839	with	_
234-44	41840-41843	Fig	_
234-45	41843-41844	.	_
234-46	41845-41847	2B	_
234-47	41847-41848	)	_
234-48	41848-41849	.	_

#Text=Relationship between the syndrome scale rating and reliability of brain responses
#Text=To explore if the observed changes in processing long time scale stimuli correspond to the syndrome scale rating in patients with schizophrenia, we tested two ROIs – the TPJ and precuneus, as only these regions exhibited synchronized responses to the story condition within patients.
235-1	41850-41862	Relationship	_
235-2	41863-41870	between	_
235-3	41871-41874	the	_
235-4	41875-41883	syndrome	_
235-5	41884-41889	scale	_
235-6	41890-41896	rating	_
235-7	41897-41900	and	_
235-8	41901-41912	reliability	_
235-9	41913-41915	of	_
235-10	41916-41921	brain	_
235-11	41922-41931	responses	_
235-12	41932-41934	To	_
235-13	41935-41942	explore	_
235-14	41943-41945	if	_
235-15	41946-41949	the	_
235-16	41950-41958	observed	_
235-17	41959-41966	changes	_
235-18	41967-41969	in	_
235-19	41970-41980	processing	_
235-20	41981-41985	long	_
235-21	41986-41990	time	_
235-22	41991-41996	scale	_
235-23	41997-42004	stimuli	_
235-24	42005-42015	correspond	_
235-25	42016-42018	to	_
235-26	42019-42022	the	_
235-27	42023-42031	syndrome	_
235-28	42032-42037	scale	_
235-29	42038-42044	rating	_
235-30	42045-42047	in	_
235-31	42048-42056	patients	_
235-32	42057-42061	with	_
235-33	42062-42075	schizophrenia	_
235-34	42075-42076	,	_
235-35	42077-42079	we	_
235-36	42080-42086	tested	_
235-37	42087-42090	two	_
235-38	42091-42095	ROIs	_
235-39	42096-42097	–	_
235-40	42098-42101	the	_
235-41	42102-42105	TPJ	_
235-42	42106-42109	and	_
235-43	42110-42119	precuneus	_
235-44	42119-42120	,	_
235-45	42121-42123	as	_
235-46	42124-42128	only	_
235-47	42129-42134	these	_
235-48	42135-42142	regions	_
235-49	42143-42152	exhibited	_
235-50	42153-42165	synchronized	_
235-51	42166-42175	responses	_
235-52	42176-42178	to	_
235-53	42179-42182	the	_
235-54	42183-42188	story	_
235-55	42189-42198	condition	_
235-56	42199-42205	within	_
235-57	42206-42214	patients	_
235-58	42214-42215	.	_

#Text=To that end, inter-SCs between each patient's time course and average time course of the healthy participants were computed.
236-1	42216-42218	To	_
236-2	42219-42223	that	_
236-3	42224-42227	end	_
236-4	42227-42228	,	_
236-5	42229-42238	inter-SCs	_
236-6	42239-42246	between	_
236-7	42247-42251	each	_
236-8	42252-42261	patient's	_
236-9	42262-42266	time	_
236-10	42267-42273	course	_
236-11	42274-42277	and	_
236-12	42278-42285	average	_
236-13	42286-42290	time	_
236-14	42291-42297	course	_
236-15	42298-42300	of	_
236-16	42301-42304	the	_
236-17	42305-42312	healthy	_
236-18	42313-42325	participants	_
236-19	42326-42330	were	_
236-20	42331-42339	computed	_
236-21	42339-42340	.	_

#Text=Fig. 6 shows the patient's positive, negative and general psychopathology scores (Supplementary Table 1, see also Methods) plotted against the calculated inter-SC coefficients for each patient.
237-1	42341-42344	Fig	_
237-2	42344-42345	.	_
237-3	42346-42347	6	_
237-4	42348-42353	shows	_
237-5	42354-42357	the	_
237-6	42358-42367	patient's	_
237-7	42368-42376	positive	_
237-8	42376-42377	,	_
237-9	42378-42386	negative	_
237-10	42387-42390	and	_
237-11	42391-42398	general	_
237-12	42399-42414	psychopathology	_
237-13	42415-42421	scores	_
237-14	42422-42423	(	_
237-15	42423-42436	Supplementary	_
237-16	42437-42442	Table	_
237-17	42443-42444	1	_
237-18	42444-42445	,	_
237-19	42446-42449	see	_
237-20	42450-42454	also	_
237-21	42455-42462	Methods	_
237-22	42462-42463	)	_
237-23	42464-42471	plotted	_
237-24	42472-42479	against	_
237-25	42480-42483	the	_
237-26	42484-42494	calculated	_
237-27	42495-42503	inter-SC	_
237-28	42504-42516	coefficients	_
237-29	42517-42520	for	_
237-30	42521-42525	each	_
237-31	42526-42533	patient	_
237-32	42533-42534	.	_

#Text=A strong correlation (TPJ: corr. coeff. = − 0.67, p = 0.02; precuneus: corr. coeff. = − 0.68, p = 0.02) was found between positive symptoms and calculated inter-SCs in both ROIs.
238-1	42535-42536	A	_
238-2	42537-42543	strong	_
238-3	42544-42555	correlation	_
238-4	42556-42557	(	_
238-5	42557-42560	TPJ	_
238-6	42560-42561	:	_
238-7	42562-42566	corr	_
238-8	42566-42567	.	_
238-9	42568-42573	coeff	_
238-10	42573-42574	.	_
238-11	42574-42575	 	_
238-12	42575-42576	=	_
238-13	42576-42577	 	_
238-14	42577-42578	−	_
238-15	42578-42579	 	_
238-16	42579-42583	0.67	_
238-17	42583-42584	,	_
238-18	42585-42586	p	_
238-19	42586-42587	 	_
238-20	42587-42588	=	_
238-21	42588-42589	 	_
238-22	42589-42593	0.02	_
238-23	42593-42594	;	_
238-24	42595-42604	precuneus	_
238-25	42604-42605	:	_
238-26	42606-42610	corr	_
238-27	42610-42611	.	_
238-28	42612-42617	coeff	_
238-29	42617-42618	.	_
238-30	42618-42619	 	_
238-31	42619-42620	=	_
238-32	42620-42621	 	_
238-33	42621-42622	−	_
238-34	42622-42623	 	_
238-35	42623-42627	0.68	_
238-36	42627-42628	,	_
238-37	42629-42630	p	_
238-38	42630-42631	 	_
238-39	42631-42632	=	_
238-40	42632-42633	 	_
238-41	42633-42637	0.02	_
238-42	42637-42638	)	_
238-43	42639-42642	was	_
238-44	42643-42648	found	_
238-45	42649-42656	between	_
238-46	42657-42665	positive	_
238-47	42666-42674	symptoms	_
238-48	42675-42678	and	_
238-49	42679-42689	calculated	_
238-50	42690-42699	inter-SCs	_
238-51	42700-42702	in	_
238-52	42703-42707	both	_
238-53	42708-42712	ROIs	_
238-54	42712-42713	.	_

#Text=In addition, in the TPJ a significant correlation (corr. coeff. = − 0.61, p = 0.048) was observed with the general symptoms (Fig. 6A).
239-1	42714-42716	In	_
239-2	42717-42725	addition	_
239-3	42725-42726	,	_
239-4	42727-42729	in	_
239-5	42730-42733	the	_
239-6	42734-42737	TPJ	_
239-7	42738-42739	a	_
239-8	42740-42751	significant	_
239-9	42752-42763	correlation	_
239-10	42764-42765	(	_
239-11	42765-42769	corr	_
239-12	42769-42770	.	_
239-13	42771-42776	coeff	_
239-14	42776-42777	.	_
239-15	42777-42778	 	_
239-16	42778-42779	=	_
239-17	42779-42780	 	_
239-18	42780-42781	−	_
239-19	42781-42782	 	_
239-20	42782-42786	0.61	_
239-21	42786-42787	,	_
239-22	42788-42789	p	_
239-23	42789-42790	 	_
239-24	42790-42791	=	_
239-25	42791-42792	 	_
239-26	42792-42797	0.048	_
239-27	42797-42798	)	_
239-28	42799-42802	was	_
239-29	42803-42811	observed	_
239-30	42812-42816	with	_
239-31	42817-42820	the	_
239-32	42821-42828	general	_
239-33	42829-42837	symptoms	_
239-34	42838-42839	(	_
239-35	42839-42842	Fig	_
239-36	42842-42843	.	_
239-37	42844-42846	6A	_
239-38	42846-42847	)	_
239-39	42847-42848	.	_

#Text=These findings offer a possible explanation for the diminished synchronization in responses during story presentation in the schizophrenia group.
240-1	42849-42854	These	_
240-2	42855-42863	findings	_
240-3	42864-42869	offer	_
240-4	42870-42871	a	_
240-5	42872-42880	possible	_
240-6	42881-42892	explanation	_
240-7	42893-42896	for	_
240-8	42897-42900	the	_
240-9	42901-42911	diminished	_
240-10	42912-42927	synchronization	_
240-11	42928-42930	in	_
240-12	42931-42940	responses	_
240-13	42941-42947	during	_
240-14	42948-42953	story	_
240-15	42954-42966	presentation	_
240-16	42967-42969	in	_
240-17	42970-42973	the	_
240-18	42974-42987	schizophrenia	_
240-19	42988-42993	group	_
240-20	42993-42994	.	_

#Text=Discussion
#Text=In the present study we examined the ability of patients with schizophrenia and their healthy siblings to accumulate and process verbal stimuli, with regard to long and short time scales in a story presented auditorilly.
241-1	42995-43005	Discussion	_
241-2	43006-43008	In	_
241-3	43009-43012	the	_
241-4	43013-43020	present	_
241-5	43021-43026	study	_
241-6	43027-43029	we	_
241-7	43030-43038	examined	_
241-8	43039-43042	the	_
241-9	43043-43050	ability	_
241-10	43051-43053	of	_
241-11	43054-43062	patients	_
241-12	43063-43067	with	_
241-13	43068-43081	schizophrenia	_
241-14	43082-43085	and	_
241-15	43086-43091	their	_
241-16	43092-43099	healthy	_
241-17	43100-43108	siblings	_
241-18	43109-43111	to	_
241-19	43112-43122	accumulate	_
241-20	43123-43126	and	_
241-21	43127-43134	process	_
241-22	43135-43141	verbal	_
241-23	43142-43149	stimuli	_
241-24	43149-43150	,	_
241-25	43151-43155	with	_
241-26	43156-43162	regard	_
241-27	43163-43165	to	_
241-28	43166-43170	long	_
241-29	43171-43174	and	_
241-30	43175-43180	short	_
241-31	43181-43185	time	_
241-32	43186-43192	scales	_
241-33	43193-43195	in	_
241-34	43196-43197	a	_
241-35	43198-43203	story	_
241-36	43204-43213	presented	_
241-37	43214-43225	auditorilly	_
241-38	43225-43226	.	_

#Text=Naturalistic presentation and a data-driven analytic method that reveals to what extent the provided input reliably affects brain dynamics allowed us to reach beyond the common research approach in schizophrenia by focusing on neural correlates of semantic processing hierarchy.
242-1	43227-43239	Naturalistic	_
242-2	43240-43252	presentation	_
242-3	43253-43256	and	_
242-4	43257-43258	a	_
242-5	43259-43270	data-driven	_
242-6	43271-43279	analytic	_
242-7	43280-43286	method	_
242-8	43287-43291	that	_
242-9	43292-43299	reveals	_
242-10	43300-43302	to	_
242-11	43303-43307	what	_
242-12	43308-43314	extent	_
242-13	43315-43318	the	_
242-14	43319-43327	provided	_
242-15	43328-43333	input	_
242-16	43334-43342	reliably	_
242-17	43343-43350	affects	_
242-18	43351-43356	brain	_
242-19	43357-43365	dynamics	_
242-20	43366-43373	allowed	_
242-21	43374-43376	us	_
242-22	43377-43379	to	_
242-23	43380-43385	reach	_
242-24	43386-43392	beyond	_
242-25	43393-43396	the	_
242-26	43397-43403	common	_
242-27	43404-43412	research	_
242-28	43413-43421	approach	_
242-29	43422-43424	in	_
242-30	43425-43438	schizophrenia	_
242-31	43439-43441	by	_
242-32	43442-43450	focusing	_
242-33	43451-43453	on	_
242-34	43454-43460	neural	_
242-35	43461-43471	correlates	_
242-36	43472-43474	of	_
242-37	43475-43483	semantic	_
242-38	43484-43494	processing	_
242-39	43495-43504	hierarchy	_
242-40	43504-43505	.	_

#Text=We documented four main results.
243-1	43506-43508	We	_
243-2	43509-43519	documented	_
243-3	43520-43524	four	_
243-4	43525-43529	main	_
243-5	43530-43537	results	_
243-6	43537-43538	.	_

#Text=First, different neural response patterns during long time scale (story condition) but not short (words) and mid (sentences) time scales, were found in first episode patients with schizophrenia compared to healthy controls.
244-1	43539-43544	First	_
244-2	43544-43545	,	_
244-3	43546-43555	different	_
244-4	43556-43562	neural	_
244-5	43563-43571	response	_
244-6	43572-43580	patterns	_
244-7	43581-43587	during	_
244-8	43588-43592	long	_
244-9	43593-43597	time	_
244-10	43598-43603	scale	_
244-11	43604-43605	(	_
244-12	43605-43610	story	_
244-13	43611-43620	condition	_
244-14	43620-43621	)	_
244-15	43622-43625	but	_
244-16	43626-43629	not	_
244-17	43630-43635	short	_
244-18	43636-43637	(	_
244-19	43637-43642	words	_
244-20	43642-43643	)	_
244-21	43644-43647	and	_
244-22	43648-43651	mid	_
244-23	43652-43653	(	_
244-24	43653-43662	sentences	_
244-25	43662-43663	)	_
244-26	43664-43668	time	_
244-27	43669-43675	scales	_
244-28	43675-43676	,	_
244-29	43677-43681	were	_
244-30	43682-43687	found	_
244-31	43688-43690	in	_
244-32	43691-43696	first	_
244-33	43697-43704	episode	_
244-34	43705-43713	patients	_
244-35	43714-43718	with	_
244-36	43719-43732	schizophrenia	_
244-37	43733-43741	compared	_
244-38	43742-43744	to	_
244-39	43745-43752	healthy	_
244-40	43753-43761	controls	_
244-41	43761-43762	.	_

#Text=This difference was most evident as low synchronization in the prefrontal cortex while listening to the whole story.
245-1	43763-43767	This	_
245-2	43768-43778	difference	_
245-3	43779-43782	was	_
245-4	43783-43787	most	_
245-5	43788-43795	evident	_
245-6	43796-43798	as	_
245-7	43799-43802	low	_
245-8	43803-43818	synchronization	_
245-9	43819-43821	in	_
245-10	43822-43825	the	_
245-11	43826-43836	prefrontal	_
245-12	43837-43843	cortex	_
245-13	43844-43849	while	_
245-14	43850-43859	listening	_
245-15	43860-43862	to	_
245-16	43863-43866	the	_
245-17	43867-43872	whole	_
245-18	43873-43878	story	_
245-19	43878-43879	.	_

#Text=Second, the more highly correlated the neural responses of a patient were with an averaged healthy group's response, the less severe the clinical condition of the patient.
246-1	43880-43886	Second	_
246-2	43886-43887	,	_
246-3	43888-43891	the	_
246-4	43892-43896	more	_
246-5	43897-43903	highly	_
246-6	43904-43914	correlated	_
246-7	43915-43918	the	_
246-8	43919-43925	neural	_
246-9	43926-43935	responses	_
246-10	43936-43938	of	_
246-11	43939-43940	a	_
246-12	43941-43948	patient	_
246-13	43949-43953	were	_
246-14	43954-43958	with	_
246-15	43959-43961	an	_
246-16	43962-43970	averaged	_
246-17	43971-43978	healthy	_
246-18	43979-43986	group's	_
246-19	43987-43995	response	_
246-20	43995-43996	,	_
246-21	43997-44000	the	_
246-22	44001-44005	less	_
246-23	44006-44012	severe	_
246-24	44013-44016	the	_
246-25	44017-44025	clinical	_
246-26	44026-44035	condition	_
246-27	44036-44038	of	_
246-28	44039-44042	the	_
246-29	44043-44050	patient	_
246-30	44050-44051	.	_

#Text=Next, siblings of patients exhibited an intermediate pattern of response coherency in the prefrontal cortex, between the patients and healthy controls.
247-1	44052-44056	Next	_
247-2	44056-44057	,	_
247-3	44058-44066	siblings	_
247-4	44067-44069	of	_
247-5	44070-44078	patients	_
247-6	44079-44088	exhibited	_
247-7	44089-44091	an	_
247-8	44092-44104	intermediate	_
247-9	44105-44112	pattern	_
247-10	44113-44115	of	_
247-11	44116-44124	response	_
247-12	44125-44134	coherency	_
247-13	44135-44137	in	_
247-14	44138-44141	the	_
247-15	44142-44152	prefrontal	_
247-16	44153-44159	cortex	_
247-17	44159-44160	,	_
247-18	44161-44168	between	_
247-19	44169-44172	the	_
247-20	44173-44181	patients	_
247-21	44182-44185	and	_
247-22	44186-44193	healthy	_
247-23	44194-44202	controls	_
247-24	44202-44203	.	_

#Text=Finally, in healthy controls, we replicated previous evidence for the gradual temporal hierarchy extending through much of the human cortex including linguistic and extra-linguistic regions.
248-1	44204-44211	Finally	_
248-2	44211-44212	,	_
248-3	44213-44215	in	_
248-4	44216-44223	healthy	_
248-5	44224-44232	controls	_
248-6	44232-44233	,	_
248-7	44234-44236	we	_
248-8	44237-44247	replicated	_
248-9	44248-44256	previous	_
248-10	44257-44265	evidence	_
248-11	44266-44269	for	_
248-12	44270-44273	the	_
248-13	44274-44281	gradual	_
248-14	44282-44290	temporal	_
248-15	44291-44300	hierarchy	_
248-16	44301-44310	extending	_
248-17	44311-44318	through	_
248-18	44319-44323	much	_
248-19	44324-44326	of	_
248-20	44327-44330	the	_
248-21	44331-44336	human	_
248-22	44337-44343	cortex	_
248-23	44344-44353	including	_
248-24	44354-44364	linguistic	_
248-25	44365-44368	and	_
248-26	44369-44385	extra-linguistic	_
248-27	44386-44393	regions	_
248-28	44393-44394	.	_

#Text=Processing of long time scales in schizophrenia
#Text=Our finding of the difference in synchronization between patients and healthy controls in the prefrontal cortex corresponds to the vast literature in schizophrenia showing decreased reactivity in this region in numerous tasks and during resting state (known as hypofrontality hypothesis).
249-1	44395-44405	Processing	_
249-2	44406-44408	of	_
249-3	44409-44413	long	_
249-4	44414-44418	time	_
249-5	44419-44425	scales	_
249-6	44426-44428	in	_
249-7	44429-44442	schizophrenia	_
249-8	44443-44446	Our	_
249-9	44447-44454	finding	_
249-10	44455-44457	of	_
249-11	44458-44461	the	_
249-12	44462-44472	difference	_
249-13	44473-44475	in	_
249-14	44476-44491	synchronization	_
249-15	44492-44499	between	_
249-16	44500-44508	patients	_
249-17	44509-44512	and	_
249-18	44513-44520	healthy	_
249-19	44521-44529	controls	_
249-20	44530-44532	in	_
249-21	44533-44536	the	_
249-22	44537-44547	prefrontal	_
249-23	44548-44554	cortex	_
249-24	44555-44566	corresponds	_
249-25	44567-44569	to	_
249-26	44570-44573	the	_
249-27	44574-44578	vast	_
249-28	44579-44589	literature	_
249-29	44590-44592	in	_
249-30	44593-44606	schizophrenia	_
249-31	44607-44614	showing	_
249-32	44615-44624	decreased	_
249-33	44625-44635	reactivity	_
249-34	44636-44638	in	_
249-35	44639-44643	this	_
249-36	44644-44650	region	_
249-37	44651-44653	in	_
249-38	44654-44662	numerous	_
249-39	44663-44668	tasks	_
249-40	44669-44672	and	_
249-41	44673-44679	during	_
249-42	44680-44687	resting	_
249-43	44688-44693	state	_
249-44	44694-44695	(	_
249-45	44695-44700	known	_
249-46	44701-44703	as	_
249-47	44704-44718	hypofrontality	_
249-48	44719-44729	hypothesis	_
249-49	44729-44730	)	_
249-50	44730-44731	.	_

#Text=Thus, low-level similarity across patients observed in the DLPFC, a central player known to be deficient in schizophrenia during cognitive tasks, might be attributed to this general effect.
250-1	44732-44736	Thus	_
250-2	44736-44737	,	_
250-3	44738-44747	low-level	_
250-4	44748-44758	similarity	_
250-5	44759-44765	across	_
250-6	44766-44774	patients	_
250-7	44775-44783	observed	_
250-8	44784-44786	in	_
250-9	44787-44790	the	_
250-10	44791-44796	DLPFC	_
250-11	44796-44797	,	_
250-12	44798-44799	a	_
250-13	44800-44807	central	_
250-14	44808-44814	player	_
250-15	44815-44820	known	_
250-16	44821-44823	to	_
250-17	44824-44826	be	_
250-18	44827-44836	deficient	_
250-19	44837-44839	in	_
250-20	44840-44853	schizophrenia	_
250-21	44854-44860	during	_
250-22	44861-44870	cognitive	_
250-23	44871-44876	tasks	_
250-24	44876-44877	,	_
250-25	44878-44883	might	_
250-26	44884-44886	be	_
250-27	44887-44897	attributed	_
250-28	44898-44900	to	_
250-29	44901-44905	this	_
250-30	44906-44913	general	_
250-31	44914-44920	effect	_
250-32	44920-44921	.	_

#Text=Here we showed that such an effect was related to processing the most complex level of verbal stimuli (i.e. a whole story).
251-1	44922-44926	Here	_
251-2	44927-44929	we	_
251-3	44930-44936	showed	_
251-4	44937-44941	that	_
251-5	44942-44946	such	_
251-6	44947-44949	an	_
251-7	44950-44956	effect	_
251-8	44957-44960	was	_
251-9	44961-44968	related	_
251-10	44969-44971	to	_
251-11	44972-44982	processing	_
251-12	44983-44986	the	_
251-13	44987-44991	most	_
251-14	44992-44999	complex	_
251-15	45000-45005	level	_
251-16	45006-45008	of	_
251-17	45009-45015	verbal	_
251-18	45016-45023	stimuli	_
251-19	45024-45025	(	_
251-20	45025-45028	i.e	_
251-21	45028-45029	.	_
251-22	45030-45031	a	_
251-23	45032-45037	whole	_
251-24	45038-45043	story	_
251-25	45043-45044	)	_
251-26	45044-45045	.	_

#Text=A leading explanation for this decreased synchronization is a large variability among patients related to abnormal/disorganized activity or functional connectivity in the prefrontal cortex when listening to the whole story.
252-1	45046-45047	A	_
252-2	45048-45055	leading	_
252-3	45056-45067	explanation	_
252-4	45068-45071	for	_
252-5	45072-45076	this	_
252-6	45077-45086	decreased	_
252-7	45087-45102	synchronization	_
252-8	45103-45105	is	_
252-9	45106-45107	a	_
252-10	45108-45113	large	_
252-11	45114-45125	variability	_
252-12	45126-45131	among	_
252-13	45132-45140	patients	_
252-14	45141-45148	related	_
252-15	45149-45151	to	_
252-16	45152-45160	abnormal	_
252-17	45160-45161	/	_
252-18	45161-45173	disorganized	_
252-19	45174-45182	activity	_
252-20	45183-45185	or	_
252-21	45186-45196	functional	_
252-22	45197-45209	connectivity	_
252-23	45210-45212	in	_
252-24	45213-45216	the	_
252-25	45217-45227	prefrontal	_
252-26	45228-45234	cortex	_
252-27	45235-45239	when	_
252-28	45240-45249	listening	_
252-29	45250-45252	to	_
252-30	45253-45256	the	_
252-31	45257-45262	whole	_
252-32	45263-45268	story	_
252-33	45268-45269	.	_

#Text=Regarding activity, the design of the current study did not allow for direct investigation of differences in activation profiles during stimuli with different time scales.
253-1	45270-45279	Regarding	_
253-2	45280-45288	activity	_
253-3	45288-45289	,	_
253-4	45290-45293	the	_
253-5	45294-45300	design	_
253-6	45301-45303	of	_
253-7	45304-45307	the	_
253-8	45308-45315	current	_
253-9	45316-45321	study	_
253-10	45322-45325	did	_
253-11	45326-45329	not	_
253-12	45330-45335	allow	_
253-13	45336-45339	for	_
253-14	45340-45346	direct	_
253-15	45347-45360	investigation	_
253-16	45361-45363	of	_
253-17	45364-45375	differences	_
253-18	45376-45378	in	_
253-19	45379-45389	activation	_
253-20	45390-45398	profiles	_
253-21	45399-45405	during	_
253-22	45406-45413	stimuli	_
253-23	45414-45418	with	_
253-24	45419-45428	different	_
253-25	45429-45433	time	_
253-26	45434-45440	scales	_
253-27	45440-45441	.	_

#Text=Further studies manipulating semantic information processing elements should be conducted to examine the amplitude of neural responses in detail.
254-1	45442-45449	Further	_
254-2	45450-45457	studies	_
254-3	45458-45470	manipulating	_
254-4	45471-45479	semantic	_
254-5	45480-45491	information	_
254-6	45492-45502	processing	_
254-7	45503-45511	elements	_
254-8	45512-45518	should	_
254-9	45519-45521	be	_
254-10	45522-45531	conducted	_
254-11	45532-45534	to	_
254-12	45535-45542	examine	_
254-13	45543-45546	the	_
254-14	45547-45556	amplitude	_
254-15	45557-45559	of	_
254-16	45560-45566	neural	_
254-17	45567-45576	responses	_
254-18	45577-45579	in	_
254-19	45580-45586	detail	_
254-20	45586-45587	.	_

#Text=The possibility of reduced functional connectivity patterns with the prefrontal cortex is supported by brain – behavior models of schizophrenia which proposed that the cognitive deficits reflect disturbances in cortico-cortical (e.g., ‘prefrontal–medial temporal lobe’) and cortico-subcortical (e.g., ‘prefrontal–basal ganglia–thalamic’) connections.
255-1	45588-45591	The	_
255-2	45592-45603	possibility	_
255-3	45604-45606	of	_
255-4	45607-45614	reduced	_
255-5	45615-45625	functional	_
255-6	45626-45638	connectivity	_
255-7	45639-45647	patterns	_
255-8	45648-45652	with	_
255-9	45653-45656	the	_
255-10	45657-45667	prefrontal	_
255-11	45668-45674	cortex	_
255-12	45675-45677	is	_
255-13	45678-45687	supported	_
255-14	45688-45690	by	_
255-15	45691-45696	brain	_
255-16	45697-45698	–	_
255-17	45699-45707	behavior	_
255-18	45708-45714	models	_
255-19	45715-45717	of	_
255-20	45718-45731	schizophrenia	_
255-21	45732-45737	which	_
255-22	45738-45746	proposed	_
255-23	45747-45751	that	_
255-24	45752-45755	the	_
255-25	45756-45765	cognitive	_
255-26	45766-45774	deficits	_
255-27	45775-45782	reflect	_
255-28	45783-45795	disturbances	_
255-29	45796-45798	in	_
255-30	45799-45815	cortico-cortical	_
255-31	45816-45817	(	_
255-32	45817-45820	e.g	_
255-33	45820-45821	.	_
255-34	45821-45822	,	_
255-35	45823-45824	‘	_
255-36	45824-45841	prefrontal–medial	_
255-37	45842-45850	temporal	_
255-38	45851-45855	lobe	_
255-39	45855-45856	’	_
255-40	45856-45857	)	_
255-41	45858-45861	and	_
255-42	45862-45881	cortico-subcortical	_
255-43	45882-45883	(	_
255-44	45883-45886	e.g	_
255-45	45886-45887	.	_
255-46	45887-45888	,	_
255-47	45889-45890	‘	_
255-48	45890-45906	prefrontal–basal	_
255-49	45907-45923	ganglia–thalamic	_
255-50	45923-45924	’	_
255-51	45924-45925	)	_
255-52	45926-45937	connections	_
255-53	45937-45938	.	_

#Text=In addition, structural studies showing white matter abnormalities in schizophrenia suggested fronto-temporal and fronto-parietal disconnectivity.
256-1	45939-45941	In	_
256-2	45942-45950	addition	_
256-3	45950-45951	,	_
256-4	45952-45962	structural	_
256-5	45963-45970	studies	_
256-6	45971-45978	showing	_
256-7	45979-45984	white	_
256-8	45985-45991	matter	_
256-9	45992-46005	abnormalities	_
256-10	46006-46008	in	_
256-11	46009-46022	schizophrenia	_
256-12	46023-46032	suggested	_
256-13	46033-46048	fronto-temporal	_
256-14	46049-46052	and	_
256-15	46053-46068	fronto-parietal	_
256-16	46069-46084	disconnectivity	_
256-17	46084-46085	.	_

#Text=Inability to suppress interrupting thoughts as a possible basis of functional psychopathology in schizophrenia
#Text=Another explanation for diminished neural synchronization in the schizophrenia group could be linked to deficient mental processing, such as divergence of attention from external stimuli toward interrupting thoughts arising in the patients' minds while listening to the story.
257-1	46086-46095	Inability	_
257-2	46096-46098	to	_
257-3	46099-46107	suppress	_
257-4	46108-46120	interrupting	_
257-5	46121-46129	thoughts	_
257-6	46130-46132	as	_
257-7	46133-46134	a	_
257-8	46135-46143	possible	_
257-9	46144-46149	basis	_
257-10	46150-46152	of	_
257-11	46153-46163	functional	_
257-12	46164-46179	psychopathology	_
257-13	46180-46182	in	_
257-14	46183-46196	schizophrenia	_
257-15	46197-46204	Another	_
257-16	46205-46216	explanation	_
257-17	46217-46220	for	_
257-18	46221-46231	diminished	_
257-19	46232-46238	neural	_
257-20	46239-46254	synchronization	_
257-21	46255-46257	in	_
257-22	46258-46261	the	_
257-23	46262-46275	schizophrenia	_
257-24	46276-46281	group	_
257-25	46282-46287	could	_
257-26	46288-46290	be	_
257-27	46291-46297	linked	_
257-28	46298-46300	to	_
257-29	46301-46310	deficient	_
257-30	46311-46317	mental	_
257-31	46318-46328	processing	_
257-32	46328-46329	,	_
257-33	46330-46334	such	_
257-34	46335-46337	as	_
257-35	46338-46348	divergence	_
257-36	46349-46351	of	_
257-37	46352-46361	attention	_
257-38	46362-46366	from	_
257-39	46367-46375	external	_
257-40	46376-46383	stimuli	_
257-41	46384-46390	toward	_
257-42	46391-46403	interrupting	_
257-43	46404-46412	thoughts	_
257-44	46413-46420	arising	_
257-45	46421-46423	in	_
257-46	46424-46427	the	_
257-47	46428-46436	patients	_
257-48	46436-46437	'	_
257-49	46438-46443	minds	_
257-50	46444-46449	while	_
257-51	46450-46459	listening	_
257-52	46460-46462	to	_
257-53	46463-46466	the	_
257-54	46467-46472	story	_
257-55	46472-46473	.	_

#Text=Although our post-scanning debriefing showed that most of the patients understood and were able to report the general line of the story (see Methods), this idea is supported by the strong negative correlation between positive symptoms and similarity of patients to the healthy group average, which we observed in the TPJ and precuneus; central nodes of the Default Mode Network (DMN).
258-1	46474-46482	Although	_
258-2	46483-46486	our	_
258-3	46487-46500	post-scanning	_
258-4	46501-46511	debriefing	_
258-5	46512-46518	showed	_
258-6	46519-46523	that	_
258-7	46524-46528	most	_
258-8	46529-46531	of	_
258-9	46532-46535	the	_
258-10	46536-46544	patients	_
258-11	46545-46555	understood	_
258-12	46556-46559	and	_
258-13	46560-46564	were	_
258-14	46565-46569	able	_
258-15	46570-46572	to	_
258-16	46573-46579	report	_
258-17	46580-46583	the	_
258-18	46584-46591	general	_
258-19	46592-46596	line	_
258-20	46597-46599	of	_
258-21	46600-46603	the	_
258-22	46604-46609	story	_
258-23	46610-46611	(	_
258-24	46611-46614	see	_
258-25	46615-46622	Methods	_
258-26	46622-46623	)	_
258-27	46623-46624	,	_
258-28	46625-46629	this	_
258-29	46630-46634	idea	_
258-30	46635-46637	is	_
258-31	46638-46647	supported	_
258-32	46648-46650	by	_
258-33	46651-46654	the	_
258-34	46655-46661	strong	_
258-35	46662-46670	negative	_
258-36	46671-46682	correlation	_
258-37	46683-46690	between	_
258-38	46691-46699	positive	_
258-39	46700-46708	symptoms	_
258-40	46709-46712	and	_
258-41	46713-46723	similarity	_
258-42	46724-46726	of	_
258-43	46727-46735	patients	_
258-44	46736-46738	to	_
258-45	46739-46742	the	_
258-46	46743-46750	healthy	_
258-47	46751-46756	group	_
258-48	46757-46764	average	_
258-49	46764-46765	,	_
258-50	46766-46771	which	_
258-51	46772-46774	we	_
258-52	46775-46783	observed	_
258-53	46784-46786	in	_
258-54	46787-46790	the	_
258-55	46791-46794	TPJ	_
258-56	46795-46798	and	_
258-57	46799-46808	precuneus	_
258-58	46808-46809	;	_
258-59	46810-46817	central	_
258-60	46818-46823	nodes	_
258-61	46824-46826	of	_
258-62	46827-46830	the	_
258-63	46831-46838	Default	_
258-64	46839-46843	Mode	_
258-65	46844-46851	Network	_
258-66	46852-46853	(	_
258-67	46853-46856	DMN	_
258-68	46856-46857	)	_
258-69	46857-46858	.	_

#Text=A similar relationship between precuneus functioning and the positive symptoms score of patients with first-episode psychosis has been recently reported by.
259-1	46859-46860	A	_
259-2	46861-46868	similar	_
259-3	46869-46881	relationship	_
259-4	46882-46889	between	_
259-5	46890-46899	precuneus	_
259-6	46900-46911	functioning	_
259-7	46912-46915	and	_
259-8	46916-46919	the	_
259-9	46920-46928	positive	_
259-10	46929-46937	symptoms	_
259-11	46938-46943	score	_
259-12	46944-46946	of	_
259-13	46947-46955	patients	_
259-14	46956-46960	with	_
259-15	46961-46974	first-episode	_
259-16	46975-46984	psychosis	_
259-17	46985-46988	has	_
259-18	46989-46993	been	_
259-19	46994-47002	recently	_
259-20	47003-47011	reported	_
259-21	47012-47014	by	_
259-22	47014-47015	.	_

#Text=It is interesting to note that the DMN, a main network for rest-related activity, plays a special role in mind-wandering, a spontaneous, uncontrolled internally-oriented condition.
260-1	47016-47018	It	_
260-2	47019-47021	is	_
260-3	47022-47033	interesting	_
260-4	47034-47036	to	_
260-5	47037-47041	note	_
260-6	47042-47046	that	_
260-7	47047-47050	the	_
260-8	47051-47054	DMN	_
260-9	47054-47055	,	_
260-10	47056-47057	a	_
260-11	47058-47062	main	_
260-12	47063-47070	network	_
260-13	47071-47074	for	_
260-14	47075-47087	rest-related	_
260-15	47088-47096	activity	_
260-16	47096-47097	,	_
260-17	47098-47103	plays	_
260-18	47104-47105	a	_
260-19	47106-47113	special	_
260-20	47114-47118	role	_
260-21	47119-47121	in	_
260-22	47122-47136	mind-wandering	_
260-23	47136-47137	,	_
260-24	47138-47139	a	_
260-25	47140-47151	spontaneous	_
260-26	47151-47152	,	_
260-27	47153-47165	uncontrolled	_
260-28	47166-47185	internally-oriented	_
260-29	47186-47195	condition	_
260-30	47195-47196	.	_

#Text=Neural activity in the regions that comprise substantial elements of the DMN has been demonstrated to occur during a process of self-oriented mentation in numerous studies.
261-1	47197-47203	Neural	_
261-2	47204-47212	activity	_
261-3	47213-47215	in	_
261-4	47216-47219	the	_
261-5	47220-47227	regions	_
261-6	47228-47232	that	_
261-7	47233-47241	comprise	_
261-8	47242-47253	substantial	_
261-9	47254-47262	elements	_
261-10	47263-47265	of	_
261-11	47266-47269	the	_
261-12	47270-47273	DMN	_
261-13	47274-47277	has	_
261-14	47278-47282	been	_
261-15	47283-47295	demonstrated	_
261-16	47296-47298	to	_
261-17	47299-47304	occur	_
261-18	47305-47311	during	_
261-19	47312-47313	a	_
261-20	47314-47321	process	_
261-21	47322-47324	of	_
261-22	47325-47338	self-oriented	_
261-23	47339-47348	mentation	_
261-24	47349-47351	in	_
261-25	47352-47360	numerous	_
261-26	47361-47368	studies	_
261-27	47368-47369	.	_

#Text=In addition, involvement of mental imagery in schizophrenia as a source of increased activation in the precuneus has been discussed in previous fMRI studies, which investigated cartoon jokes in individuals with enhanced risk of schizophrenia, comprehension of the figurative meaning of language, such as metaphor or verbal humor in patients with schizophrenia.
262-1	47370-47372	In	_
262-2	47373-47381	addition	_
262-3	47381-47382	,	_
262-4	47383-47394	involvement	_
262-5	47395-47397	of	_
262-6	47398-47404	mental	_
262-7	47405-47412	imagery	_
262-8	47413-47415	in	_
262-9	47416-47429	schizophrenia	_
262-10	47430-47432	as	_
262-11	47433-47434	a	_
262-12	47435-47441	source	_
262-13	47442-47444	of	_
262-14	47445-47454	increased	_
262-15	47455-47465	activation	_
262-16	47466-47468	in	_
262-17	47469-47472	the	_
262-18	47473-47482	precuneus	_
262-19	47483-47486	has	_
262-20	47487-47491	been	_
262-21	47492-47501	discussed	_
262-22	47502-47504	in	_
262-23	47505-47513	previous	_
262-24	47514-47518	fMRI	_
262-25	47519-47526	studies	_
262-26	47526-47527	,	_
262-27	47528-47533	which	_
262-28	47534-47546	investigated	_
262-29	47547-47554	cartoon	_
262-30	47555-47560	jokes	_
262-31	47561-47563	in	_
262-32	47564-47575	individuals	_
262-33	47576-47580	with	_
262-34	47581-47589	enhanced	_
262-35	47590-47594	risk	_
262-36	47595-47597	of	_
262-37	47598-47611	schizophrenia	_
262-38	47611-47612	,	_
262-39	47613-47626	comprehension	_
262-40	47627-47629	of	_
262-41	47630-47633	the	_
262-42	47634-47644	figurative	_
262-43	47645-47652	meaning	_
262-44	47653-47655	of	_
262-45	47656-47664	language	_
262-46	47664-47665	,	_
262-47	47666-47670	such	_
262-48	47671-47673	as	_
262-49	47674-47682	metaphor	_
262-50	47683-47685	or	_
262-51	47686-47692	verbal	_
262-52	47693-47698	humor	_
262-53	47699-47701	in	_
262-54	47702-47710	patients	_
262-55	47711-47715	with	_
262-56	47716-47729	schizophrenia	_
262-57	47729-47730	.	_

#Text=Moreover, hyper-activation in the DMN has been shown in patients with schizophrenia during task-related functioning suggesting inability to suppress non-relevant thinking.
263-1	47731-47739	Moreover	_
263-2	47739-47740	,	_
263-3	47741-47757	hyper-activation	_
263-4	47758-47760	in	_
263-5	47761-47764	the	_
263-6	47765-47768	DMN	_
263-7	47769-47772	has	_
263-8	47773-47777	been	_
263-9	47778-47783	shown	_
263-10	47784-47786	in	_
263-11	47787-47795	patients	_
263-12	47796-47800	with	_
263-13	47801-47814	schizophrenia	_
263-14	47815-47821	during	_
263-15	47822-47834	task-related	_
263-16	47835-47846	functioning	_
263-17	47847-47857	suggesting	_
263-18	47858-47867	inability	_
263-19	47868-47870	to	_
263-20	47871-47879	suppress	_
263-21	47880-47892	non-relevant	_
263-22	47893-47901	thinking	_
263-23	47901-47902	.	_

#Text=Lastly, inability to suppress irrelevant internal verbal stream while processing external stimuli might be the basis of functional psychopathology in schizophrenia.
264-1	47903-47909	Lastly	_
264-2	47909-47910	,	_
264-3	47911-47920	inability	_
264-4	47921-47923	to	_
264-5	47924-47932	suppress	_
264-6	47933-47943	irrelevant	_
264-7	47944-47952	internal	_
264-8	47953-47959	verbal	_
264-9	47960-47966	stream	_
264-10	47967-47972	while	_
264-11	47973-47983	processing	_
264-12	47984-47992	external	_
264-13	47993-48000	stimuli	_
264-14	48001-48006	might	_
264-15	48007-48009	be	_
264-16	48010-48013	the	_
264-17	48014-48019	basis	_
264-18	48020-48022	of	_
264-19	48023-48033	functional	_
264-20	48034-48049	psychopathology	_
264-21	48050-48052	in	_
264-22	48053-48066	schizophrenia	_
264-23	48066-48067	.	_

#Text=This would be consistent with reports of disturbances in the internal representation of context and deficits in linguistic information processing on EEG (, for review see).
265-1	48068-48072	This	_
265-2	48073-48078	would	_
265-3	48079-48081	be	_
265-4	48082-48092	consistent	_
265-5	48093-48097	with	_
265-6	48098-48105	reports	_
265-7	48106-48108	of	_
265-8	48109-48121	disturbances	_
265-9	48122-48124	in	_
265-10	48125-48128	the	_
265-11	48129-48137	internal	_
265-12	48138-48152	representation	_
265-13	48153-48155	of	_
265-14	48156-48163	context	_
265-15	48164-48167	and	_
265-16	48168-48176	deficits	_
265-17	48177-48179	in	_
265-18	48180-48190	linguistic	_
265-19	48191-48202	information	_
265-20	48203-48213	processing	_
265-21	48214-48216	on	_
265-22	48217-48220	EEG	_
265-23	48221-48222	(	_
265-24	48222-48223	,	_
265-25	48224-48227	for	_
265-26	48228-48234	review	_
265-27	48235-48238	see	_
265-28	48238-48239	)	_
265-29	48239-48240	.	_

#Text=Specifically, numerous studies have reported abnormalities of N400, a neural measure of semantic processing, pointing to the deficits in schizophrenia in the application of meaningful context to facilitate the processing of related information.
266-1	48241-48253	Specifically	_
266-2	48253-48254	,	_
266-3	48255-48263	numerous	_
266-4	48264-48271	studies	_
266-5	48272-48276	have	_
266-6	48277-48285	reported	_
266-7	48286-48299	abnormalities	_
266-8	48300-48302	of	_
266-9	48303-48307	N400	_
266-10	48307-48308	,	_
266-11	48309-48310	a	_
266-12	48311-48317	neural	_
266-13	48318-48325	measure	_
266-14	48326-48328	of	_
266-15	48329-48337	semantic	_
266-16	48338-48348	processing	_
266-17	48348-48349	,	_
266-18	48350-48358	pointing	_
266-19	48359-48361	to	_
266-20	48362-48365	the	_
266-21	48366-48374	deficits	_
266-22	48375-48377	in	_
266-23	48378-48391	schizophrenia	_
266-24	48392-48394	in	_
266-25	48395-48398	the	_
266-26	48399-48410	application	_
266-27	48411-48413	of	_
266-28	48414-48424	meaningful	_
266-29	48425-48432	context	_
266-30	48433-48435	to	_
266-31	48436-48446	facilitate	_
266-32	48447-48450	the	_
266-33	48451-48461	processing	_
266-34	48462-48464	of	_
266-35	48465-48472	related	_
266-36	48473-48484	information	_
266-37	48484-48485	.	_

#Text=These studies have found larger than normal N400 amplitudes related to contextually linked meanings and/or lower than normal N400 related to priming effects.
267-1	48486-48491	These	_
267-2	48492-48499	studies	_
267-3	48500-48504	have	_
267-4	48505-48510	found	_
267-5	48511-48517	larger	_
267-6	48518-48522	than	_
267-7	48523-48529	normal	_
267-8	48530-48534	N400	_
267-9	48535-48545	amplitudes	_
267-10	48546-48553	related	_
267-11	48554-48556	to	_
267-12	48557-48569	contextually	_
267-13	48570-48576	linked	_
267-14	48577-48585	meanings	_
267-15	48586-48589	and	_
267-16	48589-48590	/	_
267-17	48590-48592	or	_
267-18	48593-48598	lower	_
267-19	48599-48603	than	_
267-20	48604-48610	normal	_
267-21	48611-48615	N400	_
267-22	48616-48623	related	_
267-23	48624-48626	to	_
267-24	48627-48634	priming	_
267-25	48635-48642	effects	_
267-26	48642-48643	.	_

#Text=The findings in these studies correlated with the deficits in the degree to which meaningful stimuli (e.g., words or sentence contexts) activated the related concepts.
268-1	48644-48647	The	_
268-2	48648-48656	findings	_
268-3	48657-48659	in	_
268-4	48660-48665	these	_
268-5	48666-48673	studies	_
268-6	48674-48684	correlated	_
268-7	48685-48689	with	_
268-8	48690-48693	the	_
268-9	48694-48702	deficits	_
268-10	48703-48705	in	_
268-11	48706-48709	the	_
268-12	48710-48716	degree	_
268-13	48717-48719	to	_
268-14	48720-48725	which	_
268-15	48726-48736	meaningful	_
268-16	48737-48744	stimuli	_
268-17	48745-48746	(	_
268-18	48746-48749	e.g	_
268-19	48749-48750	.	_
268-20	48750-48751	,	_
268-21	48752-48757	words	_
268-22	48758-48760	or	_
268-23	48761-48769	sentence	_
268-24	48770-48778	contexts	_
268-25	48778-48779	)	_
268-26	48780-48789	activated	_
268-27	48790-48793	the	_
268-28	48794-48801	related	_
268-29	48802-48810	concepts	_
268-30	48810-48811	.	_

#Text=Intermediate effect of response coherency in siblings
#Text=It is noteworthy that siblings are also impaired in neural indications for long time scale processing, albeit to a lesser extent than patients with schizophrenia.
269-1	48812-48824	Intermediate	_
269-2	48825-48831	effect	_
269-3	48832-48834	of	_
269-4	48835-48843	response	_
269-5	48844-48853	coherency	_
269-6	48854-48856	in	_
269-7	48857-48865	siblings	_
269-8	48866-48868	It	_
269-9	48869-48871	is	_
269-10	48872-48882	noteworthy	_
269-11	48883-48887	that	_
269-12	48888-48896	siblings	_
269-13	48897-48900	are	_
269-14	48901-48905	also	_
269-15	48906-48914	impaired	_
269-16	48915-48917	in	_
269-17	48918-48924	neural	_
269-18	48925-48936	indications	_
269-19	48937-48940	for	_
269-20	48941-48945	long	_
269-21	48946-48950	time	_
269-22	48951-48956	scale	_
269-23	48957-48967	processing	_
269-24	48967-48968	,	_
269-25	48969-48975	albeit	_
269-26	48976-48978	to	_
269-27	48979-48980	a	_
269-28	48981-48987	lesser	_
269-29	48988-48994	extent	_
269-30	48995-48999	than	_
269-31	49000-49008	patients	_
269-32	49009-49013	with	_
269-33	49014-49027	schizophrenia	_
269-34	49027-49028	.	_

#Text=In siblings with a genetic risk of developing schizophrenia, we found intermediate effects between those of patients and controls: correlation coefficients were significantly lower in siblings than in controls in all examined ROIs, excluding A1+, a primary sensory cortex.
270-1	49029-49031	In	_
270-2	49032-49040	siblings	_
270-3	49041-49045	with	_
270-4	49046-49047	a	_
270-5	49048-49055	genetic	_
270-6	49056-49060	risk	_
270-7	49061-49063	of	_
270-8	49064-49074	developing	_
270-9	49075-49088	schizophrenia	_
270-10	49088-49089	,	_
270-11	49090-49092	we	_
270-12	49093-49098	found	_
270-13	49099-49111	intermediate	_
270-14	49112-49119	effects	_
270-15	49120-49127	between	_
270-16	49128-49133	those	_
270-17	49134-49136	of	_
270-18	49137-49145	patients	_
270-19	49146-49149	and	_
270-20	49150-49158	controls	_
270-21	49158-49159	:	_
270-22	49160-49171	correlation	_
270-23	49172-49184	coefficients	_
270-24	49185-49189	were	_
270-25	49190-49203	significantly	_
270-26	49204-49209	lower	_
270-27	49210-49212	in	_
270-28	49213-49221	siblings	_
270-29	49222-49226	than	_
270-30	49227-49229	in	_
270-31	49230-49238	controls	_
270-32	49239-49241	in	_
270-33	49242-49245	all	_
270-34	49246-49254	examined	_
270-35	49255-49259	ROIs	_
270-36	49259-49260	,	_
270-37	49261-49270	excluding	_
270-38	49271-49273	A1	_
270-39	49273-49274	+	_
270-40	49274-49275	,	_
270-41	49276-49277	a	_
270-42	49278-49285	primary	_
270-43	49286-49293	sensory	_
270-44	49294-49300	cortex	_
270-45	49300-49301	.	_

#Text=These findings are in accord with previous reports of cognitive deficits and regional brain volume abnormalities in biological relatives of patients with schizophrenia.
271-1	49302-49307	These	_
271-2	49308-49316	findings	_
271-3	49317-49320	are	_
271-4	49321-49323	in	_
271-5	49324-49330	accord	_
271-6	49331-49335	with	_
271-7	49336-49344	previous	_
271-8	49345-49352	reports	_
271-9	49353-49355	of	_
271-10	49356-49365	cognitive	_
271-11	49366-49374	deficits	_
271-12	49375-49378	and	_
271-13	49379-49387	regional	_
271-14	49388-49393	brain	_
271-15	49394-49400	volume	_
271-16	49401-49414	abnormalities	_
271-17	49415-49417	in	_
271-18	49418-49428	biological	_
271-19	49429-49438	relatives	_
271-20	49439-49441	of	_
271-21	49442-49450	patients	_
271-22	49451-49455	with	_
271-23	49456-49469	schizophrenia	_
271-24	49469-49470	.	_

#Text=Generally, findings in the first-degree relatives indicated slight impairment, much less than in patients, in various cognitive tasks, including working memory, attention, language-related tasks and facial expression recognition.
272-1	49471-49480	Generally	_
272-2	49480-49481	,	_
272-3	49482-49490	findings	_
272-4	49491-49493	in	_
272-5	49494-49497	the	_
272-6	49498-49510	first-degree	_
272-7	49511-49520	relatives	_
272-8	49521-49530	indicated	_
272-9	49531-49537	slight	_
272-10	49538-49548	impairment	_
272-11	49548-49549	,	_
272-12	49550-49554	much	_
272-13	49555-49559	less	_
272-14	49560-49564	than	_
272-15	49565-49567	in	_
272-16	49568-49576	patients	_
272-17	49576-49577	,	_
272-18	49578-49580	in	_
272-19	49581-49588	various	_
272-20	49589-49598	cognitive	_
272-21	49599-49604	tasks	_
272-22	49604-49605	,	_
272-23	49606-49615	including	_
272-24	49616-49623	working	_
272-25	49624-49630	memory	_
272-26	49630-49631	,	_
272-27	49632-49641	attention	_
272-28	49641-49642	,	_
272-29	49643-49659	language-related	_
272-30	49660-49665	tasks	_
272-31	49666-49669	and	_
272-32	49670-49676	facial	_
272-33	49677-49687	expression	_
272-34	49688-49699	recognition	_
272-35	49699-49700	.	_

#Text=No deficits were found however in executive function or antisaccade performance in individuals at high risk of developing schizophrenia.
273-1	49701-49703	No	_
273-2	49704-49712	deficits	_
273-3	49713-49717	were	_
273-4	49718-49723	found	_
273-5	49724-49731	however	_
273-6	49732-49734	in	_
273-7	49735-49744	executive	_
273-8	49745-49753	function	_
273-9	49754-49756	or	_
273-10	49757-49768	antisaccade	_
273-11	49769-49780	performance	_
273-12	49781-49783	in	_
273-13	49784-49795	individuals	_
273-14	49796-49798	at	_
273-15	49799-49803	high	_
273-16	49804-49808	risk	_
273-17	49809-49811	of	_
273-18	49812-49822	developing	_
273-19	49823-49836	schizophrenia	_
273-20	49836-49837	.	_

#Text=Taken together, the small but significant deviations in inter-SCs in siblings compared with healthy controls could be interpreted as reflecting siblings' genetic liability to develop schizophrenia.
274-1	49838-49843	Taken	_
274-2	49844-49852	together	_
274-3	49852-49853	,	_
274-4	49854-49857	the	_
274-5	49858-49863	small	_
274-6	49864-49867	but	_
274-7	49868-49879	significant	_
274-8	49880-49890	deviations	_
274-9	49891-49893	in	_
274-10	49894-49903	inter-SCs	_
274-11	49904-49906	in	_
274-12	49907-49915	siblings	_
274-13	49916-49924	compared	_
274-14	49925-49929	with	_
274-15	49930-49937	healthy	_
274-16	49938-49946	controls	_
274-17	49947-49952	could	_
274-18	49953-49955	be	_
274-19	49956-49967	interpreted	_
274-20	49968-49970	as	_
274-21	49971-49981	reflecting	_
274-22	49982-49990	siblings	_
274-23	49990-49991	'	_
274-24	49992-49999	genetic	_
274-25	50000-50009	liability	_
274-26	50010-50012	to	_
274-27	50013-50020	develop	_
274-28	50021-50034	schizophrenia	_
274-29	50034-50035	.	_

#Text=These deficits may serve as a trait marker in the study of the etiology and pathophysiology of the disease.
275-1	50036-50041	These	_
275-2	50042-50050	deficits	_
275-3	50051-50054	may	_
275-4	50055-50060	serve	_
275-5	50061-50063	as	_
275-6	50064-50065	a	_
275-7	50066-50071	trait	_
275-8	50072-50078	marker	_
275-9	50079-50081	in	_
275-10	50082-50085	the	_
275-11	50086-50091	study	_
275-12	50092-50094	of	_
275-13	50095-50098	the	_
275-14	50099-50107	etiology	_
275-15	50108-50111	and	_
275-16	50112-50127	pathophysiology	_
275-17	50128-50130	of	_
275-18	50131-50134	the	_
275-19	50135-50142	disease	_
275-20	50142-50143	.	_

#Text=Limitations and future studies
#Text=We encountered a number of limitations in the study.
276-1	50144-50155	Limitations	_
276-2	50156-50159	and	_
276-3	50160-50166	future	_
276-4	50167-50174	studies	_
276-5	50175-50177	We	_
276-6	50178-50189	encountered	_
276-7	50190-50191	a	_
276-8	50192-50198	number	_
276-9	50199-50201	of	_
276-10	50202-50213	limitations	_
276-11	50214-50216	in	_
276-12	50217-50220	the	_
276-13	50221-50226	study	_
276-14	50226-50227	.	_

#Text=First, although the selected groups were suitable for the questions being investigated and the methodological approach, the study sample was relatively small.
277-1	50228-50233	First	_
277-2	50233-50234	,	_
277-3	50235-50243	although	_
277-4	50244-50247	the	_
277-5	50248-50256	selected	_
277-6	50257-50263	groups	_
277-7	50264-50268	were	_
277-8	50269-50277	suitable	_
277-9	50278-50281	for	_
277-10	50282-50285	the	_
277-11	50286-50295	questions	_
277-12	50296-50301	being	_
277-13	50302-50314	investigated	_
277-14	50315-50318	and	_
277-15	50319-50322	the	_
277-16	50323-50337	methodological	_
277-17	50338-50346	approach	_
277-18	50346-50347	,	_
277-19	50348-50351	the	_
277-20	50352-50357	study	_
277-21	50358-50364	sample	_
277-22	50365-50368	was	_
277-23	50369-50379	relatively	_
277-24	50380-50385	small	_
277-25	50385-50386	.	_

#Text=In particular, males were overrepresented in the group of patients.
278-1	50387-50389	In	_
278-2	50390-50400	particular	_
278-3	50400-50401	,	_
278-4	50402-50407	males	_
278-5	50408-50412	were	_
278-6	50413-50428	overrepresented	_
278-7	50429-50431	in	_
278-8	50432-50435	the	_
278-9	50436-50441	group	_
278-10	50442-50444	of	_
278-11	50445-50453	patients	_
278-12	50453-50454	.	_

#Text=While no sex effect was found in the healthy participants (the main group and the group used for the ROI definition, N = 27, 14F), it could be that gender has some effect on story processing in patients with schizophrenia.
279-1	50455-50460	While	_
279-2	50461-50463	no	_
279-3	50464-50467	sex	_
279-4	50468-50474	effect	_
279-5	50475-50478	was	_
279-6	50479-50484	found	_
279-7	50485-50487	in	_
279-8	50488-50491	the	_
279-9	50492-50499	healthy	_
279-10	50500-50512	participants	_
279-11	50513-50514	(	_
279-12	50514-50517	the	_
279-13	50518-50522	main	_
279-14	50523-50528	group	_
279-15	50529-50532	and	_
279-16	50533-50536	the	_
279-17	50537-50542	group	_
279-18	50543-50547	used	_
279-19	50548-50551	for	_
279-20	50552-50555	the	_
279-21	50556-50559	ROI	_
279-22	50560-50570	definition	_
279-23	50570-50571	,	_
279-24	50572-50573	N	_
279-25	50573-50574	 	_
279-26	50574-50575	=	_
279-27	50575-50576	 	_
279-28	50576-50578	27	_
279-29	50578-50579	,	_
279-30	50580-50583	14F	_
279-31	50583-50584	)	_
279-32	50584-50585	,	_
279-33	50586-50588	it	_
279-34	50589-50594	could	_
279-35	50595-50597	be	_
279-36	50598-50602	that	_
279-37	50603-50609	gender	_
279-38	50610-50613	has	_
279-39	50614-50618	some	_
279-40	50619-50625	effect	_
279-41	50626-50628	on	_
279-42	50629-50634	story	_
279-43	50635-50645	processing	_
279-44	50646-50648	in	_
279-45	50649-50657	patients	_
279-46	50658-50662	with	_
279-47	50663-50676	schizophrenia	_
279-48	50676-50677	.	_

#Text=To verify that gender ratio difference between groups did not have an impact on our results we took out one random male from the “patients” group for several times and repeated our analyses.
280-1	50678-50680	To	_
280-2	50681-50687	verify	_
280-3	50688-50692	that	_
280-4	50693-50699	gender	_
280-5	50700-50705	ratio	_
280-6	50706-50716	difference	_
280-7	50717-50724	between	_
280-8	50725-50731	groups	_
280-9	50732-50735	did	_
280-10	50736-50739	not	_
280-11	50740-50744	have	_
280-12	50745-50747	an	_
280-13	50748-50754	impact	_
280-14	50755-50757	on	_
280-15	50758-50761	our	_
280-16	50762-50769	results	_
280-17	50770-50772	we	_
280-18	50773-50777	took	_
280-19	50778-50781	out	_
280-20	50782-50785	one	_
280-21	50786-50792	random	_
280-22	50793-50797	male	_
280-23	50798-50802	from	_
280-24	50803-50806	the	_
280-25	50807-50808	“	_
280-26	50808-50816	patients	_
280-27	50816-50817	”	_
280-28	50818-50823	group	_
280-29	50824-50827	for	_
280-30	50828-50835	several	_
280-31	50836-50841	times	_
280-32	50842-50845	and	_
280-33	50846-50854	repeated	_
280-34	50855-50858	our	_
280-35	50859-50867	analyses	_
280-36	50867-50868	.	_

#Text=No significant differences between new groups were found.
281-1	50869-50871	No	_
281-2	50872-50883	significant	_
281-3	50884-50895	differences	_
281-4	50896-50903	between	_
281-5	50904-50907	new	_
281-6	50908-50914	groups	_
281-7	50915-50919	were	_
281-8	50920-50925	found	_
281-9	50925-50926	.	_

#Text=However, taking into account that previous studies have revealed the sex-related differences in brain functioning and clinical outcome in schizophrenia, similar investigations in this clinical population but with a larger group and equal number of male and female participants are required.
282-1	50927-50934	However	_
282-2	50934-50935	,	_
282-3	50936-50942	taking	_
282-4	50943-50947	into	_
282-5	50948-50955	account	_
282-6	50956-50960	that	_
282-7	50961-50969	previous	_
282-8	50970-50977	studies	_
282-9	50978-50982	have	_
282-10	50983-50991	revealed	_
282-11	50992-50995	the	_
282-12	50996-51007	sex-related	_
282-13	51008-51019	differences	_
282-14	51020-51022	in	_
282-15	51023-51028	brain	_
282-16	51029-51040	functioning	_
282-17	51041-51044	and	_
282-18	51045-51053	clinical	_
282-19	51054-51061	outcome	_
282-20	51062-51064	in	_
282-21	51065-51078	schizophrenia	_
282-22	51078-51079	,	_
282-23	51080-51087	similar	_
282-24	51088-51102	investigations	_
282-25	51103-51105	in	_
282-26	51106-51110	this	_
282-27	51111-51119	clinical	_
282-28	51120-51130	population	_
282-29	51131-51134	but	_
282-30	51135-51139	with	_
282-31	51140-51141	a	_
282-32	51142-51148	larger	_
282-33	51149-51154	group	_
282-34	51155-51158	and	_
282-35	51159-51164	equal	_
282-36	51165-51171	number	_
282-37	51172-51174	of	_
282-38	51175-51179	male	_
282-39	51180-51183	and	_
282-40	51184-51190	female	_
282-41	51191-51203	participants	_
282-42	51204-51207	are	_
282-43	51208-51216	required	_
282-44	51216-51217	.	_

#Text=Second, the current results should be interpreted with caution in light of specific language abilities and bilingualism of the participants.
283-1	51218-51224	Second	_
283-2	51224-51225	,	_
283-3	51226-51229	the	_
283-4	51230-51237	current	_
283-5	51238-51245	results	_
283-6	51246-51252	should	_
283-7	51253-51255	be	_
283-8	51256-51267	interpreted	_
283-9	51268-51272	with	_
283-10	51273-51280	caution	_
283-11	51281-51283	in	_
283-12	51284-51289	light	_
283-13	51290-51292	of	_
283-14	51293-51301	specific	_
283-15	51302-51310	language	_
283-16	51311-51320	abilities	_
283-17	51321-51324	and	_
283-18	51325-51337	bilingualism	_
283-19	51338-51340	of	_
283-20	51341-51344	the	_
283-21	51345-51357	participants	_
283-22	51357-51358	.	_

#Text=Although similar responses to a narrative have been previously found within monolingual and bilingual healthy participants, specific language abilities of patients with schizophrenia may account for the outcome.
284-1	51359-51367	Although	_
284-2	51368-51375	similar	_
284-3	51376-51385	responses	_
284-4	51386-51388	to	_
284-5	51389-51390	a	_
284-6	51391-51400	narrative	_
284-7	51401-51405	have	_
284-8	51406-51410	been	_
284-9	51411-51421	previously	_
284-10	51422-51427	found	_
284-11	51428-51434	within	_
284-12	51435-51446	monolingual	_
284-13	51447-51450	and	_
284-14	51451-51460	bilingual	_
284-15	51461-51468	healthy	_
284-16	51469-51481	participants	_
284-17	51481-51482	,	_
284-18	51483-51491	specific	_
284-19	51492-51500	language	_
284-20	51501-51510	abilities	_
284-21	51511-51513	of	_
284-22	51514-51522	patients	_
284-23	51523-51527	with	_
284-24	51528-51541	schizophrenia	_
284-25	51542-51545	may	_
284-26	51546-51553	account	_
284-27	51554-51557	for	_
284-28	51558-51561	the	_
284-29	51562-51569	outcome	_
284-30	51569-51570	.	_

#Text=Our tests within the mono-lingual and bi-lingual sub-groups of the patients revealed very similar topography.
285-1	51571-51574	Our	_
285-2	51575-51580	tests	_
285-3	51581-51587	within	_
285-4	51588-51591	the	_
285-5	51592-51604	mono-lingual	_
285-6	51605-51608	and	_
285-7	51609-51619	bi-lingual	_
285-8	51620-51630	sub-groups	_
285-9	51631-51633	of	_
285-10	51634-51637	the	_
285-11	51638-51646	patients	_
285-12	51647-51655	revealed	_
285-13	51656-51660	very	_
285-14	51661-51668	similar	_
285-15	51669-51679	topography	_
285-16	51679-51680	.	_

#Text=However, these sub-groups were too small to draw strong conclusions and further detailed comparisons of multilingual and monolingual patients should be performed.
286-1	51681-51688	However	_
286-2	51688-51689	,	_
286-3	51690-51695	these	_
286-4	51696-51706	sub-groups	_
286-5	51707-51711	were	_
286-6	51712-51715	too	_
286-7	51716-51721	small	_
286-8	51722-51724	to	_
286-9	51725-51729	draw	_
286-10	51730-51736	strong	_
286-11	51737-51748	conclusions	_
286-12	51749-51752	and	_
286-13	51753-51760	further	_
286-14	51761-51769	detailed	_
286-15	51770-51781	comparisons	_
286-16	51782-51784	of	_
286-17	51785-51797	multilingual	_
286-18	51798-51801	and	_
286-19	51802-51813	monolingual	_
286-20	51814-51822	patients	_
286-21	51823-51829	should	_
286-22	51830-51832	be	_
286-23	51833-51842	performed	_
286-24	51842-51843	.	_

#Text=Next, although all patients were stable, it is important to remember that they were neuroleptically naïve, and thus, are vulnerable to experience non-specific side-effects from the medications.
287-1	51844-51848	Next	_
287-2	51848-51849	,	_
287-3	51850-51858	although	_
287-4	51859-51862	all	_
287-5	51863-51871	patients	_
287-6	51872-51876	were	_
287-7	51877-51883	stable	_
287-8	51883-51884	,	_
287-9	51885-51887	it	_
287-10	51888-51890	is	_
287-11	51891-51900	important	_
287-12	51901-51903	to	_
287-13	51904-51912	remember	_
287-14	51913-51917	that	_
287-15	51918-51922	they	_
287-16	51923-51927	were	_
287-17	51928-51943	neuroleptically	_
287-18	51944-51949	naïve	_
287-19	51949-51950	,	_
287-20	51951-51954	and	_
287-21	51955-51959	thus	_
287-22	51959-51960	,	_
287-23	51961-51964	are	_
287-24	51965-51975	vulnerable	_
287-25	51976-51978	to	_
287-26	51979-51989	experience	_
287-27	51990-52002	non-specific	_
287-28	52003-52015	side-effects	_
287-29	52016-52020	from	_
287-30	52021-52024	the	_
287-31	52025-52036	medications	_
287-32	52036-52037	.	_

#Text=This could be remedied by follow-up studies replicating the research at more advanced stages of treatment.
288-1	52038-52042	This	_
288-2	52043-52048	could	_
288-3	52049-52051	be	_
288-4	52052-52060	remedied	_
288-5	52061-52063	by	_
288-6	52064-52073	follow-up	_
288-7	52074-52081	studies	_
288-8	52082-52093	replicating	_
288-9	52094-52097	the	_
288-10	52098-52106	research	_
288-11	52107-52109	at	_
288-12	52110-52114	more	_
288-13	52115-52123	advanced	_
288-14	52124-52130	stages	_
288-15	52131-52133	of	_
288-16	52134-52143	treatment	_
288-17	52143-52144	.	_

#Text=Finally, findings in this study make it tempting to interpret the results as evidence for idiosyncratic responses in schizophrenia.
289-1	52145-52152	Finally	_
289-2	52152-52153	,	_
289-3	52154-52162	findings	_
289-4	52163-52165	in	_
289-5	52166-52170	this	_
289-6	52171-52176	study	_
289-7	52177-52181	make	_
289-8	52182-52184	it	_
289-9	52185-52193	tempting	_
289-10	52194-52196	to	_
289-11	52197-52206	interpret	_
289-12	52207-52210	the	_
289-13	52211-52218	results	_
289-14	52219-52221	as	_
289-15	52222-52230	evidence	_
289-16	52231-52234	for	_
289-17	52235-52248	idiosyncratic	_
289-18	52249-52258	responses	_
289-19	52259-52261	in	_
289-20	52262-52275	schizophrenia	_
289-21	52275-52276	.	_

#Text=And yet, the current design, using inter-SC approach only, did not allow for direct investigation of the issue, as the prolonged stimuli used in the study make it challenging to probe the differences in subjective use of context.
290-1	52277-52280	And	_
290-2	52281-52284	yet	_
290-3	52284-52285	,	_
290-4	52286-52289	the	_
290-5	52290-52297	current	_
290-6	52298-52304	design	_
290-7	52304-52305	,	_
290-8	52306-52311	using	_
290-9	52312-52320	inter-SC	_
290-10	52321-52329	approach	_
290-11	52330-52334	only	_
290-12	52334-52335	,	_
290-13	52336-52339	did	_
290-14	52340-52343	not	_
290-15	52344-52349	allow	_
290-16	52350-52353	for	_
290-17	52354-52360	direct	_
290-18	52361-52374	investigation	_
290-19	52375-52377	of	_
290-20	52378-52381	the	_
290-21	52382-52387	issue	_
290-22	52387-52388	,	_
290-23	52389-52391	as	_
290-24	52392-52395	the	_
290-25	52396-52405	prolonged	_
290-26	52406-52413	stimuli	_
290-27	52414-52418	used	_
290-28	52419-52421	in	_
290-29	52422-52425	the	_
290-30	52426-52431	study	_
290-31	52432-52436	make	_
290-32	52437-52439	it	_
290-33	52440-52451	challenging	_
290-34	52452-52454	to	_
290-35	52455-52460	probe	_
290-36	52461-52464	the	_
290-37	52465-52476	differences	_
290-38	52477-52479	in	_
290-39	52480-52490	subjective	_
290-40	52491-52494	use	_
290-41	52495-52497	of	_
290-42	52498-52505	context	_
290-43	52505-52506	.	_

#Text=Future studies can directly investigate whether the reduced synchrony in responses within the schizophrenic group is a result of a consistent but unique approach employed by each individual with schizophrenia.
291-1	52507-52513	Future	_
291-2	52514-52521	studies	_
291-3	52522-52525	can	_
291-4	52526-52534	directly	_
291-5	52535-52546	investigate	_
291-6	52547-52554	whether	_
291-7	52555-52558	the	_
291-8	52559-52566	reduced	_
291-9	52567-52576	synchrony	_
291-10	52577-52579	in	_
291-11	52580-52589	responses	_
291-12	52590-52596	within	_
291-13	52597-52600	the	_
291-14	52601-52614	schizophrenic	_
291-15	52615-52620	group	_
291-16	52621-52623	is	_
291-17	52624-52625	a	_
291-18	52626-52632	result	_
291-19	52633-52635	of	_
291-20	52636-52637	a	_
291-21	52638-52648	consistent	_
291-22	52649-52652	but	_
291-23	52653-52659	unique	_
291-24	52660-52668	approach	_
291-25	52669-52677	employed	_
291-26	52678-52680	by	_
291-27	52681-52685	each	_
291-28	52686-52696	individual	_
291-29	52697-52701	with	_
291-30	52702-52715	schizophrenia	_
291-31	52715-52716	.	_

#Text=To that end, the presentation of each stimulus should be repeated and the intra (within)-SC should be evaluated.
292-1	52717-52719	To	_
292-2	52720-52724	that	_
292-3	52725-52728	end	_
292-4	52728-52729	,	_
292-5	52730-52733	the	_
292-6	52734-52746	presentation	_
292-7	52747-52749	of	_
292-8	52750-52754	each	_
292-9	52755-52763	stimulus	_
292-10	52764-52770	should	_
292-11	52771-52773	be	_
292-12	52774-52782	repeated	_
292-13	52783-52786	and	_
292-14	52787-52790	the	_
292-15	52791-52796	intra	_
292-16	52797-52798	(	_
292-17	52798-52804	within	_
292-18	52804-52805	)	_
292-19	52805-52806	-	_
292-20	52806-52808	SC	_
292-21	52809-52815	should	_
292-22	52816-52818	be	_
292-23	52819-52828	evaluated	_
292-24	52828-52829	.	_

#Text=Conclusion
#Text=In summary, we employed an inter-SC approach to examine different levels of verbal information processing in schizophrenia.
293-1	52830-52840	Conclusion	_
293-2	52841-52843	In	_
293-3	52844-52851	summary	_
293-4	52851-52852	,	_
293-5	52853-52855	we	_
293-6	52856-52864	employed	_
293-7	52865-52867	an	_
293-8	52868-52876	inter-SC	_
293-9	52877-52885	approach	_
293-10	52886-52888	to	_
293-11	52889-52896	examine	_
293-12	52897-52906	different	_
293-13	52907-52913	levels	_
293-14	52914-52916	of	_
293-15	52917-52923	verbal	_
293-16	52924-52935	information	_
293-17	52936-52946	processing	_
293-18	52947-52949	in	_
293-19	52950-52963	schizophrenia	_
293-20	52963-52964	.	_

#Text=We documented both standard and distinctive patterns of cortical responses in patients and their siblings.
294-1	52965-52967	We	_
294-2	52968-52978	documented	_
294-3	52979-52983	both	_
294-4	52984-52992	standard	_
294-5	52993-52996	and	_
294-6	52997-53008	distinctive	_
294-7	53009-53017	patterns	_
294-8	53018-53020	of	_
294-9	53021-53029	cortical	_
294-10	53030-53039	responses	_
294-11	53040-53042	in	_
294-12	53043-53051	patients	_
294-13	53052-53055	and	_
294-14	53056-53061	their	_
294-15	53062-53070	siblings	_
294-16	53070-53071	.	_

#Text=Our study exhibited a substantial lack of coherency of neural responses in most high-order perceptual and cognitive areas in patients with schizophrenia during story presentation, despite the fact that patients understood the plot of the story.
295-1	53072-53075	Our	_
295-2	53076-53081	study	_
295-3	53082-53091	exhibited	_
295-4	53092-53093	a	_
295-5	53094-53105	substantial	_
295-6	53106-53110	lack	_
295-7	53111-53113	of	_
295-8	53114-53123	coherency	_
295-9	53124-53126	of	_
295-10	53127-53133	neural	_
295-11	53134-53143	responses	_
295-12	53144-53146	in	_
295-13	53147-53151	most	_
295-14	53152-53162	high-order	_
295-15	53163-53173	perceptual	_
295-16	53174-53177	and	_
295-17	53178-53187	cognitive	_
295-18	53188-53193	areas	_
295-19	53194-53196	in	_
295-20	53197-53205	patients	_
295-21	53206-53210	with	_
295-22	53211-53224	schizophrenia	_
295-23	53225-53231	during	_
295-24	53232-53237	story	_
295-25	53238-53250	presentation	_
295-26	53250-53251	,	_
295-27	53252-53259	despite	_
295-28	53260-53263	the	_
295-29	53264-53268	fact	_
295-30	53269-53273	that	_
295-31	53274-53282	patients	_
295-32	53283-53293	understood	_
295-33	53294-53297	the	_
295-34	53298-53302	plot	_
295-35	53303-53305	of	_
295-36	53306-53309	the	_
295-37	53310-53315	story	_
295-38	53315-53316	.	_

#Text=These findings point to the possibility that idiosyncratic neural profiles underlie the processing of complex dynamic stimuli in schizophrenia.
296-1	53317-53322	These	_
296-2	53323-53331	findings	_
296-3	53332-53337	point	_
296-4	53338-53340	to	_
296-5	53341-53344	the	_
296-6	53345-53356	possibility	_
296-7	53357-53361	that	_
296-8	53362-53375	idiosyncratic	_
296-9	53376-53382	neural	_
296-10	53383-53391	profiles	_
296-11	53392-53400	underlie	_
296-12	53401-53404	the	_
296-13	53405-53415	processing	_
296-14	53416-53418	of	_
296-15	53419-53426	complex	_
296-16	53427-53434	dynamic	_
296-17	53435-53442	stimuli	_
296-18	53443-53445	in	_
296-19	53446-53459	schizophrenia	_
296-20	53459-53460	.	_

#Text=We note that our methodology has great potential to characterize the neural dynamics underlying naturalistic conditions in individuals with schizophrenia, as reflected by its ability to distinguish between patients and healthy participants.
297-1	53461-53463	We	_
297-2	53464-53468	note	_
297-3	53469-53473	that	_
297-4	53474-53477	our	_
297-5	53478-53489	methodology	_
297-6	53490-53493	has	_
297-7	53494-53499	great	_
297-8	53500-53509	potential	_
297-9	53510-53512	to	_
297-10	53513-53525	characterize	_
297-11	53526-53529	the	_
297-12	53530-53536	neural	_
297-13	53537-53545	dynamics	_
297-14	53546-53556	underlying	_
297-15	53557-53569	naturalistic	_
297-16	53570-53580	conditions	_
297-17	53581-53583	in	_
297-18	53584-53595	individuals	_
297-19	53596-53600	with	_
297-20	53601-53614	schizophrenia	_
297-21	53614-53615	,	_
297-22	53616-53618	as	_
297-23	53619-53628	reflected	_
297-24	53629-53631	by	_
297-25	53632-53635	its	_
297-26	53636-53643	ability	_
297-27	53644-53646	to	_
297-28	53647-53658	distinguish	_
297-29	53659-53666	between	_
297-30	53667-53675	patients	_
297-31	53676-53679	and	_
297-32	53680-53687	healthy	_
297-33	53688-53700	participants	_
297-34	53700-53701	.	_

#Text=Overall, better understanding of the underlying neural circuitry involved in verbal information processing in patients with schizophrenia may assist in early identification of predisposition to the disease and possibly guide preventive functional brain training.
298-1	53702-53709	Overall	_
298-2	53709-53710	,	_
298-3	53711-53717	better	_
298-4	53718-53731	understanding	_
298-5	53732-53734	of	_
298-6	53735-53738	the	_
298-7	53739-53749	underlying	_
298-8	53750-53756	neural	_
298-9	53757-53766	circuitry	_
298-10	53767-53775	involved	_
298-11	53776-53778	in	_
298-12	53779-53785	verbal	_
298-13	53786-53797	information	_
298-14	53798-53808	processing	_
298-15	53809-53811	in	_
298-16	53812-53820	patients	_
298-17	53821-53825	with	_
298-18	53826-53839	schizophrenia	_
298-19	53840-53843	may	_
298-20	53844-53850	assist	_
298-21	53851-53853	in	_
298-22	53854-53859	early	_
298-23	53860-53874	identification	_
298-24	53875-53877	of	_
298-25	53878-53892	predisposition	_
298-26	53893-53895	to	_
298-27	53896-53899	the	_
298-28	53900-53907	disease	_
298-29	53908-53911	and	_
298-30	53912-53920	possibly	_
298-31	53921-53926	guide	_
298-32	53927-53937	preventive	_
298-33	53938-53948	functional	_
298-34	53949-53954	brain	_
298-35	53955-53963	training	_
298-36	53963-53964	.	_

#Text=The following are the supplementary data related to this article.
299-1	53965-53968	The	_
299-2	53969-53978	following	_
299-3	53979-53982	are	_
299-4	53983-53986	the	_
299-5	53987-54000	supplementary	_
299-6	54001-54005	data	_
299-7	54006-54013	related	_
299-8	54014-54016	to	_
299-9	54017-54021	this	_
299-10	54022-54029	article	_
299-11	54029-54030	.	_

#Text=References
#Text=Neural circuit of verbal humor comprehension in schizophrenia - an fMRI study
#Text=The computational anatomy of psychosis
#Text=Emotion recognition in unaffected first-degree relatives of individuals with first-episode schizophrenia
#Text=Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms
#Text=Spontaneous repetitive thoughts can be adaptive: postscript on "mind wandering"
#Text=Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?
300-1	54031-54041	References	_
300-2	54042-54048	Neural	_
300-3	54049-54056	circuit	_
300-4	54057-54059	of	_
300-5	54060-54066	verbal	_
300-6	54067-54072	humor	_
300-7	54073-54086	comprehension	_
300-8	54087-54089	in	_
300-9	54090-54103	schizophrenia	_
300-10	54104-54105	-	_
300-11	54106-54108	an	_
300-12	54109-54113	fMRI	_
300-13	54114-54119	study	_
300-14	54120-54123	The	_
300-15	54124-54137	computational	_
300-16	54138-54145	anatomy	_
300-17	54146-54148	of	_
300-18	54149-54158	psychosis	_
300-19	54159-54166	Emotion	_
300-20	54167-54178	recognition	_
300-21	54179-54181	in	_
300-22	54182-54192	unaffected	_
300-23	54193-54205	first-degree	_
300-24	54206-54215	relatives	_
300-25	54216-54218	of	_
300-26	54219-54230	individuals	_
300-27	54231-54235	with	_
300-28	54236-54249	first-episode	_
300-29	54250-54263	schizophrenia	_
300-30	54264-54272	Defining	_
300-31	54273-54276	the	_
300-32	54277-54286	phenotype	_
300-33	54287-54289	of	_
300-34	54290-54303	schizophrenia	_
300-35	54303-54304	:	_
300-36	54305-54314	cognitive	_
300-37	54315-54324	dysmetria	_
300-38	54325-54328	and	_
300-39	54329-54332	its	_
300-40	54333-54339	neural	_
300-41	54340-54350	mechanisms	_
300-42	54351-54362	Spontaneous	_
300-43	54363-54373	repetitive	_
300-44	54374-54382	thoughts	_
300-45	54383-54386	can	_
300-46	54387-54389	be	_
300-47	54390-54398	adaptive	_
300-48	54398-54399	:	_
300-49	54400-54410	postscript	_
300-50	54411-54413	on	_
300-51	54414-54415	"	_
300-52	54415-54419	mind	_
300-53	54420-54429	wandering	_
300-54	54429-54430	"	_
300-55	54431-54445	Neurocognitive	_
300-56	54446-54457	functioning	_
300-57	54458-54464	before	_
300-58	54465-54468	and	_
300-59	54469-54474	after	_
300-60	54475-54478	the	_
300-61	54479-54484	first	_
300-62	54485-54494	psychotic	_
300-63	54495-54502	episode	_
300-64	54502-54503	:	_
300-65	54504-54508	does	_
300-66	54509-54518	psychosis	_
300-67	54519-54525	result	_
300-68	54526-54528	in	_
300-69	54529-54538	cognitive	_
300-70	54539-54552	deterioration	_
300-71	54552-54553	?	_

#Text=Classifying individuals at high-risk for psychosis based on functional brain activity during working memory processing
#Text=The control of the false discovery rate in multiple testing under dependency
#Text=Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder – a systematic review of the magnetic resonance neuroimaging literature
#Text=Never resting region–mPFC in schizophrenia
#Text=Does discourse congruence influence spoken language comprehension before lexical association?
301-1	54554-54565	Classifying	_
301-2	54566-54577	individuals	_
301-3	54578-54580	at	_
301-4	54581-54590	high-risk	_
301-5	54591-54594	for	_
301-6	54595-54604	psychosis	_
301-7	54605-54610	based	_
301-8	54611-54613	on	_
301-9	54614-54624	functional	_
301-10	54625-54630	brain	_
301-11	54631-54639	activity	_
301-12	54640-54646	during	_
301-13	54647-54654	working	_
301-14	54655-54661	memory	_
301-15	54662-54672	processing	_
301-16	54673-54676	The	_
301-17	54677-54684	control	_
301-18	54685-54687	of	_
301-19	54688-54691	the	_
301-20	54692-54697	false	_
301-21	54698-54707	discovery	_
301-22	54708-54712	rate	_
301-23	54713-54715	in	_
301-24	54716-54724	multiple	_
301-25	54725-54732	testing	_
301-26	54733-54738	under	_
301-27	54739-54749	dependency	_
301-28	54750-54755	Brain	_
301-29	54756-54765	structure	_
301-30	54765-54766	,	_
301-31	54767-54775	function	_
301-32	54775-54776	,	_
301-33	54777-54780	and	_
301-34	54781-54795	neurochemistry	_
301-35	54796-54798	in	_
301-36	54799-54812	schizophrenia	_
301-37	54813-54816	and	_
301-38	54817-54824	bipolar	_
301-39	54825-54833	disorder	_
301-40	54834-54835	–	_
301-41	54836-54837	a	_
301-42	54838-54848	systematic	_
301-43	54849-54855	review	_
301-44	54856-54858	of	_
301-45	54859-54862	the	_
301-46	54863-54871	magnetic	_
301-47	54872-54881	resonance	_
301-48	54882-54894	neuroimaging	_
301-49	54895-54905	literature	_
301-50	54906-54911	Never	_
301-51	54912-54919	resting	_
301-52	54920-54931	region–mPFC	_
301-53	54932-54934	in	_
301-54	54935-54948	schizophrenia	_
301-55	54949-54953	Does	_
301-56	54954-54963	discourse	_
301-57	54964-54974	congruence	_
301-58	54975-54984	influence	_
301-59	54985-54991	spoken	_
301-60	54992-55000	language	_
301-61	55001-55014	comprehension	_
301-62	55015-55021	before	_
301-63	55022-55029	lexical	_
301-64	55030-55041	association	_
301-65	55041-55042	?	_

#Text=Evidence from event-related potentials
#Text=Neuropsychological profile of cognitively impaired patients with schizophrenia
#Text=A hierarchical generative framework of language processing: linking language perception, interpretation, and production abnormalities in schizophrenia
#Text=Antisaccade performance is abnormal in schizophrenia patients but not in their biological relatives
#Text=Altered functional subnetwork during emotional face processing: a potential intermediate phenotype for schizophrenia
#Text=Attention and visual orienting in siblings, schizophrenic patients, and controls: impairment in attentional disengagement
#Text=Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks
#Text=Effects of word frequency on semantic memory in schizophrenia: electrophysiological evidence for a deficit in linguistic access
#Text=The time course of building discourse coherence in schizophrenia: an ERP investigation
#Text=Slow and steady: sustained effects of lexico-semantic associations can mediate referential impairments in schizophrenia
#Text=Relative risk of attention deficits in siblings of patients with schizophrenia
#Text=Relative risk for cognitive impairments in siblings of patients with schizophrenia
#Text=
#Text=Review of functional and anatomical brain connectivity findings in schizophrenia
#Text=Schizophrenia, neuroimaging and connectomics
#Text=The disconnection hypothesis
#Text=Theory of mind and language comprehension in schizophrenia: poor mindreading affects figurative language comprehension beyond intelligence deficits
#Text=Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia
#Text=Extrinsic and intrinsic systems in the posterior cortex of the human brain revealed during natural sensory stimulation
#Text=Towards a neuroscience of mind-wandering
#Text=A hierarchy of temporal receptive windows in human cortex
#Text=Reliability of cortical activity during natural stimulation
#Text=Hierarchical process memory: memory as an integral component of information processing
#Text=Not lost in translation: neural responses shared across languages
#Text=An incongruent reality: the N400 in relation to psychosis and recovery
#Text=Disturbed sexual dimorphism of brain activation during mental rotation in schizophrenia
#Text=The positive and negative syndrome scale (PANSS) for schizophrenia
#Text=Electrophysiological evidence for primary semantic memory functional organization deficits in schizophrenia
#Text=Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk
#Text=Schizophrenia is a disorder of higher order hierarchical processing
#Text=Language in schizophrenia part 1: an introduction
#Text=Functional magnetic resonance imaging reveals neuroanatomical dissociations during semantic integration in schizophrenia
#Text=Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression
#Text=Sex-specific patterns of aberrant brain function in first-episode treatment-naive patients with schizophrenia
#Text=Topographic mapping of a hierarchy of temporal receptive windows using a narrated story
#Text=Left fronto-temporal dysconnectivity within the language network in schizophrenia: an fMRI and DTI study
#Text=Disturbed functional connectivity of cortical activation during semantic discrimination in patients with schizophrenia and subjects at genetic high-risk
#Text=A visual joke fMRI investigation into theory of mind and enhanced risk of schizophrenia
#Text=The role of the precuneus in metaphor comprehension: evidence from an fMRI study in people with schizophrenia and healthy participants
#Text=Correlations between sadness-induced cerebral activations and schizophrenia symptoms: an fmri study of sex differences
#Text=N400 in schizophrenia patients
#Text=Are there progressive brain changes in schizophrenia?
302-1	55043-55051	Evidence	_
302-2	55052-55056	from	_
302-3	55057-55070	event-related	_
302-4	55071-55081	potentials	_
302-5	55082-55100	Neuropsychological	_
302-6	55101-55108	profile	_
302-7	55109-55111	of	_
302-8	55112-55123	cognitively	_
302-9	55124-55132	impaired	_
302-10	55133-55141	patients	_
302-11	55142-55146	with	_
302-12	55147-55160	schizophrenia	_
302-13	55161-55162	A	_
302-14	55163-55175	hierarchical	_
302-15	55176-55186	generative	_
302-16	55187-55196	framework	_
302-17	55197-55199	of	_
302-18	55200-55208	language	_
302-19	55209-55219	processing	_
302-20	55219-55220	:	_
302-21	55221-55228	linking	_
302-22	55229-55237	language	_
302-23	55238-55248	perception	_
302-24	55248-55249	,	_
302-25	55250-55264	interpretation	_
302-26	55264-55265	,	_
302-27	55266-55269	and	_
302-28	55270-55280	production	_
302-29	55281-55294	abnormalities	_
302-30	55295-55297	in	_
302-31	55298-55311	schizophrenia	_
302-32	55312-55323	Antisaccade	_
302-33	55324-55335	performance	_
302-34	55336-55338	is	_
302-35	55339-55347	abnormal	_
302-36	55348-55350	in	_
302-37	55351-55364	schizophrenia	_
302-38	55365-55373	patients	_
302-39	55374-55377	but	_
302-40	55378-55381	not	_
302-41	55382-55384	in	_
302-42	55385-55390	their	_
302-43	55391-55401	biological	_
302-44	55402-55411	relatives	_
302-45	55412-55419	Altered	_
302-46	55420-55430	functional	_
302-47	55431-55441	subnetwork	_
302-48	55442-55448	during	_
302-49	55449-55458	emotional	_
302-50	55459-55463	face	_
302-51	55464-55474	processing	_
302-52	55474-55475	:	_
302-53	55476-55477	a	_
302-54	55478-55487	potential	_
302-55	55488-55500	intermediate	_
302-56	55501-55510	phenotype	_
302-57	55511-55514	for	_
302-58	55515-55528	schizophrenia	_
302-59	55529-55538	Attention	_
302-60	55539-55542	and	_
302-61	55543-55549	visual	_
302-62	55550-55559	orienting	_
302-63	55560-55562	in	_
302-64	55563-55571	siblings	_
302-65	55571-55572	,	_
302-66	55573-55586	schizophrenic	_
302-67	55587-55595	patients	_
302-68	55595-55596	,	_
302-69	55597-55600	and	_
302-70	55601-55609	controls	_
302-71	55609-55610	:	_
302-72	55611-55621	impairment	_
302-73	55622-55624	in	_
302-74	55625-55636	attentional	_
302-75	55637-55650	disengagement	_
302-76	55651-55669	Context-processing	_
302-77	55670-55678	deficits	_
302-78	55679-55681	in	_
302-79	55682-55695	schizophrenia	_
302-80	55695-55696	:	_
302-81	55697-55707	converging	_
302-82	55708-55716	evidence	_
302-83	55717-55721	from	_
302-84	55722-55727	three	_
302-85	55728-55741	theoretically	_
302-86	55742-55751	motivated	_
302-87	55752-55761	cognitive	_
302-88	55762-55767	tasks	_
302-89	55768-55775	Effects	_
302-90	55776-55778	of	_
302-91	55779-55783	word	_
302-92	55784-55793	frequency	_
302-93	55794-55796	on	_
302-94	55797-55805	semantic	_
302-95	55806-55812	memory	_
302-96	55813-55815	in	_
302-97	55816-55829	schizophrenia	_
302-98	55829-55830	:	_
302-99	55831-55851	electrophysiological	_
302-100	55852-55860	evidence	_
302-101	55861-55864	for	_
302-102	55865-55866	a	_
302-103	55867-55874	deficit	_
302-104	55875-55877	in	_
302-105	55878-55888	linguistic	_
302-106	55889-55895	access	_
302-107	55896-55899	The	_
302-108	55900-55904	time	_
302-109	55905-55911	course	_
302-110	55912-55914	of	_
302-111	55915-55923	building	_
302-112	55924-55933	discourse	_
302-113	55934-55943	coherence	_
302-114	55944-55946	in	_
302-115	55947-55960	schizophrenia	_
302-116	55960-55961	:	_
302-117	55962-55964	an	_
302-118	55965-55968	ERP	_
302-119	55969-55982	investigation	_
302-120	55983-55987	Slow	_
302-121	55988-55991	and	_
302-122	55992-55998	steady	_
302-123	55998-55999	:	_
302-124	56000-56009	sustained	_
302-125	56010-56017	effects	_
302-126	56018-56020	of	_
302-127	56021-56036	lexico-semantic	_
302-128	56037-56049	associations	_
302-129	56050-56053	can	_
302-130	56054-56061	mediate	_
302-131	56062-56073	referential	_
302-132	56074-56085	impairments	_
302-133	56086-56088	in	_
302-134	56089-56102	schizophrenia	_
302-135	56103-56111	Relative	_
302-136	56112-56116	risk	_
302-137	56117-56119	of	_
302-138	56120-56129	attention	_
302-139	56130-56138	deficits	_
302-140	56139-56141	in	_
302-141	56142-56150	siblings	_
302-142	56151-56153	of	_
302-143	56154-56162	patients	_
302-144	56163-56167	with	_
302-145	56168-56181	schizophrenia	_
302-146	56182-56190	Relative	_
302-147	56191-56195	risk	_
302-148	56196-56199	for	_
302-149	56200-56209	cognitive	_
302-150	56210-56221	impairments	_
302-151	56222-56224	in	_
302-152	56225-56233	siblings	_
302-153	56234-56236	of	_
302-154	56237-56245	patients	_
302-155	56246-56250	with	_
302-156	56251-56264	schizophrenia	_
302-157	56266-56272	Review	_
302-158	56273-56275	of	_
302-159	56276-56286	functional	_
302-160	56287-56290	and	_
302-161	56291-56301	anatomical	_
302-162	56302-56307	brain	_
302-163	56308-56320	connectivity	_
302-164	56321-56329	findings	_
302-165	56330-56332	in	_
302-166	56333-56346	schizophrenia	_
302-167	56347-56360	Schizophrenia	_
302-168	56360-56361	,	_
302-169	56362-56374	neuroimaging	_
302-170	56375-56378	and	_
302-171	56379-56391	connectomics	_
302-172	56392-56395	The	_
302-173	56396-56409	disconnection	_
302-174	56410-56420	hypothesis	_
302-175	56421-56427	Theory	_
302-176	56428-56430	of	_
302-177	56431-56435	mind	_
302-178	56436-56439	and	_
302-179	56440-56448	language	_
302-180	56449-56462	comprehension	_
302-181	56463-56465	in	_
302-182	56466-56479	schizophrenia	_
302-183	56479-56480	:	_
302-184	56481-56485	poor	_
302-185	56486-56497	mindreading	_
302-186	56498-56505	affects	_
302-187	56506-56516	figurative	_
302-188	56517-56525	language	_
302-189	56526-56539	comprehension	_
302-190	56540-56546	beyond	_
302-191	56547-56559	intelligence	_
302-192	56560-56568	deficits	_
302-193	56569-56577	Cortical	_
302-194	56578-56583	brain	_
302-195	56584-56595	development	_
302-196	56596-56598	in	_
302-197	56599-56611	nonpsychotic	_
302-198	56612-56620	siblings	_
302-199	56621-56623	of	_
302-200	56624-56632	patients	_
302-201	56633-56637	with	_
302-202	56638-56653	childhood-onset	_
302-203	56654-56667	schizophrenia	_
302-204	56668-56677	Extrinsic	_
302-205	56678-56681	and	_
302-206	56682-56691	intrinsic	_
302-207	56692-56699	systems	_
302-208	56700-56702	in	_
302-209	56703-56706	the	_
302-210	56707-56716	posterior	_
302-211	56717-56723	cortex	_
302-212	56724-56726	of	_
302-213	56727-56730	the	_
302-214	56731-56736	human	_
302-215	56737-56742	brain	_
302-216	56743-56751	revealed	_
302-217	56752-56758	during	_
302-218	56759-56766	natural	_
302-219	56767-56774	sensory	_
302-220	56775-56786	stimulation	_
302-221	56787-56794	Towards	_
302-222	56795-56796	a	_
302-223	56797-56809	neuroscience	_
302-224	56810-56812	of	_
302-225	56813-56827	mind-wandering	_
302-226	56828-56829	A	_
302-227	56830-56839	hierarchy	_
302-228	56840-56842	of	_
302-229	56843-56851	temporal	_
302-230	56852-56861	receptive	_
302-231	56862-56869	windows	_
302-232	56870-56872	in	_
302-233	56873-56878	human	_
302-234	56879-56885	cortex	_
302-235	56886-56897	Reliability	_
302-236	56898-56900	of	_
302-237	56901-56909	cortical	_
302-238	56910-56918	activity	_
302-239	56919-56925	during	_
302-240	56926-56933	natural	_
302-241	56934-56945	stimulation	_
302-242	56946-56958	Hierarchical	_
302-243	56959-56966	process	_
302-244	56967-56973	memory	_
302-245	56973-56974	:	_
302-246	56975-56981	memory	_
302-247	56982-56984	as	_
302-248	56985-56987	an	_
302-249	56988-56996	integral	_
302-250	56997-57006	component	_
302-251	57007-57009	of	_
302-252	57010-57021	information	_
302-253	57022-57032	processing	_
302-254	57033-57036	Not	_
302-255	57037-57041	lost	_
302-256	57042-57044	in	_
302-257	57045-57056	translation	_
302-258	57056-57057	:	_
302-259	57058-57064	neural	_
302-260	57065-57074	responses	_
302-261	57075-57081	shared	_
302-262	57082-57088	across	_
302-263	57089-57098	languages	_
302-264	57099-57101	An	_
302-265	57102-57113	incongruent	_
302-266	57114-57121	reality	_
302-267	57121-57122	:	_
302-268	57123-57126	the	_
302-269	57127-57131	N400	_
302-270	57132-57134	in	_
302-271	57135-57143	relation	_
302-272	57144-57146	to	_
302-273	57147-57156	psychosis	_
302-274	57157-57160	and	_
302-275	57161-57169	recovery	_
302-276	57170-57179	Disturbed	_
302-277	57180-57186	sexual	_
302-278	57187-57197	dimorphism	_
302-279	57198-57200	of	_
302-280	57201-57206	brain	_
302-281	57207-57217	activation	_
302-282	57218-57224	during	_
302-283	57225-57231	mental	_
302-284	57232-57240	rotation	_
302-285	57241-57243	in	_
302-286	57244-57257	schizophrenia	_
302-287	57258-57261	The	_
302-288	57262-57270	positive	_
302-289	57271-57274	and	_
302-290	57275-57283	negative	_
302-291	57284-57292	syndrome	_
302-292	57293-57298	scale	_
302-293	57299-57300	(	_
302-294	57300-57305	PANSS	_
302-295	57305-57306	)	_
302-296	57307-57310	for	_
302-297	57311-57324	schizophrenia	_
302-298	57325-57345	Electrophysiological	_
302-299	57346-57354	evidence	_
302-300	57355-57358	for	_
302-301	57359-57366	primary	_
302-302	57367-57375	semantic	_
302-303	57376-57382	memory	_
302-304	57383-57393	functional	_
302-305	57394-57406	organization	_
302-306	57407-57415	deficits	_
302-307	57416-57418	in	_
302-308	57419-57432	schizophrenia	_
302-309	57433-57439	Social	_
302-310	57440-57449	cognition	_
302-311	57450-57453	and	_
302-312	57454-57468	neurocognition	_
302-313	57469-57471	as	_
302-314	57472-57482	predictors	_
302-315	57483-57485	of	_
302-316	57486-57496	conversion	_
302-317	57497-57499	to	_
302-318	57500-57509	psychosis	_
302-319	57510-57512	in	_
302-320	57513-57524	individuals	_
302-321	57525-57527	at	_
302-322	57528-57538	ultra-high	_
302-323	57539-57543	risk	_
302-324	57544-57557	Schizophrenia	_
302-325	57558-57560	is	_
302-326	57561-57562	a	_
302-327	57563-57571	disorder	_
302-328	57572-57574	of	_
302-329	57575-57581	higher	_
302-330	57582-57587	order	_
302-331	57588-57600	hierarchical	_
302-332	57601-57611	processing	_
302-333	57612-57620	Language	_
302-334	57621-57623	in	_
302-335	57624-57637	schizophrenia	_
302-336	57638-57642	part	_
302-337	57643-57644	1	_
302-338	57644-57645	:	_
302-339	57646-57648	an	_
302-340	57649-57661	introduction	_
302-341	57662-57672	Functional	_
302-342	57673-57681	magnetic	_
302-343	57682-57691	resonance	_
302-344	57692-57699	imaging	_
302-345	57700-57707	reveals	_
302-346	57708-57723	neuroanatomical	_
302-347	57724-57737	dissociations	_
302-348	57738-57744	during	_
302-349	57745-57753	semantic	_
302-350	57754-57765	integration	_
302-351	57766-57768	in	_
302-352	57769-57782	schizophrenia	_
302-353	57783-57796	Morphological	_
302-354	57797-57807	correlates	_
302-355	57808-57810	to	_
302-356	57811-57820	cognitive	_
302-357	57821-57832	dysfunction	_
302-358	57833-57835	in	_
302-359	57836-57849	schizophrenia	_
302-360	57850-57852	as	_
302-361	57853-57860	studied	_
302-362	57861-57865	with	_
302-363	57866-57874	Bayesian	_
302-364	57875-57885	regression	_
302-365	57886-57898	Sex-specific	_
302-366	57899-57907	patterns	_
302-367	57908-57910	of	_
302-368	57911-57919	aberrant	_
302-369	57920-57925	brain	_
302-370	57926-57934	function	_
302-371	57935-57937	in	_
302-372	57938-57951	first-episode	_
302-373	57952-57967	treatment-naive	_
302-374	57968-57976	patients	_
302-375	57977-57981	with	_
302-376	57982-57995	schizophrenia	_
302-377	57996-58007	Topographic	_
302-378	58008-58015	mapping	_
302-379	58016-58018	of	_
302-380	58019-58020	a	_
302-381	58021-58030	hierarchy	_
302-382	58031-58033	of	_
302-383	58034-58042	temporal	_
302-384	58043-58052	receptive	_
302-385	58053-58060	windows	_
302-386	58061-58066	using	_
302-387	58067-58068	a	_
302-388	58069-58077	narrated	_
302-389	58078-58083	story	_
302-390	58084-58088	Left	_
302-391	58089-58104	fronto-temporal	_
302-392	58105-58120	dysconnectivity	_
302-393	58121-58127	within	_
302-394	58128-58131	the	_
302-395	58132-58140	language	_
302-396	58141-58148	network	_
302-397	58149-58151	in	_
302-398	58152-58165	schizophrenia	_
302-399	58165-58166	:	_
302-400	58167-58169	an	_
302-401	58170-58174	fMRI	_
302-402	58175-58178	and	_
302-403	58179-58182	DTI	_
302-404	58183-58188	study	_
302-405	58189-58198	Disturbed	_
302-406	58199-58209	functional	_
302-407	58210-58222	connectivity	_
302-408	58223-58225	of	_
302-409	58226-58234	cortical	_
302-410	58235-58245	activation	_
302-411	58246-58252	during	_
302-412	58253-58261	semantic	_
302-413	58262-58276	discrimination	_
302-414	58277-58279	in	_
302-415	58280-58288	patients	_
302-416	58289-58293	with	_
302-417	58294-58307	schizophrenia	_
302-418	58308-58311	and	_
302-419	58312-58320	subjects	_
302-420	58321-58323	at	_
302-421	58324-58331	genetic	_
302-422	58332-58341	high-risk	_
302-423	58342-58343	A	_
302-424	58344-58350	visual	_
302-425	58351-58355	joke	_
302-426	58356-58360	fMRI	_
302-427	58361-58374	investigation	_
302-428	58375-58379	into	_
302-429	58380-58386	theory	_
302-430	58387-58389	of	_
302-431	58390-58394	mind	_
302-432	58395-58398	and	_
302-433	58399-58407	enhanced	_
302-434	58408-58412	risk	_
302-435	58413-58415	of	_
302-436	58416-58429	schizophrenia	_
302-437	58430-58433	The	_
302-438	58434-58438	role	_
302-439	58439-58441	of	_
302-440	58442-58445	the	_
302-441	58446-58455	precuneus	_
302-442	58456-58458	in	_
302-443	58459-58467	metaphor	_
302-444	58468-58481	comprehension	_
302-445	58481-58482	:	_
302-446	58483-58491	evidence	_
302-447	58492-58496	from	_
302-448	58497-58499	an	_
302-449	58500-58504	fMRI	_
302-450	58505-58510	study	_
302-451	58511-58513	in	_
302-452	58514-58520	people	_
302-453	58521-58525	with	_
302-454	58526-58539	schizophrenia	_
302-455	58540-58543	and	_
302-456	58544-58551	healthy	_
302-457	58552-58564	participants	_
302-458	58565-58577	Correlations	_
302-459	58578-58585	between	_
302-460	58586-58601	sadness-induced	_
302-461	58602-58610	cerebral	_
302-462	58611-58622	activations	_
302-463	58623-58626	and	_
302-464	58627-58640	schizophrenia	_
302-465	58641-58649	symptoms	_
302-466	58649-58650	:	_
302-467	58651-58653	an	_
302-468	58654-58658	fmri	_
302-469	58659-58664	study	_
302-470	58665-58667	of	_
302-471	58668-58671	sex	_
302-472	58672-58683	differences	_
302-473	58684-58688	N400	_
302-474	58689-58691	in	_
302-475	58692-58705	schizophrenia	_
302-476	58706-58714	patients	_
302-477	58715-58718	Are	_
302-478	58719-58724	there	_
302-479	58725-58736	progressive	_
302-480	58737-58742	brain	_
302-481	58743-58750	changes	_
302-482	58751-58753	in	_
302-483	58754-58767	schizophrenia	_
302-484	58767-58768	?	_

#Text=A meta-analysis of structural magnetic resonance imaging studies
#Text=The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders
#Text=Is the concept of frontal-subcortical dementia relevant to schizophrenia?
303-1	58769-58770	A	_
303-2	58771-58784	meta-analysis	_
303-3	58785-58787	of	_
303-4	58788-58798	structural	_
303-5	58799-58807	magnetic	_
303-6	58808-58817	resonance	_
303-7	58818-58825	imaging	_
303-8	58826-58833	studies	_
303-9	58834-58837	The	_
303-10	58838-58847	cognitive	_
303-11	58848-58864	neuropsychiatric	_
303-12	58865-58873	approach	_
303-13	58874-58876	to	_
303-14	58877-58890	investigating	_
303-15	58891-58894	the	_
303-16	58895-58907	neurobiology	_
303-17	58908-58910	of	_
303-18	58911-58924	schizophrenia	_
303-19	58925-58928	and	_
303-20	58929-58934	other	_
303-21	58935-58944	disorders	_
303-22	58945-58947	Is	_
303-23	58948-58951	the	_
303-24	58952-58959	concept	_
303-25	58960-58962	of	_
303-26	58963-58982	frontal-subcortical	_
303-27	58983-58991	dementia	_
303-28	58992-59000	relevant	_
303-29	59001-59003	to	_
303-30	59004-59017	schizophrenia	_
303-31	59017-59018	?	_

#Text=Cognitive correlates of frontoparietal network connectivity 'at rest' in individuals with differential risk for psychotic disorder
#Text=Linguistic production and syntactic comprehension in schizophrenia and bipolar disorder
#Text=Is the comprehension of idiomatic sentences indeed impaired in paranoid schizophrenia?
304-1	59019-59028	Cognitive	_
304-2	59029-59039	correlates	_
304-3	59040-59042	of	_
304-4	59043-59057	frontoparietal	_
304-5	59058-59065	network	_
304-6	59066-59078	connectivity	_
304-7	59079-59080	'	_
304-8	59080-59082	at	_
304-9	59083-59087	rest	_
304-10	59087-59088	'	_
304-11	59089-59091	in	_
304-12	59092-59103	individuals	_
304-13	59104-59108	with	_
304-14	59109-59121	differential	_
304-15	59122-59126	risk	_
304-16	59127-59130	for	_
304-17	59131-59140	psychotic	_
304-18	59141-59149	disorder	_
304-19	59150-59160	Linguistic	_
304-20	59161-59171	production	_
304-21	59172-59175	and	_
304-22	59176-59185	syntactic	_
304-23	59186-59199	comprehension	_
304-24	59200-59202	in	_
304-25	59203-59216	schizophrenia	_
304-26	59217-59220	and	_
304-27	59221-59228	bipolar	_
304-28	59229-59237	disorder	_
304-29	59238-59240	Is	_
304-30	59241-59244	the	_
304-31	59245-59258	comprehension	_
304-32	59259-59261	of	_
304-33	59262-59271	idiomatic	_
304-34	59272-59281	sentences	_
304-35	59282-59288	indeed	_
304-36	59289-59297	impaired	_
304-37	59298-59300	in	_
304-38	59301-59309	paranoid	_
304-39	59310-59323	schizophrenia	_
304-40	59323-59324	?	_

#Text=A window into semantic processing deficits
#Text=Reduced activation of superior temporal gyrus during auditory comprehension in young offspring of patients with schizophrenia
#Text=Precuneus functioning differentiates first-episode psychosis patients during the fantasy movie Alice in wonderland
#Text=Schizophrenia and abnormal brain network hubs
#Text=Differential alteration of automatic semantic processing in treated patients affected by bipolar mania and schizophrenia: an N400 study
#Text=N400 to lexical ambiguity and semantic incongruity in schizophrenia
#Text=Abnormal N400 responses but intact differential hemispheric processing of ambiguity in schizophrenia
#Text=Altered DLPFC-hippocampus connectivity during working memory: independent replication and disorder specificity of a putative genetic risk phenotype for schizophrenia
#Text=Structural neuroimaging in schizophrenia: from methods to insights to treatments
#Text=Thought disorder and verbal recall in acutely psychotic patients
#Text=Similar patterns of brain activation abnormalities during emotional and non-emotional judgments of faces in a schizophrenia family study
#Text=Neural correlates of ongoing conscious experience: both task-unrelatedness and stimulus-independence are related to default network activity
#Text=Psychophysiology of language processes in psychopathology: an overview of the special issue
#Text=Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring
#Text=Thought insertion as a self-disturbance: an integration of predictive coding and phenomenological approaches
#Text=No deficit in Wisconsin card sorting test performance of schizophrenic patients' first-degree relatives
#Text=Spared and impaired spoken discourse processing in schizophrenia: effects of local and global language context
#Text=
#Text=Characterising receptive language processing in schizophrenia using word and sentence tasks
#Text=Idiom processing in schizophrenia: literal implausibility saves the day for idiom priming
#Text=Episodic memory in schizophrenic patients and their relatives
#Text=Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia
#Text=Cognitive correlates of gray matter abnormalities in adolescent siblings of patients with childhood-onset schizophrenia
#Text=Putative sex differences in verbal abilities and language cortex: a critical review
#Text=Semantic processing disturbance in patients with schizophrenia: a meta-analysis of the N400 component
#Text=Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins
#Text=Working memory in unaffected relatives of patients with schizophrenia: a meta-analysis of functional magnetic resonance imaging studies
305-1	59325-59326	A	_
305-2	59327-59333	window	_
305-3	59334-59338	into	_
305-4	59339-59347	semantic	_
305-5	59348-59358	processing	_
305-6	59359-59367	deficits	_
305-7	59368-59375	Reduced	_
305-8	59376-59386	activation	_
305-9	59387-59389	of	_
305-10	59390-59398	superior	_
305-11	59399-59407	temporal	_
305-12	59408-59413	gyrus	_
305-13	59414-59420	during	_
305-14	59421-59429	auditory	_
305-15	59430-59443	comprehension	_
305-16	59444-59446	in	_
305-17	59447-59452	young	_
305-18	59453-59462	offspring	_
305-19	59463-59465	of	_
305-20	59466-59474	patients	_
305-21	59475-59479	with	_
305-22	59480-59493	schizophrenia	_
305-23	59494-59503	Precuneus	_
305-24	59504-59515	functioning	_
305-25	59516-59530	differentiates	_
305-26	59531-59544	first-episode	_
305-27	59545-59554	psychosis	_
305-28	59555-59563	patients	_
305-29	59564-59570	during	_
305-30	59571-59574	the	_
305-31	59575-59582	fantasy	_
305-32	59583-59588	movie	_
305-33	59589-59594	Alice	_
305-34	59595-59597	in	_
305-35	59598-59608	wonderland	_
305-36	59609-59622	Schizophrenia	_
305-37	59623-59626	and	_
305-38	59627-59635	abnormal	_
305-39	59636-59641	brain	_
305-40	59642-59649	network	_
305-41	59650-59654	hubs	_
305-42	59655-59667	Differential	_
305-43	59668-59678	alteration	_
305-44	59679-59681	of	_
305-45	59682-59691	automatic	_
305-46	59692-59700	semantic	_
305-47	59701-59711	processing	_
305-48	59712-59714	in	_
305-49	59715-59722	treated	_
305-50	59723-59731	patients	_
305-51	59732-59740	affected	_
305-52	59741-59743	by	_
305-53	59744-59751	bipolar	_
305-54	59752-59757	mania	_
305-55	59758-59761	and	_
305-56	59762-59775	schizophrenia	_
305-57	59775-59776	:	_
305-58	59777-59779	an	_
305-59	59780-59784	N400	_
305-60	59785-59790	study	_
305-61	59791-59795	N400	_
305-62	59796-59798	to	_
305-63	59799-59806	lexical	_
305-64	59807-59816	ambiguity	_
305-65	59817-59820	and	_
305-66	59821-59829	semantic	_
305-67	59830-59841	incongruity	_
305-68	59842-59844	in	_
305-69	59845-59858	schizophrenia	_
305-70	59859-59867	Abnormal	_
305-71	59868-59872	N400	_
305-72	59873-59882	responses	_
305-73	59883-59886	but	_
305-74	59887-59893	intact	_
305-75	59894-59906	differential	_
305-76	59907-59918	hemispheric	_
305-77	59919-59929	processing	_
305-78	59930-59932	of	_
305-79	59933-59942	ambiguity	_
305-80	59943-59945	in	_
305-81	59946-59959	schizophrenia	_
305-82	59960-59967	Altered	_
305-83	59968-59985	DLPFC-hippocampus	_
305-84	59986-59998	connectivity	_
305-85	59999-60005	during	_
305-86	60006-60013	working	_
305-87	60014-60020	memory	_
305-88	60020-60021	:	_
305-89	60022-60033	independent	_
305-90	60034-60045	replication	_
305-91	60046-60049	and	_
305-92	60050-60058	disorder	_
305-93	60059-60070	specificity	_
305-94	60071-60073	of	_
305-95	60074-60075	a	_
305-96	60076-60084	putative	_
305-97	60085-60092	genetic	_
305-98	60093-60097	risk	_
305-99	60098-60107	phenotype	_
305-100	60108-60111	for	_
305-101	60112-60125	schizophrenia	_
305-102	60126-60136	Structural	_
305-103	60137-60149	neuroimaging	_
305-104	60150-60152	in	_
305-105	60153-60166	schizophrenia	_
305-106	60166-60167	:	_
305-107	60168-60172	from	_
305-108	60173-60180	methods	_
305-109	60181-60183	to	_
305-110	60184-60192	insights	_
305-111	60193-60195	to	_
305-112	60196-60206	treatments	_
305-113	60207-60214	Thought	_
305-114	60215-60223	disorder	_
305-115	60224-60227	and	_
305-116	60228-60234	verbal	_
305-117	60235-60241	recall	_
305-118	60242-60244	in	_
305-119	60245-60252	acutely	_
305-120	60253-60262	psychotic	_
305-121	60263-60271	patients	_
305-122	60272-60279	Similar	_
305-123	60280-60288	patterns	_
305-124	60289-60291	of	_
305-125	60292-60297	brain	_
305-126	60298-60308	activation	_
305-127	60309-60322	abnormalities	_
305-128	60323-60329	during	_
305-129	60330-60339	emotional	_
305-130	60340-60343	and	_
305-131	60344-60357	non-emotional	_
305-132	60358-60367	judgments	_
305-133	60368-60370	of	_
305-134	60371-60376	faces	_
305-135	60377-60379	in	_
305-136	60380-60381	a	_
305-137	60382-60395	schizophrenia	_
305-138	60396-60402	family	_
305-139	60403-60408	study	_
305-140	60409-60415	Neural	_
305-141	60416-60426	correlates	_
305-142	60427-60429	of	_
305-143	60430-60437	ongoing	_
305-144	60438-60447	conscious	_
305-145	60448-60458	experience	_
305-146	60458-60459	:	_
305-147	60460-60464	both	_
305-148	60465-60483	task-unrelatedness	_
305-149	60484-60487	and	_
305-150	60488-60509	stimulus-independence	_
305-151	60510-60513	are	_
305-152	60514-60521	related	_
305-153	60522-60524	to	_
305-154	60525-60532	default	_
305-155	60533-60540	network	_
305-156	60541-60549	activity	_
305-157	60550-60566	Psychophysiology	_
305-158	60567-60569	of	_
305-159	60570-60578	language	_
305-160	60579-60588	processes	_
305-161	60589-60591	in	_
305-162	60592-60607	psychopathology	_
305-163	60607-60608	:	_
305-164	60609-60611	an	_
305-165	60612-60620	overview	_
305-166	60621-60623	of	_
305-167	60624-60627	the	_
305-168	60628-60635	special	_
305-169	60636-60641	issue	_
305-170	60642-60655	Dysconnection	_
305-171	60656-60658	in	_
305-172	60659-60672	schizophrenia	_
305-173	60672-60673	:	_
305-174	60674-60678	from	_
305-175	60679-60687	abnormal	_
305-176	60688-60696	synaptic	_
305-177	60697-60707	plasticity	_
305-178	60708-60710	to	_
305-179	60711-60719	failures	_
305-180	60720-60722	of	_
305-181	60723-60738	self-monitoring	_
305-182	60739-60746	Thought	_
305-183	60747-60756	insertion	_
305-184	60757-60759	as	_
305-185	60760-60761	a	_
305-186	60762-60778	self-disturbance	_
305-187	60778-60779	:	_
305-188	60780-60782	an	_
305-189	60783-60794	integration	_
305-190	60795-60797	of	_
305-191	60798-60808	predictive	_
305-192	60809-60815	coding	_
305-193	60816-60819	and	_
305-194	60820-60836	phenomenological	_
305-195	60837-60847	approaches	_
305-196	60848-60850	No	_
305-197	60851-60858	deficit	_
305-198	60859-60861	in	_
305-199	60862-60871	Wisconsin	_
305-200	60872-60876	card	_
305-201	60877-60884	sorting	_
305-202	60885-60889	test	_
305-203	60890-60901	performance	_
305-204	60902-60904	of	_
305-205	60905-60918	schizophrenic	_
305-206	60919-60927	patients	_
305-207	60927-60928	'	_
305-208	60929-60941	first-degree	_
305-209	60942-60951	relatives	_
305-210	60952-60958	Spared	_
305-211	60959-60962	and	_
305-212	60963-60971	impaired	_
305-213	60972-60978	spoken	_
305-214	60979-60988	discourse	_
305-215	60989-60999	processing	_
305-216	61000-61002	in	_
305-217	61003-61016	schizophrenia	_
305-218	61016-61017	:	_
305-219	61018-61025	effects	_
305-220	61026-61028	of	_
305-221	61029-61034	local	_
305-222	61035-61038	and	_
305-223	61039-61045	global	_
305-224	61046-61054	language	_
305-225	61055-61062	context	_
305-226	61064-61078	Characterising	_
305-227	61079-61088	receptive	_
305-228	61089-61097	language	_
305-229	61098-61108	processing	_
305-230	61109-61111	in	_
305-231	61112-61125	schizophrenia	_
305-232	61126-61131	using	_
305-233	61132-61136	word	_
305-234	61137-61140	and	_
305-235	61141-61149	sentence	_
305-236	61150-61155	tasks	_
305-237	61156-61161	Idiom	_
305-238	61162-61172	processing	_
305-239	61173-61175	in	_
305-240	61176-61189	schizophrenia	_
305-241	61189-61190	:	_
305-242	61191-61198	literal	_
305-243	61199-61213	implausibility	_
305-244	61214-61219	saves	_
305-245	61220-61223	the	_
305-246	61224-61227	day	_
305-247	61228-61231	for	_
305-248	61232-61237	idiom	_
305-249	61238-61245	priming	_
305-250	61246-61254	Episodic	_
305-251	61255-61261	memory	_
305-252	61262-61264	in	_
305-253	61265-61278	schizophrenic	_
305-254	61279-61287	patients	_
305-255	61288-61291	and	_
305-256	61292-61297	their	_
305-257	61298-61307	relatives	_
305-258	61308-61323	Dysconnectivity	_
305-259	61323-61324	,	_
305-260	61325-61336	large-scale	_
305-261	61337-61345	networks	_
305-262	61346-61349	and	_
305-263	61350-61358	neuronal	_
305-264	61359-61367	dynamics	_
305-265	61368-61370	in	_
305-266	61371-61384	schizophrenia	_
305-267	61385-61394	Cognitive	_
305-268	61395-61405	correlates	_
305-269	61406-61408	of	_
305-270	61409-61413	gray	_
305-271	61414-61420	matter	_
305-272	61421-61434	abnormalities	_
305-273	61435-61437	in	_
305-274	61438-61448	adolescent	_
305-275	61449-61457	siblings	_
305-276	61458-61460	of	_
305-277	61461-61469	patients	_
305-278	61470-61474	with	_
305-279	61475-61490	childhood-onset	_
305-280	61491-61504	schizophrenia	_
305-281	61505-61513	Putative	_
305-282	61514-61517	sex	_
305-283	61518-61529	differences	_
305-284	61530-61532	in	_
305-285	61533-61539	verbal	_
305-286	61540-61549	abilities	_
305-287	61550-61553	and	_
305-288	61554-61562	language	_
305-289	61563-61569	cortex	_
305-290	61569-61570	:	_
305-291	61571-61572	a	_
305-292	61573-61581	critical	_
305-293	61582-61588	review	_
305-294	61589-61597	Semantic	_
305-295	61598-61608	processing	_
305-296	61609-61620	disturbance	_
305-297	61621-61623	in	_
305-298	61624-61632	patients	_
305-299	61633-61637	with	_
305-300	61638-61651	schizophrenia	_
305-301	61651-61652	:	_
305-302	61653-61654	a	_
305-303	61655-61668	meta-analysis	_
305-304	61669-61671	of	_
305-305	61672-61675	the	_
305-306	61676-61680	N400	_
305-307	61681-61690	component	_
305-308	61691-61699	Evidence	_
305-309	61700-61702	of	_
305-310	61703-61714	dysfunction	_
305-311	61715-61717	of	_
305-312	61718-61719	a	_
305-313	61720-61737	prefrontal-limbic	_
305-314	61738-61745	network	_
305-315	61746-61748	in	_
305-316	61749-61762	schizophrenia	_
305-317	61762-61763	:	_
305-318	61764-61765	a	_
305-319	61766-61774	magnetic	_
305-320	61775-61784	resonance	_
305-321	61785-61792	imaging	_
305-322	61793-61796	and	_
305-323	61797-61805	regional	_
305-324	61806-61814	cerebral	_
305-325	61815-61820	blood	_
305-326	61821-61825	flow	_
305-327	61826-61831	study	_
305-328	61832-61834	of	_
305-329	61835-61845	discordant	_
305-330	61846-61857	monozygotic	_
305-331	61858-61863	twins	_
305-332	61864-61871	Working	_
305-333	61872-61878	memory	_
305-334	61879-61881	in	_
305-335	61882-61892	unaffected	_
305-336	61893-61902	relatives	_
305-337	61903-61905	of	_
305-338	61906-61914	patients	_
305-339	61915-61919	with	_
305-340	61920-61933	schizophrenia	_
305-341	61933-61934	:	_
305-342	61935-61936	a	_
305-343	61937-61950	meta-analysis	_
305-344	61951-61953	of	_
305-345	61954-61964	functional	_
305-346	61965-61973	magnetic	_
305-347	61974-61983	resonance	_
305-348	61984-61991	imaging	_
305-349	61992-61999	studies	_
